Yaya tsawon lokacin da waɗannan alamun ke faruwa?
kuma duk ciwon kirji ya kamata a bi da shi ta wannan hanyar, musamman ma idan aka yi la'akari da shekarunka
da kuma babban zafin jiki
kuma ana bukatar a duba matakin cholesterol da kuma karfin jini
kuma kuna da zazzabi a yanzu?
kuma kuna jin wannan ciwon a kirjinku a yanzu?
Kuma shin, kunã da wahalar numfashi?
kuma za ku iya gaya mini wasu alamun da kuke da su banda wadannan?
kuma yadda zafin jikinka yake
kuma ina da ciwon kai
kuma ina da wani sanyi kadan da kuma tari
kuma ina da ciwo mai tsanani a kirji a yau
kuma ko wannan lokaci ya dace da zazzabin hay da kake fama da shi
kuma yana da ciwo a cikin kirji
kuma ina ganin na samu zazzabi kadan
kuma ina so ku bayyana inda kuke jin zafi a kirjinku
kuma suna da zafin jiki kadan
da kuma tarihin ciwon sukari.
kuma ka san, yana jin kamar kirjina na na murƙushe
kuma ka san mutane suna yawan kuskura su yi min
kuma kuna jin zafi a kirji
kuma kun ce wannan shine matsa lamba a cikin kirji
wani a cikin iyalinsa yana da matsalar zuciya, cututtukan zuciya, ciwon zuciya, yawan cholesterol, hauhawar jini
ko kuma wasu alamun cututtukan da kuka lura da su da ke da alaƙa da ciwon tsoka?
Shin kuna da wasu marasa lafiya a gida da ke da irin wannan alamun?
Shin kuna da wasu alamun cututtuka?
Shin kuna jin numfashi a yanzu?
ko har yanzu kuna jin zafi a kirjinku
Domin wannan lokacin na mura ne
Amma kuma kada mu yi watsi da ciwon kirji wanda yake da yanayin zuciya.
Amma yanzu matsalar da ta fi muhimmanci ita ce ciwon kirji.
amma ina da wahalar numfashi
amma na san mutane da yawa suna tari ni
Amma dole ne mu bi da duk wani ciwon kirji da tsanani.
Amma yanzu kuna numfashi sosai, ba haka ba?
Domin ban tuna da wannan ciwon kirji ba.
Shin yana kama ne da wani yana matse ƙirjinka?
har yanzu kuna jin numfashi
Shin suna gunaguni game da rashin lafiyarsu?
Shin kuna da wasu cututtukan cututtuka na kullum, kamar hawan jini ko wani abu?
kuna da wasu cututtuka masu tsanani ko kuma matsalolin kiwon lafiya kamar ciwon sukari?
Shin kana jin numfashi a lokacin da kake jin wannan ciwon a kirjinka?
Shin kana da karfin jini?
Shin kuna da numfashi?
Shin kun san alamun ta?
Kuna ganin wannan hoton?
sha ruwa mai yawa yau
Amma ina gwajin ciwon sukari.
Amma ta samu alamun cutar kamar yadda na samu.
Yaya zafin jikinka yake?
Yaya karfin jini kake da shi?
idan har yanzu kuna da zazzabi mai zafi
idan zafin jiki na jikinka talatin da takwas da tara ko sama da haka
idan kana ganin cewa alamun ka ko kuma matsalarka na tabbatar da cewa za ka iya yin kyau
na samu zazzabi a jiya
Na kuma samu zazzabi a jiya.
Na yi zazzabi a jiya
Ina jin zafi sosai a cikin kirji.
Ina da wahalar numfashi kuma
Zan aika muku da hoto.
Ina jin zafi a kirji a yau
Ina da ciwon kai a yau kuma zazzabi ya tashi
Ina ganin wannan shi ne mura.
Ina ganin wannan mura ce mai sauƙi.
Shin hakan yana tuna maka cewa kana da wani mutum mai nauyi sosai a wuyanka?
Dukkanin abubuwan sun fara ne a lokaci guda, tare da ciwon kai da kuma yawan zafin jiki.
Ina jin zafi a tsakiyar kirji
Yana da zafi kamar ciwon kirji.
Yana cikin ƙirjina
Yana tsakiyar ƙirjina.
Yana tsakiyar ƙirjin.
Na ji zafi a kirji
Ina matukar damuwa da wannan ciwon kirji
Ina so ku bayyana min wannan ciwon kirji.
kamar jini ko ciwon sukari
Kamar yadda yake a tsakiyar ƙirjin
A lokacin da zafin jiki ya yi yawa, za ku iya shan takapirin a cikin ice cream.
Yanzu, Mary, ka gaya mini tsawon kwanaki da ka nuna wadannan alamun.
Yanzu ka ce kana jin ciwon kirji
A wasu lokatai ina jin zafi a kirji
da kyau, shin kuna da wasu alamun bayyanar cututtuka banda ciwo?
Ko kuma wani yana zaune a kirjinka?
irin wannan zafin jiki da kuma tari, ciwon kai da ciwon tsoka
ciwo kai tsaye a tsakiyar ƙirjina
Ka nuna min a wannan hoton inda kake jin zafi
saboda kuna da zafin jiki mai yawa
Don haka kuna ganin wasu daga cikin wadannan cututtukan na iya danganta da daukar ciki?
Shin yaranku suna da wasu daga cikin alamun cutar?
Faɗa mini game da ciwon kirjinka.
zafin jiki yana tashi da dare
zafi da na samu a cikin kwanaki biyu da suka gabata
zafin jiki ya fara tashi a daren jiya
Wannan Dr. Porter ne a dakin karbar bakuncin wani asibiti.
To, za ka iya ba da ƙarin bayani game da ciwon kirjinka?
Na ji zafi a gaban jikina, a nan, a kirji.
Na ji zafi sosai a kirji.
To, idan na ji ciwon kirji,
Yaya za ka ji a kirji?
A lokacin da ka fara jin wannan ciwon a kirji?
A ina ne za ka ji ciwon kirji?
A ina ne za ka ji wannan ciwon kirji?
kana da irin wannan ƙarancin ra'ayi a cikin ƙirjinka
Na yi ciwon sukari da irin wannan.
Ka ce kana da wannan ciwon a kirjinka
Yawan kamuwa da cutar coronavirus (COVID-19) a cikin Tarayyar Turai da Burtaniya ya karu cikin sauri a tsakanin 1 ga Janairu zuwa 15 ga Maris, 2020.
Yawan kamuwa da cutar coronavirus (COVID-19) yana da irin wannan yanayin a cikin ƙasashen EU / Yankin Tattalin Arzikin Turai da kuma Burtaniya, yana tabbatar da cewa duk da matakan da ke faruwa a ƙasashe daban-daban, cutar COVID-19 tana ƙaruwa cikin sauri a duk ƙasashe.
Idan aka yi la'akari da kwarewar Italiya, ƙasashe, asibitoci da wuraren da ake ba da gagarumin magani, ana bukatar a ƙara shirye-shiryen marasa lafiya da ke fama da COVID-19 da za su bukaci magani, musamman ma, gagarumin magani.
A ranar 31 ga watan Disamba na shekarar 2019, an samu wasu cututtukan cutar huhu a birnin Wuhan da ke lardin Hubei na kasar Sin.
Ranar 9 ga watan Janairun 2020, Cibiyar Kula da Cututtuka ta kasar Sin ta sanar da cewa sabon nau'in coronavirus ne ke haifar da kamuwa da cutar, wanda yanzu ake kira cutar coronavirus ta nau'in 2 mai tsanani (SARS-CoV-2).
Daga wannan lokacin, an kira cutar da SARS-CoV-2 ke haifarwa cutar coronavirus (COVID-19).
A cewar bayanai da ake samu a yau, kusan kashi 80 cikin dari na mutanen da ke fama da cutar COVID-19 suna kamuwa da cutar a cikin nau'i mai sauƙi, wato, kamuwa da cutar numfashi tare da ko ba tare da cutar huhu ba, kuma yawancin marasa lafiya suna warkewa.
Kimanin kashi 14 cikin 100 na COVID-19 sun zama na musamman kuma suna bukatar a kwantar da su asibiti, yayin da kashi 6 cikin 100 na sauran suka zama na musamman idan ana bukatar ci gaba da magani.
Yawan mutuwar marasa lafiya da aka kwantar da su daga COVID-19 ya kai kusan kashi 4 cikin 100.
Wannan binciken ya bincika yanayin kamuwa da cutar COVID-19 a kowace ƙasa ta Tarayyar Turai (EU) / Yankin Tattalin Arzikin Turai (EEA) da Burtaniya kuma ya kwatanta su da yanayin lardin Hubei na China.
Muna kuma kwatanta adadin cututtukan COVID-19 na yanzu a cikin EU/EEA da Burtaniya da bayanan Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Cutar COVID-19 a cikin EU/EEA da Burtaniya
Bayan barkewar cutar COVID-19 a China, ta bazu zuwa wasu ƙasashe, kuma a yanzu a sauran sassan duniya cutar COVID-19 tana ci gaba daidai da yadda take a China.
A ranar 11 ga Maris, 2020, babban darektan Hukumar Lafiya ta Duniya (WHO) ya sanar da annobar COVID-19.
A cikin mujallar Eurosurveillance ta 5 ga Maris, 2020, Mista Spiteri da abokan aikinsa sun ba da rahoton farkon tabbatar da COVID-19 a Turai, wanda ya cika ƙa'idodin WHO don tantance cutar.
An fara samun mutum uku na farko a cikin EU/EEA a Faransa a ranar 24 ga Janairu, 2020.  Dukkanin mutane uku sun dawo daga Wuhan, lardin Hubei na kasar Sin.
A ranar 15 ga Maris, 2020, an gano kamuwa da COVID-19 a duk ƙasashen EU / EEA 30 da Burtaniya, tare da a cikin lokaci daga 31 ga Disamba, 2019 zuwa wannan ranar, an sami kamuwa da cutar 39,768 da mutuwar 1,727 daga cikinsu, 17,750, gami da mutuwar 1,441, a Italiya kadai.
Gano yawan kamuwa da cutar COVID-19 da kuma kamuwa da cutar
Cibiyar Kula da Cututtuka ta Turai (ECDC) a kowace rana a karfe 8:00 na safe tana sabunta bayanan adadin shari'o'in COVID-19 da aka yi rajista a kowace ƙasa a duniya, daga kafofin hukuma kamar ma'aikatun kiwon lafiya na waɗannan ƙasashe, hukumomin kiwon lafiya na ƙasa da na yanki da kuma WHO.
Ana amfani da wannan bayanan don nazarin yanayin yaduwar COVID-19 a cikin EU/EEA da Burtaniya da kuma kwatanta su da bayanan Italiya.
A matsayin ma'aunin yadda ake yada cututtukan COVID-19 na yau da kullun, an lissafa adadin cututtukan COVID-19 na kwanaki 14 tare da la'akari da yadda COVID-19 ke gudana a kowace ƙasa ta EU / EEA da Burtaniya a tsakanin Janairu 1 zuwa 15 ga Maris 2020.
Mun kuma nuna adadin adadin da aka samu a kowace ƙasa a karfe 8:00 na ranar 15 ga Maris, 2020, idan aka kwatanta da na Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Hanyoyin ci gaban COVID-19 a cikin ƙasashen EU / EEA da Burtaniya
Yanayin ci gaban cututtukan COVID-19 a cikin kwanaki 14 a cikin ƙasashen EU / EEA da Burtaniya gabaɗaya sun yi daidai da yanayin da aka lura a lardin Hubei na China (Hotuna 1).
Yawan kamuwa da cutar COVID-19 a cikin EU/EEA da Burtaniya gabaɗaya sun fara ƙaruwa a ranar 21 ga Fabrairu, kuma a ranar 28 ga Fabrairu, 2020 an sami babban tashi a wannan ma'auni (ƙarin bayani).
Wannan ya kasance saboda yawan adadin cututtukan da aka samu a Italiya, amma a duk sauran ƙasashen EU/EEA da Birtaniya, akwai irin wannan ci gaban COVID-19 (ƙarin bayani).
Hoton 2 ya nuna adadin adadin kamuwa da cutar COVID-19 a cikin ƙasashen EU / EEA da Burtaniya idan aka kwatanta da irin wannan a Italiya a tsakanin 31 ga Janairu zuwa 15 ga Maris, 2020.
Bisa ga wannan bayanan, adadin da aka riga aka samu a ranar 8 ga Maris, 15 a wasu ƙasashen EU / EEA da kuma Burtaniya, ya yi daidai da adadin da aka samu a Italiya kusan makonni 3 da suka gabata.
Sakamakonmu ya nuna cewa an samu karuwar adadin mutane da suka kamu da cutar COVID-19 a cikin EU/EEA da kuma Birtaniya.
Yanayin da ake gani na kamuwa da cutar COVID-19 ya ba da damar yin tunanin cewa annobar tana ci gaba da sauri a duk ƙasashe.
Wannan duk da bambancin matakan da ake samu a kasashe daban-daban, bambancin matakan da hukumomin kiwon lafiya na kasa ke dauka, da kuma yiwuwar bambancin ka'idojin gano cutar da kuma bambancin ka'idojin zabar marasa lafiya don gudanar da gwajin COVID-19, ciki har da gwaji mai yawa.
A farkon watan Maris na shekarar 2020, likitoci a yankunan da cutar ta shafa a Italiya sun ba da rahoton cewa kusan kashi 10 cikin dari na marasa lafiya da ke fama da COVID-19 suna bukatar ci gaba da jinya, kuma kafofin watsa labarai sun lura cewa asibitoci da wuraren jinya a waɗannan yankuna sun cika.
A halin yanzu, bayanai game da shigar da marasa lafiya da COVID-19 zuwa asibitoci da (ko) wuraren kula da matsanancin jinya a cikin EU / EEA suna samuwa ne kawai game da kashi 6 cikin ɗari da kashi 1 cikin ɗari na shari'o'in daidai (ba a gabatar da bayanai ba).
Amma, ana bukatar a yi tattara irin wannan bayanan a kai a kai don a cika bayanan da ake samu a yanzu, wato yawan wadanda suka kamu da cutar da kuma yawan wadanda suka mutu.
A sakamakon binciken da aka yi a shekara ta 2010 zuwa 2011, an samu karuwar gado a wuraren da ake kula da marasa lafiya a Turai: daga 29,2 a Jamus zuwa 4,2 a Portugal a kowace mutane 100,000.
Wannan yana nufin cewa wasu ƙasashe suna da albarkatu fiye da Italiya (wurin kwana 12.5 a cikin asibitoci masu tsanani da kuma asibitoci masu tsanani a kowace mutane 100,000 a 2010-2011).
Rahoton na shida na ECDC na sabunta sakamakon kimanta hadarin COVID-19 ya gabatar da yanayin samfurin kayan aikin tsarin kiwon lafiya tare da kimantaccen bayanan asibiti na COVID-19 a kowace ƙasa ta EU/EEA da Burtaniya, lokacin da haɗarin rashin gado mai sauƙi a cikin wuraren kulawa mai tsanani ya wuce 90%.
Tun da a halin yanzu ana rarraba cututtuka a cikin wasu yankuna na EU/EEA da na Burtaniya, kuma asibitoci da wuraren kula da gaggawa suna yawanci kula da yawan jama'ar wani yanki, ana ba da shawarar cewa a iya ba da bayanai game da cututtuka da yawan gado a wuraren kula da gaggawa a cikin na'urorin na biyu na Nomenclature na Ƙasar don dalilai na kididdiga (NUTS-2).
Kwarewar Italiya da kuma abubuwan da ke faruwa a wasu ƙasashe sun nuna cewa a cikin EU/EEA da Birtaniya, annobar COVID-19 tana ci gaba da sauri.
Saboda haka, dole ne kasashe, asibitoci da kuma cibiyoyin gaggawa su kasance a shirye don yanayin kamuwa da cutar SARS-CoV-2, wanda ba ya raguwa a cikin dogon lokaci, da kuma karuwar yawan marasa lafiya da ke fama da COVID-19, waɗanda ke buƙatar kulawa ta likita da kuma gaggawa, wanda ake iya gani a yankunan da aka shafa na Italiya, misali.
Kamar yadda rahoton ECDC na baya-bayan nan na sakamakon kimantawa na haɗari ya nuna, hanzari, hanawa da kuma daidaitaccen tsarin aiki yana da mahimmanci don hana yaduwar SARS-COV-2 daga ci gaba da ragewa zuwa rage tasirin, saboda, saboda ƙididdigar ƙaruwa mai sauri na cutar, masu yanke shawara da asibitoci na iya zama ba su da isasshen lokaci don yin tunani, ɗauka, da daidaita matakan da suka dace idan ba a yi hakan ba a gaba.
Rahoton sakamakon kimanta hadarin ya kuma lissafa matakan kiwon lafiyar jama'a da ake yi don rage tasirin cutar.
Kasashe suna da ɗan gajeren lokaci don ƙara ƙoƙari a cikin kula da su don rage yaduwar SARS-CoV-2 da rage nauyin da tsarin kiwon lafiyar su ke da shi.
Idan ba a yi haka ba, a cikin kwanaki ko makonni masu zuwa, tsarin kiwon lafiya a wasu ƙasashen EU/EEA zai yi fama da yawan marasa lafiya da ke bukatar ci gaba da kula da su.
Cutar cutar coronavirus ta 2019 (COVID-19), wanda cutar ta SARS ta 2 (SARS-CoV-2) ta haifar, ta zama bala'i ga bil'adama: a halin yanzu a China da sauran ƙasashen duniya fiye da mutane 3,000 sun mutu, kuma adadin masu kamuwa da cutar ya wuce 80,000.
Kamar cutar SARS-CoV ta homologous, wadda ta haifar da ciwon ciwon huhu mai tsanani a dubban mutane a shekara ta 2003, SARS-CoV-2 na iya kuma kamuwa da cutar daga linzamin kwamfuta kuma yana haifar da alamun bayyanar cututtuka ta amfani da irin wannan tsari.
Koyaya, COVID-19 yana da ƙananan rashin ƙarfi da ƙananan mutuwar fiye da SARS, amma yana da yawa kuma yana shafar tsofaffi fiye da matasa, maza fiye da mata.
A sakamakon ci gaba da ci gaba da ciwon, wannan talifin ya ba da cikakken bayani game da wani bincike da ke ci gaba da sauri.
Za mu tattauna fannoni na asali na ilimin cututtuka, ilimin halayyar mutum, ilimin ƙwayoyin cuta, ganewar asali, magani, tsinkaya da kuma rigakafin cutar.
Ko da yake ba a amsa tambayoyi da yawa ba, muna fata wannan binciken zai taimaka mana mu fahimci kuma mu kawar da cutar.
Bikin bazara (shekara ta sabuwar shekara ta kasar Sin) da aka yi a shekarar 2020 a ranar 25 ga watan Janairu, ya zama abin da ba a taɓa gani ba kuma ba a taɓa mantawa da shi ba ga dukan 'yan kasar Sin, waɗanda a sakamakon barkewar sabon kamuwa da cutar ta kwayar cuta, an yi kira da su su zauna a gida a duk lokacin bikin kuma har makonni da yawa bayan hakan.
Ganin cewa yana da kamanceceniya da cutar coronavirus (CoV), wanda ya haifar da barkewar cutar ta shan numfashi mai tsanani (SARS) a shekara ta 2003, Hukumar Lafiya ta Duniya (WHO) a ranar 11 ga Fabrairu, 2020, ta kira wannan cutar SARS-CoV-2, kuma cutar da ke tattare da ita ta kira cutar coronavirus 19 (COVID-19).
Cutar ta fara ne a birnin Wuhan na kasar Sin kuma ta bazu cikin sauri a duk faɗin ƙasar, kuma ta bazu a kusan ƙasashe 50 na duniya.
A ranar 2 ga Maris, 2020, an gano fiye da 80 000 na tabbatar da COVID-19, fiye da 40,000 sun warke, fiye da 3,000 sun mutu.
Hukumar ta duniya ta yi gargadin cewa COVID-19 ita ce magabcin al'umma na farko kuma yana da haɗari fiye da ta'addanci.
A cewar PubMed (https://www.ncbi.nlm.nih.gov/pubmed/), a cikin ƙasa da watanni biyu, an buga fiye da 200 game da COVID-19, gami da labarai game da ƙwayoyin cuta, cututtukan cututtuka, etiology, bincike da magani, tun daga rahoton farko na Janairu 7, 2020, wanda ya ƙayyade jerin cututtukan da aka gano daga yawancin marasa lafiya.
Wannan bita yana nufin ƙoƙarin yin nazarin binciken da aka yi a wani sabon fannin da ke ci gaba da sauri.
Idan za mu iya, za mu gwada COVID-19 da SARS da kuma wani cutar coronavirus  cutar coronavirus ta hanyar numfashi ta Gabas ta Tsakiya (MERS), wanda ya barke a shekarar 2012.
Za mu kuma tattauna wasu abubuwa da suka shafi rigakafi da kuma yadda za a yi hasashen ciwon, da kuma wasu batutuwa da suka fi muhimmanci.
A al'adance, cutar korona ta kasance cikin cututtukan da ba su da haɗari ga mutum kuma galibi suna haifar da kusan kashi 15 cikin ɗari na cututtukan numfashi 4.
Duk da haka, a wannan karni, mun fuskanci cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Saboda haka, COVID-19 na yanzu shine fashewar cutar coronavirus ta uku a tarihin ɗan adam.
Kamar yadda aka nuna a hoto na 1.1, rahoto game da tarin cututtukan cutar huhu da ba a san asalinsa ba ya fara zuwa Hukumar Lafiya ta Kasa ta kasar Sin daga birnin Wuhan a ranar 31 ga Disamba, 2019.
Bayan kwana bakwai, an gano wani abu game da kwayar halitta.
A ranar 15 ga Janairu, 2020, an yi rikodin mutuwar farko a garin Wuhan.
A lokacin, annobar ta bazu cikin sauri zuwa garuruwa, larduna da ƙasashe masu makwabtaka.
A ranar 20 ga watan Janairu, an gano cewa ma'aikatan kiwon lafiya sun kamu da cutar, wanda ya ba da damar yin tunanin yiwuwar watsa cutar daga mutum zuwa mutum.
Ranar 23 ga watan Janairu an sanya dokar hana fita a birnin Wuhan, kuma an dakatar da zirga-zirgar jama'a ta birnin.
A ranar 24 ga watan Janairu, a cewar binciken farko na cutar, an lura cewa daga cikin marasa lafiya 41 da aka tabbatar da kamuwa da cutar coronavirus, 21 suna da alaƙa kai tsaye da kasuwar abincin teku a birnin Wuhan, wanda aka ɗauka farkon hanyar da cutar ta yadu daga dabba da ba a san ta ba.
A ranar 30 ga watan Janairu, WHO ta bayyana cewa barkewar cutar coronavirus ta zama gagarumin gaggawa a duniya a fannin kiwon lafiyar jama'a.
A lokacin da aka shirya wannan rahoto , cutar ta bazu ko 'ina cikin kasar Sin kuma ta riga ta shiga wasu kasashe 50 a duniya (hoto na 2.2).
Idan aka yi la'akari da yadda yanayin yake, za a iya sanin yadda za a yi annobar da kuma yadda za a yi ta.
A ranar 11 ga Fabrairu, 2020, sakamakon binciken asibiti mai cibiyoyin da yawa, wanda ya shafi marasa lafiya 8,866, gami da marasa lafiya 4,021 da aka tabbatar da COVID-19, an gabatar da sabon hoto na ci gaban cutar (https://mp.weixin.qq.com/s/UlBi-HX_rHPXa1qHA2bhdA).
Dukkanin mutanen da ke da shekaru sun kamu da cutar SARS-CoV-2, amma yawanci mutanen da ke da shekaru 30 zuwa 65 ne suka kamu da cutar.
Kusan rabin (47.7%) na waɗanda suka kamu da cutar sun fi shekaru 50, kaɗan ne kawai suka fi shekaru 20, kuma 14 ne kawai suka kai shekaru 10 ba su cika ba.
Yawan kamuwa da cutar SARS-CoV-2 a tsakanin maza ya fi girma (0,31/100 000), fiye da na mata (0,27/100 000).
COVID-19 ya bazu cikin rukuni-rukuni, musamman a lardin Hubei da yankuna masu kusa.
A matsakaita, kwanaki 5 (29) sun wuce daga lokacin da aka nuna alamun COVID-19 har zuwa lokacin da aka gano cutar.
Lokacin yin amfani da shi yana da matsakaici na kwanaki 4.8 (3,07,2).
Daga lokacin bayyanar cututtuka zuwa lokacin mutuwa, a matsakaita, kwanaki 9.5 (4,813) sun wuce.
Matsayin asali na sake haifar da kwayoyin halitta (R0) ya kai 3,77 (95 % CI: 3,514,05), kuma daidaitaccen R0 ya kai 2,234,82.
A ranar 23 ga Janairu, 2020, an samu karuwar adadin masu kamuwa da cutar, wanda ya yi daidai da yawan sufuri a ranar bikin Sabuwar Shekarar kasar Sin.
Mutuwar da aka samu tsakanin marasa lafiya da aka tabbatar da cutar ta kai kashi 1.44% (95% CI: 1.101.86%) da kuma daidaitaccen adadin mutuwar da aka samu tsakanin marasa lafiya ya kai kashi 3.06% (95% CI: 2.024.59%).
Abubuwa uku da suka fi sa mutum cikin haɗari a cikin kamuwa da COVID-19 sune: jinsi (maza), shekaru (≥60) da kuma mummunan cutar huhu.
Kwayoyin cutar korona suna cikin manyan kwayoyin cuta na ƙwayar cuta, waɗanda ke dauke da zaren RNA.
Ana iya rarraba su zuwa nau'i hudu, wato alpha, beta, gamma da delta, kuma an san cewa alpha da beta-coronavirus suna cutar da mutane.
Idan an cutar da kwayar cutar SARS da MERS, glycoprotein na tsirrai masu launin toka (S) yana haɗuwa da ƙwayoyin ƙwayoyin ƙwayoyin angiotensin-mai canzawa na nau'in 2 (ACE2) da dipeptidylpeptidaze-4 (DPP4) daidai, sannan kuma haɗuwa da membrane.
A cikin cytoplasm, an saki RNA na kwayar cuta; bayan an sake kwayar cutar ta kwayar cuta, RNA na kwayar cuta tare da glycoproteins da nucleocapside proteins suna samar da vesicles masu ƙunsar virion, wanda daga baya ya haɗu da membrane na tantanin halitta, yana sakin cutar.
Rahotanni na farko game da tsarin kwayoyin halitta na SARS-CoV-2 sun bayyana a ranar 10 ga Janairu, 2020.
An gano cewa SARS-CoV-2 wani sabon nau'in beta-coronavirus ne wanda kwayoyinsa ya dace da kashi 99.98 cikin ɗari na samfuran 10 masu jituwa da aka tattara a farkon barkewar cutar a kasuwar abincin teku ta Huanan a Wuhan.
A fannin halitta, SARS-CoV-2 ya fi kusa da SARS-CoV fiye da MERS-CoV.
An gano SARS-CoV-2 a cikin ƙananan cututtukan jikin mutum ta hanyar yin amfani da microscopy na lantarki.
An gano cewa kwayar halitta ta ACE2 tana karɓar SARS-CoV-2, kamar yadda take karɓar SARS-CoV.
Koyaya, furotin S na SARS-CoV-2 yana da rauni sosai a cikin haɗi tare da enzyme na mutum na ACE2 fiye da SARS-CoV, wanda ke bayyana gaskiyar cewa SARS-CoV-2 yana haifar da rashin lafiya a cikin marasa lafiya ƙasa da SARS-CoV.
SARS-CoV-2 na iya samar da wani furotin mai ɗan gajeren lokaci wanda ba a sani ba, wanda aka yi wa lambar orf3b, da kuma furotin da aka yi wa lambar orf8.
Protein orf3b na SARS-CoV-2 na iya taka rawa wajen cutar cutar ta cutar kuma yana hana bayyana IFNβ; amma orf8 ba shi da wani sanannen aiki ko dalili.
A ranar 18 ga Fabrairu, 2020, ƙungiyar marubuta da Zhou ke jagorantar ta gabatar da rahotanni game da tsarin tsarin cryonectronography na cikakken girman enzym ACE2 na mutum tare da ƙuduri na 2,9 Å a cikin haɗin kai tare da mai jigilar amino acid B0AT1.
Sun gano cewa wannan tsari, wanda ya ƙunshi bayyanar da kuma rufin tsari, an tattara shi a matsayin dimer kuma ACE2-B0AT1 zai iya haɗa sunadarai biyu na S, wanda ke ba da shaida ga ganowa da kamuwa da cutar coronavirus.
B0AT1 na iya zama manufa ta magani a lokacin yin gwajin magani don hana kamuwa da cutar SARS-CoV-2.
Asalin da mai mallakar matsakaici
An san cewa SARS-CoV da MERS-CoV sun fito ne daga linzamin kwamfuta, wanda cutar ta kamu da mutum ta hanyar raƙuma da raƙuma.
Ta hanyar kwatancen ilimin halittu na SARS-CoV-2 da sauran cututtukan coronavirus, an gano cewa SARS-CoV-2 shine farkon masu watsa shiri na linzamin kwamfuta, saboda sabon kwayar cutar ta kasance daidai da kashi 96 cikin ɗari na coronavirus guda biyu masu kama da SARS, wato, linzamin kwamfuta na SL-CoVZX45 da SL-CoVZX21.
Amma, ba a san irin nau'in da ya zama mai mallakar ba, wanda ya sa cutar ta iya ƙetare ƙuntataccen yanayi kuma ta kamu da mutum; har yanzu ba a san hanyar watsawa ba.
Shi da abokan aikinsa sun ce macizai ne suka sa cutar ta zama na mutum, kuma hakan ya sa aka sake yin amfani da kwayoyin S a cikin kwayoyin.
A sakamakon binciken da suka yi, masana kimiyya na kasar Sin da ke Guangzhou sun yi hasashen cewa pangolin  dabbobi masu shayarwa masu tsayi, waɗanda suke cin abinci da tsutsotsi kuma ana amfani da su sau da yawa a cikin maganin gargajiya na kasar Sin,  su ne masu iya ɗaukar SARS-CoV-2; wannan hasashen ya dogara ne akan 99 cikin ɗari na kamanceceniya tsakanin cutar coronavirus ta pangolin da SARS-CoV-2.
Duk da haka, bambancin kashi 1 cikin dari tsakanin kwayoyin halitta biyu yana da girma sosai, saboda haka an yi imanin cewa ba a samu sakamakon ƙarshe ba tare da hujja ba (hoto na 33).
Yawancin halaye na jiki da sunadarai na SARS-CoV-2 har yanzu ba a sani ba.
A cikin dakin gwaje-gwaje, SARS-CoV da MERS-CoV na iya tsira har tsawon awanni 48 a cikin yanayin bushe kuma har zuwa kwanaki 5 a yanayin zafin jiki ƙasa da 20 °C da zafi 4050%.
SARS-CoV-2 na iya samun irin wannan fasalin.
An san cewa SARS-CoV-2 yana da ƙarancin haske da zafi har zuwa 56 °C na tsawon minti 30; ana iya toshe aikin cutar ta hanyar tasiri ta hanyar ether, 75% ethyl alcohol, chlorine-containing disinfectants, peroxyacinth, chlorophoresis da sauran masu narkewa masu dauke da kitse, amma ba chlorhexidin ba.
Yawancin mutane ba su da rigakafi ga SARS-CoV-2, saboda haka mutane suna da saukin kamuwa da sabon kwayar cutar.
A halin yanzu babu bayanai game da cikakken binciken da aka yi game da maganin rigakafi ga SARS-CoV-2.
Saboda haka, zamu iya komawa ne kawai ga binciken da aka yi a baya game da sauran cututtukan coronavirus, musamman SARS-CoV da MERS-CoV (Fig. 4).
A matsayin al'ada, wanda ya shiga cikin jikin mai shi, ƙwayar cuta ta farko tana gane tsarin rigakafi ta hanyar ganewar hoto (ORR), ciki har da masu karɓar leptin irin C, masu karɓar Toll, masu karɓar NOD da masu karɓar RIG-I.
Ta hanyar hanyoyi daban-daban, kwayar cutar tana haifar da bayyanar cututtukan kumburi, ƙwayoyin dendritic da haɓakar nau'in I na interferons, wanda ke hana yaduwar kwayar cutar da hanzarta fashewar ƙwayar cuta ta hanyar maganin rigakafin kwayar cuta.
Amma, saboda ƙwayoyin N-protein, SARS-CoV zai iya hana rigakafin jiki.
Ba da daɗewa ba, ana amfani da maganin rigakafi don magance cutar.
T lymphocytes, ciki har da CD4+ da CD8+, suna da muhimmiyar rawa wajen kāre jikin mutum.
Kwayoyin CD4+ suna sa kwayar cutar ta zama ƙwayar cutar a cikin kwayar B, kuma kwayar CD8+ tana kashe kwayar da cutar ta shafa.
T-helpers suna samar da ƙwayoyin cuta masu hana kumburi don taimakawa ƙwayoyin.
Amma, cutar korona tana iya hana ayyukan T-kwayoyin jiki, ta sa su mutu.
Hanyar rigakafin da ke cikin jiki, wanda ya ƙunshi abubuwa kamar C3a da C5a da kuma rigakafi, yana taka muhimmiyar rawa wajen yaki da kamuwa da cutar.
Alal misali, an kawar da cutar MERS-CoV daga jikin mutum da aka samu.
A wani ɓangare kuma, tsarin rigakafi na jiki yana haifar da yawan radicals kyauta a wuri mai yawa, wanda zai iya haifar da lalacewar huhu da sauran gabobin jiki, kuma a mafi munin yanayin zai haifar da rashin isasshen kwayoyin halitta har ma da mutuwa.
Cutar SARS-CoV-2, wadda ta ƙunshi bayyanar rukuni, tana iya shafar tsofaffi da ke fama da cututtuka masu zuwa da kuma mata masu juna biyu.
Mutane da yawa suna da zarafi sosai ko kuma suna da matsalar rigakafi.
Bisa ga binciken bayanan farko na kamuwa da cutar 425 a Wuhan, matsakaicin lokacin kamuwa da cutar SARS-CoV-2 ya kai kwanaki 1 zuwa 14, galibi kwanaki 37.
Amma, binciken da aka yi a kan mutane 1,099 ya nuna cewa an yi kwanaki uku a lokacin da ake yin amfani da su don yin amfani da su, kuma an yi amfani da su don yin amfani da su a kwanaki 0 zuwa 24.
Wani bincike da aka yi a baya, wanda ya dogara ne akan alƙaluma 8,866, ya nuna cewa lokacin yin amfani da kwayoyin halitta ya kai kwanaki 4.8 (3.07.2).
Don hukumomin kiwon lafiya, yana da muhimmanci a daidaita lokacin da ake yin rigakafin, a cikin mafi kyawun lissafin tsawon lokacin kamuwa da cuta, don hana yaduwar cutar ga waɗanda suka kamu da cutar ba tare da alamun bayyanar cututtuka ba.
Ana yin killace-kilise na kwanaki 14 ga mutanen da suka kamu da cutar ko kuma waɗanda suka kamu da ita.
Shin, ya kamata a tsawaita dokar hana fita zuwa kwanaki 24?
Babban kuma farkon alamun COVID-19 yawanci zafin jiki ne wanda zai iya zama bayyanar kawai ko kuma a bi shi da wasu alamun kamar tari, wahalar numfashi, ciwon tsoka, ciwon kai, ciwon kai, ciwon wuya, ciwon kirji, ciwon kirji, ciwon ciki, ƙishirwa, ƙishirwa, ƙishirwa da kuma zubar da ciki.
Wasu marasa lafiya sun sami numfashi da (ko) hypoxia bayan mako guda bayan da suka kamu da cutar.
A cikin yanayin da ya fi tsanani, cutar ta ci gaba da sauri, kuma marasa lafiya sun sami ciwon numfashi mai tsanani, tsokanar ƙwayar cuta, ƙwayar cuta mai ƙonewa da kuma coagulopathy.
Dole ne a gwada marasa lafiya da zazzabi mai yawa da (ko) alamun cutar numfashi da zazzabi mai tsanani don gano cutar da wuri ko da ba a sami cututtuka a cikin hotunan ƙirjin.
Wani bincike na al'umma da aka yi a ƙarshen Disamba na 2019 ya gano alamun bayyanar cututtuka kamar haka: 98%  zazzabi mai zafi, 76%  tari mai bushewa, 55%  numfashi da 3%  fitsari; 8% na marasa lafiya sun bukaci numfashi na huhu.
An samu irin wannan sakamakon ne a cikin bincike guda biyu na baya-bayan nan game da kamuwa da cutar a cikin iyali da kuma wanda ya kamu da cutar daga marasa bayyanar cututtuka.
An samu sakamako mai kama da haka a shekara ta 2012 a cikin binciken marasa lafiya da ke da cutar MERS-CoV, waɗanda manyan alamun su ma zafin jiki ne (98%, tari mai bushe (47%) da numfashi (55%).
Amma kashi 80 cikin 100 na su sun bukaci numfashi na huhu, wanda ya fi na marasa lafiya da COVID-19 yawa, kuma ya dace da mutuwar da ta fi na MERS fiye da na COVID-19.
Marasa lafiya da ke fama da cutar MERS sun sami ciwon ciki (26%) da kuma ciwon wuya (21%).
Babban alamun marasa lafiya da ke fama da cutar ta SARS sune zafin jiki (99100 %), tari mai bushe (2975 %), numfashi (4042 %), cututtukan ciki (2025 %) da ciwon wuya (1325 %), kuma ana buƙatar iska ta wucin gadi ta huhu 1420 % na marasa lafiya.
A ranar 14 ga Fabrairu, mutuwar COVID-19 ta kai kashi 2 cikin ɗari, kuma jimlar adadin waɗanda aka tabbatar da cutar a duniya sun kai 66,576.
Idan aka kwatanta da wannan, mutuwar SARS a watan Nuwamba na shekara ta 2002 ya kai kashi 10 cikin 100 na mutane 8,096 da aka tabbatar da cutar.
A cikin yanayin MERS, binciken binciken alƙaluma da aka gudanar a watan Yuni na 2012 ya nuna cewa mutuwar ta kai kashi 37 cikin dari daga cikin 2,494 da aka tabbatar.
A sakamakon binciken da aka yi a baya, an ƙayyade ma'aunin asali na haihuwa (R0) don SARS-CoV-2 a matakin 6.47 a cikin 95% na dogara (CI) a cikin zangon 5.717.23, yayin da R0 don SARS-CoV ya kasance a tsakanin 2 zuwa 4 kawai.
Kwatanta SARS-CoV-2 da MERS-CoV da SARA-CoV ta hanyar bayyanar cututtuka, mutuwa da R0 an nuna su a cikin tebur na Table 1.1.
Abubuwan da aka ambata a sama sun nuna cewa SARS-CoV-2 yana da mafi girman ikon yadawa idan aka kwatanta da MERS-CoV da SARS-CoV, amma yawan mutuwar da aka samu daga sabon kwayar cutar ya fi ƙasa da na ƙarshe biyu.
Saboda haka, hana cutar SARS-CoV-2 zai zama da wuya fiye da cutar MERS-CoV da SARS-CoV.
Sau da yawa ana samun kamuwa da cutar a cikin iyali ɗaya ko kuma a cikin rukuni na mutane da suka taru don wani dalili ko kuma suka taru a wata hanya ta sufuri, kamar jirgin ruwa.
A yawancin lokutan, marasa lafiya suna zuwa Wuhan ko wasu yankunan da cutar ta shafa, suna zaune a wurin ko kuma suna hulɗa da waɗanda suka kamu da cutar ko waɗanda suka kamu da cutar a cikin makonni biyu kafin cutar ta fara.
Amma rahotanni sun nuna cewa mutane za su iya zama masu dauke da cutar ba tare da wata alama ba har tsawon makonni biyu, kuma marasa lafiya da aka warkar da su bayan sun bar asibiti za su iya zama masu dauke da cutar kuma wannan yana ba da gargadi game da tsawaita lokacin killacewa.
A farkon lokaci, marasa lafiya suna da ƙananan adadin kwayoyin halitta (musamman lymphocytes) a cikin jini.
Alal misali, an gano cewa marasa lafiya 1,099 da ke fama da cutar COVID-19 suna da cutar lymphocytes da suka kai < 4×109/L, har da da cutar ta < 1×109/L, da kuma ci gaban asparagine aminotransferase da kuma cutar kwayar cutar.
A wasu marasa lafiya, an samu karuwar ƙwayar hanta, ƙwayar tsoka, da kuma ƙwayar ƙwayar ƙwayar cuta a cikin jini, kuma a yawancin marasa lafiya, an samu karuwar ƙwayar cuta mai suna C-reactive da kuma saurin zama a cikin jini.
A cikin marasa lafiya da suka kamu da cutar, yawan D-dimer, wanda ke haifar da ɓarnar jini, ya ƙaru, kuma yawan ƙwayar lymphocytes ya ragu.
Yawancin marasa lafiya da ke fama da COVID-19 sun sami cututtuka a cikin gwajin X-ray na ƙirjin da ke nuna rashin daidaituwa a ɓangarorin biyu ko kuma a cikin huhu.
A yawancin lokaci, marasa lafiya suna fama da cutar huhu, da kuma cutar numfashi mai tsanani.
Idan aka samu ciwon daji, rashin kula da kumburi, tarin ruwa da ci gaba da ciwon fibroids suna haifar da rikicewar gas.
Rashin aikin huhu na nau'i na I da II yana rage matakin haɗin haɗin kai na ƙasa da kuma ƙara ƙarfin farfajiyar ƙasa, don haka rage ƙarfin huhu don faɗaɗa da kuma ƙara haɗarin raguwa.
Saboda haka, mafi munin sakamakon binciken da aka yi a kan radiography yakan zo daidai da mafi munin cututtuka.
A ranar 18 ga Fabrairu, 2020, bincike na farko na COVID-19 ya nuna ɓoyewar ƙwayar cuta, samar da membranes na hyaline da kuma ɓoyewar lymphocyte tsakanin ƙwayoyin cuta, kuma ƙwayoyin syncytic mai ƙwayoyin cuta a cikin marasa lafiya masu mutuwa daga cutar sun dace da cututtukan kamuwa da cuta ta kwayar cuta da RRZ kuma suna kama da waɗanda aka samu a cikin marasa lafiya da SARS da MERS.
A matsayin babban ma'auni a cikin gano COVID-19 an yi amfani da hanyar gano RNA SARS-CoV-2 ta hanyar polymerase chain reaction tare da maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin maɓallin.
Duk da haka, saboda yawan sakamako na karya wanda zai iya hanzarta ci gaban annobar, daga ranar 13 ga Fabrairu, 2020, an fara yin bincike a China bisa ga bayyanar cututtuka (ba tare da dogaro kawai ga PCR tare da fassarar baya ba).
Hakazalika, an gano cutar SARS.
Saboda haka, don a iya gane cutar yadda ya kamata, yana da muhimmanci a haɗa bayanan tarihin cutar, na asibiti, na gwaji da kuma sakamakon binciken X-ray.
A ranar 14 ga Fabrairu, 2020, ƙungiyar masana karkashin jagorancin Mista Feng Zhang (Feng Zhang) sun bayyana yarjejeniyar amfani da hanyar SHERLOCK, wanda ya dogara da maimaita CRISPR, don gano SARS-CoV-2; wannan hanyar tana ba da damar gano ɓangarorin RNA na SARS-CoV-2 a cikin ƙarancin 20 × 1018 moles / l zuwa 200 × 1018 moles / l (10100 kwafi a kowace microlitir na samfurin asali) ta amfani da layin mai nuna alama a ƙasa da awa ɗaya ba tare da amfani da kayan aiki mai rikitarwa ba.
Idan aka gwada wannan sabon tsarin a kan kwayoyi, zai iya sa gwajin ya zama da sauƙi kuma ya zama da sauƙi.
Saboda rashin kwarewa wajen magance cutar coronavirus da ba a sani ba, likitoci suna iya ba da magani na goyan baya ga marasa lafiya da COVID-19 kawai, tare da ƙoƙarin yin amfani da wasu hanyoyin magance cututtukan da aka yi amfani da su ko kuma aka ba su a lokacin da ake magance sauran cututtukan coronavirus, kamar su SARS-CoV da MERS-CoV, da sauran cututtukan kwayar cuta (tebur (Table 2).
Waɗannan hanyoyin sun haɗa da amfani da magungunan rigakafin cutar a yanzu ko kuma a wataƙila, masu hana rigakafi, steroids, jini na marasa lafiya da suka warke, maganin gargajiya na kasar Sin, da kuma ba da tallafi na tunani.
An ba da shawarar yin amfani da jini na marasa lafiya da suka warke.
Kamfanonin sayar da magunguna suna gaggauta samar da maganin rigakafi da kuma allurar rigakafi don magance cutar.
A farkon matakan SARS-CoV-2 yafi kai hari ga huhu, kuma yana iya shafar sauran gabobin da ke nuna ACE2, kamar gastrointestinal tract da koda.
Duk da haka, rashin aiki da kuma rashin numfashi sune babbar barazana da kuma dalilin mutuwar marasa lafiya.
Saboda haka, don sauƙaƙe cututtuka da kuma ceton rayuka, yana da muhimmanci a tallafa wa aikin numfashi, ciki har da maganin oxygen gaba ɗaya, ba da iskar oxygen mai ƙarfi, iska mai ƙarancin ƙarfi da iska mai ƙarancin ƙarfi, da kuma iska mai ƙarancin ƙarfi na huhu, waɗanda aka tsara dangane da yanayin cutar.
Marasa lafiya da ke fama da cututtukan numfashi suna bukatar taimako ta hanyar maganin oxygenation na membrane (ECMO), wanda aka gyara don maganin cututtukan zuciya da kuma numfashi.
Bugu da ƙari, kula da daidaiton gishiri da ruwa, hanawa da kuma magance cututtukan cuta na biyu da kuma bugun jini, da kuma kare ayyukan gabobin jiki masu mahimmanci suna da mahimmanci ga marasa lafiya da SARS-CoV-2.
An san cewa hadari na cytokine sakamakon rashin karfin jiki na marasa lafiya da ke dauke da cutar SARS da MERS.
Guguwar cytokines wani nau'i ne na tsarin kumburi wanda ke tasowa a cikin martani ga sakin jerin cytokines, ciki har da TNFα, IL-1β, IL-2, IL-6, IFNα, IFNβ, IFNγ da MCP-1.
Waɗannan kwayoyin suna sa 'yancin rigakafi su fitar da ƙwayoyin da ke da yawa, kuma hakan yana sa a sami ƙwayoyin da ke sa a sami ƙwayoyin da ba su da ƙarfi sosai.
Idan ana shan maganin tsokoki, musamman a cikin marasa lafiya masu tsanani, yana da muhimmanci a hana su yin rigakafi.
Don magance hadari na cytokine, an yi amfani da corticosteroids da tocilizumab, kwayoyin antibodies na monoclonal, waɗanda ke aiki a matsayin mai hana interleukin-6.
Sauran hanyoyin da za a bi da guguwar cytokine da ke dogara ne akan hana rigakafi sun haɗa da daidaitawar rigakafin rigakafin da ke nufin sarrafa kwayoyin T; toshe samar da cytokines IFN-γ, IL-1, da TNF; hana janus kinase; amfani da blinatumomab, suppressors na siginar cytokine 4 da masu hana histone-acetalase.
Ana amfani da steroids a matsayin masu hana rigakafi don rage yawan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan.
Amma, steroids masu yawa ba su da amfani wajen magance mummunan lalacewar huhu a cikin marasa lafiya da ke fama da SARS da COVID-19.
A maimakon haka, za su iya haifar da sakamako masu illa, musamman ma osteonecrosis na ovascular, wanda zai iya sa a yi mummunan sakamako.
Duk da haka, ana ba da shawarar yin amfani da gajeren lokaci na ƙananan da matsakaiciyar sashi na corticosteroids don kula da marasa lafiya da ke da cutar COVID-19 a cikin mawuyacin hali.
A lokacin da aka rubuta wannan takardar, babu wata magani mai kyau da aka tabbatar da cewa yana da tasiri.
Amma, shan maganin remdesivir a cikin jini, wanda yake da nau'i na nucleotide, ya tabbatar da cewa yana da tasiri wajen magance wani mai cutar COVID-19 a Amurka.
Remdesivir sabon magani ne na rigakafin cutar da Gilead ta fara samarwa don magance cututtukan da Ebola da Marburg suka haifar.
Daga baya, remdesivir ya kuma nuna yiwuwar hana wasu ƙwayoyin cuta na RNA guda, ciki har da MERS da SARS.
A kan wannan bayanan, Gilead ta ba da wannan magani ga Sin don yin bincike na biyu a kan marasa lafiya da ke da cutar SARS-CoV-2, kuma suna jiran sakamakon binciken.
Bugu da ƙari, an ba da baritsitinib, α-interferon, lopinavir/ritonavir, da ribavirin a matsayin hanyoyin da za a iya bi da marasa lafiya da ke da alamun numfashi.
Ana iya samun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Ya kamata a lura da yadda waɗannan magunguna suke shafar sauran magunguna da aka ba marasa lafiya.
Plasma na marasa lafiya da suka warke da kuma samar da rigakafin jiki
Ana amfani da karɓar jini daga marasa lafiya da suka warke daga wata cuta mai yaduwa don kula da wasu marasa lafiya da ke fama da wannan cuta ko kuma don kare lafiyar jama'a tun da daɗewa.
A gaskiya ma, a cikin jinin marasa lafiya da suka warke, akwai yawan adadin rigakafin da ke hana cutar.
Ana samun rigakafi a cikin ƙwayar cuta ta B da ke samar da ƙwayar cuta ta B don yaƙi da cututtuka da wasu abubuwa masu cutarwa; suna gane kwayoyin cututtuka dabam-dabam kuma suna hana su.
A kan wannan dalili, an cire jini daga cikin jinin marasa lafiya da suka warke daga COVID-19, kuma an ba su jini daga cikin marasa lafiya 10 masu fama da cutar.
A cikin sa'o'i 24, bayyanar cututtukan sun inganta, kuma ƙwayoyin cuta da kuma ƙwayar cuta sun ragu, kuma an ƙara yawan iskar oxygen a cikin jini.
Amma, don a yi amfani da wannan hanyar a yawancin lokaci kafin a yi wani magani, ana bukatar a yi bincike da kuma bayani.
Bugu da ƙari, idan aka yi la'akari da sakamako mai kyau, ya kamata a yi la'akari da wasu ƙarancin amfani da jini.
Alal misali, ƙwayoyin rigakafi suna iya ƙarfafa tsarin rigakafi sosai kuma su jawo cututtukan fitowar cytokine, wanda idan aka yi la'akari da guba, yana iya zama barazana ga rayuwa.
Ana yawan amfani da jini mai ƙarancin ƙwayar riga-kafi, kuma ana bukatar jini mai yawa don kula da marasa lafiya da ke cikin mawuyacin hali.
Ba abu mai sauƙi ba ne a yi amfani da maganin rigakafi da sauri don magance cutar ta duniya.
Saboda haka, yana da muhimmanci a gano ƙwayoyin B na marasa lafiya da suka warke kuma a gano lambar kwayoyin halitta na ƙwayoyin riga-kafi masu tasiri ko kuma a yi bincike don gano ƙwayoyin riga-kafi masu tasiri a kan ƙwayoyin ƙwayoyin ƙwayoyin cuta masu mahimmanci.
Don haka za mu iya yin amfani da wannan hanyar don samar da kwayoyin cutar gaba ɗaya.
Mutane na ƙasar Sin sun yi shekaru dubbai suna amfani da maganin gargajiya don magance cututtuka dabam dabam.
Amma, ingancinsa ya dogara ne da haɗuwa da abubuwa da yawa na tsarin, wanda ya bambanta dangane da ganewar asali na cutar bisa ka'idodin gargajiya na gargajiya na kasar Sin.
Yawancin abubuwan da ke da tasiri har yanzu ba a san su ba ko kuma suna da tasiri ba saboda ganowa da gwada waɗannan abubuwan ko haɗuwa da su yana da wuya.
A halin yanzu, saboda rashin ingantaccen maganin COVID-19, maganin gargajiya na kasar Sin ya zama ɗayan manyan hanyoyin maye gurbin don magance marasa lafiya masu sauƙi da matsakaiciyar rashin bayyanar cututtuka ko marasa lafiya da ke warkewa daga mummunan yanayin cutar.
Alal misali, an gano cewa Shu Feng Jie Du da Lian Hua Qing Wen suna da tasiri wajen magance COVID-19.
Mafi yawan marasa lafiya da suka warke daga COVID-19 sun kasance a wasu lardunan China inda aka yi amfani da maganin gargajiya na kasar Sin wajen kula da kashi 87 cikin dari na marasa lafiya, ciki har da Gansu (63.7 cikin dari), Ningxia (50 cikin dari) da Hunan (50 cikin dari), yayin da lardin Hubei inda ake amfani da maganin gargajiya na kasar Sin wajen 30 cikin dari na marasa lafiya da ke fama da COVID-19 ne kawai aka samu mafi karancin adadin marasa lafiya (13 cikin dari).
Amma wannan kwatanci ne mai tsanani, domin ana bukatar a yi hakan ne bisa wasu dalilai masu yawa, kamar yawan marasa lafiya da kuma yadda suke da rashin lafiya.
A ranar 18 ga Fabrairu, 2020, Mista Boli Zhang da abokan aikinsa sun buga bayanan binciken da ke kwatanta magani ne kawai ta hanyar maganin yammacin duniya da kuma maganin hadewa ta hanyar maganin yammacin duniya da maganin gargajiya na kasar Sin.
Sun gano cewa lokutan da za a daidaita zafin jiki, a kawar da cututtuka, da kuma kula da marasa lafiya a asibiti sun yi ƙasa da na marasa lafiya da suka bi da maganin da ya haɗa da na gargajiya na yammacin kasar Sin fiye da na marasa lafiya da aka bi da su a yammacin duniya.
Abin mamaki shi ne, yawan marasa lafiya da suka soma samun cututtukan da suka fi muni (daga rashin lafiya zuwa rashin lafiya) sun kasance ƙasa da yawa a cikin ƙungiyar da aka bi ta hanyar haɗuwa da hanyoyin maganin gargajiya na yamma da na gargajiya na kasar Sin fiye da waɗanda aka bi ta hanyar yamma (kashi 7.4 bisa dari idan aka kwatanta da kashi 46.2 bisa dari), kuma mutuwar a cikin rukuni na farko ta kasance ƙasa da na biyu (kashi 8.8 bisa dari idan aka kwatanta da kashi 39 bisa dari).
Duk da haka, inganci da kuma lafiyar maganin gargajiya na kasar Sin har yanzu suna bukatar bincike mai zurfi da kuma kula da su a mafi girma da kuma yankuna.
Hakanan yana da sha'awa don samun kwatancen yadda ake aiki da kuma bayanin abubuwan ingancin abubuwan da ake amfani da su a cikin hanyoyin maganin gargajiya na kasar Sin, ko kuma haɗuwa da su.
Marasa lafiya da ake zargin ko kuma suka tabbatar da cewa suna da COVID-19 suna fuskantar tsoro mai tsanani na kamuwa da cutar mai tsanani har ma da mutuwa, kuma mutanen da ke cikin killacewa suna fuskantar gajiya, kadaici da kuma matsanancin fushi.
Ƙari ga haka, alamun kamuwa da cuta kamar zazzabi da kuma tari da kuma sakamako masu illa na magani, kamar rashin barci da ake samu daga maganin corticosteroid, suna iya sa mutum ya ƙara damuwa da kuma damuwa.
A farkon farkon cutar SARS, an ruwaito cewa akwai wasu cututtukan tunanin mutum, ciki har da baƙin ciki, tashin hankali, tashin hankali, tashin hankali, alamun psychotic, delirium, har ma da halinsu na kashe kansa.
Kula da hulɗa da kuma killacewa, wanda ke cikin matakan da hukumomin kiwon lafiya ke ɗauka don hana annobar COVID-19, na iya ƙara damuwa da laifi ga mutane game da yaduwar kamuwa da cuta, killacewa da kuma alamar zamantakewa a cikin iyalansu da abokansu.
Saboda haka, ya kamata a ba da taimako na tunani da kuma na tunani ga marasa lafiya da ke fama da COVID-19, waɗanda ake zargi da kuma waɗanda suka tuntube su, da kuma duk sauran mutanen da suke bukatar taimako.
A cikin tsarin tallafi na tunani, ya kamata a kafa ƙungiyoyin kula da lafiyar kwakwalwa masu yawa, a kafa cikakken bayani tare da sabunta bayanai game da cutar SARS-CoV-2 da tsare-tsaren magani da kuma amfani da na'urorin lantarki da aikace-aikace na ƙwararru don kauce wa kusanci.
Ana amfani da alluran rigakafi masu tasiri wajen kawar da cutar daga dabbobi masu kamuwa da cuta da kuma mutane masu kamuwa da cutar zuwa masu karɓa, kuma ana amfani da su sau da yawa a cikin maganin rigakafin cutar da ake amfani da shi don hana annobar da sababbin ƙwayoyin cuta ke haifarwa.
An yi aiki don ƙirƙirar alluran rigakafi bisa ga S-protein, wanda shine manufar samar da antibodies masu tsayayya da tsayayya da tsayayya da SARS-CoV.
A cikin binciken da aka yi a kan dabbobi, an yi amfani da allurar rigakafi mai rai don cutar SARS.
Amma kafin a fara bincike, dole ne a gano yadda waɗannan alluran za su iya yin aiki a yanayi na halitta a cikin tsofaffin marasa lafiya, da kuma yadda za a iya yin amfani da su don kamuwa da cutar da cutar da ke kashe mutane da kuma yadda za a iya kare su daga kamuwa da cutar da ke tattare da cutar.
Wataƙila saboda an kashe cutar ta SARS shekaru 17 da suka shige, kuma ba a samu wani sabon kamuwa da cutar ba tun daga lokacin.
A lokaci guda, ana ci gaba da samun cututtuka da kuma cututtuka na cutar MERS da ke faruwa a Gabas ta Tsakiya da kuma sauran yankuna ta hanyar adana tushen dabbobi a wuraren da ake rayuwa.
An tsara dabarun yin allurar rigakafi don magance MERS ta amfani da kwayar cutar da aka hana, plasmids na DNA, vectors na kwayar cutar, nanoparticles, ƙwayoyin cuta masu kama da kwayar cutar, da kuma abubuwan da ke cikin furotin, kuma an gwada wasu daga cikin waɗannan dabarun a cikin dabbobi.
Samar da allurar rigakafi mai lafiya da inganci ga mutanen da ba su da rigakafi na SARS-CoV-2 aiki ne na gaggawa da kuma gaggawa wanda ke bukatar a magance cutar.
Amma akwai matsaloli masu yawa da ake fuskanta saboda tsawon lokaci (watau watanni 18) da ake bukata don samar da allurar rigakafi da kuma canjin yanayin coronavirus.
A matsayin cutar da ba a sani ba, COVID-19 ta fara bayyana cikakken yanayin asibiti na cutar ta dubban marasa lafiya.
A yawancin lokuta, marasa lafiya suna samun sauƙi a hankali ba tare da samun matsaloli ba.
Amma, COVID-19, kamar SARS da MERS, yana da alaƙa da yawan cututtukan da kuma yawan mutuwar marasa lafiya masu tsanani.
Saboda haka, yana da muhimmanci ga hukumomin kiwon lafiya su tsara tsarin bincike na cutar don su san yadda za su bi da matakan da suka dace, musamman a wuraren da ake fama da karancin albarkatu.
Bisa ga bayanan binciken asibiti da aka gabatar a yanzu, waɗannan dalilai na iya tasiri kan tsinkayar cutar a cikin marasa lafiya da COVID-19 ko kuma su kasance masu alaƙa da ita (tebur (Table 33):
Shekara: Shekara ita ce muhimmiyar mahimmanci wajen hasashen cutar SARS, wanda kuma ya dace da gaskiyar COVID-19.
COVID-19 ya fi shafar marasa lafiya masu shekaru 30 zuwa 65, wanda kashi 47.7 cikin 100 na su sun fi shekaru 50 da haihuwa, a cewar binciken da aka ambata a sama, ya nuna cewa akwai mutane 8,866.
Marasa lafiya da ke bukatar jinya mai tsanani sun fi fuskantar cututtuka na asali da rikitarwa, kuma sun fi tsofaffi fiye da marasa lafiya da ba su bukaci jinya ba (a matsakaita shekaru 66 zuwa 51), wanda ya nuna cewa shekaru suna da tasiri ga masu cutar COVID-19.
Jima'i: Ana samun cutar SARS-CoV-2 a cikin maza fiye da mata (0.31/100,000 da 0.27/100,000), kamar yadda aka ambata a sama.
Cutar da kuma rikitarwa: marasa lafiya da ke fama da cutar COVID-19 da ke bukatar ci gaba da magani suna da mafi yawan haɗarin samun mummunan rauni na zuciya da kuma arrhythmia.
Hakanan cututtukan zuciya sun kasance babban dalilin mutuwar marasa lafiya na SARS.
An ruwaito cewa SARS-CoV-2 na iya haɗuwa da cholangyocytes na ACE2 mai kyau, wanda zai iya haifar da rashin aikin hanta a cikin marasa lafiya da COVID-19.
Amma, shekaru da kuma cututtuka na asali suna da alaƙa sosai kuma suna iya ɓata sakamakon.
Abubuwan da aka gano a cikin gwaje-gwaje: matakin furotin C mai amsawa a cikin jini yana nuna yadda mummunan aikin kumburi ko lalacewar ƙwayoyin cuta yake, kuma ana ba da shawarar yin la'akari da shi azaman yiwuwar hangen nesa na yanayin cutar, amsa ga magani da kuma warkewa ta ƙarshe.
An kuma ba da shawarar yin la'akari da alaƙar da ke tsakanin matakin furotin mai C, matakin cutar da kuma tsinkayen COVID-19.
Ƙari ga haka, ana iya ganin sakamako daga yawan lactate dehydrogenase, asparagine aminotransferase, alanine aminotransferase, da creatine kinase.
Ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta suna fitowa daga cikin gabobin jiki, musamman daga zuciya da hanta, kuma suna fitowa ne daga cikin ƙwayoyin da suka lalace.
Saboda haka, a al'ada, suna nuna rashin aikin zuciya ko na hanta.
Babban alamun asibiti: Don hango sakamakon da rikitarwa a lokacin maganin COVID-19, tare da wasu dalilai, ya kamata a yi la'akari da bayanan binciken X-ray na kirji da ci gaban alamun asibiti a tsawon lokaci.
Amfani da steroids: kamar yadda aka bayyana a sama, steroids  suna da ƙarfi a cikin cututtuka masu kamuwa da cuta a matsayin ƙarin magani don rage yawan ƙwayar cuta.
Saboda ana amfani da corticosteroids a yawancin mutane don magance marasa lafiya da ke fama da cutar SARS, mutane da yawa da suka tsira daga cutar sun kamu da osteonecrosis na ovarian, wanda ya haifar da rashin ƙarfi na rayuwa da rashin ingancin rayuwa.
Saboda haka, idan ana bukatar amfani da steroids don kula da marasa lafiya da COVID-19, ya kamata a ba da waɗannan magungunan a ƙananan allurai da gajerun hanyoyi.
Matsalolin tunani: Kamar yadda aka bayyana a sama, a cikin annobar COVID-19, marasa lafiya da yawa suna fama da matsanancin damuwa, saboda yawanci suna fuskantar tsawan lokacin killacewa, fuskantar rashin tabbas mai yawa, da kuma kallon mutuwar dangi da sauran marasa lafiya.
Don a rage yawan damuwa da kuma taimaka musu su koma rayuwa ta yau da kullum, dole ne a yi musu nasiha ta tunani da kuma tallafa musu na dogon lokaci.
Bisa ga binciken alƙaluma da aka gudanar a yanzu, cutar COVID-19 ta bambanta da cutar SARS a cikin alamun ta.
Baya ga yin kwayar cutar a cikin hanyoyin numfashi na ƙasa, SARS-CoV-2, kamar sauran cututtukan coronavirus da ke haifar da cututtukan sanyi na yau da kullun, na iya samun nasara a cikin hanyoyin numfashi na sama kuma yana haifar da alamun rauni ko kuma ba su haifar da alamun cutar ba a farkon kamuwa da cutar.
Saboda haka, waɗanda suka kamu da cutar a farkon lokaci ko kuma ba su gama lokacin da za su yi kamuwa da cutar ba, suna iya yin rayuwa mai kyau kuma su yi amfani da cutar a hanyoyi masu yawa, wanda hakan zai sa ya yi wuya a lura da cutar.
Duk da haka, an yi imanin cewa ƙwayar SARS-CoV tana faruwa ne lokacin da marasa lafiya ke da rashin lafiya mai tsanani, yayin da a mafi yawan lokuta ba a kamu da cutar ba a farkon lokaci.
Saboda haka, annobar COVID-19 ta yau ta fi ta SARS tsanani, kuma ta fi wuya a sarrafa ta.
A halin yanzu, ana aiki sosai a China, inda aka sanar da dokar hana fita ta duniya a Wuhan da garuruwan da ke kusa da ita, da kuma tsawaita dokar hana fita ga kusan dukkanin al'ummar kasar, wanda aka kafa don katse sarkar yaduwar cutar SARS-CoV-2.
Ko da yake waɗannan matakan suna da babbar illa ga tattalin arziki da sauran fannonin rayuwa na ƙasar, adadin sababbin marasa lafiya da aka gano suna raguwa, wanda ke nuna jinkirin yaduwar cutar.
A cewar masu kyakkyawan tunani, cutar za ta ƙare a watan Maris, kuma za a yi watanni 34 kafin ta ƙare.
Amma, wasu masana ba su da irin wannan ra'ayin.
Mr. Paul Hunter da abokan aikinsa sun kiyasta cewa barkewar cutar COVID-19, wadda ta fi ta SARS yawa, ba za ta ƙare ba a shekarar 2020.
Masu bincike daga ƙungiyar da Ira Longini ke jagoranta sun tsara wani tsari don hango ƙarshen annobar kuma sun yi hasashen cewa cutar SARS-CoV-2 na iya cutar da kashi biyu bisa uku na yawan duniya.
Wani rukuni na masana a Kanada ya bayyana cewa an gano cutar SARS-CoV-2 a cikin hanci da hanci na marasa lafiya da aka dawo da su daga asibitoci makonni biyu da suka gabata, wanda ke nuna cewa sabon cutar na iya zama cuta mai kama da mura.
Amma, rage yawan sababbin cututtuka a kasar Sin na ba da tabbaci, yana nuna cewa dabarun da ake amfani da su a yanzu suna iya samun sakamako.
An yi hasashen cewa cutar Ebola za ta iya shafan mutane miliyan ɗaya kuma ta kashe mutane miliyan biyar.
Amma, da taimakon tsauraran matakan killacewa da kuma warewa, an samu nasarar sarrafa cutar.
Kamar SARS-CoV, akwai yiwuwar cewa cutar SARS-CoV-2 za ta iya raunana kuma a tsawon lokaci za ta ɓace ko kuma ta zama ƙarancin cutar da ke tattare da mutum.
Ga kwatancen cutar COVID-19 da cutar SARS da MERS (Hotuna 55).
Ana nuna cewa cutar SARS-CoV-2 tana gudana da sauri ta hanyar tari ko tsatsa, kuma wataƙila ta hanyar tuntuɓar kai tsaye da kayan da ke da cutar.
An gano cutar a cikin ƙura kuma hakan na nufin cewa ana iya samun ta ta hanyar bakin.
Wani bincike da aka yi kwanan nan ya nuna cewa kashi 41 cikin 100 na mutane 138 da aka bincika sun kamu da cutar a asibiti, har da marasa lafiya 17 da suka kamu da wasu cututtuka da kuma ma'aikatan kiwon lafiya 40.
Saboda haka, ya kamata a yi tsauraran matakan tsaro don kare jama'a, musamman ma ma'aikatan kiwon lafiya, ma'aikatan jin kai, danginsu, abokan aiki, har ma da mutanen da ba su san su ba da ke hulɗa da marasa lafiya ko waɗanda suka kamu da cutar.
Hanyar farko ta karewa don rage haɗarin kamuwa da cuta  ita ce sanya abin rufe fuska; kuma masks na tiyata, da masu numfashi na N95 (sarai na 1860s) suna taimakawa wajen sarrafa yaduwar ƙwayoyin cuta.
Masks na tiyata ba sa barin ƙananan ƙananan ruwa daga waɗanda ke da cutar su tashi a cikin iska kuma su zauna a saman da za su iya watsawa ga mutane.
Duk da haka, kawai abin rufe fuska na N95 (sarai na 1860s) na iya kare daga numfashin virions daga 10 zuwa 80 nm, suna wucewa kawai 5% na virions; cutar SARS-CoV-2 na girman kamar SARS-CoV, kuma dukansu suna da girman kusan 85 nm.
Tun da ƙwayoyin za su iya shiga ta hanyar masks biyar na tiyata da aka haɗa, ma'aikatan kiwon lafiya da ke hulɗa da marasa lafiya kai tsaye dole ne su sa masks na N95 (sarai na 1860s), ba masks na tiyata ba.
Baya ga abin rufe fuska, ma'aikatan kiwon lafiya suna bukatar su saka rigar kariya mai ƙyalƙyali don rage haɗarin kamuwa da ƙwayoyin cuta.
Hakanan ƙwayoyin cuta suna iya shiga cikin jiki ta hanyar idanu.
A ranar 22 ga Janairu, 2020, likita ya kamu da SARS-CoV-2 duk da cewa yana saka abin rufe fuska na N95; mai yiwuwa kwayar ta shiga jikinsa ta hanyar kumburi a idanunsa.
Saboda haka, ma'aikatan kiwon lafiya suna bukatar su saka tabarau masu haske ko kuma tabarau masu rufe fuska.
Ana ba da shawarar dukan mutanen da ke yankunan da ke da rauni ko kuma waɗanda ke da haɗari su wanke hannuwansu da wanke-wanke da yawa, su guji fita gida, su yi zaman kansu, kuma su rage hulɗa da waɗanda suke da cutar.
An yi la'akari da nesa da mutum ya kai ga mai haƙuri a kusan mita.
Waɗannan matakan suna rage haɗarin kamuwa da cutar da kuma hana yaduwar cutar.
Ko da yake cutar SARS-CoV-2 ba a sani ba a baya, babban kamanceceniya da ta yi da SARS-CoV, wanda aka ruwaito a ranar 7 ga Janairu, 2020, ya zama sanarwa ga China, la'akari da kwarewar da ta samu a lokacin barkewar cutar SARS a 2003.
Sai dai bayan 19 ga watan Janairun 2020 ne shugaban Cibiyar Kula da Cututtuka a Wuhan ya kwantar da hankalin jama'a, yana mai cewa sabon kwayar cutar tana da ƙananan kamuwa da cuta da iyakancewar haifuwa yayin watsawa daga mutum zuwa mutum kuma hana yaduwar cutar da kuma kula da ita ba zai zama matsala ba.
Wannan sanarwa ta rage tashin hankali sosai a cikin al'umma, musamman a lokacin da duk kasar ke shirin bikin Sabuwar Shekarar Sin, kuma an rasa muhimmin lokacin da za a iya hana cutar a cikin Wuhan tare da ƙananan asarar.
Hukumomin kiwon lafiya na kasar Sin za su iya koyi wannan darasi mai wuya kuma su yi wasu ci gaba masu muhimmanci a nan gaba.
Alal misali, hukumomin kiwon lafiya ya kamata: (1) su yi karin hankali wajen yin sanarwa a fili, domin kowane kalma na da hankali ga 'yan ƙasa kuma zai iya shafar halayensu da shawarwarin su; (2) su sa ido sosai da kuma amsa ga bayanai na musamman da ke fitowa daga asibitoci maimakon jiran rahotanni na hukuma daga likitoci da jami'ai; (3) su ɗauki ƙarin matakan da za su iya hana yiwuwar annobar a farkon matakanta, maimakon su yi wa jama'a shakatawa; da kuma (4) su yi ƙarin darussan da za su iya yin tasiri da kuma ingantaccen horo don ƙara wayar da kan jama'a game da cututtukan annobar da kuma duba da inganta tsarin amsawar jama'a.
Cutar COVID-19, wadda ta haifar da cutar coronavirus mai tsanani mai tsanani ta hanyar numfashi (SARS-CoV-2), wadda ba a taɓa yin nazari ba, ta fara ne a ƙarshen Disamba na 2019.
A cikin ƙasa da watanni biyu, cutar ta mamaye ƙasar Sin duka kuma a lokacin da aka rubuta wannan takardar, ta faɗaɗa ƙasashe 50 a duniya.
Tun da yake cutar ta yi kama da cutar coronavirus ta cutar ta shan numfashi mai tsanani (SARS-CoV) kuma alamun COVID-19 sun yi kama da alamun cutar ta shan numfashi mai tsanani (SARS), a lokacin da COVID-19 ya barke, an ji kamar SARS ta sake dawowa.
Amma akwai wasu bambance-bambance masu muhimmanci tsakanin COVID-19 da SARS, waɗanda ke da muhimmanci wajen hana cutar da kuma kula da marasa lafiya.
COVID-19 yana shafar tsofaffi fiye da matasa, maza kuma fiye da mata; yawan cututtuka masu tsanani da kuma mutuwar tsofaffi ma sun fi na matasa.
Mutuwar SARS ta fi na COVID-19 girma (10.91 bisa dari idan aka kwatanta da 1.44 bisa dari).
Marasa lafiya da COVID-19 suna yada cutar ko da cutar ba ta da wata alama, yayin da marasa lafiya da SARS ke kamuwa da cutar a lokuta masu tsanani, saboda haka hana yaduwar COVID-19 ya fi wahala fiye da SARS.
Wannan ya bayyana dalilin da ya sa SARS-CoV-2 ke yaduwa da sauri kuma ya fi SARS-CoV girma.
Wasu marasa lafiya da ke da cutar COVID-19 na iya samun gwajin RNA na SARS-CoV-2 mara kyau.
A wani bangare kuma, marasa lafiya da suka warke za su iya sake samun gwajin cutar.
Hakan yana ƙara haɗarin yaduwar cutar.
A yayin da bincike na COVID-19 ke ci gaba da sauri, wasu muhimman tambayoyi sun kasance har yanzu ba a warware su ba, musamman:
Mene ne asalin cutar SARS-CoV-2?
Duk da cewa an gano kashi 96 cikin dari na bambancin tsakanin SARS-CoV-2 da cututtukan coronavirus guda biyu na SARS a cikin linzamin kwamfuta, har yanzu ba za mu iya tabbatar da cewa SARS-CoV-2 ya fito ne daga linzamin kwamfuta ba.
Wane dabba ne ya zama nau'in da ya canja kwayar daga mai shi, kamar su ƙwari, zuwa mutum?
Idan ba mu san amsoshin tambayoyi na farko da na biyu ba, ba za mu iya hana yaduwar cutar ba, kuma za mu iya yin rashin lafiya a kowane lokaci.
Samfurin kwayoyin halitta da gwajin halittu sun nuna cewa SARS-CoV-2 yana da alaƙa da ACE2, amma ta yaya kwayar cutar ta shiga cikin ƙwayoyin numfashi kuma ta haifar da canje-canje na yau da kullun?
Shin kwayar cutar tana da alaƙa da ƙwayoyin halitta na ACE2 a wasu gabobin jiki?
Idan ba mu da amsoshin waɗannan tambayoyin, ba za mu iya ba da tabbaci na ganewar asali da kuma magani mai kyau ba.
Har yaushe za a ci gaba da annobar?
Ta yaya kwayar cutar ta samo asali a cikin hanyar mutum zuwa mutum?
Shin zai zama sanadin annoba ta duniya, ko kuma zai mutu kamar SARS, ko kuma zai sake faruwa a wasu lokatai kamar mura?
Waɗannan batutuwa suna da muhimmanci sosai, amma za mu ɗauki lokaci kafin mu sami amsoshin waɗannan da kuma wasu tambayoyi.
Amma, ba mu da wani zaɓi sai dai mu dakatar da annobar da wuri-wuri kuma mu koma rayuwa ta yau da kullum.
Tushen dabbobi na kwayar cutar coronavirus
Cutar da kuma daidaitawa sun motsa juyin halitta na kwayar cutar coronavirus (CoV) da masu ɗaukar su, ciki har da mutane, tsawon dubbai.
Har zuwa shekara ta 2003, an san cewa cututtukan mutum guda biyu (HCoV) suna haifar da wani rashin lafiya mai sauƙi, kamar sanyi.
Cutar cutar ta hanyar numfashi mai tsanani (SARS) da kuma cutar ta hanyar numfashi ta Gabas ta Tsakiya (MERS) sun canza tunaninmu game da yadda cutar coronavirus za ta iya zama mummunar haɗari ga rayuwa.
Fitowar cutar coronavirus mai tsanani ta hanyar numfashi (SARS-CoV-2) a tsakiyar kasar Sin a ƙarshen 2019 ta sake jawo hankalin mutane game da cutar coronavirus kuma ta ba mu mamaki game da yawan watsawa amma rashin ƙarfi na cutar idan aka kwatanta da SARS-CoV.
Kwayar cutar korona ta mutum ita ce cutar dabbobi, kuma fahimtar asalin cutar dabbobi zai taimaka sosai.
Yawancin cututtukan coronavirus na mutum sun fito ne daga kwari, wanda ba su da cutar.
An kuma san tankuna masu ɗaukar wasu cututtukan coronavirus na ɗan adam.
Za a iya sanin dabbobi masu ɗaukar hoto da kai tsaye don hana yaduwar cututtukan mutane.
Nazarin yadda dabbobi suke hulɗa da juna a cikin mutane zai iya ba da haske game da cutar coronavirus.
A cikin wannan bita, mun ba da bayanai game da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Yana da muhimmanci a lura cewa muna gwadawa da kuma kwatanta cututtukan coronaviruses daban-daban na mutum dangane da juyin halitta na kwayar cutar da kuma sake haɗuwa da kwayoyin halitta.
A cikin wannan mahallin, ana yin la'akari da annobar cutar ta yau da ta haifar da cutar coronavirus da aka gano a shekarar 2019 (COVID-19).
Ƙari ga haka, an lura da yanayin da ake bukata don canja masu ɗaukar hoto da kyau, da kuma yadda juyin halittar ƙwayar cuta yake shafar yanayin rashin lafiya.
Kwayoyin cutar Coronaviridae suna cikin iyalin Coronaviridae, wanda shine rukuni na ƙwayoyin cuta na ƙwayoyin cuta tare da madaurin RNA mai kyau.
Waɗannan ƙwayoyin cuta da ke da ƙwayar cuta mafi girma a cikin ƙwayoyin cuta na RNA, wanda ke ɗauke da nucleotides 26,000 zuwa 32, sun sami suna saboda siffar da suke da ita, wanda idan aka duba ta a cikin microscope na lantarki yana kama da kambi.
A tsarin, kwayar cutar korona tana dauke da kwayoyin halitta da ba a rarraba su ba, kuma suna da tsari iri ɗaya.
Kimanin kashi biyu bisa uku na kwayoyin halitta suna dauke da manyan manyan bangarori biyu masu rufewa (ORF1a da ORF1b) wadanda suke watsawa zuwa polyproteins na pp1a da pp1ab.
Ana kuma sarrafa waɗannan furotin don samar da furotin 16 da ba a tsara su ba, wanda aka ambata nsp1 ~ 16.
Sauran ɓangaren genome yana ɗauke da buɗe ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ ƙ ƙididdigar ƙ ƙ ƙ ƙididdigar ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ ƙ
Wasu kwayoyin cutar korona suna da wasu ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Bisa ga bambance-bambance a cikin jerin sunadarai na furotin, ana rarraba kwayar cutar zuwa nau'i hudu (alfa, beta, gamma- da delta-coronavirus), yayin da nau'in beta-coronavirus ya haɗa da yawancin kwayar cutar mutum kuma an rarraba shi zuwa layi huɗu (A, B, C da D).
Akwai hujjojin ilimin halittu na cewa yawancin kwayoyin alpha da beta sune linzamin kwamfuta da kuma linzamin kwamfuta, yayin da tsuntsaye sune babban tanki don gamma da delta coronavirus.
A cikin shekaru dubbai, ƙwayoyin cuta na coronavirus sun ci gaba da ƙetare ƙalubale tsakanin nau'o'in su, kuma wasu sun samo asali zuwa cututtuka masu haɗari ga mutane.
A yau an san mutum bakwai da suka kamu da cutar korona.
HCoV-229E da HCoV-NL63 sun haɗa da alfakoronaviruses na mutum.
Sauran biyar na beta-coronavirus sun haɗa da HCoV-OC43, HCoV-HKU1, cutar sankarar rigakafin numfashi mai tsanani (SARS-CoV), cutar sankarar rigakafin numfashi mai tsanani (MERS-CoV) da kuma cutar sankarar rigakafin numfashi mai tsanani na SARS-CoV-2 na biyu.
Kwayoyin cutar HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63 na mutum galibi suna haifar da alamun bayyanar cututtuka masu sauƙi, kamar sanyi da (ko) fitsari.
Sabanin haka, SARS-CoV, MERS-CoV da kuma sabon SARS-CoV-2 suna da matukar cutarwa, suna haifar da cututtukan cututtukan ƙananan numfashi a cikin yawancin marasa lafiya tare da mafi girman yiwuwar ci gaba da cututtukan numfashi mai tsanani (ORD) da bayyanar cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
An samo igiyar farko ta cutar korona ta mutum HCoV-229E, B814, daga samfurin da aka raba daga hanci na marasa lafiya da suka kamu da sanyi a shekarun 1960.
Tun daga lokacin, bincike mai zurfi ya ba da ƙarin bayani game da cutar HCoV-229E da HCoV-OC43, waɗanda ke haifar da alamun kamuwa da cuta ta gida.
Hakika, kafin a soma cutar ta shan numfashi mai tsanani (SARS), akwai ra'ayi da aka amince da shi cewa kamuwa da cutar coronavirus ba ta da lahani.
Cutar SARS a shekara ta 2003 ta kasance ɗaya daga cikin cututtukan da suka fi muni a tarihin yau; fiye da mutane 8,000 sun kamu da cutar, kuma jimlar mutuwar ta kai kusan 10%.
Shekaru goma bayan haka, cutar ta hanyar numfashi ta Gabas ta Tsakiya (MERS) ta haifar da ciwon daji mai tsawo a yankin Larabawa, kuma ta bazu zuwa sauran ƙasashen duniya.
An gano sabon kwayar cutar coronavirus (2019-nCoV) a cikin 2019, wanda daga baya aka sake masa suna SARS-CoV-2, shine wanda ya haifar da cutar cutar ta cutar coronavirus ta 2019 (COVID-19), wacce ta kashe fiye da 3,120 mutane a ranar 3 ga Maris, 2020, kuma yawan masu kamuwa da cutar ya wuce 91,000.
An samu wata sanarwa mai ban tsoro, kuma dole ne duniya ta shirya don cutar SARS-CoV-2 mai zuwa.
Dukkanin cututtukan cutar korona guda bakwai na mutum sun fito ne daga dabbobi masu rai, kuma tushen su sune linzamin kwamfuta, linzamin kwamfuta ko dabbobi.
Ƙididdigar bayanai da yawa sun nuna cewa dukkanin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtuk
Cutar COVID-19 ta kawo wa Sin da sauran duniya kalubale mai tsanani a fannin kiwon lafiya, kimiyya, zamantakewa da kuma ɗabi'a.
Binciken yadda kwayoyin cutar korona suka samo asali a cikin dabbobi zai taimaka mana mu fahimci tarihin halitta da kuma abubuwan da ke motsa juyin halitta da kuma abubuwan da ke hana rarraba kwayoyin.
Zai iya kuma ba da shawara ko kuma hanzarta gano wani tanki, mai ɗaukar SARS-CoV-2 na matsakaici da mai haɓaka, wanda ke da mahimmanci don hana cutar ta sake yaduwa a nan gaba.
Wannan bita ya ƙunshi cikakkun bayanai game da asalin dabbobi, watsa tsakanin jinsuna da kuma kamuwa da cutar coronavirus.
A cikin wannan labarin, mun gano kuma mun tattauna wani abu na musamman: Kwayoyin cutar da suka samo asali daga kwayar cutar ta mutum ba su da cutar a cikin tanki, amma suna da cutar bayan an watsa su zuwa sabon mai ɗaukar.
Muna kuma nazarin yanayin juyin halitta na kwayar cutar a cikin mutane, wanda ya nuna cewa yawanci ana samun karuwar cutar ta hanyar rage yawan kwayoyin cutar.
A wannan mahallin kuma ana la'akari da sakamakon barkewar cutar SARS-CoV-2.
An san dabbobi masu cutar korona tun daga ƙarshen shekarun 1930.
Kafin a fara gano nau'in B814 na cutar HCoV-229E daga samfurin da aka ware daga hancin marasa lafiya masu sanyi, an gano nau'ikan coronavirus daban-daban a cikin dabbobi daban-daban da suka kamu da cutar, gami da hinds, beraye, shanu, aladu, kuliyoyi da karnuka.
A cikin shekaru goma da suka gabata, an gano mutum bakwai da ke dauke da cutar korona.
A cikin tebur na 1, an ba da taƙaitaccen tarihin gano cututtukan coronavirus na mutum a cikin tsari.
An samo nau'in farko na HCoV-229E daga samfurin numfashi na marasa lafiya da ke da cutar ta hanyar numfashi a shekara ta 1966; daga baya wannan kwayar ta dace da haɓaka a cikin layin ƙwayoyin huhu na WI-38.
Marasa lafiya da cutar HCoV-229E ta kamu da su sun nuna alamun sanyi, ciki har da ciwon kai, tsatsa, rashin lafiya na gaba ɗaya da ciwon wuya, yayin da zazzabi da tari suka kasance a 1020% na lokuta.
Daga baya, a shekara ta 1967, an cire cutar HCoV-OC43 daga al'adun kwayoyin halitta kuma aka tura ta cikin kwakwalwar da aka yi amfani da ita.
Alamun cututtukan cututtukan HCoV-OC43 suna kama da bayyanar cututtukan HCoV-229E, wanda alamun su ba su bambanta da cututtukan sauran hanyoyin numfashi ba, kamar cutar mura ta nau'in A da rhinovirus.
HCoV-229E da HCoV-OC43 suna da yawa a duniya kuma yawanci ana watsa su a cikin latitudes masu matsakaici a lokacin hunturu.
A yawancin lokaci, waɗannan ƙwayoyin cuta biyu suna da tsawon mako guda, kuma suna da kusan mako biyu na rashin lafiya.
A cewar binciken da aka yi a kan masu sa kai, mutane masu lafiya da ke dauke da cutar HCoV-229E sun kamu da sanyi mai sauƙi.
Wasu marasa lafiya da suka raunana rigakafi ne kawai suka kamu da cututtukan huhu.
Cutar SARS, wanda aka fi sani da cutar ta cutar huhu ta yau da kullum, ita ce ta farko a tarihin 'yan Adam da aka rubuta ta hanyar cutar coronavirus ta mutum, kuma cutar ta SARS-CoV, wanda shine cutar ta uku ta mutum.
An fara gano cutar SARS a ƙarshen shekara ta 2002 a lardin Guangdong na kasar Sin.
A lokacin annobar SARS, an rubuta shari'o'i 8,096 na kamuwa da cutar da mutuwar 774, kuma cutar ta bazu a ƙasashe da nahiyoyi daban-daban.
Ba tare da la'akari da masu yaduwa ba, an kiyasta cewa kowane mai cutar zai iya kamuwa da mutane biyu; lokacin incuba ya kasance daga kwanaki 4 zuwa 7, kuma ƙarancin ƙwayar cutar ya kasance a rana ta 10 na rashin lafiya.
A farkon, marasa lafiya da suka kamu da cutar SARS-CoV sun sami ciwon tsoka, ciwon kai, zazzabi mai zafi, rashin lafiya da kumburi, kuma daga baya sun sami numfashi, tari da rashin numfashi.
Abubuwan da suka fi faruwa a cikin gwajin gwaji na SARS sune lymphophenia, rashin lafiyar hanta, da kuma yawan creatine kinase.
Hakanan, marasa lafiya da ke fama da cutar SARS suna fama da lalacewar alveolar diffuse, haɓakar ƙwayoyin epithelial da haɓaka matakan macrophages.
Kimanin kashi 20 cikin 30 na marasa lafiya suna bukatar ci gaba da jinya da kuma numfashi na huhu.
A irin wannan yanayin, wasu gabobin jiki da kuma na cikin gida da kuma na cikin gida da kuma na koda suna iya kamuwa da cutar, ba kawai na cikin gida ba, amma kuma na cikin gida. Wannan yakan sa a samu hadari mai tsanani na cytokine, wanda zai iya zama mai kisa musamman ga marasa lafiya da ke da rashin ƙarfi.
A karon farko, an gano cutar ne daga wani mutum da ya zo Hong Kong daga birnin Guangzhou.
Tun daga lokacin, an yi ƙoƙari sosai wajen yin bincike a kan cututtukan coronavirus na mutane.
A ƙarshen 2004, an gano HCoV-NL63 a cikin jariri mai wata 7 daga Netherlands.
Da farko, an gano cewa yana shafan yara da tsofaffi da kuma marasa lafiya da ke fama da rashin ƙarfi da kuma cututtukan numfashi.
Cutar da HCoV-NL63 ke haifarwa ta ƙunshi cututtuka kamar kumburi, cututtukan jiki, zazzabi mai zafi, da kuma bronchiolitis.
Wani bincike na musamman ya bayyana cewa an gano wannan kwayar daga hanci na wani yaro mai wata takwas a ƙasar Netherlands da ke fama da ciwon huhu.
An gano cutar a ƙasar Netherlands, amma a gaskiya, ta bazu ko'ina.
An kiyasta cewa HCoV-NL63 yana haifar da kusan kashi 4.7% na cututtukan numfashi da yawa, kuma ƙarancin cututtukan da suke haifar da su ya faru a farkon bazara, bazara da hunturu.
HCoV-NL63 yana da alaƙa da laryngitis na obstructive, wanda ake kira curve.
An gano HCoV-HKU1 a Hong Kong a wannan shekarar daga wani mutum mai shekaru 71 da aka kwantar da shi asibiti tare da cutar huhu da bronchiolitis.
Baya ga cutar huhu da kuma cutar bronchiolitis, HCoV-HKU1 an danganta shi da ciwon asma.
Kamar HCoV-NL63, HCoV-229E, da HCoV-OC43, an gano cutar HCoV-HKU1, wadda ke haifar da cututtukan numfashi masu sauƙi a duniya.
Dukkanin cututtukan mutum guda huɗu da ke haifar da cututtukan waje sun dace da mutane sosai, kuma juyin halittarsu da ke haifar da cututtukan cututtuka masu yawa ba su da tabbas, kodayake ba a san abin da ya faru da kuma dalilinsa, kamar yadda a cikin wani misali mai ban mamaki na HCoV-NL63, wanda a kwanan nan aka ruwaito ya haifar da mummunan kamuwa da hanyoyin numfashi a China.
Yawancin lokaci, idan aka sami damar watsawa da kuma kiyayewa cikin jiki, waɗannan cututtukan za su zama marasa ƙwayoyin cuta ko kuma marasa lafiya.
An fara gano cutar ta hanyar cutar ta numfashi ta Gabas ta Tsakiya (MERS-CoV) a shekara ta 2012 a Saudiyya daga wani mutum mai shekaru 60 da haihuwa mai fama da cutar huhu mai tsanani da kuma rashin karfin koda.
Yawancin lokuta da aka tabbatar da su a cikin dakin gwaje-gwaje sun faru ne a Gabas ta Tsakiya, amma a ƙasashen Turai daban-daban da Tunisiya an yi rahoton shigo da su da kuma yaduwar cutar ta hanyar cututtukan cututtuka na biyu.
Wani fashewar ta biyu da aka tabbatar da 186 a Koriya ta Kudu a shekarar 2015.
Abubuwan da ke faruwa a cikin asibiti na ciwon hanta na gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gabashin gab da gab da gab.
Ba kamar SARS ba, yawancin marasa lafiya da ke fama da cutar MERS sun sami ciwon koda mai tsanani, wanda har yanzu ya bambanta MERS da sauran cututtukan da ke tattare da cutar coronavirus da ke yaduwa zuwa mutum.
Fiye da kashi 30 cikin dari na marasa lafiya suna da alamun hanji kamar fitsari da kuma zubar da ciki.
A ranar 14 ga Fabrairu, 2020, an tabbatar da fiye da 2,500 na asibiti na ciwon huhu na Gabas ta Tsakiya tare da babban adadin mutuwa (34.4%), saboda haka MERS-CoV ana ɗaukarsa ɗayan cututtukan da suka fi mutuwa da aka sani ga mutum.
A tsakiyar zuwa ƙarshen Disamba na 2019, an gano tarin marasa lafiya da cutar huhu a Wuhan, lardin Hubei na kasar Sin, wanda yanzu, idan aka duba baya, ana danganta shi da kamuwa da cutar coronavirus mai tsanani ta hanyar cutar ta numfashi ta nau'i na 2 (SARS-CoV-2).
Hukumar lafiya ta duniya ta bayyana cewa ci gaba da barkewar kamuwa da cutar ta hanyar numfashi ta kasa, wanda SARS-CoV-2 ya haifar, ya zama gaggawa a duniya a fannin kiwon lafiya, kuma an kira cutar ta cutar ta coronavirus 19 (COVID-19).
A ranar 3 ga Maris, 2020, an yi rajistar kamuwa da cutar 90 053 a duniya, inda mutuwar ta kai kusan 3,4%.
Ya kamata a lura cewa mutuwar a lardin Hubei na kasar Sin ta kai kashi 4.2 cikin dari, kuma a wajen kasar akwai kashi 1.2 cikin dari.
SARS-CoV-2, kamar SARS da MERS, yana haifar da mummunan kamuwa da numfashi, wanda ke nuna yawan zafin jiki, tari da numfashi.
Wasu marasa lafiya ma suna fama da ciwon hanci.
Ciwon huhu yana cikin alamun da suka fi tsanani kuma yana iya saurin zama rashin numfashi.
Duk da kamanceceniya tsakanin SARS-CoV da SARS-CoV-2, duk da cewa suna da babban homology na jerin nucleotides (82%), waɗannan ƙwayoyin cuta duk da haka suna samar da rassan daban-daban na itacen phylogenetic.
SARS-CoV-2 a bayyane yake ba shi da cutar, amma yana da ƙwarewar watsawa fiye da SARS-CoV da MERS-CoV.
An samu kamuwa da cutar SARS-CoV-2 ba tare da wata alama ba, wanda ke nuna cewa cutar tana iya yaduwa cikin sauri a duniya.
Idan aka kwatanta SARS-CoV-2 da sauran cututtukan mutum shida, za a iya gano muhimman kamanceceniya da bambance-bambance.
Na farko, cututtukan coronavirus da ake watsawa suna da lokaci na yin kamuwa da cutar da suka yi kama da na sauran cututtukan.
A wannan yanayin, SARS-CoV-2 yana nuna irin wannan yanayin da sauran cututtukan coronavirus shida na mutum ke nunawa.
Na biyu, a cikin matsanancin alamun COVID-19, akwai tsakanin SARS-CoV da cututtukan mutum guda huɗu da ke haifar da cututtukan waje (watau HCoV-229E, HCoV-OC43, HCoV-HKU1 da HCoV-NL63).
A gefe guda, bayyanar cututtukan SARS-CoV-2 sun yi kama da waɗanda aka fi gani a lokacin kamuwa da kwayar cutar coronavirus ta mutum, wanda ke haifar da cututtukan waje, gami da bayyanar cututtuka, bayyanar cututtuka masu sauƙi ko ma rashin bayyanar cututtuka.
A gefe guda kuma, kamar yadda yake a SARS-CoV, za a iya gano ƙananan ƙananan ƙananan COVID-19, ko da yake rabo a nan ya ɗan ƙasa.
Na uku, akwai wasu abubuwa masu ban sha'awa game da watsa SARS-CoV-2 da ke tattare da kwayar cutar coronavirus na mutum da ke haifar da cututtukan waje da asibiti da kuma SARS-CoV.
A gefe guda, cutar SARS-CoV-2 tana da matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin matsakaicin.
A gefe guda kuma, har yanzu ana buƙatar bincika ko za a iya rage yawan kamuwa da cutar SARS-CoV-2 tare da kowane wucewar cutar (watau kamuwa da kowane mutum na gaba), kamar yadda yake a cikin SARS-CoV da MERS-CoV.
A ƙarshe, kamar sauran cututtukan mutum na coronavirus da ke haifar da cututtukan waje, ana iya gano SARS-CoV-2 a cikin samfurori na ƙura.
Har yanzu muna da amsar tambayar ko hanyar wucewa ta hanyar SARS-CoV-2 tana da mahimmanci (aƙalla a wasu yanayi) kamar yadda yake a cikin SARS-CoV.
Wani abu kuma da ya fi sha'awa shi ne yiwuwar SARS-CoV-2 na yanayi, wanda ke haifar da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cutut
Duk da haka, ci gaban ci gaba da barkewar COVID-19 zai dogara ne akan halaye na SARS-CoV-2, gami da watsawa, kamuwa da cuta da kuma ci gaba da yaduwa bayan ya wuce mutane.
Kowane mutum guda hudu da ke kamuwa da cutar coronavirus da ke haifar da cututtuka na waje da asibiti da alamun bayyanar cututtuka sun dace da mutane sosai.
A gefe guda kuma, wataƙila mutanen sun saba da waɗannan ƙwayoyin cuta guda huɗu na mutum.
A wasu kalmomi, za a iya cewa waɗannan da wasu ne kawai suka tsira daga annobar cutar coronavirus ta mutane a baya.
Mutane da ke fama da cututtukan cututtuka masu tsanani da kuma mutanen da ke fama da cututtuka masu tsanani ba su tsira ba.
Don haka, dole ne kwayar cutar ta mutum ta yi yawa a jikin mutum don ta samu karuwar canji na daidaitawa da ke hana ƙuntatawa.
Saboda haka, idan cutar ta SARS-CoV-2 ta daɗe kuma mutane da yawa sun kamu da cutar, za a iya samun damar kamuwa da cutar sosai.
Idan aka daidaita shi sosai, zai yi wuya a hana shi yaduwa cikin mutane ta hanyar yin amfani da rigakafi ko wasu hanyoyin hana kamuwa da cututtuka.
A cikin shekaru da yawa, mutane sun kamu da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Waɗannan ƙwayoyin ba sa bukatar dabba mai tanadi.
Kwayoyin cutar SARS-CoV da MERS-CoV ba su dace da mutum ba kuma ba za a iya ci gaba da watsa su ba.
Suna bukatar su ci gaba da yin yawa a cikin tankuna na dabbobi kuma su nemi damar yin amfani da wata hanyar da za ta iya kaiwa mutane ga manufa, wataƙila ta hanyar matsakaici ko masu ƙarfafawa.
SARS-CoV-2 yana da halaye kamar SARS-CoV/MERS-CoV da kuma ƙwayoyin cuta huɗu na HCoV.
Yana da sauƙin kamuwa da cutar kamar HCoV na asibiti, aƙalla a yanzu.
Amma yana da cutar fiye da HCoV na waje, kuma ba shi da cutar fiye da SARS-CoV ko MERS-CoV.
Abin da za a gani shi ne ko zai dace da mutum sosai kuma zai yi aiki a cikin mutane ba tare da tanki ba ko kuma tare da dabba mai ɗaukar kaya.
Kafin mu tattauna asalin dabba na HCoV, zai yi kyau mu tattauna ma'anar da kuma halaye na juyin halitta, na halitta, na tsakiya, na ƙarfafawa da na tanki na HCoV.
Dabba tana da halittar HCoV idan ta ɗauki wani abu mai kama da juna wanda yake da irin wannan halayen a matakin jerin nucleotides.
A yawancin lokaci, ƙwayar da aka haifa daga wurinsa tana da kyau kuma ba ta da cutar a cikin wannan mai ɗaukar hoto.
Hakazalika, mai ɗaukar tankuna yana ɗaukar HCoV a kai a kai na dogon lokaci.
A lokuta biyu, masu ɗaukar hoto suna da kamuwa da cutar ta halitta kuma suna ɗaukar HCoV ko ƙwayar mahaifa ta halitta.
Akasin haka, idan an shigar da HCoV ne kawai a cikin wani matsakaici kafin ko kusa da lokacin da aka shigar da shi cikin mutum, ba a daidaita shi da kyau ga sabon mai ɗaukar hoto ba kuma galibi yana haifar da cutar.
Wannan matsakaiciyar hanyar tana iya zama tushen cutar dabbobi ga mutane kuma tana iya zama mai karfafawa, ta hanyar ba da damar kwayar cutar ta sake juyawa ta hanyar walƙiya, sannan kuma ta ba da ita ga mutane, ta ƙara yawan kamuwa da cutar.
HCoV na iya ɗaukar kamuwa da cutar ta ɓoye idan ba zai iya jurewa ba a cikin matsakaiciyar hanyar.
A akasin haka, HCoVs na iya daidaitawa zuwa matsakaiciyar hanyar kuma har ma da kasancewa cikin dogon lokaci.
A wannan yanayin, matsakaiciyar mai ɗaukar kaya ta zama mai ɗaukar tanki na halitta.
Bayanai na cututtuka sun nuna cewa marasa lafiya marasa lafiya na SARS suna da alaƙa da dabbobi masu farauta (wildlife).
Ƙarin bincike na sipreprevalence ya nuna cewa masu sayar da dabbobi suna da ƙarin maganin IgG ga cutar SARS-CoV fiye da yawan jama'a.
Cats na Himalayan (Paguma larvata) da kuma karnuka masu launin fata a cikin kasuwannin dabbobi sun zama masu ɗaukar kwayar cutar da aka fara ganowa, kamar SARS-CoV.
Wannan ya tabbatar da hakan ta hanyar cewa bayan an kawar da dukan ciwo a cikin kasuwanni, ba a sake samun rahoton SARS ba.
A lokaci guda kuma, an ruwaito cewa a yawancin lokuta, ba a gano SARS-CoV a cikin 'yan tsibirin Himalayan da ke rayuwa a yanayi ko gonaki ba, wanda ke ba da damar yin ƙarshe cewa tsibirin Himalayan na iya zama matsakaiciyar mai ɗaukar ƙarfi, ba tankin SARS-CoV na halitta ba.
Yana da muhimmanci a lura cewa, tun da kashi 80 cikin 100 na dabbobi a kasuwannin Guangzhou suna da maganin rigakafi ga SARS-CoV, ba za a iya ware yiwuwar cewa nau'ikan ƙananan dabbobi masu shayarwa ma za su iya zama masu karfafawa na matsakaici ba.
Dukkansu suna kama da masu dauke da cutar SARS-CoV.
Binciken da aka yi na dabba mai ɗaukar SARS-CoV ya gano wani nau'in CoV na linzamin kwamfuta wanda aka kira cutar coronavirus HKU3 (SARSr-Rh-BatCoV HKU3) da ke da alaƙa da cutar pneumonia ta linzamin kwamfuta ta China.
Waɗannan berayen sun yi aiki da maganin rigakafin SARS-CoV da kuma tsarin genomic na SARSr-Rh-BatCoV HKU3.
Waɗannan da sauran cututtukan coronavirus na linzamin kwamfuta suna da kashi 8892% na tsarin homologin nucleotides kamar SARS-CoV.
Wannan binciken ya kafa tushen wani sabon ra'ayi cewa tsuntsaye sun zama masu kawo sababbin cututtukan mutum.
An gano wasu cututtukan coronavirus (SL-CoV) da yawa a cikin linzamin kwamfuta, amma ba wanda zai iya ware shi a matsayin kwayar cutar mai rai, sai dai wanda aka ambata a matsayin WIV1.
An san cewa mai karɓar SARS-CoV shine enzyme mai canza angiotensin 2 (ACE2).
An nuna cewa WIV1, wanda aka samo daga gwajin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin.
Abin mamaki, jinin marasa lafiya da ke warkewa daga cutar SARS zai iya hana WIV1.
A yau, WIV1 yana wakiltar dangi mafi kusa na SARS-CoV a cikin linzamin kwamfuta, yana raba 95% na homology na jerin nucleotides.
Duk da cewa akwai babban homologue tsakanin waɗannan ƙwayoyin cuta biyu, an yi imani da cewa WIV1 ba shine ainihin mahaifa na SARS-CoV ba, kuma beraye ba su kasance masu ɗaukar tanki na SARS-CoV ba.
Binciken ilimin halittu ya nuna cewa cutar MERS-CoV tana cikin rukuni ɗaya da CoV-HKU4 a cikin linzamin kwamfuta da kuma CoV-HKU5 a cikin linzamin kwamfuta.
CoV-HKU4 da kuma MERS-CoV suna amfani da mai karɓar mai karɓar guda ɗaya, dipeptildippeptidease-4 (DPP4), don shigar da ƙwayoyin cuta.
Tsarin RNA-daidaitaccen RNA-polymerase na cutar MERS-CoV ya fi kusa da tsarin kwayoyin halitta na beta-coronavirus na linzamin kwamfuta da aka gano a Turai da Afirka.
Har yanzu ba a gano wani kwayar cutar MERS-CoV a cikin fararen fararen ba.
Tsarin kwayoyin halitta na MERS-CoV da CoV-HKU25 na makamai masu tashi sun dace da kashi 87 cikin ɗari.
Wannan yana nufin cewa, ƙuƙwalwa ba su da wataƙila su ne masu ɗaukar kwayar cutar MERS-CoV.
A wani bangaren kuma, bincike a Gabas ta Tsakiya ya nuna cewa raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙuman raƙ
An gano wani kwayar cutar MERS-CoV mai rai, wadda ta yi kama da wadda aka gano a cikin mutane, daga hancin raƙumi guda, wanda ya ƙara tabbatar da matsayin raƙumi a matsayin ainihin masu ɗaukar tanki na MERS-CoV.
Ya kamata a lura cewa raƙuman da aka kamu da cutar ta MERS-CoV a gwaji sun sami alamun rashin ƙarfi amma sun sami ƙwayoyin cuta masu yawa.
Ya kamata a lura cewa rakuman da suka kamu da cutar ba ta hanyar numfashi kawai ba, har ma ta hanyar magungunan da ke cikin bakinsu, wanda kuma shine babban hanyar fitar da cutar a cikin fararen.
Amma har yanzu akwai tambayoyi, saboda yawancin cututtukan cututtukan numfashi na Gabas ta Tsakiya ba su da alaƙa da raƙuma kafin bayyanar cututtuka kuma suna da tabbacin cewa ana iya ɗaukar su daga mutum zuwa mutum ko kuma ta hanyar hanyoyin da ba a san su ba, wanda ya haɗa da nau'ikan dabbobi da ba a gano ba waɗanda ke ɗaukar MERS-CoV.
Tsarin nucleotides na SARS-CoV-2 ya yi daidai da CoV RaTG13 na linzamin kwamfuta da aka gano a cikin Rhinolophus affinis na Asiya.
Kamar yadda yake a SARS-CoV da MERS-CoV, bambancin jeri tsakanin SARS-CoV-2 da RaTG13 ya yi yawa sosai don a danganta su da dangantaka ta iyaye.
Wannan yana nufin cewa, ƙuƙwalwa ba za su iya zama masu ɗaukar SARS-CoV-2 ba, sai dai idan an gano kusan irin wannan cutar a nan gaba.
An yi hasashen cewa dabbobi masu dauke da cutar SARS-CoV-2 na musamman suna cikin namun daji da ake sayar da su a kasuwar sayar da kayayyakin teku ta Wuhan, wanda ya danganta da yawan farkon COVID-19, wanda ke nuna yiwuwar watsa daga dabba zuwa mutum.
Wasu bincike na kwanan nan da aka yi ta hanyar yin jerin sunayen halittu sun nuna cewa wasu ƙananan dabbobi masu shayarwa da ke cikin haɗari da za a hallaka, waɗanda aka sani da pangolin (Manis javanica), na iya ɗaukar betacoronavirus na iyaye, nau'in SARS-CoV-2.
Hominoloji na jerin kwayoyin halitta na waɗannan sabbin kwayoyin cutar pandolines na 8592% ya dace da SARS-CoV-2.
Amma kuma suna da alaƙa da RaTG13, kuma suna da daidaito a matakin jerin nucleotides kusan kashi 90%.
Ana rarraba su a cikin bambancin bambancin kwayar cuta guda biyu, kamar SARS-CoV-2, a cikin itacen phylogenetic, ɗayan wanda yake da yankin mai ɗaure mai karɓar (RCD) mafi kusa da SARS-CoV-2 tare da daidaitattun amino acid a matakin 97,4%.
A akasin haka, SARS-CoV-2 da RaTG13 sun fi bambanta da juna, duk da cewa suna da girma a cikin tsarin homology a cikin dukan kwayoyin halitta.
Wani bincike na baya a kan marasa lafiya na pangolin ya kuma nuna cewa an gano ƙwayoyin cuta a cikin samfurori daga huhu waɗanda suka kasance cikin zumunta da SARS-CoV-2.
Wannan binciken ya yi amfani da wasu hanyoyin tattarawa da kuma sarrafawa da hannu don samun jerin kwayoyin halitta, wanda ya ƙunshi kusan kashi 86.3% na cikakken kwayoyin halitta na kwayar cutar.
Ba za a iya ware yiwuwar cewa pangolin ya zama ɗaya daga cikin dabbobi masu ɗaukar SARS-CoV-2 na tsakiya ba.
Duk da haka, saboda bambancin jerin halittu tsakanin SARS-CoV-2 da beta-coronavirus na pangolin, wanda yake da alaƙa da SARS-CoV-2, a halin yanzu babu wata hujja da ke tallafawa ainihin asalin SARS-CoV-2 daga pangolin.
Bugu da ƙari, nesa tsakanin SARS-CoV-2 da RaTG13 ya fi gajere fiye da tsakanin SARS-CoV-2 da beta-coronavirus na pangolin da ke da alaƙa da SARS-CoV-2.
Ba a gano hanyar juyin halitta ta SARS-CoV-2 a cikin beraye, pangolin da sauran dabbobi masu shayarwa ba tukuna.
Duk da yake an gano mafi girman homology na jerin a cikin RCD tsakanin SARS-CoV-2 da beta-coronavirus na pangolin, dangin SARS-CoV-2, SARS-CoV-2 da RaTG13 suna da mafi girman homology na jerin a cikin dukkanin genome.
A ka'idar, yawancin kamanceceniya tsakanin beta-coronavirus na pangolin, wanda yake da nasaba da SARS-CoV-2, da SARS-CoV-2 yana da alaƙa da juyin halitta na lokaci tare ta hanyar zaɓin.
Wannan ƙudurin ya nuna cewa ana son sake haɗuwa tsakanin cutar pandolyn beta-coronavirus, wadda ta kasance dangin SARS-CoV-2, da RaTG13 a cikin nau'in dabbobi na uku.
A matsayin mai motsa juyin halitta, sake haɗuwa yana da yawa a cikin beta-coronavirus.
Har yanzu babu wani bayani game da asalin dabbobi na SARS-CoV-2.
Baya ga cututtukan HCoV masu cutar, ana nazarin asalin dabbobi na HCoV-229E, HCoV-OC43, HCoV-NL63 da HCoV-HKU1.
Shaidar ilimin halittu ta nuna cewa HCoV-NL63 da HCoV-229E na iya fitowa daga kwayar cutar coronavirus a cikin linzamin kwamfuta, yayin da aka gano ƙwayoyin cuta na HCoV-OC43 da HCoV-HKU1 a cikin rodents.
An ruwaito cewa cutar coronavirus ta linzamin kwamfuta, wacce aka kira ARCoV.2 (Appalachian Ridge CoV) kuma an gano ta a cikin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙafin ƙ
A gefe guda kuma, HCoV-229E yana da alaƙa ta hanyar halitta da wani kwayar cutar kwayar cutar ta linzamin kwamfuta mai suna Hipposideros/GhanaKwam/19/2008, wanda aka gano a Ghana, kodayake akwai zargin cewa raƙuma na iya zama masu ɗaukarsa.
Don bayyanawa, an taƙaita ilimin zamani game da asalin dabbobi na sanannun cututtukan coronavirus a hoto na 1 da kuma tebur na 2.
Binciken ilimin lissafi ya ba da hujja game da abubuwan da suka faru na watsa HCoV tsakanin jinsuna a cikin tarihin.
A shekara ta 1890 ne aka samu kamuwa da cutar HCoV-OC43 a tsakanin jinsuna kuma mutane sun kamu da cutar daga dabbobi, an gano cutar kamuwa da cutar numfashi.
Tarihin watsa HCoV-229E tsakanin jinsuna bai bayyana ba.
An gano alpha-coronavirus a cikin linzamin kwamfuta, wanda yake da alaƙa da HCoV-229E.
A tsakanin su akwai cutar alphacoronavirus ta alpaca.
Wasu bayanai sun nuna cewa mutum zai iya samun cutar daga tsuntsaye zuwa mutum.
Na farko, mutane ne, ba Alpaks ba, suka yi hulɗa da su a cikin yanayin da ke cikin yanayi.
A lokaci guda, mutane suna da dangantaka ta kud da kud da Alpaks.
Na biyu, alpha-coronavirus na linzamin kwamfuta, wanda yake da nasaba da HCoV-229E, yana da bambanci da rashin lafiya a cikin linzamin kwamfuta, yayin da alpha-coronavirus na alpaca ya haifar da kamuwa da cutar numfashi a cikin dabbobi masu kamuwa da cutar.
A ƙarshe, ba a gano cutar alphacoronavirus a cikin dabbobin daji ba.
Saboda haka, ba za a iya ware yiwuwar cewa alpikas sun sami cutar alpha-coronavirus, wadda ta danganta da HCoV-229E, daga mutane ba.
A gaskiya, ƙuƙwalwa sune tushen kai tsaye na ƙwayoyin cuta na mutum, ciki har da ƙwayar fushi, Ebola, Nipah, da Hendra.
Saboda haka, ba abin mamaki ba ne cewa linzamin kwamfuta za su iya kai tsaye ga mutane HCoV-229E.
A gefe guda kuma, yayin da alpha-coronavirus na linzamin kwamfuta zai iya zama tushen kwayar HCoV-229E, alpacas da raƙuma na iya zama masu ɗaukar hoto na tsakanin waɗanda ke watsa kwayar cutar ga mutane, kamar yadda yake a cikin cutar MERS-CoV.
MERS-CoV misali ne mai kyau na watsawa tsakanin jinsuna daga beraye zuwa raƙuma da kuma raƙuma zuwa mutum.
An san asalin juyin halitta na cutar MERS-CoV daga linzamin kwamfuta ta hanyar gano ta farko kuma an tabbatar da shi ta hanyar bincike na gaba.
A bayyane yake cewa, ƙwayoyin cuta suna ba da tarin ƙwayoyin cuta masu yawa don rarraba kwayoyin halitta da kuma rarraba su.
Tsawon rayuwarsu, yawan mutanen da suke zama a cikin gidajen, da kuma yadda suke yin aiki tare a cikin al'umma, da kuma yadda suke yin tafiya, suna sa su zama masu rarraba abubuwa.
A wani bangaren kuma, an yi amfani da cutar ta MERS-CoV ne a kan raƙuma shekaru da yawa da suka wuce.
Ya yi aiki sosai don ya daidaita da waɗannan raƙuman, waɗanda suka zama masu riƙe da ruwa na yau da kullum.
A cikin waɗannan dabbobi, cutar MERS-CoV tana haifar da rashin lafiya mai sauƙi kuma tana da ƙananan sauye-sauye.
An yi amfani da shi a wani lokaci don ya kai ga mutum ta hanyar haɗari, kuma mutum ya kasance mai ɗaukar MERS-CoV a matsayin mai ɗaukar hoto, saboda ba a tallafawa watsawa.
Ba kamar yadda raƙuma take yi wajen watsa cutar MERS-CoV ba, bangolin suna da wani matsayi dabam a cikin watsa cutar SARS-CoV-2.
A cikin takamaiman hali, cutar beta-coronavirus ta kangolin tana da matukar cutarwa.
Suna iya zama masu ɗaukar beta-coronavirus na SARS-CoV-2 kamar yadda suke da ciwo a cikin SARS-CoV.
A cikin bincike na gaba, dole ne a tabbatar ko a cire wasu yiwuwar watsa SARS-CoV-2 daga dabbobi zuwa mutum.
Na farko, ƙuƙwalwa na iya zama mai ɗaukar tanki don cutar SARS-CoV-2, kusan kama da SARS-CoV-2.
Mutane za su iya raba yanayin da suke ciki da su ta wajen yin amfani da hayaki ko kuma rarraba ƙwayoyin dabbobi.
Na biyu, pangolin na iya kasancewa cikin masu karfafawa na matsakaici da cutar SARS-CoV-2 ta shiga kwanan nan.
Mutane suna kamuwa da cutar ta hanyar rarraba shuka da cin naman dabbobin daji.
Da alama dabbobi da yawa, har da na gida, suna da saukin kamuwa da cutar SARS-CoV-2.
Ana iya gwada maganin rigakafi a cikin dabbobi da kuma dabbobin daji.
Na uku, kamar yadda aka nuna a sama, SARS-CoV-2 zai iya sake haɗuwa da daidaitawa a cikin nau'i na uku wanda ya yi hulɗa da linzamin kwamfuta da kuma pangolin.
Ana ci gaba da binciken dabba na SARS-CoV-2.
Ban da nau'o'in dabbobi masu ɗaukar hoto, manyan abubuwa uku na ƙwayoyin cuta sun taimaka wajen ƙetare shinge tsakanin nau'o'in.
Na farko, suna da saurin juyawa a cikin kwayar RNA.
Idan aka kwatanta da sauran ƙwayoyin cuta na RNA guda ɗaya, ana iya ɗaukar yawan canjin kwayar cutar ta hanyar tsinkaye-mai girma tare da matsakaicin sauyawa na sauyawa kusan 104 a shekara a wani yanki 2 dangane da yanayin daidaitawar kwayar cutar ga sababbin masu shi.
Kwayoyin cutar korona suna da exoribonuclease mai gyara, wanda cirewa zai haifar da sauye-sauye masu yawa da kuma raunanawa ko ma rashin rayuwa.
Abin sha'awa, wani nau'in kwayoyin halitta mai suna Remdesivir yana hana kwayar cutar coronavirus ta hanyar hana wannan exoribonuclease da RNA-dependent RNA-polymerase.
Remdesivir  yana ɗaya daga cikin magungunan da suka fi ƙarfin cutar SARS-CoV-2 da ake bukata a gwada su a cikin asibiti.
Amma, yawan canjin da ke faruwa a cikin kwayar cutar korona ya kai sau miliyan fiye da na masu dauke da ita.
Bugu da ƙari, sau da yawa, yawan canjin zai iya zama mafi girma idan ba a daidaita ƙwayoyin cutar da kyau sosai ba.
Idan aka kwatanta da SARS-CoV mai yawan mutation, sauyin mutation na SARS-CoV-2 ya zama ƙasa, wanda ke nuna cewa mutane sun fi dacewa da shi.
An ce wannan kwayar ta riga ta daidaita zuwa wani mai ɗaukar hoto kusa da mutum.
Baya ga SARS-CoV-2, wannan ya shafi MERS-CoV, wanda ya dace da raƙuman raƙuma.
A ka'idar, ba zai yiwu allurar rigakafi da magungunan rigakafin cutar SARS-CoV-2 su yi saurin rasa ingancin su ba saboda yanayin kwayoyin halitta.
Na biyu, babban kwayar RNA a cikin kwayar cutar ta coronavirus yana haifar da karko a cikin gyare-gyaren kwayar halitta game da canji da sake haɗuwa, don haka yana ƙara yiwuwar haɓaka tsakanin nau'ikan, wanda ke da kyau ga sabon kwayar cutar ta coronavirus idan akwai yanayi mai kyau.
Wannan yana faruwa ne saboda ƙididdigar ƙididdigar ƙididdiga da kuma ayyukan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Na uku, saboda zaɓin matrix na musamman, cutar korona tana sauya matrix a cikin bazuwar kuma sau da yawa yayin da take sake yin amfani da RNA.
A lokacin da ake yin kwafin DNA na kwayar cutar coronavirus a cikin wani na'urar da ke aiki a matsayin na'urar haɗuwa, sau da yawa ana canza igiyoyi.
Babban kwayoyin halittar kwayoyin halittar da ke cike da kwayoyin halittar kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin kwayoyin halittar da ke cikin halittar da ke cikin halittar da ke cikin halittar da ke cikin halittar.
An gano shaidar phylogenetic na sake haɗuwa ta halitta a cikin HCoV-HKU1 da HCoV-OC43, da kuma cikin kwayar cutar dabba kamar SL-CoV da batCoV-HKU9 na linzamin kwamfuta.
Hadin gwiwar mai ɗaukar kwayar cutar dangane da watsawa
Baya ga waɗannan abubuwa uku na cutar, wani muhimmin abu da ke da muhimmanci ga watsawa tsakanin jinsuna shi ne yadda ƙwayar cuta take hulɗa da mai karɓa.
Wannan labarin ya ba da misali na SARS-CoV a matsayin misali na musamman, wanda kuma ya nuna tabbacin zaɓi mai kyau a cikin abubuwan da suka faru na watsawa tsakanin jinsuna.
Bisa ga kwatancen bincike tsakanin SARS-CoV na mutum da ciwit, ana ganin cewa SARS-CoV yana daidaitawa cikin sauri a cikin masu ɗaukar hoto daban-daban, musamman game da canji a cikin RCD na furotin S.
A wani ɓangare, ƙwayar S tana aiki tare da mai karɓar ƙwayoyin halitta, kuma ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar
RCD na SARS-CoV  amino acid ne, daga 318 zuwa 510 a kan sashin S1, wanda ke haɗuwa da enzymes na mutum na angiotensin-transforming 2 (APF2) da kuma masu karɓar kwayar cutar don shigar da kwayar cutar cikin tantanin halitta.
SARS-CoV RSD na iya gane masu karɓar APF2 na dabbobi daban-daban, gami da tsuntsaye, da tsuntsaye, da kuma karnuka masu launin fata, yana ba da damar watsa cutar tsakanin jinsuna.
A gaskiya ma, an gano amino acid guda shida kawai a cikin RSD, wanda ya bambanta da kwayar cutar mutum da ciwit, kuma 4 daga cikinsu suna cikin mai karɓar mai ɗaurewa don hulɗa da mai karɓar APF2.
SARS-CoV na civet yana da bambancin K479N da S487T a cikin RSD, wanda zai iya haɓaka ƙarancin hulɗar furotin mai kama da furotin tare da mai karɓar APF2 na mutum.
A wasu kalmomi, waɗannan amino acid biyu masu maye gurbin suna da muhimmanci sosai wajen daidaita kwayar cutar zuwa mutum.
Ya kamata a lura cewa SARS-CoV-2 yana da ƙwayar ƙwayar cuta iri ɗaya da SARS-CoV.
Bambanci na 30% tsakanin SARS-CoV-2 da SARS-CoV a sashin S1 na furotin S ya haifar da cewa haɗin haɗin furotin S zuwa APF2 na mutum na iya canzawa.
A gaskiya, binciken da aka yi ta amfani da microscope na cryophone ya nuna cewa wannan haɗin yana da dangantaka sau 1020 fiye da tsakanin APF2 na mutum da furotin S na SARS-CoV.
Zai kuma zama da ban sha'awa a gano ko ana buƙatar wasu masu karɓar saƙo don watsa SARS-CoV-2.
Abin mamaki shi ne, HCoV-NL63 yana da alaƙa da APF2 amma tare da wani ɓangare na furotin S.
Akwai sauran masu karɓar HCoV da yawa, kamar aminopeptide N don HCoV-229E da 9-O-acetylsilic acid don HCoV-OC43.
Suna iya taimaka wa mutane su daidaita waɗannan ƙwayoyin cutar bayan an ba su daga dabbobi masu ɗaukar hoto.
Baya ga ƙwayoyin cuta, sakamakon watsa HCoV tsakanin jinsuna kuma yana ƙarƙashin wasu abubuwan da ke ƙuntatawa da ƙuntatawa.
Wannan ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin cuta na HCoVs tsakanin mutane da masu ɗaukar HCoVs na halitta, kamar su linzamin kwamfuta, raƙuma, da kuma ƙwayoyin cuta, na iya zama cikas ga watsa tsakanin jinsuna.
Don a iya watsa HCoV tsakanin jinsuna, dole ne a kawar da abubuwan da ke tattare da su kuma a yi amfani da abubuwan da ke tattare da ƙuntatawa.
A wannan yanayin, ƙididdigar ƙwayoyin cuta a wannan muhimmin fannin hulɗa tsakanin ƙwayar cuta da mai ɗaukar hoto suna buƙatar ƙayyadewa da rarrabuwa.
Za a iya samun sakamako mai kyau ta hanyar yin bincike na cikakken kwayoyin halitta na masu dogaro da ƙuntatawa ga SARS-CoV-2 ta amfani da sabuwar fasahar CRISPR.
Tashin sabbin HCoV: Komawa zuwa sifili
Bambancin cututtukan coronavirus na linzamin kwamfuta yana ba da dama ga sabon HCoV.
A wannan yanayin, kwayar cutar korona ta cikin linzamin kwamfuta tana da nasaba da HCoV.
Bugu da ƙari, saurin juyawa da kuma sake haɗuwa da kwayoyin halitta suna da ƙarfi wajen juyin halitta na HCoV kuma suna da muhimman matakai biyu a cikin wannan aikin.
Alal misali, samun ko rasa sababbin kwayoyin halitta da ke ba da furotin yana da damar yin canje-canje a cikin ƙwayar cuta.
Daga cikin ƙwayoyin SARS-CoV masu dacewa da dacewa da mutane ana ɗaukar ORF8 a matsayin mahimmanci, saboda ƙwayoyin cuta na linzamin kwamfuta, waɗanda suke da alaƙa da SARS-CoV, an keɓance su, amma an gano cewa suna ba da lambar ƙwayoyin ORF8 masu rarrabe.
A cikin nau'ikan da aka keɓe a farkon annobar ɗan adam, an gano nucleotide 29 na cututtukan SARS-CoV.
Wannan rarrabuwa ta raba ORF8 zuwa ORF8a da ORF8b, kuma ana ganin shi a matsayin juyin halitta mai daidaitawa wanda ke hanzarta maye gurbin masu ɗaukar hoto.
Bugu da ƙari, SARS-CoV yana da tarihin yiwuwar sake haɗuwa da layin alpha da gamma coronavirus, inda aka gano ƙananan wuraren sake haɗuwa a cikin RNA-dogon RNA-polymerase.
An kuma gano wuraren da ake sake haɗuwa a cikin furotin nsp9 mara tsari, mafi yawan nsp10 da kuma sassan nsp14.
Hakazalika, an nuna cewa cutar ta MERS-CoV ta yi rikibin tsakanin layuka, kamar yadda ya faru a cikin raƙuman raƙuma a Saudiyya.
Baya ga SARS-CoV da MERS-CoV, an kuma lura da abubuwan da suka faru a cikin sauran HCoVs, inda HCoV suka sake haɗuwa da sauran ƙwayoyin cuta na dabba a cikin kwayoyin halitta na su.
Ya kamata kuma a yi gargaɗi cewa zaɓen kwayoyin halitta na iya haifar da canje-canje a cikin kwayoyin halitta na kwayar cuta, wanda zai iya faruwa ne ta hanyar kawar da kwayar daga matsin lamba, kamar na tsarin rigakafi na mai ɗaukar.
Misali na irin wannan tasirin shine asarar cikakken ORF4 a cikin nau'in HCoV-229E na asali saboda rarrabuwa biyu.
Yayin da za a iya ganin buɗewar ƙirar karantawa ta ORF4 a cikin ƙwayoyin cuta na linzamin kwamfuta da raƙumi na HCoV-229E, alphacoronavirus na alpaca yana nuna shigarwar nucleotide guda ɗaya, wanda ke haifar da sauya ƙirar.
A ƙarshe, juyin halitta na HCoVs na zamani ya kasance ne saboda matsin lamba a kan masu ɗaukar tankuna.
A lokacin da aka kamu da cutar coronavirus a cikin linzamin kwamfuta, an lura da alamun bayyanar cututtuka ko kuma rashin bayyanar cututtuka, wanda ke nuna cewa linzamin kwamfuta da linzamin kwamfuta sun dace.
An gano cewa ƙuƙwalwa sun dace da cutar coronavirus sosai.
Alal misali, ƙarancin amsawar ƙwayoyin cuta a cikin ƙuƙwalwa yana rage cututtukan da ke tattare da cutar coronavirus.
Bugu da ƙari, an hana ƙwayoyin halitta masu kisa a cikin linzamin kwamfuta saboda haɓakar ƙwayar cuta ta NKG2/CD94 da ƙananan ƙwayoyin ƙwayoyin ƙwayoyin cuta na babban tsarin haɗuwa da aji na 1.
Bugu da ƙari, ƙimar oxygen mai ƙarfi, wanda ke ba da ƙimar ƙwayar cuta mai ƙarfi ga linzamin kwamfuta, na iya hana kwayar cutar coronavirus, kuma a lokaci guda yana shafar ƙididdigar exoribonuclease, don haka ƙirƙirar matsin lamba don samar da nau'ikan cutar, wanda idan ya shiga sabon mai ɗaukar hoto ya zama mai cutarwa.
Ƙari ga haka, ƙwayoyin cuta na coronavirus da suka fi kamuwa da cuta za su iya samo asali ta hanyar sake haɗuwa, kuma hakan zai sa a sami sababbin sunadarai ko kuma halaye na sunadarai don daidaita mai ɗaukar su.
Saboda haka, ba zato ba tsammani ba ne cewa a cikin shekaru ashirin da suka gabata, an samu sababbin cututtukan coronavirus guda uku.
Kwayoyin cutar korona ba su da cutar ko kuma suna haifar da bayyanar cututtuka a cikin masu ɗaukar su, kamar su linzamin kwamfuta ko raƙuma.
Suna yin kwayarsu da tabbaci ba tare da yin amfani da maganin rigakafi ba.
Wannan shi ne ainihin dalilin da ya sa muke ganin masu dauke da cutar da ba su da wata alama, kuma abin da ke haifar da cututtukan cututtukan mutum masu tsanani.
Abubuwan da ke faruwa a cikin jiki suna da nasaba da yawan hawan jiki da kuma yawan ƙwayar cuta, wanda idan mutum ya yi fama da cutar, zai iya sa huhu su yi rauni sosai.
A maimakon haka, masu dauke da cututtuka ba su da ƙwayar cuta da ke sa su kamu da cutar.
Wannan dabarar ta hana rigakafin rigakafi na iya samun sakamako mai kyau a maganin SARS-CoV-2.
A cikin tsuntsaye, ana samun amsa mai ƙarfi ta hanyar interferon.
Saboda haka, shan maganin saɓo na nau'i na I, aƙalla a farkon kamuwa da cutar SARS-CoV-2 a cikin mutane, ya kamata ya kasance mai kyau.
Ƙari ga haka, ba a yi amfani da NLRP3 ba wajen yin amfani da ƙwayar cuta a cikin ƙura.
Saboda haka, hana cutar ta NLRP3 ta hanyar amfani da MCC950 zai iya zama da amfani wajen magance COVID-19.
SARS-CoV-2 ya samo asali ne daga tsarin da SARS-CoV da MERS-CoV suka samo asali.
Yayin da aka gano beta-coronavirus na linzamin kwamfuta, wanda homology na nucleotide ya yi daidai da kashi 95% na SARS-CoV, akwai kuma coronavirus na linzamin kwamfuta, wanda homology na nucleotide ya yi daidai da kashi 96% na SARS-CoV-2.
Ko da yake an gano cewa dabbobi da sauran dabbobi a cikin kasuwanni suna ɗaukar ƙwayoyin cuta, waɗanda suke kama da SARS-CoV, ba a gano masu ɗaukar SARS-CoV-2 kai tsaye ba.
An gano kwayar cutar pandemic beta-coronavirus, mai kama da SARS-CoV-2, wanda ke nuna cewa ana iya amfani da kwayar cutar a matsayin mai ɗaukar hoto ko kuma ana iya samun ɓangarorin gene na kwayar cutar pandemic beta-coronavirus a cikin sigar ƙarshe ta SARS-CoV-2.
Duk da sauran tambayoyin, babu wata hujja cewa SARS-CoV-2 ta kasance da gangan ko ta hanyar mutum.
An yi amfani da cutar coronavirus a duniya saboda barkewar cutar SARS-CoV-2.
Binciken cutar korona a cikin beraye da sauran dabbobi ya canza yadda muke ganin muhimmancin asalin dabbobi da kuma dabbobi masu adana HCoV a cikin watsawar mutum.
Shaidu sun nuna cewa SARS-CoV, MERS-CoV, da SARS-CoV-2 sun fito ne daga linzamin kwamfuta kuma an watsa su ga mutane ta hanyar masu ɗaukar hoto.
Idan kamuwa da cutar SARS-CoV ya fito ne daga haɗuwa da mutane da dabbobi a kasuwanni, rufe kasuwanni da kuma kawar da dabbobi a kansu zai iya kawo ƙarshen annobar SARS.
Saboda wannan dalili, saboda gano nau'ikan kwayoyin cutar beta-coronavirus na pangolin, SARS-CoV-2, don hana yaduwar cutar daga cikin kasuwannin abinci, ya kamata a cire pangolin.
Ko SARS-CoV-2 zai iya zuwa ga mutane ta hanyar pangolin da sauran dabbobi masu shayarwa, kuma yadda za a iya yin hakan zai kasance batun bincike na gaba.
A wani ɓangare kuma, cutar MERS-CoV ta daɗe tana nan a cikin raƙuma.
Waɗannan raƙuman suna da muhimmanci a sufuri, kuma suna da babban tushen nama, madara, fata, da kuma kayan da aka yi da ulu ga mazauna yankin.
Suna da yawa a Gabas ta Tsakiya da Afirka.
Saboda haka, ba za a iya ba da dukan raƙuman don sarrafa MERS ba, kamar yadda aka yi a kasuwannin dabbobin daji na kasar Sin don hana yaduwar SARS-CoV da SARS-CoV-2.
Don hana barkewar cutar MERS ta yau da kullum, dole ne a yi aiki mai zurfi don samar da ingantaccen allurar rigakafin MERS-CoV ga raƙuma tare da sauran matakan sarrafa kamuwa da cuta.
Tun da ba za mu iya kawar da waɗannan ƙwayoyin ba, za a iya samun sababbin kwayoyin halitta da za su iya haifar da cututtuka.
Akwai cututtukan coronavirus iri-iri a duniya.
A cikin wannan yanayin, ana samun cututtukan coronavirus na ƙwayoyin cuta masu yawa.
Akwai dama mai yawa don juyin halitta da kuma sake haɗuwa da waɗannan ƙwayoyin cuta na dabbobi, wanda zai haifar da sababbin ƙwayoyin cuta a nan gaba waɗanda ke da sauƙin watsawa kuma (ko) mafi haɗari ga mutum.
Don rage yawan haɗuwa da dabbobi, ya kamata a daina cin dabbobi a wasu yankunan ƙasar Sin.
Bayan mun sha wahala sosai a gwajin da ake yi na SARS, MERS da COVID-19, muna bukatar mu kasance a shirye kuma mu yi shiri don magance irin wannan yanayin.
A gaskiya, yawancin ƙwayoyin cuta sun kasance a duniya na dogon lokaci.
Za su zauna a cikin tankuna har sai sun sami damar yin amfani da sababbin yankuna.
Ko da yake abubuwa da yawa da suke cikin ƙudan zuma suna da amfani wajen yaɗa ƙwayoyin cuta, idan aka koya wa mutane su guji ƙwayoyin cuta, za a iya rage haɗarin da mutum zai iya yi da ƙudan zuma da sauran dabbobi.
Don fahimtar yanayin halittu na coronavirus da masu ɗaukarsa na halitta, ana buƙatar kulawar cututtuka na yau da kullun a kan dabbobi masu shayarwa, wanda zai taimaka wajen hana watsa coronavirus daga dabbobi zuwa mutum da kuma barkewar cutar a nan gaba.
A ƙarshe, hanya mafi inganci don hana cutar ta zoonotic ita ce ta nisantar mutane daga wuraren da ake ajiye kwayoyin halitta.
Har yanzu akwai wasu ɓangarori da ba a gano ba a cikin jigon asalin dabbobi na SARS-CoV-2.
Da farko, idan linzamin kwamfuta sun ba da cutar SARS-CoV-2 ga pandolins, zai zama da ban sha'awa ganin a wane yanayi linzamin kwamfuta da pandolins suna da wuri ɗaya na muhalli.
Na biyu, idan linzamin kwamfuta ya fi dacewa da mutum, to, dole ne mu san yadda mutane suka yi hulɗa da linzamin kwamfuta.
Na uku, idan dabba ta uku ce take da hakkin zama mai kula da dabbobi, za mu iya sanin yadda dabba take sha'ani da mutane da kuma tsuntsaye da kuma tsuntsaye.
A ƙarshe, tun da yake dabbobi masu shayarwa da yawa, ciki har da dabbobin gida, suna iya kamuwa da SARS-CoV-2, ana buƙatar gudanar da bincike na cututtuka da gwaji.
Ko dai tsuntsaye ne, ko pangolin, ko kuma wani dabba mai shayarwa, ana sa ran a nan gaba za a gano SARS-CoV-2 ko kuma waɗanda suka riga ya riga ya kamu da cutar a cikin masu ɗaukarsa na halitta.
Ci gaba da bincike a wannan fannin zai ba da haske game da juyin halitta na SARS-CoV-2 a cikin dabbobi, wanda zai sami muhimman sakamako ga rigakafi da kula da COVID-19 a cikin mutane.
Ana bukatar sabunta ka'idojin bincike don zargin kamuwa da cutar COVID-19 da kuma tabbatar da cutar
A ranar 6 ga Fabrairu, 2020, ƙungiyarmu ta wallafa taƙaitaccen jagorar bincike don ganewa da kuma magance sabon kamuwa da cutar coronavirus ta 2019 (2019-nCoV), wanda ke ba da bayanai game da kwarewar da muka samu da kuma ba da shawarwari masu inganci game da magance cutar a duniya.
Amma cutar korona ta 2019 (COVID-19) sabuwar cuta ce, saboda haka fahimtarmu da iliminmu sun ƙaru a hankali bisa ga binciken da aka samu a yanzu da kuma kwarewar asibiti; don haka dabarun bincike da kuma hanyoyin magance cututtuka suna ci gaba da sabuntawa.
A cikin wannan wasikar, mun amsa wata sharhi game da shawarwarinmu kuma mun kawo sabbin ka'idojin bincike don haɗarin da ake zargi da cutar  da haɗarin da aka tabbatar  bisa ga takardar Hujja kan ganewar asali da magani ga COVID-19 (sarrafa ta bakwai), da kwamitin kiwon lafiya na kasar Sin ya fitar.
A watan Disambar 2019 ne aka samu barkewar sabuwar cutar coronavirus 2019 (2019-nCoV), wadda yanzu ta sami sunan coronavirus 2019 (COVID-19), kuma cutar kanta ta kira ta da cutar ta 2 (SARS-CoV-2).
A ranar 11 ga Maris, 2020, Hukumar Lafiya ta Duniya ta bayyana COVID-19 a matsayin annoba.
Don magance kamuwa da cutar SARS-CoV-2, ƙungiyarmu ta kirkiro gajeren jagorar bincike kuma ta buga shi a yanar gizo a shafin yanar gizon mujallar Military Medical Research a ranar 6 ga Fabrairu, 2020.
Wannan littafin ya jawo hankalin mutane sosai.
A wannan lokacin, COVID-19 sabon cuta ne, don haka fahimtarmu da iliminmu sun ƙaru a hankali bisa ga binciken da aka samu a yanzu da kuma kwarewar asibiti; don haka dabarun bincike da ayyukan magani suna ci gaba da sabuntawa.
Alal misali, a tsakanin 16 ga Janairu zuwa 3 ga Maris, 2020, an fitar da takardun 7 na Shawarwarin Gwaji da Magani ga COVID-19, wanda Kwamitin Lafiya na Kasa na kasar Sin (http://www.nhc.gov.cn/) ya wallafa, kuma an sauya wasu ka'idojinsa.
Zhou da kuma wasu daga cikin marubuta sun yi wani bincike da ya ba da bayani game da shawarwarinmu, kuma sun ba da shawarwari masu sauƙi game da ganewar asali bisa ga ilimin asibiti.
Wannan aikin ya kara da cewa mun samu wasu sababbin shaidu masu amfani, kuma ya ba da bayanai masu amfani game da wannan annoba da ta shafi duniya.
Muna nuna godiya ga aikin da suka yi kuma muna nuna cewa suna da muhimmanci sosai.
Duk da haka, bisa ga sabon fitowar Shawarwarin bincike da magani don COVID-19 (suna gwaji na bakwai) da kuma sakamakon binciken da ake yi a yanzu, kuma aikin su yana bukatar sabuntawa.
A cewar fitowar bakwai ta wannan takaddar (daga 3 ga Maris, 2020), don gudanar da bincike mai zurfi yayin tabbatar da zargin cutar ya zama dole a haɗa wani abu ɗaya daga cikin bayanan tarihin cututtukan cututtuka tare da bayyanar cututtuka biyu:
Tarihin cututtukan cututtuka: (1) tarihin motsi ko kasancewa a Wuhan da kewaye da shi ko kuma a wasu mazaunan da aka samu COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (2) tarihin hulɗa da marasa lafiya da ke da cutar SARS-CoV-2 (tare da gwajin gwajin nucleic acid); (3) tarihin hulɗa da marasa lafiya da ke da zafin jiki ko alamun numfashi daga Wuhan da kewaye da shi ko kuma daga wasu mazaunan da aka samu COVID-19 a cikin kwanaki 14 kafin bayyanar cututtuka; (4) tarihin hulɗa da ƙungiyoyin marasa lafiya da suka tabbatar da cutar (≥ 2 lokuta da ke da alamun zafin jiki ko alamun numfashi, kamar su dakunan makaranta da dakunan aji, dakunan aji, da wuraren aji na tsawon makonni 2 da aka yi rajista).
Abubuwan da ke faruwa a asibiti: (1) zafin jiki da kuma/ko alamun numfashi; (2) bayyanar bayyanar COVID-19 na waje; (3) yawan kwayoyin cutar leukocyte na al'ada ko kuma ya ragu tare da raguwar yawan kwayoyin lymphocytes a farkon bayyanar cututtuka.
Ana iya gano wani mutum da aka tabbatar da cutar ne bisa ga wata sanadiyar cutar da ke nuna cewa akwai wata hujja ta hanyar kamuwa da cuta ko kuma wani abu mai kama da cutar, wato: (1) gwajin PCR na ainihi yana da kyau ga SARS-CoV-2; (2) cikakken tsarin tsara kwayar cutar yana nuna babban daidaituwa game da sabon coronavirus; (3) sakamako mai kyau na serotest ga magungunan IgM da IgG na musamman ga SARS-CoV-2; ko canza sakamakon gwajin daga mummunan zuwa tabbatacce ga magungunan IgG na musamman ga SARS-CoV-2, ko ƙaruwa a cikin titra aƙalla sau 4 a lokacin warkewa game da alamar da ta dace a cikin mawuyacin lokaci.
Hakanan za'a iya lura cewa a cikin na biyu (18 ga Janairu, 2020) da na uku (22 ga Janairu, 2020) na wannan takaddar an ƙara gwajin PCR na ainihin lokaci don nucleic acid a cikin numfashi ko kuma gwajin jini.
An ƙara binciken cututtukan jini a fitowar na huɗu (27 ga Janairu, 2020) da na biyar (8 ga Fabrairu, 2020); sannan a fitowar ta bakwai an ƙara buƙatar tabbacin serological.
Waɗannan canje-canjen sun dogara ne akan ci gaba da bincike na masu bincike da ke neman mafi kyawun tsari don gano nucleic acid a cikin sauri, da kuma nazarin samfurin numfashi, gami da zaɓi na jini, wanda ke ƙara samun samfurori daban-daban kuma yana taimakawa wajen haɗa sakamakon gwajin tabbatacce don takamaiman antibodies cikin ƙimar tabbatar da cutar.
Duk da haka, akwai ƙarin tabbaci game da yin hankali a lokacin da ake kula da marasa lafiya da ba su da alamun bayyanar cututtuka.
Saboda haka, dole ne a sabunta taswirar da Zhou ya gabatar, saboda a cikinta, an rarraba mutanen da ba su da alamun asibiti a matsayin rukunin haɗari mai ƙarancin haɗari.
Ƙarin bincike da kuma bincike na asibiti na bukatar a yi bayani dalla-dalla a kan tsarin ƙididdiga.
A ƙarshe, muna fatan samun ƙarin hujja kai tsaye kuma muna ƙarfafa masu karatu su bar ra'ayoyinsu.
A fannin bincike na rashin lafiya da kuma wadanda aka tabbatar da cutar, muna ba masu karatu shawara su bi kuma su bi shawarwarin da aka bayar a ƙasashen da suke zaune.
Ƙungiyarmu za ta sabunta shawarwarinmu a kan lokaci don samar da taimako mai kyau.
Bangladesh ta ba da rahoton sabbin mutuwar COVID-19 guda biyar  a kowace rana
Jiya Bangladesh ta tabbatar da sabbin mutum biyar da suka mutu sakamakon COVID-19 a rana.
Wannan shi ne adadin mutuwar da aka samu a kowace rana.
A jiya, Cibiyar Kula da Cututtuka, Kulawa da Binciken Cututtuka ta Bangladesh (IEDCR) ta ce, akwai mutane 114 da suka kamu da cutar a yanzu, da kuma marasa lafiya 33 da suka warke da ke gida.
An yi sanadiyar mutuwar mutane 17.
A wani taron tattaunawa na kan layi, darektan IEDCR, Dokta Mirjabi Sabrina Flora ta bayyana cewa, mata hudu da maza hudu ne suka mutu.
A cewar Dakta Mirjabi, mutane biyu sun mutu a cikin shekaru 60, biyu suna tsakanin shekaru 51 zuwa 60, daya kuma yana da shekaru 41 zuwa 50.
Ta kuma ce mutanen da suka mutu biyu sun fito ne daga Dhaka.
A ranar 11 ga watan Maris, Hukumar Lafiya ta Duniya (WHO) ta sanar da annobar COVID-19.
Wani ma'aikacin asibitin ya shaida wa kamfanin dillancin labaran kasar Anadolu cewa, daya daga cikin wadanda suka mutu shi ne Jalal Sayfur Rahman, darektan hukumar yaki da cin hanci da rashawa a Bengal, wanda ke kula da shi a asibitin Meithri a Kuwait.
A ranar Asabar, a cikin wani bidiyo na kan layi, Ministan sufuri da gadaje na Bangladesh, Obaydul Quader, ya bayyana cewa za a dakatar da ayyukan sufuri na jama'a na tsawon lokaci fiye da yadda aka tsara, har zuwa Asabar mai zuwa.
An dakatar da ayyukan sufuri na jama'a daga ranar 26 ga Maris kuma ya kamata a ci gaba da aiki a ranar Asabar, 4 ga Afrilu.
Har yanzu an ba da izinin jigilar kayayyakin da ake bukata, wato magunguna, man fetur da abinci.
An fara samun kamuwa da cutar COVID-19 a Bangladesh a ranar 8 ga Maris a cikin mutane biyu da suka dawo daga Italiya, da kuma matar wani daga cikinsu.
A ranar 19 ga Maris, waɗannan mutane uku sun warke.
SARS-CoV-2 ya wuce iyakar kamuwa da cutar miliyan a duniya
A cewar Jami'ar Johns Hopkins, a ranar Alhamis, jimlar adadin mutane da suka kamu da cutar SARS-CoV-2 a duniya ta wuce miliyan daya.
Akalla mutane dubu 52 ne suka mutu sakamakon cutar COVID-19.
Wannan ya faru ne a ranar da aka samu kamuwa da cutar a Malawi, kuma a Zambia aka samu kamuwa da cutar ta coronavirus.
Koriya ta Arewa ta ce a ranar Alhamis ta kasance daya daga cikin kasashe da ba a samu kamuwa da cutar coronavirus ba.
A ranar da ta gabata, Hukumar Lafiya ta Duniya ta ba da rahoton kamuwa da cuta 1,051,635, ciki har da 79,332 a cikin awanni ashirin da huɗu kafin 10:00 na yammacin Turai (0800 UTC) na 4 ga Afrilu.
A Amurka an samu mutane fiye da 244,000 da suka kamu da cutar coronavirus, kuma aƙalla 5,900 daga cikinsu sun mutu.
CBS News ta yi magana ne game da bayanan Jami'ar Johns Hopkins, inda ta ce a ranar Laraba, an samu mutuwar sama da 1,000 a Amurka sakamakon kamuwa da cutar coronavirus.
Kasashen duniya sun sanar da tsaurara matakan hana yaduwar cutar.
A ranar Alhamis, magajin birnin, Sergei Sobyanin, ya tsawaita dokar ware kai na 'yan kasar har zuwa ranar 1 ga watan Mayu.
A baya, shugaban kasar Vladimir Putin ya ce duk da cewa 'yan Rasha a duk fadin kasar suna cikin warewa, za su samu albashin su har zuwa ranar 30 ga watan Afrilu.
Majalisar Dokokin Portugal ta amince da tsawaita dokar ta baci na kwanaki 15; sakamakon kuri'un: 215 a madadin, goma sun ƙi kuma guda ɗaya ya ƙi.
Saudiyya ta tsawaita dokar hana fita a biranen Makka da Madina har tsawon yini guda, inda a baya dokar ta hana fita ta kasance daga karfe 3 na rana zuwa 6 na safe.
Thailand ta shirya yin dokar hana fita daga karfe 10 na dare zuwa karfe 4 na safe.
Gwamnan jihar Ohio, Mike DeWine, ya sanar da cewa an tsawaita dokar keɓe kai a gida a jihar har zuwa ranar 1 ga Mayu.
Shaguna a Ostiraliya sun ƙuntata yawan takardar bayan gida da za a iya saya a lokaci ɗaya
A ranar Lahadi da Asabar da yamma, cibiyoyin sayar da kayan gida na Woolworths da Coles a Ostiraliya sun rage yawan takardar bayan gida da za a iya saya a duk shagunan ƙasar zuwa biyu da ɗaya.
A ranar Litinin, ALDI ta kuma saita takunkumi na kwalliyar guda ɗaya.
An yi sanarwa game da wannan takunkumin a cikin tallace-tallace da kuma shafin Facebook.
An ruwaito cewa 'yan kasar sun fara yin tanadi na gaggawa saboda tsoron cewa COVID-19 na iya haifar da tsarin keɓe kai na kowa.
A ranar Laraba, kamfanin Woolworths ya kuma rage yawan takardar bayan gida zuwa kwalliyar guda.
A ranar 4 da 5 ga watan Maris, Woolworths da Coles sun rage adadin zuwa 4 a cikin waɗannan fakitin.
Cibiyar kasuwanci ta Coles a cikin sanarwar ta na 8 ga Maris ta ruwaito cewa tare da sanyawa takunkumi na kunshin hudu a cikin shaguna da yawa ana sayen takarda na gida da sauri sake kawowa cikin awa, kuma ta kira wannan bukatar marasa-matuƙa, yayin da ALDI a cikin wani sakon Facebook da aka buga a ranar Talata, ya kira wannan yanayin ba zato.
Wani wakilin kamfanin Woolworths ya ce, a makon da ya gabata, an samu karuwar tallace-tallace.
A makon da ya gabata, Costco a Canberra ta rage adadin kayayyakin da aka yi amfani da su zuwa biyu.
Don biyan rashi, Coles ta fara yin odar manyan kaya daga masu samarwa kuma ta ƙara yawan isar da kayayyaki, Woolworths ta yi odar ƙarin kaya, yayin da ALDI ta yi tanadi don wani tallace-tallace na musamman na farkon ranar Laraba.
Russell Zimmerman, babban darektan kungiyar masu sayar da kayayyaki ta Australiya, ya ce masu sayar da kayayyaki suna ƙoƙarin ƙara yawan kayayyaki, amma hakan yana da wuya saboda ƙuntatawa na hukumomin gida game da jadawalin tafiya na manyan motoci.
Yana sa ran farashin kayayyakin zai karu, domin masu samarwa suna ƙoƙari su biya bukatar, amma akwai ƙarancin tayin da za a iya samu.
A ranar Talata, ALDI ta sanar da cewa saboda karancin kayayyaki, wasu shaguna ba za su iya gudanar da tallace-tallace a ranar Laraba ba.
A cikin wani rahoto da aka wallafa a News.com.au, Dokta Gary Mortimer, masanin sayar da kayayyaki a Jami'ar Fasaha ta Queensland, ya ce, shaguna suna cike kayayyaki a kowace dare.
Ya ce, takardar bayan gida abu ne mai yawa, saboda haka, yawan kayayyakin ajiya ba su da yawa, kuma bayan an sayar da kayayyakin, an ajiye jerin gwano masu tsawo, wanda hakan ya sa aka ji cewa babu kayayyaki.
'Coles da Woolworths sun ce idan ana iya cika ɗakunan ajiya kuma ana iya ajiye kayayyaki masu yawa a kan ɗakunan ajiya kamar takardar wanka da kuma maganin hana hannu, masu sayen ba za su yi fargaba ba,' in ji Russell Zimmerman.
A ranar Laraba, mai kera takardar bayan gida mai suna Who Gives a Crap ya ce kayayyakin sun ƙare.
A cewar wani rahoto daga News.com.au, Kimberly-Clark, kamfanin kera takardar wanka Kleenex da Solaris Paper, wanda kuma ke samar da kayayyakin Sorbent, sun ce suna aiki a duk tsawon rana don samar da isasshen kayayyaki.
Wani shafin sayar da dukiya mai suna Domain.com ya ruwaito cewa lokacin da aka rage yawan gwanjo a birnin Melbourne saboda rashin masu sayarwa a makon ranar ma'aikata, wasu masu sayar da dukiya sun fara ba da takardar wanka kyauta ga masu fara gwanjo.
Littafin yau da kullum na NT News, wanda Darwin ya buga a ranar huɗu, ya ƙunshi shafi takwas da aka yi amfani da shi don yankewa da amfani da shi a matsayin takarda na gidan wanka.
A cewar rahoton ABC Australia na 3 ga Maris, da farko, shagunan sun ƙi su ƙuntata yawan kayayyakin da ake saya, suna cewa ba su shirya yin hakan ba.
Russell Zimmerman ya kara da cewa wasu kayayyakin suna da bukatarsu, ciki har da masks na likita, kayan shafawa, kayan shafawa, kayan wanke hannu da gari.
Hakazalika, ban da abubuwan da suka faru a Ostiraliya, an lura da ranar Lahadi da yamma cewa kantin sayar da kayan shagon Ocado na Burtaniya ya rage sayar da takardar bayan gida ta Andres a cikin kunshe-kunshe biyu na 12 rolls.
Hukumar Lafiya ta Duniya ta sanar da annobar COVID-19
A ranar Laraba, Hukumar Lafiya ta Duniya (WHO) ta sanar da annobar cutar COVID-19, wanda cutar SARS-CoV-2 ta haifar.
Ko da yake kalmar "matsananci" tana nuna girman cutar ne kawai, ba haɗarin wasu lokuta ba, WHO ta lura cewa gwamnatocin ƙasashe suna bukatar su ɗauki matakan:
Dukkanin kasashe suna iya yin tasiri a kan yadda cutar ke gudana.
Wannan zai yiwu idan kasashen suka yi aiki wajen ganowa, gwadawa, kula da marasa lafiya, ware su, kula da cutar, da kuma karfafa wa 'yan kasarsu damar yin aiki, in ji Mista Tedros Adhan Gebreissus, Darakta Janar na WHO.
"Muna matukar damuwa da yadda cutar ta kamu da cutar da kuma yadda ta yi tsanani, da kuma rashin aikin da ake yi".
A cewar Dokta Tom Friedan, tsohon darektan cibiyoyin kula da cututtuka na Amirka, wannan annoba ba a taɓa gani ba.
A wata hira da ya yi da CNN a watan Fabrairu, ya ce ba a gano wani kwayar cutar da ta shafi numfashi ba tun lokacin da ta fara har zuwa ci gaba da yaduwar duniya.
Mista Gebreissus ya yi irin wannan bayanin, yana cewa ba mu taɓa ganin annobar coronavirus ba.
Ba mu taɓa ganin annobar da za a iya sarrafawa ba.
Da farko, a watan Janairu, WHO ta bayyana barkewar cutar a matsayin gaggawa na kiwon lafiya na duniya, sannan ta sake sanya ta a matsayin cutar.
Shugaban Cibiyar Kula da Cututtuka da Cututtuka ta Kasa ta Amurka, Dokta Anthony Fauci, ya ce game da cutar: "Wannan farkon ne, za ta fi muni".
A cewar Associated Press a ranar Alhamis, an samu aƙalla mutane 126,000 da suka kamu da cutar COVID-19, fiye da mutane 4,600 sun mutu.
Cutar coronavirus 20192020  cutar ta coronavirus ta 2019 (COVID-19), wanda cutar ta coronavirus ta haifar da mummunan cutar numfashi mai tsanani-2 (SARS-CoV-2).
An gano barkewar cutar a Wuhan, China, a watan Disambar 2019, kuma a ranar 30 ga Janairu, 2020, an bayyana dokar ta baci ta duniya a fannin kiwon lafiyar jama'a, wanda daga baya, a ranar 11 ga Maris, 2020, aka gano cutar ta zama annoba.
A ranar 10 ga Afrilu, 2020, an samu kimanin mutane miliyan 1.61 da suka kamu da cutar COVID-19 a kasashe da yankuna 210 da ke duniya, inda kusan mutane 97,000 suka mutu.
Mutane 364,000 ne suka warke.
Yawan mutuwar a kasar Sin ya kai kashi 4 cikin 100, yayin da a duniya ya kai kashi 13.04 cikin 100 a Aljeriya zuwa kashi 0.08 cikin 100 a New Zealand.
Abubuwan da suka fi kowa a cikin cututtuka sun haɗa da zazzabi, tari da kuma wahalar numfashi.
Abubuwan da za su iya jawo wannan matsalar su ne cutar pneumonia da kuma ciwon hanta mai tsanani.
Lokaci daga bayyanar cututtuka na farko zuwa ciwon cutar yana da kusan kwanaki biyar, amma kuma yana iya bambanta daga kwana biyu zuwa goma sha huɗu.
A yanzu haka, babu wani magani ko allurar rigakafi.
Ana ba da shawarar yin amfani da maganin rigakafi don wanke hannu, rufe baki a lokacin tari, kiyaye nesa tsakanin mutane, ganowa da kuma ware mutane da suke da shakku game da kamuwa da cutar.
Hukumomi a duniya sun amsa wannan ta hanyar sanya takunkumin tafiye-tafiye, matakan killace mutane, dokar hana fita, kula da haɗari a wuraren aiki da rufe wurare daban-daban.
Cutar ta haifar da mummunan tasirin zamantakewa da tattalin arziki na duniya, jinkirta ko soke ayyukan wasanni, addini, siyasa da al'adu, da kuma yawan karancin kayayyaki, wanda ake kara da shi ta hanyar sayayya.
An rufe makarantu da jami'o'i a matakin ƙasa ko na yanki a ƙasashe 193, wanda ya shafi kusan kashi 99.4% na ɗaliban duniya.
An fara samun rashin fahimta game da cutar a Intanet, akwai rashin jin daɗin jama'a da nuna bambanci ga 'yan kasar Sin, wasu 'yan kasar Gabas da kudu maso gabashin Asiya, ko kuma wasu mutane da suke kama da su, da kuma wasu kungiyoyin mutane da ke zaune a yankunan da aka lura da yawan yaduwar cutar.
Saboda rage yawan tafiye-tafiye da kuma rufe masana'antun masana'antu masu nauyi, an rage yawan gurɓataccen iska da kuma fitar da carbon.
A ranar 31 ga watan Disamba na shekarar 2019, hukumomin kiwon lafiya na birnin Wuhan (babbar birnin lardin Hubei), China, sun sanar da cewa akwai wasu cututtukan huhu da ba a san dalilin da ya sa ba, kuma a farkon watan Janairun shekarar 2020 an fara binciken lamarin.
Yawancin cututtukan sun kasance game da kasuwar sayar da kayayyakin teku ta Hunan, saboda haka an yi imanin cewa cutar ta fito ne daga cikin dabbobi.
Wannan kwayar cutar da ta haifar da cutar ta sananne ne da SARS-CoV-2. Wannan sabon kwayar cutar ce da ta bayyana da yawa kamar kwayar cutar kwayar cutar ta fuka-fuki, kwayar cutar pangolin, da SARS-CoV. Daga baya an gano cewa farkon kamuwa da cutar ya faru ne a ranar 1 ga Disamba, 2019, kuma wanda ya kamu da cutar bai ziyarci kasuwa ba bayan wannan ranar.
Kashi biyu bisa uku na kamuwa da cutar da aka samu a watan Disamba na 2019 sun shafi wannan kasuwar.
A ranar 13 ga Maris, 2020, wani labarin da ba a tabbatar da shi ba a cikin sashen kudancin kasar Sin na jaridar Morning Post ya nuna cewa an fara samun kamuwa da cutar ne da wani mutum mai shekaru 55 a lardin Hubei a ranar 17 ga Nuwamba, 2019. A ranar 26 ga Fabrairu, 2020, WHO ta ba da rahoton cewa adadin sabbin kamuwa da cutar a China ya ragu amma ya karu ba zato ba tsammani a Italiya, Iran da Koriya ta Kudu, kuma adadin sababbin kamuwa da cutar a wajen kasar Sin ya wuce adadin sabbin kamuwa da cutar a kasar Sin a karon farko.
Yawan cututtuka na iya zama ƙasa da yawa, musamman saboda yawan cututtuka da ba su da alamun bayyanar cututtuka.
A ranar 26 ga Fabrairu, an sami ƙananan ƙwayoyin cuta a tsakanin matasa, tare da marasa lafiya masu shekaru 19 da ƙasa da kashi 2.4% na ƙwayoyin cuta a duniya. Babban mai ba da shawara kan kimiyya na Burtaniya Patrick Wallans ya kiyasta cewa 60% na yawan mutanen Burtaniya za su kamu da cutar kafin a sami rigakafin rukuni mai tasiri a cikin al'ummar ƙasar.
Wannan kididdigar ta ƙunshi mutanen da aka gwada su da COVID-19 kuma suka tabbatar da cewa sun yi nasara bisa ga tsarin aikin.
A ranar 23 ga Maris, babu wata ƙasa da ta iya gwada fiye da kashi 3 cikin 100 na yawanta, kuma a ƙasashe da yawa kamar Italiya, Netherlands, Spain, da Switzerland, an yi manufofin hukuma waɗanda ke ba da umarnin kada a gwada su idan akwai ƙananan alamomi.
Wani bincike da aka wallafa a ranar 16 ga Maris ya nuna cewa har zuwa 23 ga watan Janairu, kashi 86 cikin 100 na mutanen da ke dauke da cutar COVID-19 ba su samu ba a kasar Sin, kuma irin wadannan marasa lafiya da ba a yi musu rajista ba sun zama tushen kamuwa da cutar ga kashi 79 cikin 100 na wadanda aka yi musu rajista.
Binciken da aka yi a ranar 30 ga Maris ya nuna cewa adadin mutanen da suka kamu da cutar a Italiya ya fi yawan wadanda aka samu.
Matsayi na farko na yawan kamuwa da cuta (R0) na COVID-19 ya kasance daga 1,4 zuwa 2,4.
Wani bincike da Cibiyar Kula da Cututtuka ta Amirka ta wallafa ya nuna cewa wannan zai iya zama 5.7.
Yawancin marasa lafiya da ke fama da cutar COVID-19 suna samun sauki.
A wasu, mafi tsanani, lokaci daga bayyanar cututtuka zuwa mutuwa ya kai kwanaki 6 zuwa 41, mafi yawan kwanaki 14.
A ranar 10 ga Afrilu, 2020, kimanin mutuwar 97,000 sun kasance da alaƙa da COVID-19.
A kasar Sin, kimanin kashi 80% na mutuwar mutane sun wuce shekaru 60 a ranar 5 ga Fabrairu, kuma kashi 75% na waɗanda suka mutu suna da cututtuka masu zuwa, gami da cututtukan zuciya da ciwon sukari. Bayanai na mutuwa na COVID-19 na yau da kullun sun haɗa da mutuwar marasa lafiya waɗanda suka sami gwajin COVID mai kyau, wanda aka yi daidai da tsarin hukuma.
Yawan mutuwar COVID-19 na iya zama mafi girma, saboda ƙididdigar hukuma ba za ta iya ɗaukar mutuwar mutanen da ba su yi gwajin ba  misali, idan sun mutu a gidajensu, a gidajen tsofaffi, da sauransu.
Bayanai marasa cikakke a Italiya sun nuna cewa ainihin adadin mutuwar a lokacin annobar ya fi na COVID sau 45 girma.
Sakataren yada labarai na Cibiyoyin Kula da Cututtuka na Amurka (CDC) ya yarda: Mun san cewa [ƙididdigar mutuwar] ta ƙasa da ainihin . An tabbatar da kalmominsa ta hanyar wasu rahotanni game da wasu lokuta a Amurka. Irin wannan lissafin tare da bayanan da ba cikakke ba sau da yawa yana faruwa a lokacin annoba kamar cutar sankarar alade H1N1 a shekarar 2009.
An yi rahoton mutuwar farko a wajen kasar Sin a ranar 1 ga watan Fabrairu a ƙasar Filifin, kuma a wajen Asiya a Faransa a ranar 14 ga watan Fabrairu.
A ranar 28 ga watan Fabrairu, an samu mutuwar mutane fiye da goma a wajen kasar Sin: a Iran, Koriya ta Kudu da Italiya.
A ranar 13 ga Maris, fiye da ƙasashe da yankuna arba'in a duk nahiyoyi, banda Antarctica, sun ba da rahoton mutuwar.
Dukkanin alamun sun bambanta dangane da yankin da lokacin yaduwar cutar; kuma suna rinjayar yawan gwajin gwaji, ingancin tsarin kiwon lafiya, tsarin magani da aka yi amfani da shi, lokacin da cutar ta fara, da kuma sigogin yawan jama'a kamar shekaru, jinsi, da kuma yanayin lafiyar gaba ɗaya.
A cewar kididdigar Jami'ar Johns Hopkins, a ranar 10 ga Afrilu, 2020, adadin mutuwar duniya da cututtukan kamuwa da cuta ya kai kashi 6.0% (97 039/1 617 204).
Bayanai sun bambanta a yankuna dabam dabam.
A China, yawan mutuwar da rashin lafiya ya ragu daga kashi 17.3% (ga waɗanda suka fara bayyanar cututtuka a ranar 1 ga Janairu, 2020) zuwa kashi 0.7% (ga waɗanda suka fara bayyanar cututtuka bayan 1 ga Fabrairu, 2020). Sauran hanyoyin sun haɗa da ƙayyade yawan mutuwar cutar (CFR)  kashi na marasa lafiya da aka gano waɗanda ke mutuwa daga cutar, da kuma yawan mutuwar kamuwa da cuta (IFR), wanda ke nuna yawan marasa lafiya da suka kamu (duka waɗanda aka gano da waɗanda ba a gano ba) waɗanda suka mutu daga cutar.
Wannan ƙididdigar ba ta da wani lokaci na musamman kuma tana nuna alamun wasu rukunin mutane daga lokacin kamuwa da cutar har zuwa ƙarshen cutar.
Wasu masana kimiyya sun yi ƙoƙari su ƙayyade waɗannan ƙididdigar a kan wasu rukuni na mutane.
A cewar cibiyar tabbatar da magani ta jami'ar Oxford, yawan mutuwar da ake samu daga cutar ta kasance daga kashi 0.1 zuwa 0.39%.
Wannan babban adadin ya jitu da sakamakon gwajin COVID-19 na farko a Jamus, da kuma binciken kididdiga da ke nazarin tasirin gwajin akan ƙimar CFR.
Hukumar lafiya ta duniya ta ce za a iya sarrafa cutar a yanzu.
Ba a iya sanin lokacin da za a yi fashewar da kuma tsawon lokacin da za a yi fashewar ba kuma za su iya bambanta dangane da wurin da aka yi.
Mace Bonnie, ma'aikaciyar jami'ar Pennsylvania, ta ce, cutar da ba a sarrafa ba, tana fitowa daga kan tudu, kuma sa'ad da aka kammala yawan masu dauke da cutar, sai ta fara kashewa.
Amma a halin da muke ciki, ba za mu iya yin hasashen lokacin da hakan zai faru ba.
Babban mai ba da shawara kan harkokin kiwon lafiya na gwamnatin kasar Sin, Zhong Nanshang, ya ce, "Duk abin zai iya ƙare a watan Yuni idan dukan ƙasashe suka yi aiki tare kuma suka bi shawarwarin WHO game da matakan da za a iya dauka don hana yaduwar cutar".
A ranar 17 ga watan Maris, Adam Kucharsky na Makarantar Lafiya da Lafiya ta Tropical ta London ya bayyana cewa SARS-CoV-2 za ta yi yawo, wataƙila cikin shekara ɗaya ko biyu.
Wani bincike da kwalejin sarauta ta yi a ƙarƙashin jagorancin Neil Ferguson ya nuna cewa, har sai an yi allurar rigakafi (watannin 18 ko fiye), za a bukaci a kiyaye nisan jiki da sauran matakan.
William Shaffner, wani jami'in Vanderbilt ya ce: "Ba na tsammanin cutar coronavirus za ta taɓa ɓacewa gaba ɗaya, domin tana da sauƙin kamuwa da ita, kuma tana iya zama cuta ta yanayi, tana fitowa kowace shekara".
Yadda za a yi amfani da sabon cutar zai dogara ne da ƙarfin mutum da kuma yanayin da ya kamu da cutar.
Alamun COVID-19 na iya zama marasa ƙayyadaddun, kuma wasu mutane masu kamuwa da cutar na iya ɗaukar cutar ba tare da alamun ba.
Abubuwa biyu da suka fi kowa a duniya sune zazzabi mai yawa (88%) da kuma tari mai zafi (68%).
Alamomin da ba su da yawa sun haɗa da gajiya, kumburi a cikin numfashi (slizz), rashin wari, numfashi, ciwon tsoka da haɗin gwiwa, ciwon wuya, ciwon kai, kumburi, zubar da jini, fitsari ko ciyanosis. WHO ta ce kusan kowane mutum shida yana fama da rashin lafiya mai tsanani tare da ciwon matsalolin numfashi.
Cibiyoyin Kula da Cututtuka na Amurka (CDC) sun lissafa alamun gaggawa kamar wahalar numfashi, ciwo na yau da kullum ko kuma damuwa a kirji, rashin hankali na kwatsam, wahalar farkawa da kuma launin toka a fuska ko lebe. Idan akwai waɗannan alamun, ya kamata a nemi taimakon likita nan da nan.
Wasu mutane da suka kamu da cutar za su iya kamuwa da cutar ba tare da wata alama ba, amma sakamakon gwajin ya tabbatar da cewa sun kamu da cutar, saboda haka likitoci sun ba da shawarar a saka waɗanda suka yi kusa da marasa lafiya da aka gano cewa suna da cutar a ƙarƙashin kula da su sosai kuma a bincika su don gano ko suna da cutar.
Masana kimiyya a ƙasar Sin sun ce yawan mutanen da ke fama da cutar ba su da wata alama ba ya ƙaruwa daga kashi ɗaya zuwa kashi 44 cikin ɗari na dukan mutanen da ke fama da ita.
Lokacin da ake yin amfani da shi a lokacin da ake yin amfani da shi a cikin wani abu, yana da yawa daga kwana ɗaya zuwa 14 a lokacin da ake yin amfani da shi a lokacin da ake yin amfani da shi.
Har yanzu ba a san wasu bayanai game da yadda cutar take yaduwa ba.
Ana ganin cewa cutar tana kamuwa da ita ne ta hanyar tuntuɓar juna, ko ta hanyar ƙananan saukad da ke fitowa a cikin iska tare da tari, kuka ko lokacin magana; ta hanyar tuntuɓar juna, ana nufin tuntuɓar a cikin radius na mita 1 zuwa 2 (daga 3 zuwa 6 ƙafa).
Wasu bincike sun nuna cewa a lokacin da ake tari, saukad da za su iya kaiwa daga mita 4,5 zuwa mita 8,2.
Akwai ra'ayoyi cewa kwayar cutar na iya zama ta hanyar ƙananan saukad da aka jefa cikin iska yayin magana, wanda zai iya kasancewa cikin iska na dogon lokaci. Saukad da numfashi na iya zama a lokacin numfashi, gami da lokacin magana, kodayake yawanci ba a watsa kwayar cutar ta iska.
Sa'ad da aka yi amfani da ruwa, za su iya shiga baki ko hanci, ko kuma a cikin huhu.
Wasu hanyoyin magani kamar intubation da kuma aikin numfashi na zuciya (CPR) na iya haifar da yayyafa kayan numfashi kuma, saboda haka, yaɗa cutar a cikin iska.
Zai iya shiga cikin jiki idan mutum ya taɓa wani gurɓataccen wuri, har da fata, kuma ya taɓa idanunsa, hanci ko bakinsa.
Akwai kuma wasu masu tsoron cewa cutar za ta iya kamuwa ta hanyar ƙura, amma ana ganin cewa haɗarin wannan hanyar ba shi da yawa.
Gwamnatin kasar Sin ta musanta yiwuwar watsa SARS-CoV-2 ta hanyar magunguna. Kwayar cutar tana da matukar kamuwa da ita a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan cutar.
Akwai wasu lokuta da aka gwada gwajin a kwanaki uku kafin bayyanar cututtuka, kuma hakan ya nuna cewa za a iya watsa cutar kafin bayyanar cututtuka ta bayyana.
Akwai rahotanni da yawa game da rashin bayyanar cututtuka da aka tabbatar da su a cikin dakin gwaje-gwaje, amma a wasu ƙasashe, an gano wasu cututtuka na rashin bayyanar cututtuka.
Ma'aikatan Cibiyar Tsare-tsare ta Turai (ECDC) sun ce ba a san yadda cutar take da sauƙi ba, amma an san cewa mutum ɗaya yana kamuwa da mutane 23 kuma yana iya rayuwa a cikin sa'o'i da yawa zuwa kwanaki.
A cikin takamaiman, an gano cewa a kan filastik (polypropylene) da kuma bakin karfe (304) kwayar cutar tana iya rayuwa har zuwa kwanaki uku, a kan katako  na kwana ɗaya, kuma a kan tagulla  har zuwa awanni 4.
Duk da haka, wannan ya bambanta dangane da yanayin zafi da zafi. Dabbobin gida da sauran dabbobi sun sami sakamako mai kyau na COVID-19.
Babu wata hujja da ta nuna cewa dabbobi za su iya watsa cutar ga mutane, ko da yake hukumomin Birtaniya sun ba da shawarar wanke hannuwanka bayan ka taɓa dabbobi, kamar yadda kake yin bayan ka taɓa wasu wurare da mutane suka kamu da cutar.
Cutar cututtukan huhu mai tsanani ta coronavirus 2 (SARS-CoV-2)  sabon kwayar cuta ce, wanda aka fara ganowa a cikin mutane uku da ke fama da cutar huhu daga cikin rukunin da ke fama da cututtukan numfashi mai tsanani da aka yi rajista a Wuhan.
Duk alamun sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin yanayi a cikin coronavirus na dangi. Ana iya lalata kwayar cutar a waje da jikin mutum ta amfani da sabulu na gida wanda ke warware ƙwayar kariya. SARS-CoV-2 yana da kamanceceniya da asalin SARS-CoV.
An yi zaton cewa shi ɗan asalin dabba ne.
Binciken kwayoyin halitta na coronavirus ya nuna cewa yana tattare da kwayoyin halitta tare da Betacoronavirus, nau'in Sarbecovirus (layin sel B) tare da wasu nau'ikan kwayoyin cuta guda biyu na linzamin kwamfuta.
A matakin gaba ɗaya na kwayoyin halitta, yana da kashi 96% na kama da sauran kwayoyin cutar coronavirus na linzamin kwamfuta (BatCov RaTG13).
A watan Fabrairun 2020, masu binciken kasar Sin sun gano cewa akwai bambanci guda daya kawai tsakanin amino acid na wasu sassan tsarin kwayoyin cutar pangolin da na mutum.
Kwatantaccen kwayoyin halitta ya nuna cewa akwai babban adadin kama (92%) tsakanin cutar pandemic da SARS-CoV-2, amma wannan bai isa ya tabbatar da cewa pandemic ne masu karɓar cutar ba.
Ana iya gano cutar ta farko ta hanyar bayyanar cututtuka, ko da yake a ƙarshe ana iya tabbatar da hakan ta hanyar nazarin polymerase chain reaction with reverse transcription (RT-PCR) na asirin da aka kamu da shi ko kuma CT scan.
Wani bincike da aka yi a Wuhan ya nuna cewa CT ya fi tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsananin tsanan
Tun watan Maris na shekarar 2020, Kwalejin Radiology ta Amirka ta wallafa shawarwari game da kada a yi amfani da CT don yin bincike ko a matsayin hanyar gwajin farko a cikin binciken COVID-19.
Hukumar ta WHO ta wallafa wasu takardun shaida na gwajin RNA akan SARS-CoV-2, wanda aka buga a ranar 17 ga Janairu.
Ana yin gwaji akan polymerase chain reaction a cikin yanayin lokaci na ainihi (RT-PCR).
Ana iya yin gwajin a cikin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin numfashin
Ana shirya sakamakon a cikin sa'o'i da kwanaki.
Ana amfani da maganin shafawa na hanci don yin gwajin, amma ana iya amfani da maganin shafawa na zuma.
A ranar 6 ga Afrilu, 2020, babu ɗayan da ya tabbatar da cewa ya isa ya sami amincewa don amfani da shi a ko'ina.
A Amirka, an amince da gwajin magani da Cellex ta yi don gaggawa a cikin dakunan gwaje-gwaje da aka yi wa takardar shaida.
Abubuwan da ke nuna alamun bayyanar cututtuka a kan radiographs da kuma CT sune asymmetrical peripheral blurring a cikin nau'in gilashin gilashin gilashi da rashin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙaran.
Ƙungiyar Radiology ta Italiya ce ke tattare da hotunan hotunan mutanen da suka kamu da cutar.
Saboda kama da sauran cututtukan, kamar adenoviruses, idan aka gano COVID-19, hotunan da ba a tabbatar da su ba a gwajin PCR suna da iyakantaccen yanayin asibiti.
Wani babban bincike da aka yi a kasar Sin, wanda ya kwatanta sakamakon CT na kirji da gwajin PCR, ya nuna cewa, ko da yake hotuna ba su da ƙayyadaddun bayanai game da kamuwa da cuta, za a iya fassara su da sauri; kuma sun fi saurin fahimta, saboda haka, ana iya amfani da wannan hanyar bincike a matsayin kayan aikin bincike a wuraren da cutar ta kamu.
Don gano cutar ta amfani da radiographs da kuma CT, an tsara cibiyoyin kwakwalwa masu haɗuwa da ƙwayoyin cuta bisa ga ilimin kere-kere.
Ka'idojin hana kamuwa da cutar sun haɗa da tsabtace mutum gaba ɗaya, wanke hannu, guje wa taɓa idanu, hanci ko baki da hannu mai ƙazanta, yin amfani da sutura don tari ko kuma yin tari, wanda ya kamata a zubar da su nan da nan bayan amfani.
Waɗanda suka riga sun kamu da cutar ya kamata su saka abin rufe fuska a wuraren da mutane suke.
Don hana kamuwa da cutar, ana kuma ba da shawarar yin nesa da mutane. Gwamnatoci da yawa suna ba da shawarar kada su yi balaguro ba tare da lokaci ba zuwa ƙasashe da yankunan da cutar ta shafa, kuma suna ƙuntata motsi na 'yan ƙasa.
Duk da haka, cutar ta yi nasara wajen yadawa a yawancin yankunan duniya.
Wannan yana nufin cewa cutar tana yaduwa tsakanin al'umma, wasu membobin ba su san inda suka kamu ba ko yadda suka kamu. Ana ba da shawarar cewa ma'aikatan kiwon lafiya da ke kula da marasa lafiya waɗanda za su iya kamuwa da cutar su yi amfani da matakan tsaro na yau da kullun, da kuma matakan tsaro yayin hulɗa da wasu mutane da kuma kayan kariya na ido.
Yin amfani da bayanan mazauna ƙasa ta wayoyin hannu na gwamnatoci don wannan dalili ya haifar da damuwa game da kiyaye sirrin, kuma ƙungiyoyi kamar Amnesty International, da fiye da 100 wasu ƙungiyoyi sun yi sanarwa suna neman a iyakance irin wannan kallon mutane.
An tsara kuma an ba da aikace-aikacen hannu daban-daban don amfani da son rai; kamar yadda aka yi a ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyin ƙwararru goma sun yi aiki kan samar da mafita don tabbatar da sirrin bayanan sirri  misali, yin rijistar kusanci ga mai amfani da sauran wayoyin hannu ta amfani da fasahar Bluetooth.
Idan mai amfani da wayar hannu ya kasance a kusa da mutumin da gwajin COVID-19 ya tabbata, sai ya sami sanarwar da ta dace. Akwai kuma wasu ra'ayoyi marasa tushe game da yadda za a hana kamuwa da cutar  misali, shafa hanci da baki, wanda ba shi da tasiri.
A halin yanzu babu allurar rigakafin COVID-19, ko da yake ƙungiyoyi da yawa suna aiki don ƙirƙirar ta.
Don hana yaduwar cutar, ana bada shawara a wanke hannu.
Cibiyar Kula da Cututtuka da Cututtuka ta CDC ta kuma ba da shawarar yin wanka a hannuwanku da sabulu da ruwa aƙalla na tsawon dakika 20, musamman bayan ka je bayan gida ko kuma ka gurɓata hannuwanka sosai, kafin ka ci abinci, bayan ka yi tururuwa, ka yi tari ko ka yi tsotsa.
Wannan yana da muhimmanci domin a waje da jikin mutum, ana kashe kwayar da sabulu na gida da ke buɗe jikinta.
Bugu da ƙari, idan sabulu da ruwa ba su samuwa ba, CDC ta ba da shawarar yin amfani da maganin kashe kashewa na hannu da aka yi amfani da shi a cikin giya, wanda ya ƙunshi aƙalla kashi 60 cikin ɗari na giya.
Hukumar lafiya ta duniya ta ce kada mutum ya taɓa idanunsa ko hanci ko bakinsa da hannu mai ƙazanta.
Ana iya lalata farfajiya ta hanyar wasu magunguna (a kan farfajiya na bakin karfe mai tsabtace jiki yana aiki minti ɗaya bayan an yi amfani da shi) tare da 6271% ethanol, 50100% isopropanol, 0,1% sodium hypochlorite, 0,5% hydrogen peroxide da 0,2 7,5% iodine.
Wasu abubuwa kamar benzodiazepine chloride da chlorhexidine gluconate ba su da tasiri sosai.
CDC ta ba da shawarar cewa idan ana zargin COVID ko kuma an tabbatar da shi a wani wuri kamar ofishi ko asibitin kwana, duk wuraren da ke cikin wannan dakin, gami da dakunan aiki, dakunan wanka, wuraren amfani da jama'a, kayan lantarki kamar kwamfutoci, allon taɓawa, keyboard, kwamfutocin nesa da ATMs da marasa lafiya ke amfani da su, su kasance masu ƙonewa.
Ƙungiyoyin kiwon lafiya sun ce idan kana tari ko kana tari, ka rufe bakinka da hancinka da takalma ko kuma ka kawar da kayan tsabta da ka yi amfani da su nan da nan.
Waɗanda suka kamu da cutar, ana ba da shawarar yin amfani da abin rufe fuska na likita, saboda yin amfani da abin rufe fuska na iya iyakance yawan da kuma yawan yaduwar kayayyakin numfashi da ke yawo a cikin iska yayin magana, numfashi da tari.
Hukumar lafiya ta duniya ta ba da umarni game da lokacin da za a yi amfani da abin rufe fuska na likita da kuma yadda za a yi amfani da shi.
Stephen Griffin, masanin ilimin cututtuka na jami'ar Leeds, ya ce, "Amfani da abin rufe fuska na iya rage yawan mutane su taɓa fuskarsu, kuma taɓa fuskarsu da hannuwan da suka ƙazanta shine babban hanyar kamuwa da cuta.
Hukumar lafiya ta duniya ta ba da shawarar cewa mutane masu lafiya su sa abin rufe fuska na likita, sai dai idan suna da haɗari mai yawa, kamar waɗanda ke kula da wani wanda ke da COVID-19, ko da yake ta kuma yarda cewa yin amfani da abin rufe fuska yana iya rage yawan taɓa fuska.
Kasashe da dama sun fara kiran yin amfani da abin rufe fuska a wuraren jama'a.
Cibiyoyin CDC, Amurka, sun ba da shawarar yin amfani da abin rufe fuska na ƙwayoyin halitta don dalilai na likita. China ta jaddada muhimmancin amfani da abin rufe fuska na likita na yau da kullun ga mutane masu lafiya, musamman idan suna cikin kusanci (1 mita (3 ƙafa) ko ƙasa da haka) da wasu mutane.
A Hong Kong ana ba da shawarar saka abin rufe fuska a cikin motocin hawa da jama'a ko wuraren da mutane suke.
Jami'an kiwon lafiya a Thailand sun bukaci mutane su yi amfani da fuska a gida kuma su wanke su kullum.
A Jamhuriyar Czech da Slovakia an hana 'yan ƙasa fita a titi ba tare da abin rufe fuska da rufe bakinsu ba.
A ranar 16 ga Maris, gwamnatin Vietnam ta nemi dukan 'yan kasar su saka abin rufe fuska a wuraren jama'a domin kare kansu da kuma wasu.
Gwamnatin Austria ta bukaci duk masu ziyartar shagunan abinci su sa abin rufe fuska na likita.
Gwamnatin Isra'ila ta kuma nemi 'yan kasar su saka abin rufe fuska a wuraren jama'a.
A ranar 1 ga Afrilu, a Taiwan, inda ake yin masks na kiwon lafiya miliyan goma a rana tun tsakiyar watan Maris, an umurci duk fasinjojin jiragen kasa da bas na gari su yi amfani da masks na kiwon lafiya.
A Panama, an bukaci mazauna su saka abin rufe fuska na likita a lokacin da suke fita waje; an shawarci mazauna da ba za su iya sayen abin rufe fuska su saka shi a gida ba.
Masks na likita kuma suna amfani da su sosai a Japan, Koriya ta Kudu, Malaysia da Singapore.
Tsare-tsare na zamantakewa (wanda aka fi sani da nesa na jiki)  ita ce hanyar da za a iya magance kamuwa da cuta ta hanyar rage yawan mutane.
Ana yin amfani da matakan tsaro kamar su killace mutane, hana su fita ko su yi tafiya, rufe makarantu, wuraren aiki, filayen wasa, da kuma wuraren cinikayya.
Mutane za su iya yin amfani da matakan nesa ta hanyar kasancewa a gida, ta hanyar iyakance tafiye-tafiye, ta hanyar guje wa wuraren da mutane suke, ta hanyar yin amfani da gaisuwa ta hanyar tuntuɓar juna, da kuma ta hanyar nisanta kansu daga wasu.
Gwamnatocin yankuna da yawa, musamman waɗanda cutar ta shafa, a yanzu suna ba da umarni ko kuma suna ba da shawarar yin nesa da jama'a.
An rage yawan mutanen da za su iya taruwa a wuri guda bisa ga shawarwarin hukumomin gwamnati da na kiwon lafiya na Amurka, daga mutane 250 (a yankunan da ba a samu bayanai game da yaduwar COVID-19 ba) zuwa mutane 50 kuma daga baya zuwa mutane 10.
A ranar 22 ga Maris, 2020, Jamus ta haramta taruwa a cikin ƙungiyoyi fiye da mutane biyu. Manya da mutane masu fama da cututtuka kamar ciwon sukari, cututtukan zuciya, cututtukan numfashi, hawan jini, da kuma raunanan tsarin rigakafi suna fuskantar haɗarin kamuwa da cutar a cikin mummunan tsari. CDC ta ba da shawarar su zauna a gida mafi tsawo idan akwai barkewar cutar a yankin. A ƙarshen Maris, 2020, WHO da sauran hukumomin kiwon lafiya sun fara maye gurbin amfani da kalmar social distancing zuwa  physical distancing, don haka bayyana manufar wannan matakin  rage hulɗa ta jiki a cikin hanyoyin sadarwar zamantakewa, ko ta hanyar sadarwa ta hanyar sadarwa ta hanyar sadarwa ko kiyaye nesa ta jiki.
An yi amfani da kalmar tsarewar zamantakewa ta hanyar cewa mutane su sanya kansu cikin cikakken keɓewa ta zamantakewa maimakon kasancewa tare da wasu mutane ta hanyoyi na daban. Wasu hukumomi sun buga jagororin lafiyar jima'i waɗanda ya kamata a yi amfani da su yayin annobar.
Wasu sun ce ka yi jima'i da abokin aurenka na dindindin ne kawai, wanda ka san ba shi da cutar ko alamunta.
Ana ba da shawarar cewa mutanen da aka gano suna da COVID-19 da kuma waɗanda suka yi zaton suna da cutar su keɓe kansu a gida.
Hukumomin ƙasashe da yawa sun kuma tilasta wa dukan mutanen da ke yankunan da aka yi wa annoba su yi zaman kansu.
An yi wa mutanen da ke cikin rukunin da ke da haɗari sosai dokar hana fita.
An shawarci mutanen da suka yi hulɗa da waɗanda suka kamu da COVID-19, ko kuma suka ziyarci wata ƙasa ko yanki da cutar ta shafa sosai kwanan nan su kasance cikin killacewa na kwanaki 14 daga lokacin da suka yi hulɗa da su.
Dabarun yaki da cutar sun haɗa da hana yaduwar cutar, hana ta ko kuma rage ta.
Ana hana yaduwar cutar a farkon lokaci kuma ana nufin bin diddigin waɗanda suka kamu da cutar da keɓe su, kuma ana ɗaukar wasu matakan sarrafa kamuwa da cuta da yin allurar rigakafi don dakatar da yaduwar cutar tsakanin sauran al'umma.
A lokacin da ba za a iya hana yaduwar cutar ba, ana yin ƙoƙari don rage shi: ana yin aiki don rage yaduwar cutar da kuma rage tasirin cutar a kan tsarin kiwon lafiya da kuma al'umma.
Ana iya ɗaukar matakan hanawa da kuma rage cutar a lokaci guda.
Dakatar da kamuwa da cuta na bukatar karin tsauraran matakai don juyar da cutar ta koma baya, ta rage yawan kamuwa da cutar zuwa kasa da matakin 1. Wani ɓangare na ƙoƙarin sarrafa barkewar cutar ta kamuwa da cuta ya shafi rage ƙaruwar cutar, wanda aka sani da daidaita cutar ta cutar.
Irin waɗannan ayyukan suna rage haɗarin yin amfani da ayyukan kiwon lafiya da yawa kuma suna ba da ƙarin lokaci don yin allurar rigakafi da hanyoyin magani.
Hanyoyin da ba na magani ba waɗanda zasu iya taimakawa wajen magance barkewar cutar sun haɗa da matakan kariya ta mutum kamar tsabtace hannu, amfani da masks na likita da keɓewa; matakan zamantakewa don nisantar da jiki kamar rufe makarantu da soke taron taro; shigar da al'umma don taimakawa wajen aiwatar da irin waɗannan matakan da shiga cikin su; da kuma matakan kare muhalli kamar tsabtace farfajiya. Bayan an bayyana mahimmancin barkewar cutar a China, an ɗauki ƙarin matakan da aka ɗauka don hana barkewar cutar, kamar warewar birane gaba ɗaya da kuma sanya tsauraran takunkumin hana tafiya.
Sauran ƙasashe ma sun ɗauki wasu matakai don rage yaduwar cutar.
A Koriya ta Kudu, an yi amfani da allurar rigakafi da kuma killace mutane, kuma an tsara tsarin sanar da mutane da ke da cutar.
A Singapore, an ba da tallafi ga mutanen da ke da cutar da ke keɓe kansu kuma an yi wa waɗanda ba su yi hakan ba tsabar kudi.
A Taiwan an kara samar da masks na kiwon lafiya kuma an yi musu tarawa don tara kayayyakin magani masu yawa. Tsarin da aka yi a Burtaniya da Amurka ya nuna cewa akwai matsaloli masu tsanani game da sauƙaƙewa ( jinkirta, amma ba dakatar da yaduwar cutar ba) da kuma dannewa (dakatar da ci gaban cutar).
Ƙaddamar da manufofin da za su iya rage yawan ciwon zai iya rage yawan yawan mutuwar da ke faruwa a tsarin kiwon lafiya da kashi biyu cikin uku, amma zai iya jawo mutuwar dubban dubbai da kuma rushewar tsarin kiwon lafiya.
Ana iya amfani da maganin kashewa, amma ana bukatar yin amfani da shi har sai an yi amfani da cutar a cikin al'umma (ko kuma kafin a yi maganin, idan an yi hakan a baya), domin idan ba haka ba, za a sake yaduwar cutar da sauri lokacin da aka rage matakan.
Yin amfani da lokaci mai tsawo don shawo kan annobar yana jawo farashi na zamantakewa da tattalin arziki.
Babu magungunan rigakafin cutar da aka amince da su don magance COVID-19 a yanzu, amma ana ƙoƙari don haɓaka su, gami da gwada magungunan da ke akwai.
Yin amfani da maganin sanyi da ba a rubuta ba, shan ruwa da yawa, da kuma yin hutu zai iya taimaka maka ka rage alamun.
Dangane da irin yanayin da mutum yake ciki, zai iya bukatar maganin oxygen, da kuma taimakon numfashi.
Yin amfani da kwayoyin steroid zai iya cutar da kai.
Wasu da aka amince da su a baya don magance wasu cututtukan kwayar cutar suna kuma a kan yin amfani da su wajen magance COVID-19.
Hukumar ta WHO ta kuma ce wasu magungunan gargajiya da na gida za su iya sauƙaƙa alamun cutar ta SARS-CoV-19.
Hukumar ta WHO ta dauki bunkasa iyawa da kuma daidaita kiwon lafiya ga bukatun marasa lafiya da COVID-19 a matsayin babban mataki na amsawa ga barkewar cutar.
Cibiyar Tallafawa da Kula da Cututtuka ta Turai (ECDC) da Hukumar Kula da Lafiya ta WHO ta Turai sun fitar da jagororin asibitoci da sabis na kiwon lafiya na farko don taimakawa wajen sake rarraba albarkatu a matakai da yawa, gami da mayar da hankali ga ayyukan dakin gwaje-gwaje don gwajin COVID-19, soke hanyoyin ba tare da lokaci ba, inda zai yiwu, gano cutar da kewaye da marasa lafiya da aka tabbatar da cutar COVID-19, da kuma faɗaɗa damar maganin gaggawa ta hanyar horar da ma'aikata da haɓaka yawan na'urorin IVL da gado masu samuwa.
Akwai ra'ayoyi game da inda mutum na farko ya kamu da cutar, wato, mai cutar da ake kira "Zero Patient".
Wataƙila an fara samun sabon kamuwa da cutar korona a ranar 1 ga Disamba, 2019, a Wuhan, lardin Hubei, China.
A cikin wata guda, adadin mutanen da suka kamu da cutar korona a lardin Hubei ya ci gaba da ƙaruwa.
A ranar 26 ga watan Disamba, an yi wani bincike a asibitin lardin Hubei na fama da cutar huhu da ba a san asalinsa ba, wanda likitan Zhang Tianjin ya yi aiki da shi, wanda ya ba da rahoton wannan labarin a ranar 27 ga watan Disamba a Cibiyar Kula da Cututtuka da Cututtuka ta Jianghan a birnin Wuhan.
A ranar 30 ga watan Disamba, wata ƙungiyar likitoci a asibitin Wuhan ta gargadi abokan aikinta game da cutar coronavirus, wadda ta yi kama da SARS.
Likitoci takwas, ciki har da Li Wenlian, sun yi gargadin cewa 'yan sanda za su yi musu laifi don yada jita-jita, kuma likitan mai suna Ai Feng ya yi wa shugabansa horo don ya yi ta tsoratar da mutane.
Daga baya, a ranar 31 ga watan Disamba, Hukumar Kula da Lafiya ta Wuhan ta wallafa sanarwar jama'a kuma ta sanar da WHO game da halin da ake ciki.
Hukumomin lafiya na Wuhan sun ba da rahoton adadin mutanen da suka kamu da cutar ta sanannen huhu, wanda ya zama babban bincike a farkon watan Janairu.
A farkon da tsakiyar watan Janairu na shekarar 2020, cutar ta kuma yadu zuwa wasu lardunan kasar Sin, wanda bikin Sabuwar Shekara ta kasar Sin da kuma yadda Wuhan ke zama tashar sufuri da kuma babbar hanyar jirgin kasa ta taimaka.
A ranar 20 ga watan Janairu, kasar Sin ta ba da rahoton sabbin mutane 140 da suka kamu da cutar a rana guda, ciki har da mutane biyu da suka kamu da cutar a Beijing da kuma daya a birnin Shenzhen.
A ranar 20 ga watan Janairun 2020, an samu alamun cutar a cikin mutane 6,174. A ranar 26 ga Maris, Amurka ta fi China da Italiya a duniya a cikin mafi yawan adadin mutane da suka kamu da cutar. A ranar 9 ga Afrilu, 2020, an sami sama da mutane miliyan 1.61 a duniya, sama da mutane 97,000 sun mutu, kuma sama da 364,000 sun warke.
Kasashe da yankuna kusan 200 sun yi rahoton cewa sun kamu da cutar aƙalla sau ɗaya.
Saboda annobar, ƙasashen Turai da yawa a yankin Schengen sun ƙuntata motsi da kuma kafa iyakokin.
Matakan da aka yi a cikin ƙasa sun haɗa da matakan hana yaduwar cutar kamar killace (wanda aka sani da zama a gida, gida ko zaman gida), da kuma sa'a ta yin shinge. Kamar yadda a ranar 2 ga Afrilu, kusan mutane miliyan 300, ko kusan kashi 90% na yawan Amurka, suna cikin wani nau'in killace, fiye da mutane miliyan 50 suna cikin killacewa a Philippines, kusan mutane miliyan 59 suna cikin killacewa a Afirka ta Kudu, da mutane biliyan 1.3 a Indiya.
A ranar 26 ga Maris, mutane biliyan 1.7 a duniya suna cikin wata irin makanta, kuma bayan kwana biyu, adadin ya karu zuwa biliyan 2.6  kusan kashi ɗaya bisa uku na yawan duniya.
An yi rahoton cewa an fara samun kamuwa da cutar COVID-19 a Wuhan a ranar 1 ga Disamba, 2019; a cewar wani rahoto da ba a tabbatar da gaskiyar bayanan ba, ranar 17 ga Nuwamba.
A ranar 26 ga watan Disamba, likitan Zhang Jissian ya yi aiki da wani mutum mai fama da cutar huhu da ba a san irinsa ba, kuma a ranar 27 ga watan Disamba, Cibiyar Kula da Cututtuka da Rigakafin Cutar Jianghan a birnin Wuhan ta sanar da asibitin.
Gwajin kwayoyin halitta na farko na marasa lafiya da aka yi a ranar 27 ga Disamba, 2019, ya nuna cewa akwai wani coronavirus mai kama da SARS.
A ranar 31 ga watan Disamba, Hukumar Kula da Lafiya ta Wuhan ta buga sanarwar da ta dace.
An sanar da Hukumar Lafiya ta Duniya a wannan ranar.
Da aka samu irin wannan sanarwar, 'yan sanda sun gargadi likitoci a Wuhan game da alhakin yada jita-jita game da barkewar cutar.
Da farko Hukumar Lafiya ta Kasa ta kasar Sin ta ce babu wata hujja da ta nuna cewa cutar da aka gano a baya tana iya yaduwa daga mutum zuwa mutum.
A ƙarshen watan Janairu, gwamnatin kasar Sin ta kaddamar da wani babban yunkuri na hana yaduwar cutar, wanda daga baya Babban Sakataren Jam'iyyar Kwaminisancin China Xi Jinping ya kira "Yaƙin Jama'a".
A ranar 23 ga watan Janairu aka sanar da dokar hana fita zuwa Wuhan da kuma komawa zuwa wasu birane a lardin Hubei, kuma an kai ga mutane miliyan 57.
An haramta amfani da motocin hawa na sirri a birnin.
A wurare da yawa an soke bikin Sabuwar Shekarar Sin (25 ga Janairu).
Hukumomi sun kuma sanar da cewa za a gina asibitin wucin gadi na Hooshenshang, wanda aka kammala a cikin kwanaki 10.
Daga baya, an gina wani asibiti, Leishenshan, wanda ya karɓi sauran marasa lafiya da ke shigowa.
Baya ga sababbin asibitocin da aka gina, kasar Sin ta sake yin amfani da wasu cibiyoyi 14 a Wuhan, kamar cibiyoyin taro da filayen wasa, a matsayin asibitoci na wucin gadi. A ranar 26 ga Janairu, gwamnati ta ɗauki ƙarin matakan dakile barkewar COVID-19, gami da samar da takardun lafiyar matafiya da tsawaita lokacin bikin Sabuwar Shekarar Sin.
An rufe jami'o'i da makarantu a duk faɗin ƙasar.
Ƙasar Hong Kong da Macau sun ɗauki wasu matakai, musamman ma a kan makarantu da jami'o'i.
A wasu yankuna a kasar Sin, hukumomi sun saka dokar hana fita.
An yi wa'azi a lardin Hubei da wajensa.
An canja tsarin tafiye-tafiyen jama'a, kuma an rufe gidajen tarihi a duk faɗin ƙasar Sin.
An kafa tsarin kula da motsi na 'yan ƙasa a birane da yawa, kuma an kiyasta cewa kusan mutane miliyan 760 (fiye da rabin yawan jama'a) sun fuskanci wasu nau'ikan ƙuntatawa na motsi a waje. Bayan barkewar cutar ta shiga cikin duniya a watan Maris, hukumomin China sun ɗauki tsauraran matakai don hana shigo da cutar daga wasu ƙasashe.
Alal misali, an kafa dokar killace-killace na kwanaki 14 ga dukan matafiya na duniya da ke shiga birnin a birnin Beijing. A ranar 23 ga Maris, an yi rikodin kamuwa da cutar guda ɗaya a cikin ƙasar Sin, wanda ya faru kwanaki biyar kafin wannan, a wannan yanayin daga mutumin da ya dawo Guangzhou daga Istanbul.
A ranar 24 ga Maris, 2020, Firayim Ministan kasar Sin Li Keqiang ya sanar da cewa an dakatar da yaduwar cutar da ke yaduwa a cikin kasar, kuma an kame barkewar cutar a kasar Sin.
A wannan ranar an cire takunkumin tafiya zuwa Hubei, banda Wuhan, bayan watanni biyu bayan rufe lardin don yin rigakafi. A ranar 26 ga Maris, 2020, Ma'aikatar Harkokin Wajen China ta ba da sanarwar cewa daga ranar 28 ga Maris, za a dakatar da shiga ga mutanen da ke da biza ko takardar izinin zama.
Duk wanda ya so ya zo kasar Sin zai nemi takardar izini a ofisoshin jakadancin kasar Sin ko kuma a ofisoshin jakadancin kasar.
A ranar 30 ga watan Maris, gwamnatin kasar Sin ta yi kira ga kamfanoni da masana'antu su ci gaba da aiki kuma ta samar wa kamfanoni da wasu matakan karfafa kudi. A ranar 4 ga watan Afrilu da karfe 10:00 na yamma, an gudanar da wani lokacin shiru na minti uku na kasa, wanda ya fara da ranar makoki ga wadanda suka mutu saboda cutar coronavirus, wanda Majalisar Dinkin Duniya ta sanar da shi kuma ya dace da bikin Quinmin, amma gwamnatin tsakiya ta nemi 'yan ƙasa su girmama wadanda suka mutu ta hanyar layi, suna kiyaye nesa ta jiki don kauce wa sake fashewar COVID-19.
An tabbatar da cewa COVID-19 ta bazu zuwa Koriya ta Kudu a ranar 20 ga Janairu, 2020 daga China.
A ranar 20 ga watan Fabrairu, Ma'aikatar Lafiya ta Kasa ta ba da rahoton cewa an sami karuwar adadin mutanen da suka kamu da cutar, wanda ya faru ne saboda yawan mabiyan sabon addini da ake kira Shinchongji Church sun taru a Tag.
Mabiya Shinchongji sun zo Tag daga Wuhan, wanda ake zaton shi ne tushen fashewar.
A ranar 22 ga Fabrairu, daga cikin mabiya cocin 9,336, 1,261 (kimanin kashi 13%) sun ba da rahoton cewa suna da alamun cutar.
A ranar 28 ga Fabrairu, an samu karin mutane 2,000 da suka kamu da cutar a Koriya, kuma a ranar 29 ga Fabrairu, adadin ya ƙaru zuwa 3,150.
An sanya dukkan sansanonin sojin Koriya ta Kudu a cikin killace bayan an tabbatar da cewa sojoji uku sun kamu da cutar.
An yi amfani da shirin da ke tattare da binciken cutar don bincika mutane da cutar, saka idanu kan tuntuɓar su, da kuma tsara matakan killacewa ga waɗanda suka tuntube su. Wannan shirin an dauke shi mafi girma da kuma mafi kyau a cikin tsarinsa a duniya.
Hanyar yin gwaji ta ƙunshi sanar da duk waɗanda suka zo daga ƙasashen waje game da alamunsu ta hanyar wayar hannu, yin gwajin gwaji na cutar a rana mai zuwa, da kuma faɗaɗa damar gwaji don gwada mutane 20,000 a kowace rana.
An yi la'akari da shirin Koriya ta Kudu a nasarar yaki da cutar, duk da cewa ba a ware birane ba.
Yawancin 'yan Koriya sun sanya hannu kan takardun da suka yaba wa aikin shugaban kasar ko kuma suka bukaci a yi wa Mista Moon hukuncin kisa saboda rashin dacewar da suka ga gwamnatin ta yi game da barkewar cutar.
A ranar 23 ga watan Maris, an samu rahoton cewa Koriya ta Kudu ta sami mafi ƙarancin adadin kamuwa da cutar a cikin kwana ɗaya a cikin makonni huɗu.
A ranar 29 ga watan Maris ne aka samu sanarwar cewa daga ranar 1 ga watan Afrilu, za a sanya duk wadanda suka dawo daga kasashen waje a cikin killace na makonni biyu.
Rahotanni sun ce a ranar 1 ga Afrilu, ƙasashe 121 sun nemi taimakon Koriya ta Kudu wajen gwada cutar.
A ranar 19 ga watan Fabrairu, Iran ta ba da rahoton farkon tabbatar da kamuwa da cutar SARS-CoV-2 a Kum, inda, a cewar Ma'aikatar Lafiya da Ilimin Lafiya, mutane biyu suka mutu a wannan rana.
Matakan farko da gwamnati ta ɗauka sun haɗa da soke kide-kide da sauran al'adu da wasanni, addu'o'in Juma'a, da rufe jami'o'i, manyan makarantu da makarantu.
Iran ta ba da riyal tiriliyan biyar don yaki da cutar.
A ranar 26 ga watan Fabrairun 2020, Shugaba Hassan Rouhani ya bayyana cewa gwamnati ba ta shirin sanya dukkanin yankunan da cutar ta shafa a cikin killacewa, amma za a sanya wasu mutane a cikin killacewa.
A watan Maris an sanar da shirin rage tafiye-tafiye tsakanin birane, amma har yanzu ana ci gaba da yin motsi tsakanin birane kafin Sabuwar Shekarar Farisa.
Har zuwa ranar 16 ga watan Maris na shekarar 2020, wuraren ibada na Shi'a a Kume sun kasance a bude domin masu yin sujada.
A cikin bayanan da ke nuna cewa an ɓoye yadda cutar ta barke a Iran, a ranar 28 ga Fabrairu, fiye da kasashe goma sun danganta kamuwa da cutar da Iran, wanda ke nuna cewa cutar za ta iya zama mafi tsanani a wurin fiye da shari'o'in 388 da gwamnatin Iran ta yi rajista a wannan lokacin.
Majalisar dokokin Iran ta rufe, kuma a ranar 3 ga Maris, an samu gwajin cutar a 23 daga cikin mambobi 290 na majalisar.
A ranar 12 ga watan Maris, Human Rights Watch (A kan Hakkin Dan Adam) ta yi kira ga hukumomin kurkuku na Iran da su saki masu kare hakkin mutane da aka tsare saboda rashin amincewarsu da zaman lafiya, da kuma 'yancin dukan fursunoni da suka dace da wannan rukuni.
Kungiyar ta ce akwai haɗarin yaduwar cutar a wuraren da aka rufe kamar kurkuku inda rashin kulawar lafiya ya rage.
A ranar 15 ga watan Maris, gwamnatin Iran ta ba da rahoton mutuwar mutane 100 a cikin rana guda, wanda ya fi yawan mutuwar da aka samu a kasar tun lokacin da cutar ta barke.
A ranar 17 ga watan Maris, aƙalla 'yan siyasa da jami'an gwamnati 12 da suka kasance a Iran sun mutu saboda wannan cuta.
A ranar 23 ga watan Maris, a Iran, ana samun sababbin mutane 50 da suka kamu da cutar korona a kowace awa kuma a kowane minti goma, ana samun sabon mutum daya da ya mutu sakamakon cutar.
Wani wakilin WHO ya ce, cutar za ta iya kaiwa Iran sau biyar fiye da yadda aka samu a hukumance.
An kuma yi zaton cewa takunkumin da Amurka ta dauka kan Iran zai iya shafar tattalin arzikin kasar wajen kare kanta daga yaduwar cutar.
Babban kwamishinan Majalisar Dinkin Duniya kan 'yancin bil'adama ya bukaci a sassauta takunkumin tattalin arziki a kan kasashen da cutar ta fi shafa, ciki har da Iran.
A ranar 31 ga watan Janairu, an tabbatar da cewa cutar ta shiga ƙasar Italiya, lokacin da wasu matafiya biyu na ƙasar Sin suka sami sakamako mai kyau a gwajin SARS-CoV-2 da aka yi a Roma.
Yawan kamuwa da cutar ya karu sosai, wanda ya sa gwamnatin Italiya ta dakatar da duk jiragen zuwa da daga China kuma ta ayyana dokar ta baci.
Daga baya an gano wani tarin mutane marasa alaƙa da kamuwa da cutar COVID-19. Wannan ya fara ne da yin rajistar mutane 16 da aka tabbatar da cutar a Lombardy a ranar 21 ga Fabrairu. A ranar 22 ga Fabrairu, Majalisar Ministoci ta fitar da sabuwar dokar hana barkewar cutar, wacce ta sanya mutane sama da 50,000 daga garuruwa 11 daban-daban a arewacin Italiya a cikin killace.
Firayim Minista Giuseppe Conte ya ce: "Za a rufe ko a rufe shiga da fita daga yankin da cutar ta bulla.
A cikin waɗannan yankuna an riga an ba da umarnin dakatar da ayyukan masana'antu da soke ayyukan wasanni. A ranar 4 ga Maris, gwamnatin Italiya ta ba da umarnin rufe dukkan makarantu da jami'o'i a duk faɗin ƙasar, saboda a lokacin an riga an rubuta mutuwar mutane 100 a Italiya.
Duk manyan wasanni, ciki har da wasannin ƙwallon ƙafa na jerin A, ya kamata su gudana a rufe har zuwa Afrilu, amma a ranar 9 ga Maris an dage duk wasanni na wasanni na akalla wata ɗaya.
A ranar 11 ga Maris, Firayim Minista Conte ya ba da umarnin dakatar da kusan dukkanin kasuwancin kasuwanci da rufe masana'antu, sai dai manyan kantuna da kantuna. A ranar 6 ga Maris, Kwalejin Italiyanci ta Anesthesia, Analgia, Reanimation da Intensive Therapy (SIAARTI) ta wallafa shawarwari kan ɗabi'ar likita game da yarjejeniyar saita lokaci don ba da taimako ga marasa lafiya, wanda zai iya zama dole a yi amfani da shi.
A ranar 19 ga watan Maris, Italiya ta fi China gaba a yawan mutuwar da ta kamu da cutar coronavirus, ta zama ta farko a duniya, bayan da ta sanar da mutuwar 3,405.
A ranar 22 ga watan Maris, an sanar da cewa Rasha ta tura jiragen yaki tara zuwa Italiya da ke dauke da kayan aikin likita.
A ranar 5 ga Afrilu, a Italiya akwai mutane 128,948 da suka kamu da cutar coronavirus, mutane 15,887 da suka mutu, da kuma mutane 21,815 da suka warke, kuma yawancin waɗannan sun kasance a yankin Lombardy.
Wani rahoto na CNN ya ce, akwai abubuwa biyu da za su iya sa mutuwar ta yi yawa a Italiya: yawan tsofaffi a ƙasar da kuma rashin damar yin bincike a kan kowa da kowa da ke fama da cutar.
Burtaniya ta yi murna sosai da cutar daga cikin ƙasashen da ta sha wahala, kuma har zuwa 18 ga Maris, 2020, gwamnatin Burtaniya ba ta tilasta wa 'yan ƙasa su bi kowane nau'in nisan jama'a ko matakan killacewa ba.
A sakamakon haka, an soki gwamnati saboda rashin saurin amsawa da gaggawa ga haɗarin da ke cikin ƙasar. A ranar 16 ga Maris, Firayim Minista Boris Johnson ya ba da sanarwar da ta ba da shawarar cewa a guji duk wani tafiya da kuma hulɗa na zamantakewa wanda ba shi da mahimmanci, yana ba mutane damar yin aiki daga gida kuma su guji wuraren jama'a kamar mashaya, gidajen abinci da gidajen wasan kwaikwayo.
A ranar 20 ga Maris, gwamnatin ta sanar da cewa duk wuraren nishaɗi kamar pubs da kungiyoyin wasanni dole ne a rufe su da wuri-wuri, kuma ta yi alkawarin biyan albashi har zuwa kashi 80% na albashi ga 'yan ƙasa masu aiki, amma ba fiye da £ 2,500 a wata a matsayin matakin tallafi ga jama'a a lokacin rikici. A ranar 23 ga Maris, Firayim Minista ya sanar da tsauraran matakan nesa da zamantakewa, ya hana taron mutane fiye da biyu da kuma iyakance tafiya da hutu na waje kawai a cikin matsanancin bukata.
Ba kamar yadda aka yi a dā ba, an yi amfani da waɗannan ƙuntatawa don jawo 'yan sanda, yin tarkace da kuma fitar da mutane.
An umarci rufe yawancin masana'antu, sai dai masana'antun da ke ba da sabis na rayuwa ga jama'a, ciki har da manyan kantuna, kantuna, bankuna, shagunan kasuwanci, tashoshin mai da kaya da garages.
A ranar 20 ga watan Janairu a jihar Washington ta arewa maso yammacin Pacific, an tabbatar da mutum na farko da ya kamu da cutar COVID-19 a cikin ƙasar daga Wuhan a ranar 15 ga watan Janairu.
A ranar 29 ga watan Janairu, an kafa Ƙungiyar Aiki ta Ƙasa da Korona a fadar White House.
A ranar 31 ga watan Janairu, gwamnatin Trump ta yi dokar ta baci a fannin kiwon lafiya ta jama'a kuma ta sanya takunkumin shiga kasar Sin.
A ranar 28 ga Janairu, 2020, Cibiyar Kula da Cututtuka da Rigakafin Cututtuka, babbar ƙungiyar kula da lafiyar jama'a ta gwamnatin Amurka, ta sanar da cewa ta kirkiro ta ta ta gwajin gwaji.
Duk da haka, ba a fara gwajin mutane a Amirka nan da nan ba, kuma sakamakon haka, an ɓoye ainihin yadda cutar ta ɓarke a wannan lokacin.
Gwajin ya kasance da wahala saboda rashin gwajin gwajin da gwamnatin tarayya ta fitar a watan Fabrairu, rashin izinin gwamnatin tarayya har zuwa ƙarshen Fabrairu don amfani da gwajin gwajin da ba na gwamnati ba wanda kungiyoyin kimiyya, kamfanoni daban-daban da asibitoci ke haɓaka, da kuma ƙuntatawa kafin farkon Maris wanda zai ba da damar yin gwaji ga citizensan ƙasa (wanda zai iya yin hakan ne kawai bisa ga umarnin likitan da ke bi da shi).
Jaridar The Washington Post ta ruwaito cewa a ranar 27 ga Fabrairu, an yi gwajin gwaji kasa da 4,000 a Amurka.
The Atlantic ta ruwaito cewa, a ranar 13 ga Maris, an yi gwajin da ya kai kasa da 14,000.
A ranar 22 ga watan Maris, Associated Press ta ruwaito: "Masu yawa, har ma da bayyanar cututtuka da kuma umarnin likita, suna jiran su yi bincike na awanni ko kwanaki. Bayan Washington ta samu rahoton mutuwar farko na coronavirus a Amurka a ranar 29 ga Fabrairu, Gwamna Jay Innsley ya ba da sanarwar dokar ta baci, wanda wasu jihohi suka sanar da shi ba da daɗewa ba.
A ranar 3 ga Maris, an soke darussan a makarantun Seattle, kuma a tsakiyar watan Maris, an rufe makarantun a duk faɗin ƙasar. A ranar 6 ga Maris, 2020, ƙungiyar masu ilimin cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cuttukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
A wannan ranar ne Shugaba Trump ya rattaba hannu kan Dokar Ƙarin Kudade don Shirya da Amsa don Yakin Coronavirus, wadda ta ba da taimakon gaggawa na dala biliyan 8.3 ga hukumomin tarayya don magance barkewar cutar.
Ƙungiyoyi sun saita ƙuntatawa ga tafiye-tafiyen ma'aikata, sun soke taron, kuma sun bukaci ma'aikata su yi aiki daga gida.
An soke wasanni da yanayi. A ranar 11 ga Maris, Trump ya sanar da ƙuntatawa kan tafiya zuwa yawancin Turai, ban da Burtaniya, na kwanaki 30, farawa daga 13 ga Maris.
Kashegari, ya faɗaɗa takunkumin, ya haɗa da Burtaniya da Ireland a cikin wannan jerin.
A ranar 13 ga Maris, shugaban ya sanar da dokar ta baci a kasar, wanda ya ba da damar amfani da kudaden tarayya don magance rikicin.
Tun daga ranar 15 ga Maris, kamfanoni da yawa sun rufe ko rage awoyi a duk faɗin Amurka don taimakawa wajen yaki da yaduwar cutar.
A ranar 17 ga Maris, an tabbatar da cutar a jihohi 50 da kuma gundumar Columbia. A ranar 23 ga Maris, an samu rahoton cewa an samu kamuwa da cutar 10,700 a New York a rana, wanda ya fi yawan mutanen Koriya ta Kudu.
A ranar 25 ga Maris, gwamnan ya ce, ana iya ganin cewa yin nesa da jama'a zai taimaka sosai, domin an rage yawan adadin mutane daga kwana 2.0 zuwa kwana 4.7.
A ranar 28 ga watan Maris, an yi rahoton cewa an samu mutane 32,308 da suka kamu da cutar a birnin New York, inda mutane 672 suka mutu. An ruwaito cewa a ranar 26 ga watan Maris, Amurka ta samu karin mutane da suka kamu da cutar coronavirus fiye da kowace ƙasa a duniya, ciki har da China da Italiya.
Rahotanni na kafofin watsa labarai na ranar 30 ga watan Maris sun ce shugaba Trump ya yanke shawarar tsawaita dokar hana fita har zuwa ranar 30 ga watan Afrilu.
A wannan rana, jirgin asibiti na USNS Comfort mai dakuna 1,000 ya sauka a tashar jiragen ruwa ta New York.
A ranar 3 ga watan Afrilu, an samu mutuwar mutane 884 sakamakon cutar coronavirus a cikin sa'o'i 24.
A jihar New York, adadin mutane da suka kamu da cutar ya wuce 100,000 a ranar 3 ga Afrilu. An soki fadar White House saboda ta yi watsi da barazanar da kuma ƙuntata bayanan da ke shiga cikin jama'a, ta hanyar amfani da ofishin Mataimakin Shugaban Amurka Mike Pence don sarrafa bayanan jama'a da kuma wallafe-wallafen jami'an kiwon lafiya da masana kimiyya game da cutar.
A gaba ɗaya, magoya bayan Shugaba Trump sun rarrabe ra'ayoyin game da yadda ya yi nasara wajen magance rikicin.
Wasu jami'ai da masu lura sun soki yadda Amurka ta dogara da shigo da kayayyaki masu muhimmanci daga China, ciki har da kayayyakin da ake bukata.
A tsakiyar watan Janairun 2020, mujallar Travel Medicine ta wallafa wani bincike na tsarin tafiye-tafiye na iska wanda aka yi amfani da shi don tsarawa da kuma hasashen yanayin yaduwar cutar.
Bisa ga bayanan da kungiyar jiragen sama ta kasa da kasa ta bayar a shekarar 2018, Bangkok, Hong Kong, Tokyo da Taipei sun dauki bakuncin mafi yawan matafiya daga Wuhan.
Dubai, Sydney, da kuma Melbourne sun kasance shahararrun wuraren da waɗannan masu yawon buɗe ido suka ziyarta.
Daga cikin shahararrun wurare 20 da aka fi so a yawon bude ido, an kira Bali mafi ƙarancin shirye-shiryen cutar, yayin da biranen Ostiraliya suka fi dacewa. A ranar 7 ga Fabrairu Ostiraliya ta ɗauki shirin gaggawa na gaggawa game da sabon coronavirus (COVID-19).
A wannan yanayin, an ce akwai abubuwa da yawa da za a sani game da COVID-19, kuma cewa Ostiraliya za ta ba da hankali ga kula da iyaka da sadarwa a cikin yanayin barazana.
A ranar 21 ga Maris, an sanar da dokar ta baci a Australia game da lafiyar mutum.
Saboda ingantattun matakan killace mutane da aka yi amfani da su a harkokin sufuri a Wuhan da Hubei, wasu ƙasashe sun shirya don kwashe 'yan ƙasarsu da jami'an diflomasiyya daga yankin, musamman ta hanyar jiragen haya na ƙasashensu, wanda hukumomin China suka ba da izinin su.
Kanada, Amurka, Japan, Indiya, Sri Lanka, Australia, Faransa, Argentina, Jamus da Thailand sun kasance daga cikin na farko da suka shirya don kwashe 'yan ƙasarsu.
Pakistan ta ce ba za ta kwashe 'yan kasar Sin ba.
A ranar 7 ga Fabrairu, Brazil ta kwashe 'yan Brazil 34 da dangin' yan Brazil, da kuma wasu 'yan Poland hudu, da na kasar Sin da kuma dan kasar Indiya.
'Yan ƙasar Poland, China da Indiya sun sauka a ƙasar Poland, inda jirgin Brazil ya tsaya kafin ya tashi zuwa Brazil bisa ga hanyar da ake nufi.
An saka 'yan ƙasar Brazil da suka ziyarci Wuhan a cikin wani sansanin soja kusa da birnin Brasilia.
A wannan ranar an kwashe 'yan kasar Kanada 215 (mutanen 176 daga jirgin sama na farko da 39 daga jirgin sama na biyu da gwamnatin Amurka ta haya) daga Wuhan, aka kai su sansanin Sojojin Kanada na Trenton kuma aka sanya su cikin killace na makonni biyu.
A ranar 11 ga Fabrairu, wani jirgin sama tare da 'yan ƙasar Kanada 185, wanda kuma aka fitar daga Wuhan, ya sauka a tashar CFB Trenton.
A ranar 3 da 4 ga Fabrairu, hukumomin Ostiraliya sun kwashe 'yan ƙasarsu 277 suka kai su wurin zama na wucin gadi a tsibirin Kirsimeti, wanda aka mayar da su cibiyar killace mutane, inda suka zauna har tsawon kwanaki 14.
A ranar 5 ga Fabrairu, jirgin motsa jiki na New Zealand ya isa Auckland; an sanya fasinjojinsa (ciki har da wasu daga Ostiraliya da yankin Asiya da Pacific) a cikin killace a sansanin sojan ruwa a Vangaparoa, arewacin Auckland.
A ranar 15 ga Fabrairu, Amurka ta sanar da cewa za ta kwashe 'yan ƙasar Amurka da ke jirgin jirgin ruwa mai suna Diamond Princess.
A ranar 21 ga Fabrairu, jirgin sama tare da fasinjojin Kanada 129 da aka kwashe daga Princess Diamond ya sauka a Trenton, Ontario.
A farkon watan Maris, gwamnatin Indiya ta fara kwashe 'yan kasar daga Iran. A ranar 14 ga Maris, jirgin saman kamfanin jirgin saman South African Airways, wanda gwamnatin Afirka ta Kudu ta haya, ya tashi tare da' yan Afirka ta Kudu 112 a cikin jirgin.
An yi wa fasinjojin gwajin likita kafin su tashi, kuma an bar 'yan Afirka ta Kudu hudu da aka gano sun nuna alamun cutar a China don rage haɗarin.
Sai dai 'yan Afirka ta Kudu da aka yi musu gwajin cutar korona ne kawai suka yi gudun hijira.
An bincika dukkan 'yan Afirka ta Kudu, gami da ma'aikatan jirgin sama, matukan jirgi, ma'aikatan otal, 'yan sanda da sojoji da suka shiga aikin agaji, kuma a matsayin matakin tsaro dukansu sun kasance a karkashin sa ido kuma suna cikin killacewa na kwanaki 14 a The Ranch Resort.
A ranar 20 ga watan Maris, Amurka ta fara janye dakarunta daga Iraki saboda annobar.
A ranar 5 ga watan Fabrairu, Ma'aikatar Harkokin Wajen kasar Sin ta sanar da cewa kasashe 21 (ciki har da Belarus, Pakistan, Trinidad da Tobago, Masar da Iran) sun tura taimakon su zuwa kasar Sin.
Wasu daliban kasar Sin da ke karatu a jami'o'in Amurka sun hada kai don tarawa da aika taimako zuwa yankunan China da suka sha wahala daga cutar, yayin da wata kungiya daga Chicago ta ba da rahoton cewa a ranar 30 ga Janairu ta aika da kayan numfashi na N95,000 zuwa asibitocin lardin Hubei.
A ranar 5 ga watan Fabrairu, Bill da Melinda Gates sun ba da sanarwar ba da gudummawar dala miliyan 100 ga WHO don tallafawa allurar rigakafi da maganin cutar coronavirus, da kuma kare mutanen Afirka da Kudancin Asiya daga barazanar cutar.
Interaksyon ta ruwaito cewa a ranar 6 ga watan Fabrairu, gwamnatin kasar Sin ta ba da masks na kiwon lafiya 200,000 a matsayin kyauta ga Philippines bayan Sanata Richard Gordon ya aika da masks miliyan 3.16 zuwa Wuhan.
A ranar 19 ga watan Fabrairu, kungiyar agaji ta Red Cross ta Singapore ta sanar da cewa za ta tura tallafin dala miliyan 2.26 zuwa kasar Sin.
Japan ta kuma ba da masks miliyan ɗaya a Wuhan, Turkiyya ta aika da kayan aikin likita, Rasha ta tura fiye da tan 13 na magunguna, Malaysia ta ba da sanarwar bayar da safofin hannu miliyan 18, Jamus ta aika da kayan aikin likita daban-daban, gami da kayan kariya 10,000, Amurka ta ba da tan 17.8 na magunguna, kuma ta yi alkawarin bayar da dala miliyan 100 a matsayin tallafi na kuɗi ga ƙasashen da suka sha wahala. Bayan da yanayin ya daidaita a China, ƙasar ta kuma aika da taimako ga sauran ƙasashe da cutar ta shafa.
A watan Maris, kasar Sin da Cuba da kuma Rasha sun tura magunguna da masana zuwa Italiya don taimakawa al'ummar kasar wajen magance annobar coronavirus.
Wani dan kasuwa Jack Ma ya aika wa kungiyar tarayyar Afirka, Addis Ababa, Habasha, kayayyaki miliyan 1.1 don gwaji, da masks na likita miliyan shida da kuma riguna 60,000 don kungiyar ta rarraba su ga kasashe masu shiga.
Daga baya ya kuma tura kayan gwaji 5,000, masks 100,000 da na'urori 5 na iska mai iska zuwa Panama.
Ma kuma ta ba da magunguna ga Kanada. Netherlands, Spain, Turkiyya, Georgia da Jamhuriyar Czech sun nuna damuwa game da masks na likita da kayan aikin gwaji na kasar Sin.
Alal misali, Spain ta soke kayayyakin gwajin cutar coronavirus na kasar Sin 58,000 da ke da daidaito har zuwa kashi 30 cikin dari, kuma Netherlands ta soke kayayyakin rigakafin asibiti na kasar Sin 600,000.
Belgium ta kuma janye masks 100,000 da ba su dace da amfani ba: an yi zaton an yi su a China, amma daga baya an gano cewa sun fito ne daga Colombia.
A wani bangare kuma, ana samun karbuwa sosai a wasu sassan Latin Amurka da Afirka. A ranar 2 ga Afrilu, Bankin Duniya ya soma ba da taimako na gaggawa ga ƙasashe masu tasowa.
Hukumar ta WHO ta yaba wa kokarin da gwamnatin kasar Sin ke yi na yaki da annobar da kuma hana yaduwar cutar.
WHO ta lura da bambanci tsakanin halin da ake ciki na annobar cutar huhu ta 2002-2004, inda aka zargi hukumomin kasar Sin da ɓoye bayanan da ake zargin sun hana hana rigakafin cutar da kuma hana ta yaduwa, a gefe guda, da kuma rikicin da ke faruwa a yanzu, inda gwamnatin tsakiya ta ba da sabuntawa game da halin da ake ciki a kai a kai don kauce wa firgita a ranar Sabuwar Shekarar Sin.
A ranar 23 ga watan Janairu, a mayar da martani ga shawarar da hukumomin tsakiya suka yanke na hana zirga-zirgar motoci a Wuhan, wakilin WHO, Goden Galea, ya lura cewa, ko da yake ba WHO ba ne ke ba da shawarar wannan matakin ba, shi ma yana da matukar muhimmanci a tabbatar da cika alƙawarin hana cutar a wurin da ta fi yaduwa, kuma ya kira shi ba a taɓa gani ba a tarihin lafiyar jama'a.
Babban daraktan WHO, Mista Tedros Adhanon, ya ce sanarwar PHEIC ta haifar da barazanar yaduwar duniya, musamman a ƙasashen da ke da ƙananan da matsakaitan albashi da ba su da ingantaccen tsarin kiwon lafiya.
A lokacin da yake magana game da takunkumin tafiye-tafiye, Mista Tedros ya ce babu wani dalili da zai hana tafiye-tafiye da cinikayya ta duniya, kuma WHO ba ta ba da shawarar ta hana cinikayya da cinikayya.
A ranar 5 ga watan Fabrairu, WHO ta nemi al'umma ta duniya ta ba da dala miliyan 675 don tabbatar da shirye-shiryen annobar a ƙasashen da ke da ƙananan kuɗaɗe, ta ba da sanarwar bukatar ba da gaggawa ga ƙasashen da ba su da tsarin gano mutanen da suka kamu da cutar, duk da cewa annobar ba ta kai waɗannan ƙasashen ba.
Mr Tedros ya kuma bayyana cewa, "aikinmu na shirye-shirye" shine yadda muke shirye-shirye don cutar ta raunana, kuma ya bukaci al'ummar duniya su zabi su zuba jari a yau ko su biya a nan gaba. A wani taron manema labarai da aka yi a ranar 11 ga watan Fabrairu, WHO ta ba da sunan COVID-19 a hukumance.
A wannan rana, Tedros ya ce Sakataren Majalisar Dinkin Duniya, Antonio Guterres, ya amince ya ba da damar dukan tsarin Majalisar Dinkin Duniya don amsa matsalar.
A sakamakon haka, an kafa Ƙungiyar Kula da Yanayin Yanayi ta Majalisar Dinkin Duniya, wadda ke daidaita duk matakan da Majalisar Dinkin Duniya ta ɗauka; WHO ta ce waɗannan matakan za su ba da damar da su mai da hankali kan amsawar kiwon lafiya, yayin da sauran hukumomi za su iya amfani da kwarewarsu don magance barkewar cutar a cikin mafi girman zamantakewa da tattalin arziki.
A ranar 14 ga watan Fabrairu, WHO da China sun yi shirin kafa wata kungiya ta musamman da ta samar da kwararrun masana na duniya da ma'aikatan WHO a kasar Sin don taimakawa wajen magance matsalar a cikin kasar da kuma tantance yadda cutar take da kuma yadda ta kamu da cutar, ta shirya taro da taro da manyan hukumomi na kasa, da kuma ziyartar wurare don tantance yadda matakan da ake dauka a larduna da kananan hukumomi, ciki har da birane da yankunan karkara suka yi tasiri. A ranar 25 ga watan Fabrairu, WHO ta ce dole ne duniya ta yi karin aiki don shirya don yiwuwar annobar coronavirus, ta ce har yanzu ba a yi lokaci ba don kiran cutar cutar cutar annobar, amma kasashe dole ne su kasance a shirye don hakan.
A ranar 28 ga watan Fabrairu, jami'an WHO sun ce za a kara yawan yaduwar cutar coronavirus a duniya, idan aka nuna cewa akwai shiri da haɗari sosai.
Mike Ryan, darektan WHO na gaggawa na kiwon lafiya, ya yi gargadin a cikin wata sanarwa cewa: "Wannan gwajin ne ga kowace gwamnati a duniya don kasancewa a shirye don halin da ake ciki: lokaci ya yi da za a yi aiki.
Wannan cutar tana iya zuwa ƙasarku, kuma kuna buƙatar ku kasance a shirye, kuma ya kuma nuna cewa matakan da suka dace na iya taimaka wa duniya ta guji mummunan yanayin.
Ryan ya kuma ce bayanan da ake samu yanzu ba su da wani dalili na sanar da cutar ta duniya ta hanyar jami'an kiwon lafiya na jama'a, kuma ya kara da cewa sanar da cutar zai nuna cewa mu mu amince da cewa kowa a duniya zai iya kamuwa da cutar .
A ranar 11 ga watan Maris, Hukumar ta Duniya ta bayyana barkewar cutar korona a matsayin annobar annoba.
Babban daraktan WHO ya bayyana cewa WHO ta damu sosai game da yawan yaduwar cutar da kuma yadda cutar take da tsanani, da kuma rashin aikin da ake yi a kan wannan matsalar. WHO tana fuskantar mummunan zargi saboda rashin dacewa da tsarin fahimtar cutar, gami da sanar da dokar ta baci ta kiwon lafiya ta jama'a da kuma rarraba cutar a matsayin annobar.
A sakamakon haka, an gabatar da wata takarda da ta ce a yi murabus ga Darakta Janar na WHO, Tedros Adnanom, wanda mutane 733,000 ne suka yi wa'adi a ranar 6 ga Afrilu.
A ranar 26 ga Maris, 2020, da dama daga cikin masana na Majalisar Dinkin Duniya kan haƙƙin ɗan adam sun jaddada muhimmancin kiyaye haƙƙin kowane mutum a lokacin annobar COVID-19.
Kungiyar ta ce kowa yana da 'yancin yin amfani da matakan da za su ceci rayuka, kuma gwamnati ce ke da alhakin yin hakan.
Ƙungiyar ta jaddada cewa rashin albarkatu ko inshorar lafiya ba ya kamata ya zama hujja ga nuna bambanci ga wani rukuni na mutane.
Masana sun jaddada cewa kowa yana da hakkin samun lafiya, ciki har da nakasassu, wakilan ƙalilan, tsofaffi, masu gudun hijira, marasa gida, 'yan ƙasa da ke zaune a cikin yanayi mai wuya, fursunoni, da kuma 'yan gudun hijira da sauran kungiyoyin da ba a bayyana su ba da ke bukatar tallafi daga gwamnati.
Kungiyoyin gwamnati na duniya suna duba tasirin tattalin arziki da zamantakewar al'umma na rikicin da ke tattare da COVID-19.
Kungiyar Tattalin Arziki da Ci Gaban ta kafa dandamali don samar da cikakken bayani game da matakan da ake bi a ƙasashe a duniya, da kuma samun ra'ayoyi da shawarwari.
Cibiyar ta dijital tana ba da bayanai game da matakan siyasa na ƙasashe daban-daban (Country Policy Tracker) don ƙarfafa tsarin kiwon lafiya da tattalin arzikin duniya, kawar da tasirin quarantine da ƙuntatawa kan tafiya don taimakawa ƙasashe su koya daga juna da kuma taimakawa daidaitaccen martani na duniya kan cutar coronavirus.
Gwamnatin kasar Sin ta fuskanci sukar Amurka, Ministan majalisar dattijai na Birtaniya Michael Gow da Eduardo Bolsonaro, dan shugaban Brazil Jair Bolsonaro, saboda ayyukan da suka yi wajen yaki da annobar da ta fara a lardin Hubei na kasar Sin.
An sallami wasu shugabannin jam'iyyar kwaminis ta kasar Sin (CPC) a matakin larduna saboda matakan killace da suka dauka a tsakiyar kasar Sin, kuma wannan sallamar ta nuna rashin jin dadin da 'yan siyasa suka yi a kan barkewar cutar a wadannan yankuna.
Wasu masu sharhi sun ce wannan matakin na nufin kare babban sakataren jam'iyyar kwaminis ta kasar Sin, Xi Jinping, daga fushin jama'a game da barkewar cutar coronavirus.
Wasu jami'an kasar Sin, kamar Zhao Lijiang, sun nuna rashin amincewa da sanarwa da aka yi a baya cewa cutar ta coronavirus ta fara ne a Wuhan, amma sun yi watsi da ka'idar makirci da ke cewa COVID-19 ta samo asali ne daga Amurka ko Italiya.
Gwamnatin shugaban Amurka Donald Trump ta kira coronavirus cutar ta kasar Sin ko kuma cutar Wuhan, ta ce, ƙuntatawa a kasar Sin na kara tsanantawa ne kawai game da cutar, wadda ta zama annobar duniya, kuma wasu masu sharhi sun yi ta sukar wannan bayanin, suna cewa irin wannan tsarin yana nuna wariyar launin fata ne kuma yana janyo hankalin gwamnatin shugaban Amurka daga rashin iyawar ta hana yaduwar cutar.
Daily Beast ta samu damar shiga cikin sakon gwamnatin Amurka wanda ya ƙunshi dabarun sadarwa na dabarun sadarwa, wanda ake ganin Majalisar Tsaro ta Kasa ta ƙirƙira; tare da ambaton dabarun: Dukkanin China ne.
An nemi mu yada wannan bayanin ta kowace hanya da za mu iya, ciki har da taron manema labarai da kuma gabatarwar talabijin.  Ƙungiyoyi kamar Politico, Foreign Policy da Bloomberg sun ce ƙoƙarin da China ke yi na taimaka wa ƙasashen da ke fama da cutar  wani ɓangare ne na ƙoƙarin yada labarai  don samun tasiri a duniya.
Shugaban ma'aikatar harkokin wajen EU Joseph Borrell ya yi gargadin cewa akwai wani bangare na 'yan siyasa na duniya, wanda ya hada da yaki da tasiri ta hanyar 'yanci da kuma irin wannan manufofin karimci.
Borrell ya kuma ce, "China ta ci gaba da inganta manufar kasancewa mai ba da gaskiya da kuma amintaccen abokin tarayya, ba kamar Amurka ba".
China ta kuma bukaci Amurka ta soke takunkumin da ta dauka kan Syria da Venezuela da Iran, inda ta ce ta tura taimakon kasashen biyu da suka gabata.
An haramta bayar da masks 100,000 na likita ga Cuba ta hanyar Jack Ma saboda takunkumin da Amurka ta sanya a ranar 3 ga Afrilu.
An kuma zargi hukumomin Amurka da tura taimakon da aka ba wasu ƙasashe zuwa nasu ƙasar.
Ƙasar Jamus, Austria da Switzerland, Czech da Italiya sun yi jayayya game da abin da ake amfani da su don yin amfani da masks.
Ƙari ga haka, Turkiyya ta ba da wasu jiragen sama da ke amfani da su a ƙasar Spain.
A farkon watan Maris, gwamnatin Italiya ta soki rashin goyon bayan da Tarayyar Turai ke yi wa Italiya da cutar ta coronavirus.
Jakadan Italiya a Tarayyar Turai, Maurizio Massari, ya ce, kasar Sin ce kawai ta yi aiki a kan batun.
Wannan ba ya nuna haɗin kai na Turai.
A ranar 22 ga watan Maris, bayan tattaunawa ta tarho da Firayim Ministan Italiya Giuseppe Conte, shugaban Rasha Vladimir Putin ya shirya tura sojoji na Rasha zuwa Italiya, da sufuri na kashe kamuwa da cuta da sauran kayan aikin likita.
Jaridar La Stampa ta Italiya ta yi ƙaulin wani babban jami'in siyasa mai suna , wanda ya ce kashi 80 cikin dari na taimakon da Rasha ta ba da ba su da amfani ko kuma ba su da amfani ga Italiya.
Majiyar ta zargi Rasha da cewa tana neman yin tasiri mai kyau a kan al'ummar duniya a matakin 'jiopolitical da diplomasiyya'.
Shugaban Lombardy Attilio Fontana da Ministan Harkokin Wajen Italiya Luigi Di Mayo sun yi watsi da hare-haren kafofin watsa labarai kuma sun nuna godiya ga taimakon da aka yi.
Rasha ta kuma tura jirgin saman sufuri zuwa Amurka.
Sakataren yada labarai na Kremlin Dmitry Peskov ya ce, ta wajen ba da taimako ga abokan aikinsa na Amurka, [Putin] ya yi tunanin cewa, idan masana'antun Amurka na kayan aikin kiwon lafiya da kayan aiki suka kara yawan samarwa, za su iya ba da taimako idan ya cancanta.
Aikin soja na NATO Defender-2020, wanda aka shirya a Jamus, Poland da Baltic countries  Babban aikin soja na NATO bayan ƙarshen Cold War  za a gudanar a cikin gajeren tsari.
Babban sakataren Kamfen na Rushewar Nukiliya Kate Hudson ta soki koyarwar Defender 2020 (Defender-2020) : A cikin rikicin da ya faru a yau a fannin kiwon lafiya na jama'a, gudanar da waɗannan horo yana barazana ga rayuwar ba kawai sojojin Amurka da yawancin ƙasashen Turai ba, har ma da mazaunan ƙasashen da ake buƙatar gudanar da irin waɗannan ayyukan . Gwamnatin Iran ta sha wahala sosai daga cutar.
A ranar 14 ga Maris, 2020, shugaban Iran Hassan Rouhani ya yi kira ga shugabannin duniya da su nemi taimako a cikin wata wasika ta bude, yana cewa kasarsa tana fuskantar matsaloli wajen yaki da annobar saboda rashin samun damar shiga kasuwannin duniya sakamakon takunkumin da Amurka ta sanya wa Iran.
Masana siyasa sun yi tsammanin hakan zai iya shafar damar da Donald Trump zai samu na sake zaɓe a zaben shugaban kasa na 2020.
Koriya ta Kudu ta soki Japan da ta yi amfani da matakan killace mutane da kuma yin amfani da su bayan da Japan ta ce za a yi wa duk wani ɗan ƙasar da ya zo daga Koriya ta Kudu killace mutane na mako biyu a wuraren da gwamnati ta keɓe.
An fara raba al'ummar Koriya ta Kudu saboda yadda Shugaba Moon Jae-in ya amsa wannan matsalar.
Yawancin 'yan Koriya sun sanya hannu kan takardun da suka yaba wa aikin shugaban kasar ko kuma suka bukaci a yi wa Mista Moon tsiwirwirwirinsu saboda yadda gwamnatin kasar ta yi aiki da rashin dacewar cutar.
Wasu masu sharhi sun nuna damuwa cewa wannan matakin zai ba gwamnatoci damar ƙarfafa ikonsu.
A Hungary, majalisar dokokin kasar ta amince da ba wa Firayim Minista Viktor Orbán damar da ba ta da iyaka na gudanar da mulki ta hanyar umarni, dakatar da aikin majalisar, da kuma gudanar da zabe da kuma hukunta wadanda za a zargi da yada labaran karya game da cutar da kuma matakan gwamnati na yaki da rikicin.
An bayyana barkewar cutar korona a matsayin dalilin karancin kayayyaki da yawa saboda karuwar amfani da kayan aiki don yaki da cutar, sayen kayayyaki a cikin yanayin firgici da kuma katse ayyukan samarwa da kayan aiki.
Hukumar kula da ingancin abinci da magunguna ta Amurka ta ba da gargadi game da rashin magani da kayan aikin likita, saboda karuwar bukatar masu amfani da kuma rashin aiki na masu samarwa.
A wasu yankuna, an yi sayayya da ta yi firgita; hakan ya sa kayayyakin da ake bukata, kamar abinci, takarda na gida da kuma ruwa mai kwalba, suka ɓace daga shagon, kuma hakan ya sa kayayyaki suka ragu.
A wasu lokatai, masana'antun fasaha sun yi gargadin cewa za a yi jinkiri wajen kawo kayayyakin lantarki.
A cewar babban darektan WHO, Tedros Adhanom, bukatar kayan kariya ta mutum ta karu da sau 100.
Wannan ya sa farashin kayayyaki ya ƙaru sau ashirin a kan farashin da ake yi a yau da kullum, kuma an yi jinkirin kawo kayayyakin kiwon lafiya na watanni huɗu zuwa shida.
Wannan kuma ya haifar da rashin tsaro a duniya, kuma WHO ta yi gargadin cewa saboda wannan dalili ma'aikatan kiwon lafiya za su fuskanci barazana.
A Ostiraliya, masu sayen daigou sun sami sabuwar dama don sayar da kayayyakin Ostiraliya zuwa China saboda annobar.
Wannan aikin ya haifar da karancin abinci ga yara a wasu manyan kantuna kuma daga baya gwamnatin Ostiraliya ta hana shi. Duk da yawan cututtukan COVID-19 a Arewacin Italiya da yankin Wuhan, da kuma babban buƙatar abinci, an sami nasarar kauce wa karancin abinci a duka yankuna.
Matakan da kasar Sin da Italiya suka ɗauka don hana adana kayayyaki da kuma cinikin kayayyaki masu muhimmanci da ba bisa doka ba sun taimaka wajen kauce wa ƙarancin abinci da ake tsammani a Turai da kuma Arewacin Amirka.
Arewacin Italiya, inda ake samar da kananan kayan noma, ba ta fuskantar raguwa mai yawa ba, amma a cewar masana'antun, farashin kayayyakin gona na iya tashi.
Ana barin ɗakunan sayar da abinci a lokacin da ba a yi amfani da su ba, har ma a birnin Wuhan, yayin da jami'an gwamnatin kasar Sin suka ba da damar yin amfani da naman alade don samar da abinci mai kyau ga jama'a.
A Italiya ma, akwai irin wannan dokar da ta bukaci masana'antun abinci su ajiye abinci a lokacin da ake bukatar gaggawa.
Tattalin Arziki na Duniya ya shafi kasar Sin: A cewar kafofin watsa labarai na 16 ga Maris, tattalin arzikin kasar Sin ya sha wahala sosai a farkon watanni biyu na shekarar 2020 saboda matakan da gwamnati ta dauka na yaki da yaduwar cutar, wanda ya sa tallace-tallace suka ragu da kashi 20.5%.
Babban yankin Sin babban cibiyar tattalin arziki ne da masana'antu, saboda haka ana ganin cewa cutar ta haifar da babbar barazana ga tattalin arzikin duniya.
A cewar Agate Demarai, ma'aikaci a Economist Intelligence Unit, rashin daidaito a kasuwannin zai ci gaba har sai an samu karin haske game da sakamakon da zai iya samu.
A watan Janairun 2020, wasu manazarta sun kiyasta cewa sakamakon tattalin arzikin annobar a duniya zai iya wuce sakamakon annobar cutar huhu ta 2002 zuwa 2004.
Wani masanin jami'ar Washington a St. Louis ya ce, za a iya cinye kayayyakin da ke samar da kayayyaki a duniya da suka kai dala biliyan 300 kuma hakan zai iya shafan duniya har tsawon shekaru biyu.
An ruwaito cewa kungiyar kasashen da ke fitar da man fetur (OPEC) ta fara daukar matakan tsawan lokaci bayan da farashin man fetur ya ragu sosai saboda rashin bukatar kasar Sin.
A ranar 24 ga watan Fabrairu, kasuwannin jari na duniya sun fadi saboda yawan mutanen da suka kamu da COVID-19 a wajen kasar Sin.
A ranar 27 ga Fabrairu, saboda damuwa game da barkewar cutar coronavirus, alamun jari daban-daban na Amurka, gami da NASDAQ-100, S&P 500 da Dow Jones Index don hannun jari na kamfanoni na masana'antu, sun nuna raguwa mafi girma tun daga 2008, yayin da Dow ya faɗi da 1191 maki  mafi girma a cikin rana ɗaya bayan rikicin kuɗi na 2007 2008.
A ƙarshen makon, duk waɗannan alamun sun nuna raguwa fiye da kashi 10.
A ranar 28 ga watan Fabrairu, kamfanin Scope Ratings GmbH ya tabbatar da darajar cinikin kasar Sin, amma ya ci gaba da yin hasashen rashin cin nasara.
Kasashen da ke da damuwa game da yaduwar cutar korona sun sake faɗuwa, kuma mafi yawan faɗuwa ta faru ne a ranar 16 ga Maris.
Mutane da yawa suna ganin cewa tattalin arziki zai yi koma baya.
Masanin tattalin arziki Mohammed El-Erian ya yaba da matakan gaggawa da manyan bankunan kasar da kuma jihohi suka dauka.
Babban bankin ya yi sauri fiye da yadda ya yi a lokacin rikicin kudi na 2008.
Yawon shakatawa  yana ɗaya daga cikin ɓangarorin da suka fi fama da cutar saboda hana zirga-zirga, rufe wuraren jama'a, gami da wuraren yawon buɗe ido, da kuma shawarwarin gwamnatoci da ba su yi tafiya ba.
A sakamakon duk waɗannan matakan, kamfanonin jiragen sama da yawa sun soke jiragen saboda raguwar bukatar tikiti, ciki har da British Airways, China Eastern Airlines da Qantas, kuma kamfanin jirgin sama na yankin Flybe na Burtaniya ya daina aiki.
Tasirin da ya shafi masana'antar jirgin ruwa ya kasance mai ƙarfi fiye da kowane lokaci.
An rufe tashoshin jirgin kasa da tashoshin jiragen ruwa da yawa.
Wannan annoba ta yi daidai da Chong Yun, babban lokacin yawon shakatawa na bikin Sabuwar Shekara ta kasar Sin.
Gwamnatocin ƙasa da na yanki sun soke wasu ayyuka masu yawa, gami da bukukuwa na shekara-shekara na Sabuwar Shekara; kamfanoni masu zaman kansu sun rufe shagunan su da wuraren yawon buɗe ido kamar Disneyland na Hong Kong da Shanghai.
An soke yawancin bukukuwan Sabuwar Shekara, kuma an rufe wuraren yawon shakatawa don hana mutane taro; kamar, a Beijing an rufe birnin da aka hana kuma an soke bikin adana haikali na gargajiya.
A larduna 24 daga cikin 31 da ke kasar Sin, hukumomi sun tsawaita hutun sabuwar shekara har zuwa 10 ga watan Fabrairu, suna ba da umarnin yawancin masana'antu kada su bude kafin wannan ranar.
Waɗannan yankuna sun kai kashi 80 cikin 100 na GDP na ƙasar da kuma kashi 90 cikin 100 na fitarwa.
Hukumomin Hong Kong sun ɗaga matakin amsawa ga cututtukan kamuwa da cuta zuwa mafi girma kuma sun ayyana dokar ta baci ta rufe makarantu har zuwa watan Maris kuma sun soke bikin Sabuwar Shekara.
Kasuwancin da ke Turai da Latin Amirka sun ragu da kashi 40 cikin ɗari.
Kasashen da ke sayar da kayayyaki a Arewacin Amirka da Gabas ta Tsakiya sun rage yawan tallace-tallace da kashi 50 zuwa 60 cikin ɗari.
A sakamakon haka, a watan Maris, yawan masu zuwa cibiyoyin kasuwanci ya ragu da kashi 3343% idan aka kwatanta da Fabrairu.
Masu gudanar da cibiyoyin kasuwanci a duk faɗin duniya sun sanya ƙarin matakan kamar inganta yanayin kiwon lafiya, shigar da kayan aiki don bincika zafin jiki na baƙi da soke ayyukan. A cewar kimantawar Hukumar Tattalin Arziki ta Majalisar Dinkin Duniya don Latin Amurka, koma bayan tattalin arziki a Latin Amurka da cutar ta haifar na iya barin mutane miliyan 14 22 a bayan talauci fiye da yadda zai kasance a cikin irin wannan yanayin, amma ba tare da cutar ba.
A watan Janairu da Fabrairu na shekarar 2020, a lokacin da annobar ta barke a Wuhan, mutane miliyan biyar ne suka rasa ayyukansu a kasar Sin.
Yawancin 'yan gudun hijira miliyan 300 na kasar Sin sun kasance a gidajensu a lardunan kasarsu ko kuma a kulle su a lardin Hubei. A watan Maris na shekarar 2020, fiye da Amirkawa miliyan 10 sun rasa ayyukansu kuma sun nemi taimakon gwamnati.
A cewar kimar Babban Bankin Tarayya na St. Louis, barkewar cutar coronavirus na iya rasa mutane miliyan 47 a cikin Amurka, kuma rashin aikin yi na iya kaiwa kashi 32%. Matakan keɓe kai da aka gabatar a Indiya za su bar dubban miliyoyin ma'aikatan Indiya masu ƙaura ba tare da aiki ba, waɗanda ke karɓar albashi na yau da kullun. Binciken da Cibiyar Angus Reid ta gudanar ya nuna cewa kashi 44% na gidajen Kanada sun fuskanci rashin aikin yi a kowane hali. Kusan 900,000 ma'aikatan Spain sun rasa ayyukansu tun lokacin da aka fara keɓewa a Spain a tsakiyar watan Maris na 2020.
A rabin watan Maris, ma'aikata miliyan 4 na Faransa sun nemi taimakon rashin aikin yi na wucin gadi, kuma ma'aikata miliyan 1 na Burtaniya sun nemi biyan kuɗi na zamantakewa guda ɗaya. Kusan kamfanoni miliyan biyar a Jamus sun sauya ma'aikatansu zuwa ga rage yawan aikin da gwamnati ke tallafawa  na ɗan lokaci.
An kuma gabatar da tsarin biyan kuɗi na Jamus don aiki na ɗan lokaci a Faransa da Burtaniya.
Har ila yau, fannonin fasaha da al'adu sun sha wahala sosai daga annobar, wanda ya shafi ayyukan ƙungiyoyi da kuma mutane, ko da sun yi aiki ko kuma sun yi aiki da kansu, a duk faɗin duniya.
Kungiyoyin al'adu da fasaha sun yi ƙoƙari su tallafa wa manufofin su (wanda galibi gwamnati ke tallafawa) na samar da damar samun al'adun al'adu ga al'umma ta hanyar tabbatar da lafiyar ma'aikatan su da jama'a, da kuma, idan ya yiwu, tallafawa mutanen fasaha.
A watan Maris na 2020, gidajen tarihi, dakunan karatu, zauren taro da sauran cibiyoyin al'adu sun rufe a duk faɗin duniya har abada, ko kuma an iyakance su zuwa wasu, kuma an soke ko kuma an dage baje kolin, abubuwan da suka faru da kuma gabatarwa zuwa wasu kwanakin.
Wani sabon abu kuma da ke ci gaba da samun ci gaba shi ne sakamakon yaduwar cutar  soke ayyukan addini, manyan wasanni da sauran ayyukan jama'a kamar bukukuwa da kide kide, taro na fasaha da kuma nuna kayan zamani.
A cikin masana'antar fim din, an yi rashin nasara, kuma Vatican ya sanar da soke ayyukan da ake yi a makon mako na Roman, wanda ake gudanarwa a makon ƙarshe na lokacin tuba na Kirista  Babban Azumi.
Yawancin majami'u sun ba da shawarar dattawa su zauna a gida kuma su guji zuwa coci a ranar Lahadi; a wasu majami'u, ana watsa ayyukan coci ta rediyo, a kan layi, ko a talabijin, yayin da shugabannin wasu majami'u suka ba da shawarar yin ibada a waje.
Ikilisiyar Roman Katolika ta rufe majami'unsu, majami'unsu da kuma filin St. Peter, inda ba a ƙara samun masu hawan haikalin Kirista ba, kuma daga baya wasu kungiyoyin addini sun soke ayyukan ibada kuma sun iyakance damar yin ayyukan ibada a coci, masallatai, majami'u, haikalin da gurdwara.
Ma'aikatar lafiya ta Iran ta sanar da soke sallar Juma'a a yankunan da cutar ta shafa, kuma an rufe wuraren ibada daga baya; Saudiyya ta haramta masu hajjin kasashen waje da mazauna gida zuwa wuraren tsarki na Makka da Madina.
Wannan annoba ta haifar da canje-canje mafi girma a kalandar wasanni na duniya tun lokacin yakin duniya na biyu.
Yawancin manyan wasanni an soke ko kuma an dage su, ciki har da gasar zakarun Turai 201920, gasar Premier 201920, Euro-2020 UEFA, kakar NBA 201920 da kakar NHL 201920.
Futar cutar coronavirus ta kuma rushe tsare-tsaren gudanar da wasannin Olympics na bazara na shekarar 2020, wanda ya kamata a fara a ƙarshen Yuli; a ranar 24 ga Maris, kwamitin Olympics na Duniya ya ba da sanarwar cewa za a dage taron zuwa bayan shekarar 2020, amma ba da daɗewa ba kafin lokacin bazara na 2021. An rufe gidajen caca da sauran wuraren caca a duk duniya, kuma an dage ko kuma an soke wasannin karta, waɗanda yawanci ana watsa su kai tsaye.
Wannan ya sa 'yan wasa da yawa suka koma kan layi, kuma shafukan yanar gizo da yawa da ke da alaƙa da caca sun ba da rahoton ƙaruwar sabbin masu biyan kuɗi.
Yawancin manyan gidajen wasan kwaikwayo, kamar Broadway, sun soke duk wasan kwaikwayon su.
A madadin ayyukan offline na gargajiya, wasu masu fasaha da mawaƙa sun fara nazarin hanyoyin ci gaba da ayyukansu da kuma raba sakamakon su ta Intanet, suna shirya watsa shirye-shiryen kai tsaye na kide kide na kan layi ko bukukuwa na yanar gizo; wannan yana taimaka wa mutane masu sana'a don ci gaba da yin aiki, fitarwa ko buga ayyukansu.
Akwai wasu shafukan intanet da ke magana game da cutar coronavirus a yanar gizo, da yawa daga cikinsu suna da ban dariya kuma suna sauƙaƙe yanayi mai ban tsoro na lokacin rashin tabbas.
Tun lokacin da COVID-19 ta fara, an lura da ƙiyayya, ƙiyayya da wariyar launin fata a kan 'yan kasar Sin da mutanen da ke fitowa daga Gabashin Asiya, da kuma wakilan yankunan Turai, Amurka da sauran ƙasashe.
Akwai tsoro, shakku, da kuma ƙiyayya a ƙasashe da yawa, musamman a Turai, Gabashin Asiya, Arewacin Amirka, da kuma yankin Asiya da Pacific.
A cikin bayanan watan Fabrairu (lokacin da yawancin kamuwa da cutar har yanzu ke iyakance ga China) an lura da halin wariyar launin fata da kungiyoyi daban-daban a duniya suka nuna game da 'yan kasar Sin da suka cancanci cutar ko kuma an yi musu adalci.
Wasu ƙasashen Afirka suna da ƙwazo a nuna rashin goyon bayan kasar Sin.
Mutane da yawa a Wuhan da Hubei sun yi rahoton nuna bambanci saboda asalin yankin.
An ba da tallafi ga 'yan kasar Sin da ke zaune a yankunan da cutar ta shafa, a layi da kuma wajen layi.
A cikin sabon ƙasashe, musamman Italiya  ƙasa ta farko a Turai da ta fuskanci mummunan barkewar COVID-19; saboda haka, 'yan ƙasa na waɗannan yankuna na iya fara jin tasirin shakku da ƙiyayya. 'Yan ƙasa na Malaysia, New Zealand, Singapore da Koriya ta Kudu a farkon matakin sun sanya hannu kan takardar neman hana' yan ƙasar Sin shiga ƙasashensu don hana annobar.
A Japan, hashtag #ChineseDontComeToJapan (#Masu ChinaKada Ku Zo Japan) ya kasance a matsayi na farko a shafin Twitter.
'Yan kasar Sin da kuma wasu 'yan Asiya da ke zaune a Birtaniya da Amirka sun ba da rahoton cewa an samu karuwar nuna bambanci da harin.
Shugaban Amurka Donald Trump ya fuskanci zargi saboda ya kira coronavirus tabbatar cutar Sin; masu sukar suna ganin wannan ra'ayi ne na wariyar launin fata da kuma adawa da kasar Sin.
A Ukraine, masu zanga-zangar sun kai hari kan motocin da ke kaiwa 'yan kasar Ukraine da na kasashen waje da aka kwashe daga Wuhan zuwa New Sanjara.
Dalibai da ke zuwa daga arewa maso gabashin Indiya da ke kan iyaka da Sin da kuma manyan biranen Indiya sun ba da rahoton cewa an tsananta musu saboda annobar coronavirus.
Dilip Ghosh, shugaban jam'iyyar Bharatiya Janata Party, West Bengal, ya ce, 'Yan kasar Sin sun lalata yanayi, kuma saboda haka Allah ya yi musu rashi.
Daga baya, ofishin jakadancin kasar Sin a Kolkata ya yi watsi da wannan furucin, ya kira shi "ruɗu". A China, cutar ta sake haifar da rashin jin daɗin jama'a da kuma nuna wariyar launin fata ga mutanen da ba 'yan kasar Sin ba: an kira baƙi "ɓataccen waje" da kuma "abubuwan da za a yi amfani da su".
Jaridu da yawa da ke da damar samun bayanai na biya sun kawar da irin wannan ƙuntatawa ga wasu ko duk yankunan da cutar ta shafa.
Yawancin masu wallafa kimiyya sun wallafa takardun kimiyya game da cutar coronavirus.
Wasu masana sun yanke shawarar ba da damar gajeren lokaci ga sakamakon binciken su a kan sabobin wallafa kayan aiki kamar bioRxiv.
Cutar da ke yaduwa  Cutar da ke yaduwa daga cutar da ke dawowa, wanda yawanci ba a san yadda ake yadawa ko kuma yadda ake watsawa ba
Duniya da Cututtuka  Binciken Duniya da Yaduwar Cututtuka
Jerin annoba da annoba  Jerin wadanda suka mutu sakamakon kamuwa da cuta
Cin hanci da rashawa da kuma cututtukan da ke gudana daga dabba zuwa mutum  Hadarin kiwon lafiya da ke tattare da cinikin dabbobi.
Gwajin gwaji na coronavirus na numfashi na 2019 (COVID-19) da kuma SARS-CoV-2 da ke da alaƙa ya haɗa da hanyoyin gano cutar da kuma hanyoyin gano rigakafin da ake samarwa don amsa kamuwa da cuta.
Ana tabbatar da cewa akwai ƙwayoyin cuta a cikin samfurin ta hanyar OT-PCR, wanda ke gane RNA na coronavirus.
Wannan gwajin na musamman ne kuma an yi shi ne don gano RNA na SARS-CoV-2.
Ana amfani da shi don tabbatar da cewa akwai cututtuka da suka faru kwanan nan ko kuma suna aiki sosai.
Ana iya amfani da gano maganin rigakafi (serology) don ganewar asali da kuma kula da yawan jama'a.
Ana gwada adadin mutanen da suka kamu da cutar, har da waɗanda ba su da alamun cutar sosai don a kai su asibiti ko kuma ba su kasance a wurin ba.
Za a iya sanin ainihin mutuwar da ake yi a wannan cuta da kuma rashin lafiyar da ake yi a cikin mutane ta wajen yin irin wannan gwajin.
A watan Maris na shekarar 2020, saboda ƙarancin damar yin gwaji, babu wata ƙasa da ta sami tabbataccen bayanai game da yaduwar cutar tsakanin jama'a.
A ranar 23 ga watan Maris, babu wata ƙasa da ta samu nasarar gwada fiye da kashi 3 cikin 100 na yawan jama'arta, kuma bayanai game da yawan gwaje-gwajen da aka yi a ƙasashe daban-daban sun kasance masu rikitarwa.
Wataƙila irin wannan bambancin yana shafar yawan mutuwar da aka yi a wasu ƙasashe, amma hakan yana iya kasancewa da muhimmanci.
Ana iya yin gwajin ta hanyar amfani da polymerase chain reaction reverse transcription in real time (rRT-PCR) a kan gwajin numfashi da aka samu ta hanyoyi daban-daban, ciki har da nasal swab ko samfurin kumfa.
Ana samun sakamako a cikin sa'o'i da yawa zuwa kwanaki biyu.
Gwajin OTC-PCR da aka yi a kan wani shafawa da aka ɗauka daga cikin wuyansa yana da inganci a mako na farko na rashin lafiya.
Daga baya, cutar za ta iya fita daga cikin makogwaro, amma ta ci gaba da ƙaruwa a cikin huhu.
A cikin marasa lafiya da ke kamuwa da cutar da ake gwadawa a mako na biyu na cutar, za a iya ɗaukar kayan daga cikin ƙananan hanyoyin numfashi ta hanyar amfani da kateter mai ɗaukar ruwa, ko kuma za a iya amfani da kayan cin abinci (mai ƙyama).
An yi wani gwajin PCR na farko a asibitin Sharite, Berlin, a watan Janairun 2020 ta amfani da polymerase chain reaction tare da ainihin lokacin sake fasalin (rRT-PCR) kuma ya zama tushen samfuran 250,000 waɗanda aka rarraba daga baya ta Hukumar Lafiya ta Duniya (WHO).
A ranar 23 ga Janairu, 2020, Burtaniya ta kuma samar da gwajinta. A ranar 28 ga Janairu, 2020, kamfanin Kogenebiotech na Koriya ta Kudu ya samar da wani tsari don gano SARS-CoV-2 bisa ga PCR na asibiti (PowerChek Coronavirus).
Yana gano kwayar halitta E, wacce ta kasance ta kowa ga dukkan beta-coronavirus, da kuma kwayar halitta RdRp, wacce ta kasance ta musamman ga SARS-CoV-2. Kamfanin BGI Group na China ya zama ɗaya daga cikin kamfanoni na farko da suka sami izinin Hukumar Kula da Magunguna ta Kasa ta China don amfani da kayan aikin gaggawa don gano SARS-CoV-2 bisa PCR. A Amurka Cibiyoyin Kula da Cututtuka da Cututtuka (CDC) suna rarraba ta hanyar International Reagent Resource dashboard don gudanar da PCR na ainihin lokaci (2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel) a cikin dakunan gwaje-gwaje na kiwon lafiya na jama'a.
Ɗaya daga cikin gwaje-gwaje guda uku na asali daga tsofaffin sigogin gwajin gwajin ya ba da sakamako mara kyau saboda rashin ingantattun magungunan da kuma ƙarancin yankin gwajin da CDC ke gudanarwa a Atlanta; sakamakon haka, a cikin watan Fabrairu na 2020, an yi nasarar sarrafa samfurori ƙasa da 100 a rana.
Gwaje-gwajen da aka yi amfani da sassan biyu ba a yi la'akari da su a matsayin abin dogaro ba har zuwa 28 ga Fabrairu, 2020, kuma bayan wannan ranar ne aka ba da izinin fara gwajin ga dakunan gwaje-gwaje na ƙasa da na gida.
Hukumar Kula da Ingancin Abinci da Magunguna ta amince da gwajin a matsayin wani tsari na gaggawa.
A ranar 5 ga Maris, 2020, LabCorp ta sanar da yiwuwar yin gwaji don kamuwa da COVID-19 a duk faɗin ƙasar ta hanyar RT-PCR.
Quest Diagnostics ta fara gwajin COVID-19 a duk faɗin ƙasar daga ranar 9 ga Maris, 2020.
Babu wani ƙuntatawa na adadi da aka bayyana; ana buƙatar yin bincike da kuma sarrafawa bisa ga bukatun CDC.
A Rasha, Cibiyar Nazarin Kimiyya da Kimiyya ta Jihar Virology da Biotechnology VECTOR ta tsara kuma ta samar da gwajin COVID-19.
A ranar 11 ga Fabrairu, 2020, Hukumar Kula da Lafiya ta Tarayya ta yi rajista da gwajin. An ruwaito cewa a ranar 12 ga Maris, 2020, asibitin Mayo ya haɓaka gwajin gano kamuwa da COVID-19. A ranar 13 ga Maris, 2020, Roche Diagnostics ta sami amincewar FDA don amfani da gwajin da za a iya gudanar da shi cikin awanni 3.5 akan manyan gwaje-gwaje, wanda ke ba da damar injin ɗaya ya aiwatar da kusan gwaje-gwaje 4128 a cikin awanni 24.
A ranar 19 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani (EUA) ga dakunan gwaje-gwaje na Abbott don gwada tsarin Abbott m2000; FDA ta ba da izinin Hologic, LabCorp da Thermo Fisher Scientific.
A ranar 21 ga Maris, 2020, Cepheid ta kuma sami EUA daga FDA don gwajin da zai ɗauki kimanin minti 45.
Hukumar ta amince da gwajin da zai maye gurbin PCR da fasahar ƙara yawan isothermic nucleic acids.
Tun da yake ba a bukatar a yi gwajin a cikin jerin lokutan zafin jiki, wannan hanyar za ta iya nuna sakamako mai kyau a cikin minti biyar kawai, kuma sakamakon da ba shi da kyau a cikin minti 13.
A halin yanzu, akwai kimanin 18,000 na irin waɗannan injunan a Amurka, kuma Abbott na shirin ƙara yawan gwajin zuwa 50,000 a kowace rana. A halin yanzu, ana yin gwaji a Taiwan ta amfani da maganin rigakafi na monoclonal wanda ke haɗuwa da ƙwayoyin nucleocapsid (N-protein) na sabon coronavirus a hanyar da ta dace, kuma ana fatan samun sakamako a cikin minti 15 zuwa 20, kamar gwajin sauri na mura.
A cikin bita na wallafe-wallafen da aka yi a watan Maris na shekarar 2020, an kammala cewa hotunan hotunan hotunan kirji na kirji suna da ƙarancin ƙimar ganewar asali a farkon matakan, yayin da sakamakon CT [tomography na kwamfuta] zai iya samun ƙimar har ma kafin bayyanar cututtuka.
Alamomin da aka gano a cikin CT sun haɗa da matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar matattarar mat
Ƙarƙashin ƙwayar cuta, bayyanar cututtuka da kuma haɗuwa suna ci gaba da ci gaba da cutar.
Sakamakon binciken da ya kwatanta hanyoyin PCR da CT da aka yi amfani da su a Wuhan a lokacin da annobar ta barke ya nuna cewa CT ya fi PCR da yawa, kodayake ba shi da ƙarancin ƙwarewa, saboda yawancin ayyukan gani suna haɗuwa da sauran hanyoyin cutar huhu da sauran cututtuka.
Tun daga watan Maris na 2020, Kwalejin Radiology ta Amurka ta ba da shawarar  kada a yi amfani da CT don yin bincike ko a matsayin hanyar gwajin layi na farko a cikin gano COVID-19. Kamar yadda ya kasance a watan Maris na 2020, CDC ta ba da shawarar yin amfani da hanyar PCR don yin bincike na farko.
Sau da yawa, ana yin maganin rigakafi don kamuwa da cuta ta wajen samar da rigakafi, ciki har da IgM da IgG.
Ana iya amfani da waɗannan rigakafin don gano kamuwa da cuta a cikin mutane bayan rana ta 7 na bayyanar cututtuka, don ƙayyade rigakafi da kuma gudanar da kulawar jama'a. Ana iya yin bincike a cikin manyan dakunan gwaje-gwaje (CLT) ko ta hanyar ganewar asali (PoCT)
A cikin dakunan gwaje-gwaje da yawa, za a iya yin waɗannan gwaje-gwajen ta hanyar tsarin sarrafa kansa mai aiki sosai, amma za a iya samun su ta hanyar saurin samar da kowane irin tsarin.
A cikin CLT, ana amfani da jini guda ɗaya na jini, ko da yake ana iya amfani da samfurin jini don bin diddigin amsawar rigakafi.
A lokacin da aka yi PoCT, ana yin jini guda ɗaya ta hanyar suturar fata.
Ba kamar hanyoyin PCR ba, ba a buƙatar ɗaukar jini don a yi gwajin gwaji. A ranar 26 ga Maris, 2020, FDA ta ba da jerin ƙungiyoyi 29 da suka yi rajista da suka dace kuma yanzu za su iya rarraba gwajin su ga rigakafi.
A ƙarshen Maris 2020, Euroimmun Medical Laboratory Diagnostics da Epitope Diagnostics sun sami izinin Turai don amfani da gwajin su na gwajin da zai iya gano IgG da IgA antibodies a cikin samfurin jini wanda ke da ikon yaƙi da cutar.
Ana gwada samfurin a cikin sa'o'i da yawa, kuma hakan ya sa wannan aikin ya fi sauri fiye da na PCR na yau da kullum na RNA.
A farkon watan Afrilu, Birtaniya ta gano cewa babu wani samfurin da ta samu don bincika rigakafi da ya ba da sakamako mai gamsarwa.
A Hong Kong an kirkiro tsarin da zai ba marasa lafiya da ake zargi da cutar damar zama a gida: ma'aikatan asibiti na gaggawa suna ba da samfurin samfurin ga mai haƙuri, mai haƙuri yana fesawa, ya dawo da shi, kuma bayan wani lokaci yana samun sakamakon gwajin. NHS ta Burtaniya ta sanar da ƙaddamar da tsarin gwajin gwaji na gida wanda ke kawar da haɗarin kamuwa da marasa lafiya daga sauran masu zuwa asibitoci, ko buƙatar kashe motar asibiti idan ana amfani da ita don jigilar mai haƙuri. A lokacin gwajin COVID-19 na sauri, a cikin lokuta masu shakka, ma'aikacin likita yana yin bincike, yana amfani da duk matakan tsaro.
Cibiyoyin gwaji na sauri sun taimaka wa Koriya ta Kudu ta gudanar da gwajin gwaji mafi sauri da kuma girma fiye da kowace ƙasa. A ranar 2 ga Maris, a Jamus, Ƙungiyar Likitocin Kula da Kula da Lafiya ta Ƙasa ta ce ta shirya don yin gwajin asibiti na kusan 12,000 a rana, yayin da mako guda da suka gabata suka iya yin gwajin 10,700 a mako.
Idan likita ne ya ba da izinin yin bincike, za a biya kuɗin da inshorar lafiya ta biya.
Shugaban cibiyar Robert Koch ya ce, Jamus tana yin gwaji wajen gwaji 160,000 a mako.
A ranar 19 ga watan Maris, an ba da shawarar yin gwaji a wasu manyan birane.
A ranar 26 ga Maris, 2020, ba a san yawan gwajin da aka yi a Jamus ba, saboda ana samun sakamako mai kyau kawai.
Binciken farko na dakin gwaje-gwaje ya nuna cewa a makon kalanda na 12/2020 an yi bincike a kan SARS-CoV-2 aƙalla 483,295 har zuwa makon 12/2020, kuma aƙalla samfurin 33,491 (6.9%) ya kasance mai kyau. Masu bincike na asibitocin Technion da Rambam Hospital na Isra'ila sun haɓaka kuma sun gwada hanyar gwadawa tare da samfuran da aka ɗauka daga marasa lafiya 64, suna haɗa samfura da gudanar da ƙarin bincike kawai idan samfurin haɗin ya nuna sakamako mai kyau. A Wuhan, 5 ga Fabrairu, 2020, kamfanin BGI ya buɗe dakin gwaje-gwaje na gaggawa na mita 2000 don gano yanayin gaggawa mai suna  Hook-Yang ( Yan-yang), wanda zai iya yin samfurori fiye da 10,000 a rana.
Wanda ya kafa BGI, Wang Jian, ne ya shirya gina wannan dakin gwaje-gwaje kuma ya kammala aikin a cikin kwanaki biyar; kuma yin amfani da samfurin ya nuna cewa idan ba a fara amfani da dakin gwaje-gwaje a cikin wannan saurin ba, cutar za ta kasance kashi 47% a Hubei, kuma a daidai wannan, farashin rigakafi zai ninka sau biyu.
Bayan da aka bude dakin gwaje-gwaje a Wuhan, nan da nan aka bude dakin gwaje-gwaje na Hu Yan a birnin Shenzhen, Tianjin, Beijing da Shanghai  a cikin birane 12 na kasar Sin.
A ranar 4 ga Maris, 2020, yawan gwajin yau da kullun ya kai 50,000 a rana. An saki tsarin Origami Assays na buɗewa wanda zai iya gwada gwajin COVID19 na marasa lafiya 1,122 ta amfani da allunan 93 kawai. Irin waɗannan ƙirar daidaitaccen tsari na iya aiki a ƙananan dakunan gwaje-gwaje, ba tare da buƙatar amfani da sarrafa ruwa na mutum-mutumi ba.
A watan Maris, saboda rashin isasshen magungunan, gwajin gwaji a cikin EU, Birtaniya da Amurka ya zama matsala.
A sakamakon haka, wasu marubuta sun nemi takardun shaida na gwajin gwaji, wanda ya ba da shawarar yin zafi a 98 °C (208 °F) na tsawon minti 5 don sakin kwayoyin RNA don ƙarin gwaji. A ranar 31 ga Maris, an sanar da cewa gwajin cutar coronavirus da Hadaddiyar Daular Larabawa ke gudanarwa a halin yanzu ya fi na kowace ƙasa, kuma ba da daɗewa ba za a gwada yawancin jama'a.
Wannan ya faru ne saboda damar yin gwajin gwaji, tare da sayen dakin gwaje-gwaje na jama'a daga Group 42 da BGI (wanda aka kafa a kan dakin gwaje-gwaje na gano abubuwan da suka faru na musamman na Huo-Yang a China).
Wannan dakin gwaje-gwaje da aka kafa a cikin kwanaki 14 yana iya yin gwaje-gwaje na PCR na RCT da yawa a kowace rana kuma shi ne dakin gwaje-gwaje na farko a duniya da ke aiki a waje da kasar Sin.
An yi amfani da wasu hanyoyin gwaji don gano fannoni daban-daban na kwayar cutar a kasar Sin, Faransa, Jamus, Hong Kong, Japan da Amurka.
Hukumar lafiya ta duniya ta amince da tsarin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin gwajin
An buga wani nau'in Jamusanci a ranar 17 ga Janairu, 2020; yarjejeniyar da cibiyoyin kula da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
A Koriya ta Kudu, masana sun ce, samun damar yin gwaji ya rage yaduwar sabon coronavirus.
A cikin shekaru da yawa, gwamnatin Koriya ta Kudu ta yi aiki don samar da damar yin gwaji, galibi a cikin dakunan gwaje-gwaje masu zaman kansu.
A ranar 16 ga Maris, Hukumar Lafiya ta Duniya ta yi kira da a kara samar da shirye-shiryen gwaji a matsayin hanya mafi kyau don rage yaduwar cutar COVID-19. Sakamakon karuwar bukatar gwaji saboda saurin yaduwar cutar, yawancin dakunan gwaje-gwaje na Amurka da ke karɓar dubban dubban samfurori sun cika, kuma kayan adana kayan shafawa da magungunan sun ƙare cikin sauri.
A watan Maris na shekarar 2020, kasar Sin ta ba da rahoton cewa tana fama da matsaloli a gwajinta.
Kayan gwajin Amurka da CDC ta tsara sun kasance masu ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙarancin ƙ
Kamfanin ya bayyana cewa, sakamakon da ba daidai ba zai iya faruwa ba idan ba a yi amfani da samfurin ba ko kuma ba a yi amfani da kayan aikin ba.
Ma'aikatar Spain ta ce za ta soke wasu samfurori da suka ba da sakamako mai kyau kuma ta maye gurbin su da wasu samfurori na Shenzhen Bioeasy. 80% na samfurori na gwaji da Czech ta saya daga China sun ba da sakamako mara kyau.
Firayim Minista Matović ya ba da shawarar sauke su a Danube. Atesh Kara, ma'aikacin Ma'aikatar Lafiya ta Turkiyya, ya ce kayan gwajin da aka saya a China suna da babban kuskuren kuskure kuma Ma'aikatar ba ta fara amfani da su ba.
Ana yin amfani da matakan killacewa ga mutanen da gwajin su ya tabbatar da cewa suna da cutar SARS-CoV-2, da kuma lura da mutanen da marasa lafiya suka yi hulɗa da su.
Masu bincike da ke aiki a garin Vo na Italiya, inda mutum ya mutu na farko a Italiya daga COVID-19, sun gudanar da sake zagayowar gwaji guda biyu na yawan jama'a kusan 3,400, a tsakanin kwanaki goma.
Kimanin rabin mutanen da suka samu cutar ba su da wata alama, kuma an sanya duk waɗanda suka kamu da cutar a cikin killace.
An rufe ƙofar zuwa yankin, kuma wannan matakin ya hana kamuwa da cuta.
A cikin yanayin da ake saka idanu sosai kan mutane, da kuma takunkumin shiga, gwaji, da kuma matakan killacewa, annobar coronavirus ta 2020 a Singapore ta kasance da matukar damuwa fiye da sauran ƙasashe masu tasowa, kuma ba a buƙatar sanya wasu ƙuntatawa masu tsanani kamar rufe gidajen abinci da shagunan ba.
An soke yawancin ayyukan da ake yi a wurin, kuma a ranar 28 ga Maris, Singapore ta fara ba da shawara ga mazauna gida, amma makarantun da suka ƙare a ranar 23 ga Maris sun buɗe a kan jadawalin.
Wasu kasashe kamar Iceland da Koriya ta Kudu sun yi nasara da annobar ta hanyar saka idanu kan mutane da yawa, da kuma takunkumin shiga, gwaji da kuma matakan killacewa, amma ƙuntatawa ba ta da ƙarfi.
Wani bincike ya nuna cewa a ƙasashen da aka yi gwaji da yawa a kan yawan mutuwar, yawan mutuwar ya ragu sosai, wataƙila saboda waɗannan ƙasashen sun sami ƙarin marasa lafiya da ba su da alamun bayyanar cututtuka ko kuma ba su da alamun bayyanar cututtuka.
WHO ta ba da shawarar ƙasashe da ba su da albarkatun gwaji mai yawa, da kuma dakunan gwaje-gwaje na ƙasa waɗanda ba su da ƙwarewar COVID-19 su aika da sakamakon gwajin COVID-19 na farko biyar da na farko goma zuwa ɗayan dakunan gwaje-gwaje na WHO 16 don tabbatar da gwaji.
Daga cikin wadannan dakunan gwaje-gwaje guda 16, 7 suna Asiya, 5 a Turai, 2 a Afirka, 1 a Arewacin Amirka, da kuma 1 a Ostiraliya.
A cikin jadawalin da ke gaba, ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙididdigar ƙ.
Ƙasar da ake gwada marasa lafiya kawai a asibiti za ta sami sakamako mafi girma a cikin kashi fiye da ƙasar da ake gwada dukkan 'yan ƙasa, ko da kuwa suna da alamun cutar, a ƙarƙashin wasu yanayi masu daidaito.
Wanke hannu, wanda aka fi sani da tsabtace hannu, tsari ne na tsabtace hannu don cire gurɓataccen abu, mai, ƙwayoyin cuta, ko wasu abubuwa masu cutarwa.
Yin wanka a kai a kai da sabulu a lokatai masu muhimmanci a rana yana hana kamuwa da cututtuka da yawa, kamar fitsari da kuma cutar cholera.
Mutum zai iya kamuwa da cututtukan numfashi kamar mura ko sanyi na yau da kullum, kamar idan ya taɓa idanunsa, hanci ko bakinsa (watau ƙwayar ƙwayar cuta) da hannayensa marasa wanka.
Abubuwa biyar masu muhimmanci a rana su ne wanke hannuwanka da sabulu kafin ka zubar da ciki da kuma bayan ka zubar da ciki, bayan ka wanke ƙwallon ƙafa ko kuma ka canja sutura, kafin ka ciyar da yaro, kafin ka ci abinci, da kuma kafin ka dafa abinci ko kuma bayan ka dafa naman alade, kifi da namomin kaza.
Idan babu ruwa da sabulu, za ka iya wanke hannuwanka da ruwan wanka.
Kafin, a lokacin da kuma bayan da aka shirya abinci.
Kafin da kuma bayan kula da wani mai ciwo.
Bayan an canja suturar tufafi ko kuma an wanke yaron da ya je gidan wanka.
Bayan ka yi sanyin gwiwa, ka yi tari ko ka yi tari.
Bayan ka taɓa dabbobi, abinci ko sharar dabba.
Aikin tsabtace hannu na nufin tsabtace hannu da ke tattare da aikin likita.
Yin wanka kafin shan magani ko kuma yin magani zai iya hana ko rage yaduwar cutar.
Babban manufar wanke hannu a likita shi ne tsabtace hannu daga kwayoyin cuta (kwayoyin cuta, ƙwayoyin cuta ko wasu ƙwayoyin cuta), da kuma sunadarai da za su iya cutarwa ko kuma haifar da wasu cututtuka.
Wannan aikin yana da muhimmanci musamman ga mutanen da suke dafa abinci ko kuma waɗanda suke aiki a fannin kiwon lafiya, amma yana da muhimmanci ga dukan mutane.
Yin wanka hannu yana da amfani sosai ga lafiyar mutum, kamar rage yaduwar mura, coronavirus da sauran cututtuka masu yaduwa, hana kamuwa da cutar sankarar zuciya, rage yaduwar kamuwa da cutar numfashi,
kuma yana rage yawan mutuwar jarirai a lokacin haihuwar gida.
Wani bincike da aka yi a shekara ta 2013 ya nuna cewa wanke hannu mai kyau zai iya sa yara da ba su kai shekara biyar ba su yi girma sosai.
A ƙasashe masu tasowa, ana iya rage yawan yaran da ke mutuwa daga cututtukan numfashi da kuma fitsari ta wajen yin amfani da sabulu don wanke hannu.
Wannan hanya mai sauƙi za ta iya rage yawan mutuwar da ake yi a waɗannan cututtukan da kusan kashi 50 cikin ɗari.
Tunawa da mutane game da amfanin wanke hannu zai iya rage yawan cututtukan da ke faruwa a cikin gida da kashi ɗaya bisa uku, kuma hakan zai iya kwatanta amfanin da samun ruwa mai tsabta a yankuna da ba su da isashen kuɗi.
Ruwa da sabulu na iya rage yawan cututtukan da ke tattare da cutar ta shan iska da kashi 48 cikin ɗari. Wanke hannu da sabulu shine hanya ɗaya mafi inganci da rahusa don hana cutar ta shan iska da cututtukan numfashi (RRNs) idan an kafa halaye masu kyau a kowane gida, makaranta da sauran wuraren jama'a a duniya.
Ciwon huhu, ɗaya daga cikin manyan cututtukan cutar, shi ne babban dalilin mutuwar yara 'yan ƙasa da shekara biyar, wanda ke kashe kusan yara miliyan 1.8 a kowace shekara.
A kowace shekara, kusan yara miliyan 3.5 suna mutuwa daga ciwon kumburi da kumburi.
Asusun Yara na Majalisar Ɗinkin Duniya ya ce wanke hannu da sabulu kafin abinci da bayan bayan wanka, wanda ya zama al'ada mai ƙarfi, zai iya ceton rayuka fiye da kowane magani ko allurar rigakafi dabam-dabam, kuma zai rage yawan mutuwar da ke tattare da ciwon kumburi kusan sau biyu, kuma zai rage yawan mutuwar da ke tattare da cututtukan numfashi da ke tattare da cutar ta shan numfashi da kashi huɗu.
A yawancin lokaci, ana yin wanke hannu tare da wasu ayyukan tsabtace jiki da ake yi a cikin tsarin samar da ruwa, tsabtace jiki da tsabtace jiki (WASH).
Yin wanka yana hana kamuwa da cutar da ake kira impetigo, wadda za a iya kamuwa da ita ta wurin yin jima'i da kai tsaye.
Ƙananan sakamako marar kyau na wanke hannuwanmu sau da yawa shi ne cewa zai iya sa mu bushe da kuma lalata fata.
Wani bincike a ƙasar Denmark a shekara ta 2012 ya nuna cewa wanke hannu sau da yawa zai iya sa mutum ya yi tari kuma ya yi ta yin taurin kai. Hakan zai iya sa mutum ya kamu da cutar da ake kira eczema ko kuma cututtukan hannu, wadda ke da yawa a tsakanin ma'aikatan kiwon lafiya.
Yin wanke hannu sau da yawa yana iya zama alama ce ta rashin hankali .
Akwai abubuwa biyar da ake kira matsayi a rana, inda wanke hannu da sabulu yake da muhimmanci wajen rage haɗarin kamuwa da cutar ta hanyar magunguna: bayan an zubar da ciki (sanya, zubar da ciki), bayan an wanke ƙwallon jariri (canja sutura), kafin a ciyar da jariri, kafin a ci abinci da kuma kafin / bayan shirya abinci ko sarrafa naman raw, kifi ko tsuntsu.
Wasu lokuta kuma da ya kamata a wanke hannu kafin ko bayan an yi wa wani yanki ko rauni, bayan an yi masa cizon yatsa, ko kuma an yi masa tari, ko kuma bayan ya taɓa wasu abubuwa ko kuma ya taɓa wasu abubuwa.
A ƙasashe da yawa, wanke hannu da sabulu ba shi da yawa.
Wani bincike da aka yi a shekara ta 2015 a kasashe 54 ya nuna cewa a matsakaita, yawanci 38.7% na iyalai suna wanke hannu da sabulu . Wani bincike a shekara ta 2014 ya nuna cewa mafi yawan kashi, kashi 97%, an samu a Saudiyya; Amurka a wannan jerin ta kasance a tsakiyar, kashi  77%; mafi ƙasƙanci a China  23%. Akwai hanyoyin da za a iya canza halayyarsu da kuma inganta halayyar wanke hannu a cikin yanayi mai tsanani. A ƙasashen da ke tasowa, wanke hannu a cikin ɗalibai a cikin lokaci mai tsawo .
Hanyar kula da gaggawa ta ma'aikatar ilimi ta ƙasar Filifin  misali ne na manyan ayyuka na inganta lafiyar yara da kuma inganta ilimin yara.
Wannan shirin na ƙasa ya ƙunshi cire gumaka sau biyu a shekara, wanke hannu da sabulu a kullum, da kuma tsabtace hakora da ruwan zãfi a kullum.
A ƙasar Indonesia, ana yin wannan shirin sosai.
Idan aka ƙara sabulu ko kayan wanki, za a iya cire ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Babban aikin sabulu da kayan wanka shi ne kawar da shinge don narkewa da kuma ƙara yawan sa.
Ruwa da kansa ba shi da amfani wajen tsabtace fata, domin kitse da furotin da ke cikin gurɓataccen abubuwa ba su da kyau a cikin ruwa.
Amma, idan ruwa ya isa, hakan zai taimaka mana mu tsabtace mu.
Sabulu mai ƙarfi, saboda sau da yawa ana amfani da shi, yana iya ƙunsar ƙwayoyin cuta waɗanda za su iya shiga cikin sabulu a lokacin da aka yi amfani da shi.
Ƙananan bincike da aka yi game da yadda kwayoyin cuta suka shiga fata daga takardar sabulu mai ƙazanta ya nuna cewa ba za su iya yin hakan ba, domin suna wankewa da toka.
Hukumar ta ce sabulu mai ruwan sha da aka yi amfani da shi a hannu ne mafi kyau a wanke hannu.
Ana tallata sabulu na maganin rigakafi a cikin al'ummomin da ke kula da lafiyarsu.
A yau, babu wata hujja da ta nuna cewa amfani da maganin antiseptic ko kuma maganin kashe kwayoyin cuta yana da tasiri ga kwayoyin da suke da tsayayya da maganin rigakafi.
Amma sabulu na maganin ƙwayoyin cuta yana ɗauke da wasu kwayoyin cuta kamar trichlozan, wanda yawancin kwayoyin da ke da ƙarfi suke iya jurewa.
Saboda haka, ko da kwayoyin da ba su da maganin rigakafi sun fi na sabulu, ba za su iya yin tasiri kamar yadda ake tallatawa ba.
Baya ga kayan aiki na farfajiya da kayan kare fata, mahadi mai rikitarwa na iya ƙunsar acid (acid, ascorbic, lactic) a matsayin mai daidaita pH, da kuma maganin sinadarin benzoic acid mai aiki da sauran numfashi (aloe vera, bitamin, menthol, tsantsa na tsire-tsire).
Ruwan da ke da zafi da zafin jiki mai kyau ga fata ba shi da zafi sosai don kashe ƙwayoyin cuta.
Kwayoyin ƙwayoyin cuta suna ƙaruwa da sauri a yanayin jiki na 37 ° C.
Amma, ruwan sabulu mai zafi ya fi ruwan sanyi kyau wajen kawar da kitse masu ƙazanta da ƙwayoyin cuta.
A wani ɓangare kuma, bincike na kimiyya ya nuna cewa yin amfani da ruwa mai dumi ba ya rage yawan ƙwayar cuta a hannayenmu.
Kayan tsabtace hannu (sanitizer) ko maganin hana shan magani na hannu  kayan tsabtace hannu ne wanda ba shi da ruwa.
A ƙarshen shekarun 1990 da farkon karni na 21, kayan aikin tsabtace hannu na giya da ba su da ruwa (wanda aka fi sani da maganin kashe hannu a kan giya, maganin hana hana hannu ko sanitizers) sun fara samun karbuwa.
Yawancin waɗannan magungunan suna da isopropyl alcohol ko ethanol tare da ƙara kayan ƙonewa kamar carbomer (acrylic acid polymer) a cikin gel, ko kuma masu ƙonewa kamar glycerin a cikin ruwa ko foam, wanda ke ba da amfani da waɗannan magungunan da rage tasirin bushewar fata da giya.
Ƙara hydrogen peroxide yana ƙara ƙwayoyin cuta masu ƙonewa, kuma maganin kashe kwayoyin cuta da ke dauke da barasa aƙalla kashi 60 zuwa 95% na iya kashe kwayoyin cuta.
Magungunan kashe kwayoyin cuta suna kashe kwayoyin cuta, ciki har da kwayoyin da ke da juriya ga magunguna da yawa (MRSA da VRE), sashin cutar sankara, da wasu ƙwayoyin cuta (ciki har da HIV, herpes, RSV, rhinovirus, allurar rigakafi, mura da hepatitis) da kumfa.
Magungunan kashe kwayoyin cuta da ke dauke da kashi 70% na barasa suna kashe kashi 99.97% na kwayoyin cuta (ƙarancin sigogi 3.5 kamar ragewa da 35 decibels) a hannayen mutum bayan dakika 30 bayan amfani da kuma kashi 99.99%  99.999% na kwayoyin cuta (ƙarancin sigogi 45) a hannayen mutum bayan minti 1 bayan amfani da su. Magungunan kashe kwayoyin cuta na hannu sun fi tasiri akan kwayoyin cuta kuma sun fi tasiri akan wasu ƙwayoyin cuta.
Magungunan kashe kwayoyin da ke cikin giya ba su da tasiri sosai a kan ƙwayoyin cuta na Norovirus (ko Norwalk), wanda shine mafi yawan cututtukan gastroenteritis. Dole ne a yi amfani da isasshen maganin rigakafi ko maganin shan giya don sarrafa da kuma ciyar da fata na hannu a gefe biyu.
Ana shafa fuska da baya na hannayenka, da kuma yatsunsu a tsakanin su, na tsawon dakika 30 kafin ruwa, kumfa ko gel su soma sha.
Cibiyar Kula da Cututtuka ta Amirka ta ce ya kamata a yi amfani da wanke hannu maimakon yin amfani da maganin kashe cuta, musamman idan hannuwanmu sun gurɓata sosai.
Ana amfani da irin waɗannan maganin kashe ƙwayoyin cuta sosai don sauƙin amfani da su da kuma saurin hallaka kwayoyin cuta, amma ba za su zama abin maye gurbin wanke hannu ba idan akwai ruwan sabulu.
Yin amfani da maganin kashe ƙwayoyin cuta na hannu a kan giya sau da yawa zai iya haifar da bushewar fata idan ba a ƙunshi kayan taushi da (ko) mai narkewa na fata ba.
Za a iya rage ko kawar da sakamakon shan giya ta hanyar ƙara glycerin da (ko) wasu abubuwa masu laushi a cikin kayan aikin.
A gwajin asibiti, maganin kashe kashe hannu da aka yi amfani da giya da ke ɗauke da abubuwa masu sanyaya jiki ya sa fata ta yi sanyin gwiwa sosai fiye da sabulu ko kuma wanke-wanke.
Ba a taɓa samun cututtukan fata na allergy, cututtukan cututtukan fata na tuntuɓar jiki ko kuma rashin jin daɗin barasa ko ƙarin abubuwa da ke cikin maganin kashe cuta.
Ƙananan yiwuwar samun cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan da cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Duk da yadda suke da tasiri, kayan da ba su da ruwa ba suna tsabtace hannayenmu daga abubuwa masu ƙanshi, suna kashe su kawai.
Saboda haka, maganin kashe ƙwayoyin hannu ba ya hana ƙwayoyin cuta da yawa su yadu kamar sabulu da ruwa, domin idan aka yi amfani da su, ƙwayoyin cuta suna ci gaba da kasancewa a hannunka.
Aikin kashe kashe kashe kashe hannu da ba shi da barasa ya dogara da abubuwan da ke ciki da kuma yadda aka yi amfani da shi, kuma a tarihi ya kasance ƙasa da yadda ake amfani da maganin kashe kashe hannu da kuma maganin kashe kashe kashe kashewa.
Kwanan nan, an tabbatar da cewa maganin da ake amfani da shi a cikin benzodiazepine chloride yana da ƙarfin antibacterial da kuma haɗuwa da kwayoyin halitta, ba kamar giya ba, wanda aka tabbatar da cewa yana rasa tasiri bayan amfani da shi sau da yawa, mai yiwuwa saboda ci gaba da sakamako na fata.
Mutane da yawa a yankunan da ba su da kuɗi sosai ba za su iya sayen sabulu kuma za su maye gurbinsa da zinariya ko yumbu.
Ƙura ko yumɓu suna iya zama da amfani fiye da ruwa, amma suna da amfani sosai fiye da sabulu.
Wata matsala da wannan hanyar take fuskanta ita ce, idan an gurɓata ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayoyin ƙwayo.
Kamar sabulu, zuma yana da tsabtace jiki, domin idan ya zo ruwa, zai iya zama mai narkewa.
Idan ba a samu sabulu ba, sai a yi amfani da ash ko yashi.
Don hana kamuwa da cuta, Cibiyar Kula da Cututtuka ta Amirka ta ba da shawarar yin amfani da wanke hannu, wanda ya ƙunshi waɗannan matakai:
Ka wanke hannunka a ƙarƙashin ruwan sanyi ko mai dumi.
Ana ba da shawarar ruwa mai gudana domin ruwan da ke tsaye zai iya gurɓata, amma zafin jiki ba shi da muhimmanci.
Ka wanke hannunka da sabulu mai yawa, ka wanke gefen hannunka da yatsunka da kuma ƙarƙashin ƙusa.
Sabulu yana cire ƙwayoyin cuta daga fata, kuma bincike ya nuna cewa idan mutum ya yi amfani da sabulu (ba ruwa ɗaya kawai ba) zai iya wanke hannuwansa sosai.
Ka wanke hannunka na akalla na tsawon sa'o'i 20.
Ƙarƙashin ƙwayoyin cuta yana taimaka wa mutum ya kawar da ƙwayoyin cuta daga fata, kuma idan ya daɗe yana riƙe da hannunsa, zai kawar da ƙwayoyin cuta da yawa.
Ka yi amfani da ruwa mai kyau don ka wanke hannunka.
Rashin ruwa a hannu zai iya jawo kamuwa da cutar.
Ka wanke hannayenka da tawul mai tsabta ko kuma ka bar su su bushe da kansu.
Hannun da suke da ruwa da kuma rigarsu suna da sauƙi su gurɓata. Mafi yawan mutane suna watsi da wuraren kamar yatsunsu, ƙuƙwalwarsu, da kuma tsakanin yatsunsu da ƙusa.
Ƙusa da ƙusa da aka yi amfani da su a ƙusa suna iya ƙunsar ƙwayoyin cuta da yawa.
Ana yawan ba da shawarar yin amfani da wani kayan shafawa don hana hannun ya bushe, wanda zai iya haifar da lalacewar fata da kuma ƙara haɗarin kamuwa da cuta.
Idan babu ruwa mai gudana da sabulu, akwai hanyoyi masu yawa masu arha don wanke hannu: zuba ruwa daga kwandon ruwa mai rataye ko kwalban kwalban tare da ramuka da aka yi da (ko) amfani da tukunya idan ya cancanta, kamar yadda ake yi a ƙasashen da ke tasowa. A wuraren da ruwa ya ƙuntata (misali a makarantu ko yankunan karkara a ƙasashen da ke tasowa) akwai hanyoyin da za a iya ajiye ruwa kamar ƙusa da ƙusa da sauran zaɓuɓɓuka masu arha.
Kiran da ke da ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafafun ƙafa
Yin bushewa da kyau na hannu yana da muhimmanci a cikin tsabtace hannu, amma akwai wasu muhawara game da yadda za a bushe a cikin gidajen wanka na jama'a.
Ƙara bincike ya nuna cewa tawul ɗin takarda ya fi tsabta fiye da na'urorin wanke hannu na lantarki da aka saka a cikin gidajen wanka da yawa.
A shekara ta 2008, Jami'ar Westminster a London ta gudanar da bincike wanda taron taron Turai na samar da takarda da kayan shafawa ya tallafawa; batun wannan binciken ya kasance kwatanta matakan tsabtace takarda, bushewar hannu tare da iska mai dumi da kuma kayan bushewar iska na yau da kullun don hannu.
An gano cewa bayan an wanke hannuwanmu kuma an bushe su a cikin na'urar busar da iska mai zafi, adadin ƙwayoyin cuta a yatsunsu ya ƙaru da kashi 194%, kuma a hannayensu ya ƙaru da kashi 254%.
Bayan an wanke hannuwanmu kuma an bushe su a cikin na'urar busar da ke da iska, adadin ƙwayoyin cuta a yatsunsu ya ƙaru da kashi 42 cikin ɗari, kuma a hannayensu ya ƙaru da kashi 15 cikin ɗari.
Bayan an wanke hannuwanmu da kuma bushe su da tawul, yawan kwayoyin a yatsunsu ya ragu zuwa kashi 76 cikin ɗari, kuma a hannayensu ya ragu zuwa kashi 77 cikin ɗari.
Mai bushewa mai iska mai iska wanda ke fitar da iska da saurin gudu 180 m/s (650 km/h, 400 mph), yana iya hura kwayoyin cuta daga hannayensu da kuma daga bangaren kansa kuma yana iya kamuwa da sauran masu amfani da gidan wanka da kuma sanus a cikin radius har zuwa mita 2.
Yin amfani da na'urar bushewa don hannaye mai iska mai dumi yana yada kwayoyin a cikin radius na mita 0.25 daga na'urar bushewa.
A shekara ta 2005, kamfanin TÜV Produkt und Umwelt ya gudanar da bincike don tantance hanyoyin bushewa na hannu.
A cikin adadin kwayoyin, ana ganin canje-canje kamar haka dangane da yadda ake bushe hannu:
Akwai masana'antun bushewa da yawa, kuma ana kwatanta bushewa da wanka na takarda.
Yin wanka da hannu da kuma yin amfani da kayan shafawa na iya zama zaɓi na gaba a lokacin tafiya idan babu sabulu da ruwa.
Abincin kashewa na hannu a kan barasa ya ƙunshi aƙalla kashi 60% na barasa.
Hanyar likita ta wanke hannu ta zama wajibi tun bayan likitan Hungary Ignace Zemelweis ya gano cewa yana da tasiri sosai (a cikin 1846) wajen hana cututtuka a cikin yanayin da ba a iya amfani da shi ba.
Akwai na'urori na lantarki da ke gaya wa ma'aikatan asibitoci su wanke hannu idan sun manta.
Wani bincike ya nuna cewa yin amfani da irin waɗannan na'urori yana taimaka wajen rage yawan kamuwa da cuta.
Ana wanke hannuwanmu na tsawon lokaci na tsawon dakika 15, kuma ana amfani da sabulu da ruwa da kuma gel don wanke da kuma shafa kowane ɓangaren hannu.
Ka yi amfani da yatsun kaɗaɗa don ka ɗora hannayenka a hankali.
Idan akwai ƙura a ƙarƙashin ƙusa, za ka iya cire ta da goga.
Tun da yake ƙwayoyin cuta suna iya kasancewa a cikin ruwa a hannu, yana da muhimmanci a wanke su sosai kuma a shafa su da tawul mai tsabta.
Bayan an bushe hannayen, a rufe famfo, kuma idan ya cancanta, a rufe kofa ko buɗe kofa, ya kamata a yi amfani da tawul ɗin takarda.
Wannan zai hana a sake gurɓata hannayensu daga waɗannan farfajiyar.
Manufar wanke hannu a wuraren kiwon lafiya  kawar da kwayoyin cuta (microbes) da kuma hana su yaduwa.
Jaridar New England Journal of Medicine ta ce, yawancin wuraren kiwon lafiya ba sa yin wanka da hannu. Domin likitoci da ma'aikatan jinya da yawa suna manta su wanke hannu kafin su taɓa marasa lafiya, suna iya yin amfani da su wajen yaɗa ƙwayoyin cuta.
Wani bincike ya nuna cewa wanke hannu da kuma wasu ayyuka na yau da kullum na iya rage yawan cututtukan jini da ke tattare da yin amfani da kateter da kashi 66%.
Za a iya samun wannan takardar a shafin yanar gizon WHO kuma za a iya tattaunawa da jama'a.
Whitby ya yi nazari a kan wannan batun.
Idan ana bukatar a tabbatar da cewa ka'idojin sun yi daidai, za ka iya amfani da na'urori na kasuwanci don auna alamun da kuma duba lafiyar hannu.
Hukumar lafiya ta duniya ta ce akwai lokatai biyar da za a wanke hannu:
bayan haɗuwa da jini ko ruwa mai ƙwayoyin halitta,
kafin amfani da maganin rigakafi, da
Idan aka ƙara sinadarai masu saurin hana kumburi a sabulu a lokacin wanke hannu, zai taimaka wajen kawar da ƙwayoyin cuta.
Ana iya amfani da irin waɗannan maganin rigakafi kafin a yi tiyata ko kuma a cikin yanayin da ke da ƙwayoyin cuta masu tsayayya da maganin rigakafi. Don tsabtace hannu kafin tiyata, ana buƙatar famfo wanda za'a iya kunnawa da kashewa ba tare da taɓa hannayen ba; kuma ana buƙatar amfani da ƙaramin chlorhexide ko ruwan iodine don wanke hannu, tawul ɗin sterile don bushewa bayan wanka, goga mai lalata don shafawa da sauran kayan aikin sterile don tsabtace ƙusa.
Dole ne a cire dukan kayan ado.
Wannan aikin yana bukatar a wanke hannayenka da hannunka har zuwa kafadarka na tsawon minti 2.
Ba za ka yi amfani da hannunka ba don ka yi ta ɗora hannu sosai, kamar minti 10.
A lokacin da kake wanke hannu, kada ruwan da ke gabanka ya koma hannuwanka.
Bayan an gama wanke hannu, sai a bushe hannayensu da takalma kuma a saka rigar tiyata.
Don rage yaduwar ƙwayoyin cuta, ya fi kyau a wanke hannuwanku ko kuma a yi amfani da maganin hana kumburi kafin kuma bayan kula da marasa lafiya.
Domin magance cututtukan staphylococcal a asibitoci, an gano cewa kashi 20 cikin 100 na farko na wanke hannu ya fi amfani da shi, kuma an samu ƙarancin ƙarin amfanin da aka samu idan aka ƙara yawan wanke hannu fiye da kashi 35 cikin ɗari.
Idan aka kwatanta da wanke hannu da sabulu na yau da kullum, wanke hannu da sabulu na yau da kullum yana da sau uku da yawa na yawan cututtukan cututtukan cuta na cuta da ake watsawa ta hanyar abinci. Idan aka kwatanta wanke hannu da sabulu na giya da wanke hannu da sabulu na cuta, a matsakaita na tsawon dakika 30 a kowace hanya, an nuna cewa yin amfani da sabulu na giya ya rage gurɓatawar kwayoyin cuta da kashi 26% idan aka kwatanta da wanke hannu da sabulu na cuta.
Duk da haka, sabulu da ruwa sun fi maganin shan giya don hannu a rage yawan cutar mura ta H1N1 A da kuma cutar Clostridium difficile. Ayyukan ci gaba da tsabtace hannu a cikin cibiyoyin kiwon lafiya na iya haɗawa da horar da ma'aikatan wanke hannu, haɓaka samun maganin shan giya don hannu, da kuma tunatar da ma'aikata a rubuce da kuma baki game da bukatar wanke hannu.
Ana bukatar ƙarin bincike game da irin matakan da suka fi dacewa a cibiyoyin kiwon lafiya daban-daban.
A ƙasashe masu tasowa, wanke hannu da sabulu ya zama abin da ya fi dacewa a tattalin arziki kuma yana da muhimmanci wajen inganta lafiyar jiki ko ma wajen narkewa.
Amma rashin isashen ruwa, sabulu ko kuma wanke hannu a gidaje da makarantu da kuma wuraren aiki yana sa yin wanke hannu a kai a kai ya zama da wuya.
Alal misali, a yawancin yankunan Afirka na ƙauyuka, ba a kowane gidan wanka na jama'a ko na masu zaman kansu ba ne ake samun famfo don wanke hannu, ko da yake akwai wasu hanyoyin da za a iya yin wanke hannu a waɗannan wuraren.
Amma, rashin tsabta a hannu zai iya faruwa ne domin halaye da suka riga sun riga sun soma, ba don babu sabulu ko ruwa ba.
Ƙarfafawa da kuma inganta wanke hannu da sabulu na iya rinjayar yanke shawara na siyasa, da kuma ƙara wayar da kan jama'a game da amfanin wanke hannu, da kuma kawo canji na dogon lokaci a cikin halayyar jama'a.
Don tabbatar da ingancin irin waɗannan matakan, dole ne a lura da kuma kimanta sakamakon.
A cikin nazarin tsarin bincike na bincike 70 an gano cewa don inganta yanayin tsabtace hannu a ƙasashe masu samun kuɗi a ƙasa da matsakaici, kula da lafiya da cututtuka a matakin al'umma suna da tasiri, yayin da kamfen ɗin tallan jama'a ba su da tasiri. Misali ɗaya na tallatawa game da wanke hannu a makarantu  Hanyar Yara ta Majalisar Dinkin Duniya Three Star Approach: yana tallata aiwatar da matakan tattalin arziki a makarantu, wanda ke ƙarfafa wanke hannu ta hanyar amfani da sabulu, da kuma cika wasu buƙatun tsabtace jiki.
Idan aka tabbatar da cewa an bi ƙa'idodin ƙa'idodi, za a iya ƙara yawan ɗaliban daga taurari ɗaya zuwa uku.
Shigar da wuraren ajiye hannu  yana ɗaya daga cikin matakan da ake yi a cikin kamfen na wayar da kan jama'a game da tsabtace hannu don rage yawan rashin lafiya da mutuwar yara.
Ranar wanke hannu ta duniya (Global Hand Washing Day)  wani misali ne na kamfen na yada labarai da ke neman sauya hali. A sakamakon annobar cutar coronavirus ta 2019-20, Asusun Yara na Majalisar Dinkin Duniya yana inganta amfani da emojis da ke nuna wanke hannu.
Wasu bincike sun yi la'akari da yadda ake wanke hannu a ƙasashe masu tasowa idan aka kwatanta da DALYs (shekaru da aka ajiye ba tare da nakasa ba).
Amma, wani bincike ya nuna cewa wanke hannu da sabulu yana da amfani sosai idan aka kwatanta da wasu hanyoyin tsabta.
Muhimmancin wanke hannu ga lafiyar mutum  musamman ga mutanen da ke cikin rauni kamar matasa mata ko sojojin da aka ji rauni a asibitoci  an fara gane shi a tsakiyar karni na 19 ta hanyar sabbin abubuwa biyu a fannin tsabtace hannu: likitan Hungary Ignaz Semmelweis (Ignaz Semmelweis), wanda ke aiki a Vienna (Austria), da Florence Nightingale (Florence Nightingale), wani likitan Ingila da kuma mai kafa kula da marasa lafiya na zamani 
A lokacin, mutane da yawa sun gaskata cewa ƙwayoyin cuta suna sa mutane su yi ƙiba.
A shekarun 1980, da aka samu cututtuka da ke yaduwa ta hanyar narkewa da kuma cututtuka da ke tattare da kula da lafiya, Cibiyoyin Kula da Cututtuka da Tsare-tsare a Amurka sun ƙara inganta tsabtace hannu a matsayin muhimmin mataki na hana yaduwar kamuwa da cuta.
Bayan barkewar cutar sankarar alade a shekara ta 2009 da kuma annobar COVID-19 a shekara ta 2020, mutane a ƙasashe da yawa sun fahimci muhimmancin wanke hannu da sabulu don kare jiki daga irin waɗannan cututtukan cututtuka.
Alal misali, a Jamus, a kusa da masu wanke hannu a cikin gidajen wanka na jama'a, da kuma a cikin gidajen wanka na ofisoshi da filayen jirgin sama, ana rataye wasu hotunan da ke ɗauke da kayan wanke hannu.
Yin wanka yana nufin nuna rashin son kai ga wani abu ko kuma kasancewa cikin wani abu.
An samo wannan furcin daga Littafi Mai Tsarki, Linjila daga Matta: Bilatus ya wanke hannuwansa sa'ad da ya yanke shawarar gicciye Yesu Kristi; daga baya wannan furcin ya sami amfani sosai a wasu al'ummomin Turanci.
A cikin wasan kwaikwayo na Shakespeare Macbeth, Lady Macbeth ta fara wanke hannayenta ba da son rai ba don ƙoƙarin tsabtace kanta daga wani tabo mai tunani, wanda ke nuna lamiri marar kyau, dangane da laifukan da ta aikata da kuma sa mijinta ya aikata.
An kuma gano cewa mutanen da suka tuna ko kuma suka lura da wani abu marar kyau sun fi wanke hannu fiye da wasu, kuma suna da muhimmanci sosai a gare su.
Hakazalika, mutane da suka yi wanka bayan sun gani ba za su iya yin wasu ayyukan da za su iya taimaka musu ba, kamar su aikin agaji.
A cikin addinai wanke hannu yana da ma'ana da kuma ma'ana na alama. Wanke hannu na alama da ruwa, amma ba tare da sabulu ba,  wani ɓangare ne na al'ada da aka tsara a cikin addinai da yawa, ciki har da Baha'u'llah, Hindu, tevilah da netilat yadayim a Yahudanci, Lavabo a Kiristanci da Wudhu a Islama. Addinai kuma suna ba da umarnin wanke hannu na tsabta, musamman bayan wasu ayyuka.
Addinin Hindu, Yahudanci da Musulunci sun ce a wanke hannu bayan ka je gidan wanka.
A addinin Hindu, Buddha, Sikh, da kuma Musulunci, ana ganin ya zama wajibi a wanke hannu kafin da kuma bayan cin abinci.
Kula da abubuwan samarwa dangane da COVID-19
Kula da abubuwan samarwa dangane da COVID-19 na nufin amfani da hanyoyin tabbatar da lafiyar aiki da kiyaye lafiya don kula da haɗari da kuma yaki da cutar coronavirus ta 2019 (COVID-19).
Kula da haɗari a wurin aiki ya dogara da wurin aiki da kuma aikin aiki, yana dogara ne akan kimanta haɗari, yadda mummunan yanayin annobar yake a cikin al'umma, da kuma abubuwan haɗari ga ma'aikata na musamman waɗanda za su iya zama masu rauni saboda COVID-19.
Hukumar Kula da Ayyukan Ma'aikata da Lafiya ta Masana'antu ta Amurka (OSHA) ta ce wuraren da ke da ƙananan haɗari suna da ƙarancin hulɗa na ƙwararru tare da jama'a da abokan aiki, kuma a irin waɗannan lokuta ana buƙatar matakan ƙididdigar ƙwayoyin cuta, gami da wanke hannu, ƙarfafa ma'aikata su kasance a gida yayin alamun rashin lafiya, kiyaye ɗabi'ar numfashi, da kuma tsabtace yau da kullun da kuma lalata yanayin aiki.
Matsayi mai matsakaicin haɗari yana buƙatar sau da yawa ko kuma kusanci da mutane waɗanda ba su da tabbataccen ko kuma waɗanda ake zargin an gano COVID-19 amma suna iya kamuwa da cutar saboda yaduwar cutar a yanzu ko yayin tafiya ta duniya.
Wannan rukunin na iya kasancewa ma'aikata da ke hulɗa da jama'a, kamar makarantu, wuraren aiki masu yawan jama'a da kuma wasu manyan shagunan sayar da kayayyaki.
Abubuwan da za a yi don sarrafa haɗarin wannan rukunin, ban da matakan rigakafin kamuwa da cuta na asali, sun haɗa da iska ta amfani da matattarar iska mai inganci, amfani da allon kariya da kuma kayan kariya ta mutum a lokacin da mutum ya haɗu da wanda ke da cutar COVID-19.
OSHA ta yi imanin cewa ma'aikatan cibiyoyin kiwon lafiya da kuma asibitoci da suka tuntubi mutum da aka tabbatar da cutar ko kuma ake zargin cewa yana da cutar COVID-19 suna cikin haɗarin haɗari; kuma haɗarin yana ƙaruwa zuwa matakin da ya fi girma yayin da ma'aikatan ke gudanar da hanyoyin da ke tattare da samar da iska mai iska, ko tattara / sarrafa samfurori daga mutum da aka tabbatar da cutar ko ake zargin COVID-19.
Matakan kula da haɗari da suka dace da irin waɗannan ma'aikatan sun haɗa da amfani da kayan aikin injiniya da fasaha na tsaro, kamar ɗakunan iska masu ƙarancin ƙarfi, da kuma kayan kariya na mutum waɗanda suka dace da aikin da ya dace.
Cutar COVID-19 na iya haifar da tasiri iri-iri a wurin aiki.
Ma'aikata na iya kasancewa a wurin aiki saboda rashin lafiyar kansu, ko kuma tsoron kamuwa da cutar.
Tsarin kasuwanci na iya canzawa dangane da nau'ikan kayayyaki da ake buƙata da kuma hanyoyin siyan waɗannan kayayyaki (misali, sayayya a lokacin da ba a kai ba tare da isarwa ko sabis ba, ba tare da barin mota ba).
A ƙarshe, za a iya samun katsewa a jigilar kayayyaki daga yankunan da COVID-19 ya shafa. Za a iya amfani da shirin shiri da kuma mayar da martani don tsara kariya.
A cikin tsare-tsaren, an tattauna batutuwan haɗari da ke tattare da ayyuka da ayyuka daban-daban, gami da tushen kamuwa da cuta, abubuwan haɗari da ke faruwa a gida da kuma al'ummomi, da kuma abubuwan haɗari ga ma'aikata kamar tsufa ko rashin lafiya na kullum.
Shirye-shiryen kuma ya nuna hanyoyin da za a iya sarrafawa don magance matsalolin da ke tattare da irin wannan haɗarin, da kuma shirye-shiryen gaggawa don yanayin da zai iya tasowa sakamakon annobar.
Shirye-shiryen shirye-shiryen annobar da kuma mayar da martani na iya bin shawarwarin matakin ƙasa ko na jihar.
Wasu daga cikin manufofin da ake da su na samar da martani game da annobar sune rage yaduwar cutar tsakanin ma'aikata, kare mutanen da ke fuskantar haɗarin samun ciwon lafiya mai tsanani, kula da ayyukan kasuwanci da rage mummunan sakamako ga sauran ƙungiyoyi a cikin sarkar samar da su.
Matsayin da ake fama da cutar a cikin al'ummar da ake kasuwanci yana shafan yadda ake bi da ita.
Tsarin tsarin kula da haɗari  tsari ne da aka yi amfani da shi sosai wajen tabbatar da lafiyar aiki da tsabtace jiki don rarraba irin waɗannan kayan aiki bisa ga inganci.
Idan ba za a iya kawar da haɗarin COVID-19 ba, ingantattun hanyoyin tsaro ne suka fi tasiri, sannan  matakan gudanarwa, kuma ƙarshe  hanyoyin kariya ta mutum.
Kayan aikin tsaro na injiniya yana nufin ware ma'aikata daga wuraren haɗari da ke tattare da aiki, kuma ba su dogara da halayen ma'aikaci ba, wanda zai iya zama mafi kyawun tattalin arziki.
Ayyukan gwamnati suna nufin sauya manufofin aiki ko hanyoyin da ke buƙatar aiki daga ma'aikaci ko ma'aikaci.
Ana ganin cewa kayan kare kanka (PPE) ba su da inganci idan aka kwatanta da aikin injiniya ko na gwamnati, amma suna iya taimakawa wajen kawar da wasu haɗari.
Duk nau'ikan kayan kariya na mutum dole ne a zaɓa bisa ga haɗarin da ma'aikaci ke fuskanta, a daidaita su (misali masu numfashi), a yi amfani da su koyaushe da yadda ya kamata, a bincika su akai-akai, a kiyaye su a cikin yanayin da ya dace kuma a maye gurbin su idan ya cancanta, kuma a cire su daidai, a tsabtace su kuma a adana su ko a yi amfani da su don kauce wa kamuwa da cuta.
Hukumar Kula da Ayyukan Ma'aikata da kuma Kula da Lafiya a Amurka (OSHA) ta ce, wuraren da ba su da haɗari sosai ba su da wata dangantaka da jama'a da abokan aiki.
Abubuwan da ake bukata don magance cutar da ake ba da shawara ga duk wuraren aiki sun haɗa da wanke hannuwanmu a kai a kai, da kuma a hankali, da kuma ba da shawara ga ma'aikata masu rashin lafiya su zauna a gida, da kuma kiyaye ka'idodin numfashi, ciki har da rufe bakinsu da hannu a lokacin tari da kuma numfashi, da kuma samar da kayan shafa da kwantena don shara, da kuma kasancewa a shirye don aiki na nesa ko canji, idan ya cancanta, da kuma ba da shawara ga ma'aikata su guji amfani da wasu kayan aiki da kayan aiki, da kuma yin tsabtace da kuma kashe muhalli a kullum.
Gano da kuma ware mutanen da ke da cutar nan da nan yana da muhimmanci sosai wajen kare ma'aikata, abokan ciniki, baƙi da kuma wasu a wurin aiki.
Cibiyoyin Kula da Cututtuka da Cututtuka na Amurka (CDC) sun ba da shawarar ma'aikatan da ke da alamun cututtukan numfashi na gaggawa su zauna a gida har sai zafin jiki ya ƙare, rashin zafin jiki, da sauran alamun alamun sun ƙare aƙalla awanni 24 ba tare da amfani da maganin rage zafin jiki ko wasu magunguna masu kawar da alamun ba, kuma sun ba da umarnin samar da sassauƙa a cikin manufofin asibiti, ba da izinin ma'aikatan su zauna a gida don kula da wani dangin da ke ciwo, da kuma tabbatar da sanarwar ma'aikatan game da irin waɗannan manufofin.
A cewar OSHA, matsayi mai matsakaicin haɗari yana buƙatar sau da yawa da kuma kusanci da mutane a nesa da mita 1.8 ba tare da tabbaci ko zargin kamuwa da COVID-19 ba, amma akwai yiwuwar kamuwa da SARS-CoV-2 saboda yaduwar cutar a cikin al'umma a yankin da kasuwancin ke ciki, ko kuma saboda ziyarar da aka yi kwanan nan zuwa wuraren COVID-19.
Waɗannan sun haɗa da ma'aikata da ke da hulɗa da jama'a, kamar makarantu, wuraren aiki masu yawa da manyan shagunan sayar da kaya. Abubuwan da ke cikin aikin injiniya da tsaro ga waɗannan ƙungiyoyi da ƙungiyoyi masu haɗari sun haɗa da sanya matattarar iska mai inganci, haɓaka ƙarfin iska, sanya shinge na zahiri kamar allon filastik mai tsabta, da kuma shigar da windows don sabis na abokin ciniki ba tare da barin mota ba. Abubuwan da ke cikin aikin gudanarwa ga waɗannan ƙungiyoyi da ƙungiyoyin haɗari masu yawa sun haɗa da ba da shawara ga ma'aikata marasa lafiya su zauna a gida, maye gurbin tarurruka na sadarwar kai tsaye na ma'aikata, sanya alamun shaida tare da daidaitaccen lokaci, waɗanda ba sa buƙatar dakatar da tafiya daga COVID-19, amma haɗarin haɗari da ke cikin yanayin, ƙuntatawa da kuma ƙuntatawa na sirri, ƙuntatawa da kuma ba da izini ga ma'aikata, ƙuntatawar buƙatun don kare kansu daga COVID-19, ƙuntatawar buƙatunmu, ƙuntatawar kayan aiki da ƙuntatawar aiki, ƙuntatawar buƙatunmu na sirri, ƙuntatawar ƙuntatawar ƙuntatawar aiki, ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar aiki, ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar COVID-19, ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar, ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntata, ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙuntatawar ƙ
A wasu lokatai ma'aikatan da ke cikin wannan rukunin haɗari suna bukatar su yi amfani da na'urar numfashi.
Idan mutum ya yi rashin lafiya a cikin jirgin sama, don tabbatar da amincin ma'aikatan jirgin sama da sauran fasinjoji, ana buƙatar matakan kamar ware mai haƙuri daga wasu mutane a nesa da ƙafa 6, sanya wani memba na jirgin don kula da mai haƙuri, ba mai haƙuri abin rufe fuska ko kuma neman mutumin ya rufe hanci da bakinsa da takalma don tari ko tsotsa.
Ma'aikatan jirgin biyu suna bukatar su sa sa safofin hannu na likita na lokaci guda idan sun kusanci mai tafiya mai ciwo ko kuma sun fuskanci ruwa na jiki ko kuma wasu wurare da ke da cutar, kuma suna iya amfani da ƙarin kayan kariya idan suna da zazzabi, tari ko wahalar numfashi.
Dole ne a sanya safofin hannu da sauran kayan amfani da su a cikin jaka mai aminci, sannan a tsabtace da kuma kashe ƙwayoyin cuta a bayan haka. A cikin yanayin tafiye-tafiye na kasuwanci, gami da jiragen ruwa masu tafiya da sauran jiragen ruwa, matakan tsaro sun haɗa da jinkirta tafiya idan akwai rashin lafiya, keɓancewa da sanar da cibiyar likitanci a jirgin nan da nan idan akwai zazzabi ko wasu alamun cutar a cikin jirgin.
A mafi kyau, ana buƙatar a yi bincike na likita a cikin ɗakin da ke keɓewa na wannan mutumin. A cikin makarantu da wuraren kula da yara, CDC ta ba da shawarar rufewa na ɗan gajeren lokaci don tsaftacewa ko kashewa idan mutumin da ke da cutar ya kasance a cikin makarantar, ba tare da la'akari da yadda cutar ta yadu a cikin al'umma ba.
Idan akwai ƙananan ko matsakaiciyar yaduwar kamuwa da cuta a cikin al'umma, ana iya aiwatar da dabarun nesa da zamantakewa, kamar soke tafiye-tafiye don tarurruka na mutum, tarurruka da sauran ayyukan taro, kamar motsa jiki ko waƙar mawaƙa, cin abinci a cikin cafes, ƙara nesa tsakanin ƙungiyoyi, daidaita lokacin isowa da fita, iyakance ziyarar da ba ta da mahimmanci, amfani da wuri na musamman na cibiyoyin kiwon lafiya don yara masu alamun mura.
A cikin al'umma, a cikin gagarumin yanayin, ban da dabarun nesa da zamantakewa, ana iya la'akari da matakan rashin halartar makaranta na dogon lokaci.
Ma'aikatan tsaro da ke bukatar tuntuɓar mutanen da aka tabbatar da cutar ko kuma ake zargin suna da cutar COVID-19 an shawarce su su bi umarnin da aka ba ma'aikatan gaggawa, gami da yin amfani da kayan kariya na sirri.
Idan akwai kusanci a lokacin tsarewa, dole ne ma'aikata su tsabtace da kuma lalata belunansu da kayan aiki kafin su sake amfani da su ta hanyar tsabtace gida ko ta hanyar shafawa, su bi ka'idodin aikin aiki don hana yaduwar cutar da kuma amfani da kayan kariya na mutum, da kuma amfani da tufafi da wanke su.
OSHA ta ce wasu rukunin ma'aikatan kiwon lafiya da kuma gidan kiwon lafiya suna da haɗari sosai ko kuma suna da haɗari sosai.
A cikin ayyukan da ke da haɗari mai yawa, akwai ma'aikatan kiwon lafiya, masu tallafawa, ma'aikatan dakunan gwaje-gwaje da kuma sufuri na kiwon lafiya da ke hulɗa da marasa lafiya da aka tabbatar da cutar ko kuma waɗanda ake zaton suna da cutar COVID-19.
Suna da haɗarin kamuwa da cutar sosai yayin da suke yin aikin da ke tattare da samar da aerosol, ko kuma lokacin da suke tattara/sampulu daga mutanen da aka tabbatar da cutar ko kuma waɗanda ake zaton suna da cutar COVID-19.
Ayyukan da ke tattare da samar da aerosol sun haɗa da yin bincike, yin aikin da zai sa mutum ya yi tari, yin bronchoscopy, wasu hanyoyin hakori da kuma bincika ko tattara samfurori ta hanyar hauka.
Ma'aikatan da ke cikin gidan mutuwa masu haɗari sun haɗa da ma'aikatan da ke kula da gawawwakin mutanen da aka tabbatar da cutar ko ake zargin suna da cutar COVID-19 a lokacin mutuwarsu; idan irin waɗannan ma'aikatan suka yi binciken, to suna zuwa rukunin haɗari mai girma. Ƙarin kayan aikin injiniya da fasaha na aminci ga waɗannan rukunin haɗari sun haɗa da amfani da ɗakunan keɓewa don marasa lafiya da aka tabbatar da cutar ko ake zargin suna da COVID-19, gami da yin hanyoyin da ke tattare da samar da iska.
A wasu wuraren kiwon lafiya da kuma wuraren shan magani, ana iya amfani da iska mai iska mai ƙarancin ƙarfi.
Ya kamata a yi amfani da samfurori a cikin matakan tsaro na matakan tsaro 3.
Hukumar Lafiya ta Duniya (WHO) ta ba da shawarar rarraba marasa lafiya masu shigowa zuwa yankunan jiran da aka tsara dangane da yiwuwar kamuwa da COVID-19. Baya ga wasu hanyoyin kariya ta mutum, OSHA ta ba da shawarar yin amfani da kayan numfashi ga ma'aikatan da ke hulɗa da juna har zuwa mita 6 tare da marasa lafiya da aka tabbatar da cutar ko waɗanda ake zargin suna da cutar SARS-CoV-2, da kuma mutanen da ke gudanar da hanyoyin da ke tattare da samar da iska.
A Amirka, ana bukatar a yi amfani da na'urorin numfashi da aka amince da su ta hanyar NIOSH don waɗanda suke da matattarar N95 ko kuma mafi girma a cikin tsarin tsare-tsaren numfashi da ke nuna bukatun da ake bukata don a yi wa mutum magani da kuma duba lafiyarsa.
Wasu nau'ikan kayan numfashi na iya ba da ƙarin tsaro da kwanciyar hankali ga ma'aikaci. WHO ba ta ba da shawarar yin amfani da tufafi na musamman ba saboda COVID-19  cuta ce da ake watsawa ta hanyar numfashi, ba ta hanyar ruwa ba.
Hukumar lafiya ta duniya ta ba da shawarar yin amfani da abin rufe fuska na tiyata kawai ga ma'aikatan da ke yin bincike a wurin da ake karɓar marasa lafiya.
Ga waɗanda ke tattara samfurori daga hanyoyin numfashi na marasa lafiya da COVID-19 ko masu ɗaukar cutar ba tare da hanyoyin da ke tattare da samar da aerosols ba, WHO ta ba da shawarar su sa abin rufe fuska na tiyata, tabarau na kariya ko allon kariya na fuska, riguna da safofin hannu.
Idan ana yin aikin da ke tattare da samar da iska mai iska, ya kamata a saka numfashi na N95 ko FFP2 maimakon abin rufe fuska.
Ganin rashin wadatar kayan kariya ta mutum a duniya, WHO ta ba da shawarar rage bukatar irin waɗannan kayan kariya ta hanyar amfani da damar magani na nesa, shinge na zahiri, kamar windows masu haske, samar da damar zuwa ga mai haƙuri da ke da COVID-19, kawai ga waɗanda ke ba da kulawa ta kai tsaye, amfani da kayan kariya na mutum kawai waɗanda suke da mahimmanci don takamaiman aiki, amfani da numfashi ɗaya ba tare da cirewa ba, yayin aiki tare da marasa lafiya da yawa tare da cututtuka iri ɗaya, saka idanu da daidaita sarkar samar da kayan kariya ta mutum, da kuma ba da shawara don amfani da abin rufe fuska ga waɗanda ba su da alamun bayyanar cututtuka.
MAGANTA: Katherine Maher, babban darektan zartarwa na Wikimedia Foundation
MUTANE: Dukan ma'aikatan Wikimedia Foundation
TAMBAYA: [Covid-19] Ragewa da kuma shiri don nan gaba
RANAR DAGA/LAMAR KARYA: 14 ga Maris, 2020, 00:24 UTC
SHUGA: CC0: Ba a da haƙƙoƙin da aka kāre ba
A wannan watan, muna rayuwa a cikin yanayi mai ban mamaki.
Cutar COVID-19 wani abu ne da ya sa mutane a duniya su fahimci yadda muke hulɗa da juna da kuma yadda muke da alhakin juna.
Ba mu da irin wannan matsalar a baya, amma mun san cewa yadda za mu yi aiki da kyau ya dogara ne da iyawarmu na nuna tausayi, haɗin kai da kuma ci gaban al'ummomi a duniya, wanda ke da tushe a cikin wannan ƙungiyar.
Mun ga yadda abokan aikinmu suke nuna ƙauna da kuma kula da juna, kuma hakan ya bayyana a cikin wasiƙun imel da kira da kuma tattaunawa. Wannan tabbaci ne mai kyau na cewa muna da mutane masu ban mamaki da suke aiki tare da mu.
Ina da matuƙar godiya da kuma alfahari da ku, a matsayin abokan aikina.
A makon da ya gabata, na samu labari cewa an yaba mini sosai.
An tunatar da ni game da muhimmancin samun damar shiga Wikipedia a duniya a yanzu, da kuma yadda yake da amfani ga kowa ya sami damar shiga wannan muhimmin albarkatun ta yanar gizo.
Kuma wannan zai yiwu ne saboda aikinku, ko don inganta ayyukan yanar gizo, ko don biyan kuɗin abokan aikinmu ko don kare lafiyar al'umma.
Duniya tana bukatar bayanan da ke cikin Wikipedia, kuma a yau yana da muhimmanci fiye da kowane lokaci.
A wannan zamani, ba wai kawai abin da muke yi ba ne yake da muhimmanci don samun sakamako mai kyau ga duniya, amma kuma yadda muke yin hakan.
Saboda muhimmancin wannan manufa da kuma rawar da kuke takawa a wannan tsari, za mu yi canje-canje masu muhimmanci a tsarin aikinmu na haɗin gwiwa, daga mako mai zuwa.
Gyara tsarin aikinmu da jadawalinmu
Kamar yadda Robin ya ce, ƙungiyar c-team sun taru a daren jiya don tattauna tsarinmu da jadawalinmu na kwanaki da watanni masu zuwa.
A lokacin tattaunawar, mun tattauna ra'ayoyinmu game da yadda za mu yi aiki sosai a wannan yanayin da kuma yadda za mu iya tabbatar da dorewar ƙungiyar a wannan lokacin.
Yawancinmu muna so mu rage damuwa kuma mu tallafa wa aikinmu na dogon lokaci.
Idan kana so ka janye, to, ka yi haka.
Ga dukan ma'aikata, masu kwangila da kuma ma'aikatan waje:
Muna tsammanin za mu yi aiki na tsawon sa'o'i 4 a rana ko 20 a mako kafin mu samu umarni.
Ba ma yin amfani da ranar hutu don yin aiki na tsawon lokaci, amma idan za ku iya yin aiki na tsawon lokaci, za a ba ku izinin yin hakan don manufar aikinmu.
Amma, ba za a iya sanin yadda duniya za ta kasance ba a yanzu; ko da menene bukatunku, ko kula da danginku, ko sayen abinci, ko zuwa asibiti, lafiyarku ita ce fifiko na farko.
Ba mu lura da lokutan aikinku ba.
Idan kana rashin lafiya, kada ka yi aiki.
Wannan abu ne mai kyau da kuma tabbatacce, amma mun ambaci shi.
Ba a bukatar ka rubuta takardar asibiti ko kuma ka yi hutu. Ka gaya wa shugabanka kuma ka taimaka wa ƙungiyarka ta sake duba kalandar da jadawalin aikin don ka samu damar yin hakan.
(Idan ka sami tabbacin kamuwa da COVID-19, ka sanar da Brian daga T&C Ops don T&C ta iya ba ka goyon baya da kuma kulawar da kake bukata daga masu kula da yanayinka).
Za a biya kuɗin awa ɗaya a cikakken lokaci.
Mun riga mun sanar kuma mun tabbatar da niyyarmu ta cika alkawuranmu ga masu kwangila da ma'aikatanmu a kan biyan kuɗin awa.
Kowane mutum zai sami kuɗin da ake biyansa a kowane lokaci.
Wannan ya shafi lokutan rashin lafiya musamman ma, lokacin da ba za ka iya yin aiki ba.
Idan kana son ka yi aiki, za mu goyi bayanka.
Mutane da yawa suna amfani da aikin su wajen nuna cewa suna son su yi wa duniya hidima.
Abin da muke yi zai iya kawo sakamako mai ban mamaki, musamman a irin wannan lokacin.
Kuma wannan shi ne batun taimakon kai.
Muna rokon ku ku tuntubi shugabanku don mu san abin da za mu yi tsammani kuma mu daidaita ayyukanmu yadda ya kamata.
Wasu ayyuka suna da muhimmanci.
Ya kamata mu ci gaba da yin irin waɗannan ayyukan.
Ƙungiyoyin SRE, HR Ops, Trust&Safety da Fundraising (a tsakanin sauran) suna yin aiki mai mahimmanci wanda zai iya buƙatar ƙarin tallafi.
Muna ba da tsari ga dukkan sassan don tantance manufofinmu na yanzu da kuma mayar da hankali kan samar da tallafi, wanda yake da matukar muhimmanci ga aikinmu.
Akwai ayyuka da yawa da za mu yi, kuma muna mai da hankali ga ayyukan da suka fi muhimmanci.
Idan muka yi jinkiri a yau, hakan ba zai shafi rayuwarmu ba.
Ba mu da niyyar yin aiki sau biyu don dawo da abin da muka rasa bayan an kammala annobar.
Ba za ku yi aiki na tsawon lokaci ba don ku yi aiki a kan lokaci.
Mun amince cewa yanayin ya canja kuma za mu yi aiki don kafa sababbin manufofi da kuma takaddun shaida, idan za mu iya.
Mene ne shirin APP yake yi?
Don daidaitawa da sabon yanayin da ake tsammani game da yawan aiki na yau da kullum, muna da niyyar daidaita lokacin aiwatar da Shirin Shekararmu na 2020-2021.
Muna da niyyar bayar da shawarar tsawaita lokacin shirinmu na 2019-2020, don haka samar da karin lokaci don tsara kasafin kuɗi, wanda zai ba ma'aikata damar ba da fifiko ga aiki mai mahimmanci, taimakon kai da kula da ƙaunatattun su, kuma a lokaci guda duk wanda yake buƙata ko yana son aiki, za a samar da gajeren jadawalin makonni masu zuwa.
Irin wannan tsawaitawa zai iya rage yawan ayyukan tsarawa da kuma tashin hankali a dukan ƙungiyar.
A mako mai zuwa za mu gabatar da shawarwarinmu ga Majalisar, za mu sanar da wakilan da kungiyoyin da ke gaba da matakan da za su biyo baya nan da nan bayan an tabbatar da hakan.
Na gode wa ƙungiyar APP da suka ba da gudummawa a wannan aikin.
Yanayin ofishin, haɗari da tsabtace
A makon da ya gabata, mun samu labari cewa wani abokin aikinmu a San Francisco na iya kamuwa da cutar COVID-19.
Amma, ban da matakan tsaro da yawa, mun kuma ɗauki ƙungiyar tsabtace cutar don yin amfani da allurar rigakafi a ofishinmu a San Francisco.
Sun yi amfani da maganin rigakafi na likita don kawar da cutar a duk fadin duniya, da kuma wuraren shiga da kuma ɗakunan hawa da za su iya shiga bene.
A cikin ginin, an yi amfani da dokoki na musamman da suka ce a yi hankali, kuma a yi amfani da kayayyakin da ke ba da lafiyar masu haya.
Muna ganin cewa ofishin zai kasance a shirye don lokacin da za mu koma.
Ofishinmu a gundumar Columbia (DC) yana cikin hanyar sadarwar WeWork, wadda ta ba mu da kuma dukan ma'aikatanmu a DC dokoki game da COVID-19.
A makon da ya gabata, ofishinmu a gundumar Columbia ya koma aiki a nesa bisa ga umarnin da aka ba shi a San Francisco.
Kamar yadda wasu abokan aikinmu a birnin New York suka sani, mun tattauna batun haya a Brooklyn.
Ana ci gaba da yin irin wannan muhawara, amma za a iya jinkirta ta.
Wasu abokan aikinmu sun fara aiki a nesa.
Tsoffin abokan aikinmu da ke aiki daga nesa sun san yadda za a gyara wannan kuma suna so su ba ku wasu shawarwari:
Ana bada shawara cewa a rage tsawon taron zuwa sa'o'i ɗaya ko biyu.
Idan kana bukatar ƙarin lokaci, ka yi la'akari da yadda za ka iya raba shi zuwa kwanaki da yawa.
Ka san dalilin taron da kuma abin da za a yi a kai a kai kuma ka aika da bayanan da za ka koya.
Ka yi amfani da bidiyo ta hanyar tsoho, kuma ka yi amfani da kayan aiki kamar Google Docs da Zoom don yin hulɗa da sadarwa.
Don saukakawa, ka naɗa mai tsarawa  wanda zai lura da tambayoyin da ke cikin hira kuma ya lura da jerin masu magana, kuma ya kula da yin tsokaci (ko kuma duba tare).
Idan kana bukatar ka yi amfani da kayan kwalliya mai kyau, ka tuntubi sabis na goyon bayan fasaha ta imel.
Ka yi amfani da abubuwan da ka samu a cikin shirin Wellness Reimbursement don samun abinci mai ɗanɗano.
Ka shiga tashar #remoties ta Slack don ka tattauna da abokan aikinka game da aikin da aka rarraba.
Ƙungiyar HR Operations tana nazarin jagororin ergonomics da ke samuwa a cikin tsarin yanar gizo don taimakawa wajen inganta aikin rarraba a duk faɗin ƙungiyar.
A makon da ya gabata, mun nemi duk masu karbar tallafin al'umma su soke ayyukan da Wikimedia ke tallafawa, kamar editathons, har sai WHO ta sanar da cewa annobar ta ƙare.
Mun fahimci kuma mun sanar da cewa bukatarmu ta irin wannan jinkiri da wasu ƙuntatawa na iya haifar da rashin yiwuwar gudanar da ayyukan da aka tsara don tallafin, kuma ba za a caje kowa ba don jinkirta ko sauya waɗannan manufofin.
A mako mai zuwa za mu gudanar da wasu ayyuka na gaba da kuma ƙarin bayani game da Wikimania da kuma sauran taron yanki da na al'umma.
Yanayin da jama'a ke ciki a cikin al'ummar duniya  ba wai kawai baƙin ciki ba ne saboda dakatarwar, amma kuma wani ɗan sauƙi saboda fahimtar juna da kuma damar da za a mayar da hankali ga al'ummominmu, Wikimedia da ƙari.
A cikin hangen nesa, CRT tana aiki a kan wani shafi a Meta-Wiki wanda zai samar da sarari ga al'umma don bin diddigin tasiri da sadarwa.
Muna ci gaba da tuntuɓarmu game da COVID-19.
Za mu aika da gayyatar zuwa taron ma'aikata na musamman a kalandarku a ranar Alhamis mai zuwa, 14:00 UTC/07:00 PT.
A wannan karon, za mu yi amfani da wannan zarafin don mu ba da ƙarin bayani, mu amsa tambayoyinku, kuma mu yi lokaci tare don mu haɗa kai.
Muna tare a wannan yanayin kuma muna shirye mu taimaka wa duk wanda za mu iya.
Za ka iya samun ƙarin bayani daga wannan wasiƙar ta imel da kuma wasu muhimman bayanai game da COVID-19  daga Office Wiki.
CRT za ta sabunta waɗannan shafuka kuma za a tattara dukan bayanan a wuri ɗaya.
Muna kuma aiki don mu ci gaba da sadarwa tare da ma'aikatan da ke zaune a ƙasashen da yanayin ya shafi su sosai.
Idan kana da tambayoyi game da tafiye-tafiye, ayyuka, manyan ayyukan aiki, matsalolin bayani ko kuma idan kana bukatar taimako, ka tuntubi CRT.
Muna shirye mu tallafawa da kuma sadarwa idan ya cancanta.
Idan kana da wata matsala game da sirrinka, ka aika imel zuwa Brian Judan, shugaban HR International Global Operations.
Bai kamata a ɗauki irin wannan canjin a matsayin watsi da aikinmu da kuma alkawuranmu ba.
A'a, ya fi ma'ana: sanin cewa muna bukatar mu daidaita aikinmu da kuma alkawuranmu a yanzu.
Mun yi imanin cewa irin wannan matakin yana da muhimmanci don tallafa wa juna da kuma samar da damar ci gaba da aiki, don tallafawa motsinmu da kuma duniya ta hanyar ba da sabis da ake bukata.
Ayyukanmu na yau da kullum za su jira har zuwa lokacin da ya dace.
Yanzu ne lokacin da za mu tallafa wa juna kuma mu samar da sarari don yin aiki mai muhimmanci da za a yi a makonni masu zuwa, wataƙila ma watanni masu zuwa.
Don wannan, muna bukatar taimakon ku duka; kuma muna bukatar ku iya kula da kanku da iyalanku, kuma ku yi aiki da ƙwazo a duk lokacin da ake bukatar hakan.
Yanzu, don Allah ku wanke hannuwanku kuma ku guji taɓa fuskarku!
Katherine, CRT (Amanda K, Amy V, Bryan J, Doreen D, Gregory V, Jaime V, Joel L, Lynette L, Ryan M, Tony S), da sauran mambobin ƙungiyar Leadership Team (Grant I, Heather W, Jaime V, Janeen U, Lisa S, Robyn A, Ryan M, da Toby N).
ACE2 (Angiotensin-transforming enzyme 2) wani enzyme ne wanda aka haɗa da farfajiya (ƙwayoyin halitta) na ƙwayoyin cuta a cikin huhu, jijiyoyi, zuciya, koda da hanji.
ACE2 yana hana aikin enzymes masu canza angiotensin (ACE) ta rage ƙimar angiotensin-II da haɓaka Ang (1-7), yana mai da shi kyakkyawan bayani don magance cututtukan zuciya. AC2 kuma yana aiki a matsayin hanyar shiga sel don wasu ƙwayoyin cuta.
Ana kiran sigar mutum ta wannan enzyme hACE2.
Anjiotensin-mai canzawa 2  shine ƙarfe mai ƙunsar zinc wanda ke kan farfajiya na endothelial da sauran ƙwayoyin halitta.
Kwayar ACE2 tana dauke da nau'in N-farko na peptidase na M2 da kuma nau'in C-farko na jigilar renal amino acid.
ACE2 shine furotin membrane mai wucewa ɗaya na nau'in I, wanda ke da ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta da sauran ƙwayoyin cuta.
Wani enzyme da ake kira sheddaze ya cire yankin ACE2 daga cikin kwayoyin halitta, kuma an fitar da furotin mai narkewa daga cikin jini kuma a ƙarshe an cire shi daga cikin fitsari.
ACE2 yana cikin yawancin gabobin: ACE2 yana haɗe da membrane na yawancin ƙwayoyin huhu na alveolar na nau'in II, ƙwayoyin gut na ciki, ƙwayoyin endothelial na jini da na jini da ƙwayoyin jijiyoyin jijiyoyin jijiyoyin mafi yawan gabobin.
Ana kuma lura da ACE2 da RNA a cikin ƙwaƙwalwar kwakwalwa, striautum, hypothalamus, da kuma ƙwaƙwalwar kwakwalwa.
Babban aikin ACE2 shine ya zama abin da ya dace da ACE.
ACE tana raba hormone angiotensin I zuwa angiotensin II.
ACE2, a cikin juyawa, yana raba amino acid na ƙarshe na carboxy na phenylalanine daga angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) kuma yana hydrolyzing shi zuwa angiotensin vasodilator (1-7), (H-Asp-Arg Val-Tyr-Ile-His-Pro-OH).
ACE2 kuma yana iya raba wasu sauran peptides, ciki har da [des-Arg9] -bradykinin, orange, neurotensin, dinorphine A, da ghrelin.
ACE2 kuma yana daidaita tashar tashar tashar SLC6A19 mai tsaka tsaki kuma yana kasancewa a cikin cutar Hartnep.
A matsayinta na furotin mai ƙwayar cuta, ACE2 yana aiki ne a matsayin babban hanyar shiga cikin ƙwayoyin halitta don wasu ƙwayoyin cuta, gami da HCoV-NL63; SARS-CoV (ƙwayoyin cuta da ke haifar da SARS); da kuma SARS-CoV-2 (ƙwayoyin cuta da ke haifar da COVID-19).
A takaice dai, haɗuwa da furotin S1 na SARS-CoV da SARS-CoV2 zuwa yankin ACE2 mai ƙwayoyin halitta a saman sel yana haifar da endocytosis da kuma sauyawar duka ƙwayoyin cuta da kuma enzyme zuwa endosomes a cikin sel.
Wannan tsarin shigarwa kuma yana buƙatar yin amfani da TMPRSS2 mai ɗaukar protease na Sarin Protein, wanda ake nazarin hana shi a matsayin mai yiwuwa magani. Wannan ya haifar da wasu tunanin cewa rage matakan ACE2 a cikin ƙwayoyin zai iya taimakawa wajen yaki da kamuwa da cuta.
Duk da haka, yawancin kungiyoyi da kuma hukumomi suna ba da shawarar ci gaba da yin amfani da maganin rigakafin APF da BRF.
A cikin wani bincike da aka yi a ranar 11 ga Yuli, 2012, an gano cewa yin amfani da rigakafin cutar ta iska ya rage haɗarin kamuwa da cutar ta iska da kashi 34% idan aka kwatanta da na rukuni mai kula.
Ƙari ga haka, an rage haɗarin kamuwa da cutar a cikin marasa lafiya da ke shan maganin hana cutar, waɗanda suke da haɗarin kamuwa da cutar, musamman ma waɗanda ke fama da bugun jini da kuma rashin karfin zuciya.
Ana kuma danganta yin amfani da rigakafin APF da rage yawan mutuwa daga cutar huhu, ko da yake sakamakon bai kasance mai aminci ba fiye da marasa lafiya da ke da haɗarin cutar huhu.
Ana ganin cewa ACE2 na mutum mai haɗuwa (rhACE2) sabon abu ne a cikin maganin lalacewar huhu kuma ana ganin yana inganta haemodynamics na huhu da oxygenation a cikin aladu tare da cututtukan numfashi mai tsanani wanda lipopolysaccharides ke haifar.
A cikin mutane, rhACE2 yana da rabin lokaci na kimanin sa'o'i 10, kuma yana da minti 30 kafin ya fara aiki, ban da tsawon sa'o'i 24.
Wasu bayanai sun nuna cewa rhACE2 na iya zama mai ban sha'awa ga mutanen da ke fama da rashin haƙuri ga masu hanawa na tsarin Rhinin-angiotensin (RAS inhibitors) ko kuma a cikin cututtuka da ke da karuwar angiotensin II. An ƙaddara rhACE2 a cikin gwaji na asibiti don magance mawuyacin yanayin numfashi.
Aikace-aikacen COVID-19 aikace-aikace ne na wayar hannu waɗanda aka tsara don taimakawa wajen binciken cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cuttukan cututtukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cuttukan cut
A wasu yankuna, an tsara ko kuma an gabatar da aikace-aikace da yawa da hukumomi ke tallafawa.
An yi amfani da wasu aikace-aikace don bin diddigin lambobin sadarwa.
Wannan ya jawo muhawara game da matsalolin tsare sirri, musamman ma game da tsarin da ke bin diddigin wuraren da masu amfani da aikace-aikacen suke.
Zaɓuɓɓuka masu sauƙi a wannan batun sun haɗa da amfani da siginar Bluetooth don yin rikodin kusanci na mai amfani da wasu wayoyin hannu.
A ranar 10 ga Afrilu, 2020, Google da Apple sun sanar da cewa za su haɗa kai don haɗa aikin tallafi na irin waɗannan aikace-aikacen da ke da tushen Bluetooth kai tsaye zuwa tsarin aiki na Android da iOS.
A kasar Sin, gwamnati da Alipay sun haɗa kai da aikace-aikacen da ke ba 'yan ƙasa damar bincika ko sun yi magana da mutanen da ke da cutar COVID-19.
Ana amfani da shi a birane fiye da 200 a kasar Sin. A Singapore ana amfani da wani app mai suna TraceTogether.
An samar da wannan app ne daga kamfanonin IT na gida, kuma yana da lambar budewa kuma za a ba shi ikon gwamnati.
Ma'aikatar Sadarwa da Fasaha da kuma Ma'aikatar Lafiya sun hada kai wajen samar da wannan aikace-aikacen.
A ranar 14 ga Afrilu, 2020 an yi rajistar aikace-aikacen a cikin Google Play Store da Apple App Store.
A ranar 12 ga Afrilu, gwamnatin ta bayyana cewa aikace-aikacen bin diddigin lamba yana cikin tsari na ƙarshe kuma zai kasance a cikin 'yan makonni don ƙaddamarwa. Ana shirin ƙaddamar da irin waɗannan aikace-aikacen a Ireland da Faransa (StopCovid).
Ostiraliya da New Zealand suna neman amfani da aikace-aikacen da ke kan hanyar Singapore TraceTogether da kuma yarjejeniyar BlueTrace. Rasha na son amfani da aikace-aikacen da ke da aikin geo-zone don  lura da marasa lafiya da aka gano COVID-19 da ke zaune a Moscow don kada su bar gidajensu.
Ross Anderson, wani farfesa a fannin tsaro a Jami'ar Cambridge, ya nuna wasu matsaloli masu amfani da za su iya tasowa tare da tsarin da ke da aikace-aikace, ciki har da rashin aiki da rashin tasiri idan ƙananan mutane ne kawai ke amfani da aikace-aikacen.
Da yake Apple na da damuwa game da yadda ake amfani da aikace-aikacen da ke haifar da ɓacin rai ko kuma cutarwa ta coronavirus, ta ƙuntata jerin kungiyoyin da za su iya ba da aikace-aikacen da ke da alaƙa da cutar a cikin App Store, ta haɗa da kawai masu amfani da su ko wasu amintattun ƙungiyoyi.
Google da Amazon sun kuma sanya irin wannan takunkumi.
Masu shiga yakin kare sirrin sun nuna damuwa game da sakamakon saka idanu kan al'umma ta hanyar aikace-aikacen da suka shafi coronavirus; musamman, an yi tambaya ko za a rushe kayan aikin saka idanu da aka gina don yaƙar cutar coronavirus lokacin da barazanar ta ɓace.
Amnesty International da wasu kungiyoyi sama da 100 sun wallafa wata sanarwa da ke kira ga a hana irin wannan kulawar.
Ƙungiyoyi sun sanar da yanayi takwas da suke ba da su ga ayyukan gwamnati:
Dole ne a yi bincike bisa doka, da kuma bukatarsa.
fadada sa ido da sa ido ya kamata a bi shi da takardun da suka shafi iyakancewar tsawon lokacin aiki;
amfani da bayanan ya kamata a iyakance shi da manufar yaki da yaduwar COVID-19;
Ana buƙatar tabbatar da tsaro da kuma tabbatar da cewa bayanan sun kasance ba a sani ba, kuma ana buƙatar tabbatar da cewa an tabbatar da wannan.
lura ta dijital ya kamata ta ware lokuta na kara nuna wariya da kuma warewa;
duk wani musayar bayanai da bangarori na uku ya kamata a tantance shi a matakin doka;
ya kamata a tabbatar da kariya daga cin zarafi, da kuma hakkin 'yan kasa na yin martani ga cin zarafi;
Dole ne a tabbatar da muhimmancin shiga dukkan masu ruwa da tsaki, ciki har da masana kiwon lafiya da kuma wakilan kungiyoyin da ke cikin matsananciyar yanayi.
Google da Apple suna ba da shirin haɗin gwiwa don magance matsalar saka idanu na yau da kullum, wanda shine cire tsarin saka idanu daga tsarin aiki na na'urorin su da zarar an kawar da buƙatar.
A wasu ƙasashe, ana amfani da bin diddigin wuri a kan layi maimakon aikace-aikace, wanda ke kawar da buƙatar loda aikace-aikacen da kuma yiwuwar kauce wa bin diddigin.
An amince da bin diddigin a Isra'ila.
Shafukan sadarwa da ke samun damar samun bayanan wuri na asali suna da manyan matsalolin sirri.
Duk da haka, ba duk tsarin da ke da cibiyar sadarwa ba ne ya kamata su sami damar samun bayanan sirri game da wurin; an tsara wasu tsarin tsare sirri waɗanda ke amfani da cibiyar sadarwa kawai don sadarwa (duba sashe a ƙasa).
A Koriya ta Kudu, ana amfani da tsarin da ba ya amfani da aikace-aikace a matsayin tushen bin diddigin.
Maimakon yin amfani da wani aikace-aikacen da aka tsara, tsarin ya tattara bayanan sa ido daga wurare daban-daban, ciki har da bayanan sa ido na na'urorin hannu da kuma ma'amaloli na katin, sannan ya haɗa su don ƙirƙirar sanarwar saƙon rubutu da aka aika wa waɗanda ke da cutar.
Gwamnati ba wai kawai ta yi amfani da wannan bayanin don gargadi 'yan ƙasa game da yiwuwar tuntuɓar waɗanda ke da cutar ba, amma kuma ta sanya bayanin wurin jama'a, wanda ya zama mai yiwuwa saboda canje-canje masu mahimmanci a cikin dokokin kare bayanai da aka yi bayan barkewar cutar MERS a wannan ƙasar.
Ana iya samun wannan bayanin ta hanyar wasu aikace-aikace da kuma shafukan yanar gizo. Kasashe, ciki har da Jamus, suna neman amfani da tsarin da aka tsara da kuma tsarin da ke kiyaye sirrin.
A ranar 6 ga Afrilu, 2020, ba a bayyana cikakken bayani ba.
Kula da hulɗa wanda ke kiyaye sirri  wani tsari ne mai kyau, wanda yawancin littattafan bincike suka fara aƙalla 2013. Kamar yadda aka yi a ranar 7 ga Afrilu, 2020, fiye da ƙungiyoyi goma na masana sun yi aiki a kan hanyoyin da ke tabbatar da sirri, kamar amfani da Bluetooth Low Energy (BLE) don yin rikodin kusanci ga mai amfani da wasu wayoyin hannu.
Duk da haka, PEPP-PT samfurin haɗin kai ne wanda ya haɗa da hanyoyin da aka tsara da kuma rarraba, kuma ba yarjejeniya guda ɗaya ba. Yarjejeniyar da aka tsara ta ƙunshi ɓoye ɓoye ɓoye ɓoye (DP-PPT/DP-3T), lambobin tuntuɓar lokaci (TCN, fka Contact EventNumbers, CEN), yarjejeniyar tabbatar da sirri, hanyoyin bin diddigin wayar hannu (PACT) da sauransu.
Waɗannan hanyoyin suna tabbatar da cewa bayanan da za a iya ganowa ba su taɓa barin na'urar ba, kuma duk kwatancen suna faruwa a kanta.
The Privacy Group, MIT Media Lab tana aiki ne wajen samar da SafePaths, dandamali wanda ke ba da damar kiyaye sirrin lokacin tattarawa da amfani da bayanan wuri ko hanyar haɗi don bin diddigin yaduwar COVID-19.
Aikin wannan dandamali ya dogara ne da binciken da aka bayar a cikin takaddar Apps Gone Rogue: Maintaining Personal Privacy in an Epidemic (Apps-Cruisin: Yadda za a kiyaye sirri yayin annobar), wanda aka buga a watan Maris na 2020. Wani irin wannan aikin shine dandalin SafeTrace, wanda Enigma MPC, kamfanin da ke haɓaka fasahar tabbatar da sirrin sirri, wanda kuma ya fara kafa MIT Media Lab.
SafeTrace tana amfani da ingantaccen fasahar na'ura don ba masu amfani damar musayar bayanan sirri game da wurin da kuma lafiyarsu tare da sauran masu amfani da jami'ai ba tare da yin barazanar sirrin wannan bayanan ba.
Ranar 5 ga Afrilu, 2020, ƙungiyoyi masu ra'ayi iri ɗaya da kuma amfani da yarjejeniyoyi iri ɗaya sun kafa ƙungiyar TCN ta duniya, wanda ke da manufar  rage ɓarna da kuma tabbatar da daidaito na duniya na aikace-aikace don bin sawu da faɗakarwa, wanda shine babban abin da ke haifar da yaduwar su.
A ranar 9 ga Afrilu, 2020, gwamnatin Singapore ta sanar da cewa ta bude lambar asali ta BlueTrace, wanda ake amfani da shi wajen yin aikin aikace-aikacen ta na hukuma.
A ranar 10 ga Afrilu, 2020, Google da Apple, kamfanonin da ke kula da ayyukan Android da iOS, sun sanar da shirin bin diddigin lambobin sadarwa, wanda suka yi ikirarin zai tabbatar da sirrin sirri, kuma wanda ya danganta da haɗin Bluetooth Low Energy da kuma ɓoye bayanan sirri.
Sun kuma wallafa bayanan fasaha na manyan fasahohin da ake amfani da su wajen yin aikin.
Apple da Google sun ce za a fara amfani da tsarin a matakai uku:
tura kayan aiki da ke bawa gwamnatoci damar kirkirar aikace-aikacen hukuma don bin diddigin motsi na 'yan kasar da ke dauke da cutar coronavirus, amma tare da kiyaye sirrin bayanai
Ta hanyar haɗa wannan aikin kai tsaye a cikin iOS da Android, Google da Apple suna shirin magance matsalolin sa ido na yau da kullun ta hanyar shigar da tsarin ta hanyar sabunta tsarin aiki, sannan cire shi ta wannan hanyar bayan barazanar ta ɓace.
Sake tsara magani (wanda aka fi sani da sake tsarawa, sake tsarawa, canzawa, ko kuma sake tsarawa)  sake tsara magani ne don magance cutar ko yanayin likita wanda ya bambanta da wanda aka tsara a farkon.
Wannan shi ne wani fannin bincike na kimiyya da ake amfani da shi a yanzu don samar da hanyoyin lafiya da ingantattun hanyoyin magance COVID-19.
Sauran fannonin bincike sun haɗa da samar da allurar rigakafi don COVID-19 da kuma zuba jini na reconvalescent. SARS-CoV-2 yana dauke da sunadarai 66 da ke da tasiri ga magunguna, kowannensu yana da yankuna masu ɗaure ligand.
Binciken waɗannan wuraren haɗin yana ba da kyakkyawan tushe don haɓaka ingantaccen maganin rigakafin cutar kan furotin COVID-19.
Abubuwan da suka fi muhimmanci a cikin SARS-CoV-2 sune protease mai kama da papine, RNA mai dogaro da RNA polymerase, helicaxis, S da ADP ribophosphatase.
Hussein A.A. da kuma abokan aikinsa a cikin binciken su na farko sun yi nazarin wasu magungunan masu neman neman magani waɗanda aka inganta su sannan kuma suka bincika kamanceceniyar su da irin waɗannan magungunan da aka amince da su don hanzarta haɓaka magani mai tasiri akan SARS-CoV-2, wanda za'a ba da shawarar don binciken asibiti.
Chlorohin magani ne na maganin zazzabin cizon sauro wanda ake amfani da shi wajen magance wasu cututtukan da ke hana kamuwa da cutar.
A ranar 18 ga Maris, WHO ta sanar da cewa chlorine da kuma hydroxychloroquine da ke da alaƙa da shi za su kasance cikin magunguna huɗu da ake bincike a cikin gwajin gwaji na Solidarity.
Gwamnan New York Andrew Cuomo ya sanar da cewa gwajin chlorine da hydroxychloroquine zai fara ne a jihar New York a ranar 24 ga Maris. A ranar 28 ga Maris, FDA ta ba da izinin amfani da sulfate na hydroxychloroquine da phosphate na chlorine bisa ga izinin gaggawa (EUA).
Ba a amince da tsarin kula da lafiyar ba a lokacin gwajin gwaji na FDA kuma an ba da izinin EUA a matsayin gwaji na gaggawa don marasa lafiya da ke asibiti amma ba za su iya samun magani a ƙarƙashin tsarin gwajin gwaji ba.
Hukumar ta CDC ta ce ba a riga an kafa tsarin amfani da maganin ba, ko kuma tsawon lokacin shan hydroxychloroquine don rigakafi ko maganin kamuwa da cutar SARS-CoV-2.
Likitoci sun ce suna amfani da miyagun ƙwayoyi a lokacin da babu wata hanyar fita.
Wata ƙungiyar bincike ta Turkiyya a birnin Istanbul ta yi bincike a kan amfani da chlorine a hade da zinc da bitamin A, C da D.
Ana gudanar da bincike mai zurfi a Jami'ar Duke da Jami'ar Oxford.
Makarantar likitancin Jami'ar New York a Langon tana nazarin yadda za a iya yin amfani da hydroxychloroquine a hanyar da ba ta da lahani.
Gwaje-gwajen asibiti da aka yi a birnin Wuhan da birnin Shenzhen a kasar Sin sun nuna cewa favipirivir yana da tasiri sosai.
A cikin mutane 35 da ke shan maganin a birnin Shenzhen, an samu sakamako mai kyau a cikin kwanaki hudu, yayin da a cikin marasa lafiya 45 da ba su sha magani ba, sun yi kwanaki 11.
A Wuhan, an yi wani bincike da aka yi a kan marasa lafiya 240 da ke fama da cutar huhu, kuma rabin su sun karɓi favipirivir, kuma rabin su sun karɓi  umfenovir.
Hukumar magani ta Italiya ta tunatar da jama'a cewa sakamakon da ke nuna cewa maganin yana da tasiri ba shi da yawa kuma bai kamata a ɗauka cewa yana da inganci ba.
A ranar 2 ga Afrilu, Jamus ta sanar da cewa za ta sayi magani daga Japan don ta kara yawan kayayyakinta, kuma za ta yi amfani da albarkatun soja don kai shi asibitocin jami'a, inda za a yi amfani da maganin don kula da marasa lafiya da COVID-19.
A cewar jaridar South China Morning Post, Shinzo Abe ya sanar da gwamnatin Trump cewa za a iya sayen maganin, wanda zai iya zama da tasiri a cikin yanayin rashin lafiya.
Yana iya zama haɗari ga mata masu ciki ko waɗanda suke ƙoƙarin yin ciki.
A wani bincike da aka yi game da haɗuwa da maganin cutar lopinvir da ritonavir (Caletra), an kammala cewa ba a gano amfanin amfani da maganin ba.
An tsara miyagun ƙwayoyi don hana kwayar cutar ta HIV ta hanyar ɗaure shi da protease.
Wata ƙungiyar masu bincike daga Jami'ar Colorado suna ƙoƙarin gyara magunguna don gano mahadar da za ta danganta da cutar SARS-CoV-2 protease.
Hukumar ta Duniya ta haɗa da haɗakar da ke tsakanin lopinavir da ritonavir a cikin gwajin duniya Solidarity.
An kirkiro remdesivir kuma an haɓaka shi ta Gilead Sciences don magance cutar Ebola da cututtukan cutar Marburg. Daga baya, ma'aikatan Gilead Sciences sun gano cewa remdesivir yana da aikin anti-virus in vitro a kan yawancin phyl-, pneumonia-, paramix-, da coronavirus.
Ɗaya daga cikin matsalolin da ke tattare da maganin cutar ita ce, ci gaba da jurewa ta hanyar maye gurbin da zai iya haifar da cututtuka masu tsanani da kuma watsa su.
Wasu bincike na farko sun nuna cewa remdesivir na iya samun babban shinge na kwayoyin halitta don juriya. Ana gudanar da gwaje-gwaje na asibiti da yawa a halin yanzu, ciki har da biyu da ke gudanar da su a asibitocin jami'ar Cleveland; ɗaya a kan marasa lafiya da ke da yanayin rashin lafiya mai matsakaici, ɗayan kuma a kan marasa lafiya da ke da yanayin rashin lafiya mai tsanani.
A halin yanzu ana gudanar da gwaje-gwaje uku na shan bitamin C a cikin jini ga mutanen da ke asibiti da mummunan COVID-19: gwaje-gwaje biyu na placebo (China, Kanada) da kuma ɗaya ba tare da amfani da placebo ba (Italiya).
A ranar 24 ga Maris, 2020, an fara gwajin maganin azithromycin a jihar New York.
Cibiyar Kula da Lafiya da Lafiya ta Duniya (NCGM) ta Japan ta shirya gudanar da bincike na asibiti na Alvesco (cyclosonide) Tejins, wani nau'in corticosteroid mai shan iska don maganin asma, don amfani da shi wajen magance marasa lafiya masu cutar coronavirus.
Ana gudanar da gwajin mataki na biyu, wani nau'i na angiotensin-transforming enzyme 2, tare da 200 daga Denmark, Jamus da Austria da aka kwantar da su asibiti tare da nau'o'in cutar mai tsanani, don a iya tantance yadda magani yake da tasiri.
Masu bincike daga Cibiyar cututtukan zuciya ta Montreal, Kanada, a yanzu suna nazarin rawar da kolchicine ke takawa wajen rage kumburi da cututtukan huhu a cikin marasa lafiya da ke da alamun COVID-19.
A cikin binciken da ake kira COLCORONA, an gayyaci manya 6,000 da suka kai shekara 40 da haihuwa da aka gano suna da COVID-19, da alamun da ba su da tsanani sosai kuma ba sa bukatar zuwa asibiti.
Mata masu ciki da masu shayarwa da kuma waɗanda ba su yi amfani da maganin hana haihuwa ba za su iya shiga cikin wannan binciken ba.
A Italiya, ana gwada wasu coagulants.
Ana amfani da ƙananan kwayoyin heparin a yawancin mutane don magance marasa lafiya, kuma hakan ya sa Hukumar Kula da Magunguna ta Italiya ta wallafa shawarwari game da yin amfani da wannan magani.
A ranar 14 ga Afrilu, an sanar da wani bincike mai ci gaba a Italiya, wanda ya shafi marasa lafiya 300 don nazarin amfani da sodium enoxaparin a allurai masu rigakafi da na magani.
Tun da SARS-CoV-2 kwayar cuta ce, an mai da hankali sosai ga sake fasalin magungunan ƙwayoyin cuta da aka amince da su waɗanda aka haɓaka don annobar da ta gabata kamar su MERS, SARS da West Nile Virus.
Ribarin: An ba da shawarar ribarin don maganin COVID-19 bisa ga bugu na 7 na shawarwarin kasar Sin.
Umfenovir: An bada shawarar umfenovir don maganin COVID-19 bisa ga bugu na 7 na shawarwarin kasar Sin
Wasu kwayoyin rigakafi da aka gano suna da amfani a matsayin maganin COVID-19:
Tocilizumab (mai karɓar maganin IL-6): an amince da shi a China.
Hakanan gwajin gwaji a Italiya da China, duba Tocilizumab#COVID-19.
Allurar rigakafin COVID-19  allurar rigakafin cutar coronavirus ta 2019 ce (COVID-19).
Ko da yake babu wani magani da ya ci gaba da gwaji, ana ci gaba da yin ƙoƙari sosai don yin wannan maganin.
A karshen watan Fabrairun 2020, Hukumar Lafiya ta Duniya (WHO) ta ce ba ta tsammanin za a samu allurar rigakafin cutar SARS-CoV-2 ba kafin watanni 18 daga baya.
A watan Afrilu, 'yan takarar biyar sun yi gwajin lafiya na mataki na 1.
An gano cutar COVID-19 a watan Disambar 2019.
A shekarar 2020, babban barkewar cutar ta bazu a duk faɗin duniya, wanda ya haifar da saka hannun jari mai yawa a cikin samar da allurar rigakafi da ayyukan bincike dangane da ita.
Ƙungiyoyi da yawa suna amfani da kwayoyin halitta da aka wallafa don samar da allurar rigakafin SARS-CoV-2.
Kamar yadda aka sanar a watan Afrilu, manyan manufofin CEPI na samar da allurar rigakafi  shine samar da saurin da ake buƙata, ƙarfin samarwa, turawa mai yawa da samun damar duniya.
A watan Afrilu, masana kimiyya na CEPI sun ba da rahoton cewa a farkon shekarar 2020, akwai dandamali daban-daban na fasaha 10 da ke cikin bincike da ci gaba don ƙirƙirar allurar rigakafin COVID-19.
Wasu muhimman manufofin dandamali da aka haɗa a cikin binciken tsaro na mataki na I:
nucleic acid (DNA da RNK) (mai haɓaka mataki na I da kuma samfurin samfurin samfurin: Moderna, iRNK-1273)
mai ɗaukar hoto (mai haɓaka mataki na I da kuma samfurin mai neman allurar rigakafi: CanSino Biologics, mai ɗaukar hoto na adenovirus na nau'i na 5)
A cewar masana CEPI a watan Afrilu, ana ci gaba da samar da alluran rigakafi guda 115 a farkon matakin, 78 daga cikinsu ana amfani da su a cikin ayyukan aiki da aka amince da su (79, a cewar Cibiyar Milken); ban da haka an bayyana ƙarin alluran rigakafi 37 masu neman, amma akwai bayanai kaɗan game da su (da alama suna cikin tsari ko ci gaba).
A matakai na I zuwa II ana gudanar da gwajin farko na aminci da rigakafi, yawanci bazuwar, placebo-controlled da kuma wurare da yawa tare da ƙayyade ƙarin ƙayyadaddun dabaru.
A lokacin gwaji na III, yawanci ana gwada ƙarin mutane, har da masu kula da su; a wannan lokacin ana gwada magungunan don yin tasiri a cikin rigakafin cutar kuma ana bin diddigin sakamako masu illa a cikin mafi kyawun sashi.
Daga cikin alluran rigakafi 79 da ke cikin ci gaba (an tabbatar da su a farkon Afrilu 2020), 74 har yanzu ba su yi gwaji a kan mutum ba (duk suna cikin matakan binciken asibiti).
A ranar 24 ga Janairu, 2020, Jami'ar Queensland, Ostiraliya, ta sanar da cewa tana nazarin yiwuwar allurar rigakafin kwayoyin halitta da ke canza kwayoyin cutar don motsawar rigakafin jiki.
A ranar 24 ga Janairu, 2020, Cibiyar alluran rigakafi ta duniya (VIDO-InterVac) ta Jami'ar Saskatchewan, Kanada, ta sanar da fara aikin allurar rigakafi don fara gwajin mutum a cikin 2021.
An kuma sanar da fara ayyukan samar da alluran rigakafi a Cibiyar Kula da Cututtuka da Cututtuka ta China a ranar 26 ga Janairu, 2020 da Jami'ar Hong Kong a ranar 28 ga Janairu.
Ranar 29 ga Janairu, 2020, kamfanonin likitanci na Janssen karkashin Hanneke Schützmecker sun sanar da fara aikin samar da allurar rigakafin su.
Janssen da abokinsa na fannin halittu, Vaxart, suna samar da allurar rigakafi ta baki.
A ranar 18 ga Maris, 2020, Emergent BioSolutions ta sanar da haɗin gwiwa tare da Vaxart don haɓaka allurar.
A ranar 8 ga Fabrairu, 2020, dakin gwaje-gwaje na OncoGen a Romania ya wallafa takarda game da samar da allurar rigakafi ta hanyar fasaha, kamar wanda ake amfani da shi don yin allurar rigakafin cutar kansa.
A ranar 25 ga watan Maris, shugaban cibiyar bincike ya sanar da kammala aikin samar da allurar rigakafi da fara gwaji.
A ranar 27 ga Fabrairu, 2020, wani kamfanin da ke da alaka da Generex, NuGenerex Immuno-Oncology, ya sanar da cewa yana fara aikin samar da maganin peptide Ii-Key na COVID-19.
Manufarsu ita ce su samar da wani magani da zai iya zama takarar rigakafin da za a iya gwadawa a jikin mutane a cikin kwanaki 90.
A ranar 5 ga Maris, 2020, Jami'ar Washington a St. Louis ta sanar da ayyukanta na samar da allurar rigakafi.
A ranar 5 ga Maris, 2020, Rundunar Sojojin Amurka ta Kula da Kula da Lafiya da Kayan Aiki, Fort Detrick, da Cibiyar Nazarin Sojojin Walter Reed, Silver Spring, da ke yammacin jihar Maryland, sun sanar da cewa suna haɓaka allurar rigakafin su.
A ranar 10 ga Maris, 2020, Emergent Biosolutions ta sanar da cewa ta shiga cikin haɗin gwiwa tare da Novavax Inc.
don samar da allurar rigakafi.
Abokan hulɗa sun kuma sanar da shirin gudanar da gwajin gwaji na farko da gwajin gwaji na farko zuwa Yuli 2020.
A ranar 12 ga Maris, 2020, Ma'aikatar Lafiya ta Indiya ta sanar da cewa suna nazarin marasa lafiya 11 da ke keɓewa, kuma ko da a cikin saurin gudu, za a ɗauki aƙalla shekaru biyu da rabi don samar da allurar.
A ranar 12 ga Maris, 2020, kamfanin Medicago, na kamfanin fasaha na halittu na Quebec, ya ba da rahoton cewa, da wani ɓangare na kudaden da Cibiyar Nazarin Lafiya ta Kanada ta bayar, sun ƙirƙiri wani abu mai kama da cutar coronavirus.
Ana gudanar da gwaje-gwaje na gwaji na allurar rigakafi, kuma ana shirin gwada ta a jikin mutane a watan Yuli ko Agusta na shekarar 2020.
A farkon wannan makon jaridar The Guardian ta ruwaito cewa shugaban Amurka Donald Trump ya ba CureVac babbar kudade don samun damar yin amfani da allurar rigakafin Covid-19, abin da gwamnatin Jamus ta yi ta nuna rashin amincewa da shi.
A ranar 17 ga Maris, 2020, kamfanin farmashiya na Amurka Pfizer ya sanar da cewa ya kulla yarjejeniya da kamfanin BioNTech na Jamus don samar da allurar rigakafi ta hanyar RNA.
BNT162 mai neman allurar ne ta hanyar RNA; a halin yanzu ana gwada maganin kafin asibiti, kuma gwajin asibiti zai fara a watan Afrilu na 2020.
A ranar 17 ga Maris, 2020, kamfanin fasaha na zamani na Italiya Takis Biotech ya sanar da cewa a watan Afrilu na 2020, za ta sami sakamakon gwajin farko, kuma za a iya fara gwajin samfurin karshe na allurar a cikin mutane a cikin kaka.
A ranar 19 ga Maris, 2020, Coalition for Innovation in the Prep to Epidemic (CEPI), Faransa, ta sanar da saka hannun jari na dala miliyan 4.9 a cikin ƙungiyar samar da allurar rigakafin COVID-19 tare da haɗin gwiwar Cibiyar Pasteur, Themis Bioscience (Vienna, Austria) da Jami'ar Pittsburgh.
Sauran abokan cinikin CEPI a cikin samar da allurar COVID-19 sune Moderna, Curevac, Inovio, Novavax, Jami'o'in Hong Kong, Oxford da Queensland.
A ranar 20 ga Maris, 2020, jami'an kiwon lafiya na Rasha sun sanar da cewa masana sun fara gwajin 'yan takara shida daban-daban na allurar rigakafi ga dabbobi.
Masu bincike a Kwalejin Imperial ta London sun sanar a ranar 20 ga Maris, 2020 cewa suna samar da allurar rigakafin COVID-19 mai karfafa kansa ta RNA.
An yi amfani da maganin a cikin kwanaki 14 bayan an samu samfurin daga kasar Sin.
A ƙarshen watan Maris, gwamnatin Kanada ta sanar da bayar da dala miliyan 275 na Kanada don tallafawa ayyukan bincike 96 na maganin COVID-19, gami da samar da magungunan da yawa don yin allurar rigakafi a kamfanoni da jami'o'i na Kanada, kamar su Medicago da Jami'ar Saskatchewan.
A daidai wannan lokacin, gwamnatin Kanada ta sanar da cewa za a ba da dala miliyan 192 na Kanada don samar da allurar rigakafin COVID-19, da kuma shirin kafa bankin alluran rigakafi na kasa, wanda zai haɗa da wasu sabbin alluran rigakafi da za a iya amfani da su a yayin da cutar ta barke.
A ranar 2 ga Afrilu, 2020, masu bincike daga Makarantar Likitancin Jami'ar Pittsburgh sun ba da rahoton gwajin PittCoVacc, yiwuwar allurar rigakafin COVID-19 a cikin beraye, suna cewa MNA ta gabatar da allurar SARS-CoV-2 S1 na subunit, yana haifar da martani mai ƙarfi ga antigen-specific antibodies [a cikin beraye], wanda ya bayyana makonni 2 bayan rigakafin.
A ranar 16 ga Afrilu, 2020, Makarantar Magunguna ta Jami'ar Waterloo ta Kanada ta sanar da cewa za a yi wani allurar rigakafi na DNA, wanda zai iya fitowa a cikin nasal spray.
Ta hanyar amfani da kwayoyin cuta, DNA za ta iya ƙaruwa a cikin kwayoyin mutum kuma ta samar da ƙwayoyin cuta marasa lahani waɗanda za su iya ƙarfafa tsarin rigakafi don samar da rigakafi ga cutar SARS-CoV-2.
A watan Maris na shekarar 2020, gwamnatin Amurka, masana'antu, da jami'o'i uku sun haɗa albarkatun manyan kwamfutocin IBM tare da albarkatun girgije na Hewlett Packard Enterprise, Amazon, Microsoft, da Google.
Wasu alluran rigakafi suna da sakamako na heterological, wanda ake kira effects na non-specific.
Wannan yana nufin cewa suna da wasu amfanin da suka shafi rigakafin cututtuka.
Wani bincike na bazuwar da aka yi a Ostiraliya ya shafi ma'aikatan kiwon lafiya 4,170.
Wataƙila alluran rigakafin da ake yi ba su da lafiya ko kuma ba su da tasiri.
Binciken farko na kimanta ingancin allurar rigakafi ta amfani da samfurin dabba wanda ke da COVID-19, kamar ACE2 mice, sauran dabbobi na dakin gwaje-gwaje, da ƙananan primates, ya nuna buƙatar matakan hana kamuwa da cuta tare da matakin aminci na 3 yayin sarrafa kwayar cuta mai rai, da kuma daidaitaccen daidaitaccen tsarin tsaro na duniya.
An gwada alluran rigakafin SARS da MERS a kan dabbobi.
A shekarar 2020, babu magani ko allurar rigakafi da za ta iya magance cutar SARS da za ta kasance da aminci da tasiri ga mutane.
A cewar wani bincike da aka buga a 2005 da 2006, ganowa da kuma samar da sababbin alluran rigakafi da magunguna don magance cutar huhu ta yau da kullum sun kasance fifiko ga gwamnatoci da cibiyoyin kiwon lafiya a duniya.
Lokacin da cutar ta MERS ta fara yaduwa, an yi imanin cewa binciken SARS da ake yi a lokacin zai iya zama misali don samar da alluran rigakafi da magunguna don kamuwa da cutar MERS-CoV.
A watan Maris na 2020, akwai allurar rigakafi guda ɗaya (wanda ya dogara da DNA) don cutar MERS, wanda ya wuce gwajin gwaji na farko a cikin mutane, da kuma ƙarin alluran rigakafi guda uku, dukansu alluran rigakafi ne na tushen ƙwayar cuta kuma suna cikin ci gaba, biyu adenoviral (ChAdOx1-MERS, BVRS-GamVac) da ɗaya MVA-vector (MVA-MERS-S).
A shafukan sada zumunta, an yi amfani da ka'idar ta'addanci, wadda ta ce COVID-19 ba sabon abu ba ne kuma riga an riga an samu allurar rigakafinsa.
Shafukan sada zumunta sun yi ƙaulin wasu marasa lafiya da suka ce akwai takardun shaida game da tsarin halittu na wasu nau'ikan coronavirus kamar SARS, da kuma alluran rigakafin waɗannan nau'ikan.
Coronavirus  cuta ce da aka gano a shekarar 2019 (COVID-19), cuta ce mai kamuwa da cuta da cutar coronavirus 2 (SARS-CoV-2) ta haifar.
Abubuwan da suka fi kowa a cikin cututtuka sun haɗa da zazzabi, tari da kuma rashin numfashi.
Sauran alamun sun haɗa da gajiya, ciwon tsoka, fitsari, ciwon wuya, rashin wari, da kuma ciwon ciki.
Lokaci daga bayyanar cututtuka na farko zuwa ciwon cutar yana da kusan kwanaki biyar, amma kuma yana iya bambanta daga kwana biyu zuwa goma sha huɗu.
Yawancin cututtuka suna nuna alamun bayyanar cututtuka, amma a wasu lokuta, cutar tana haifar da cutar huhu da rashin isasshen kwayoyin halitta.
A ranar 17 ga Afrilu, 2020, an yi rajistar fiye da miliyan 2.24 na kamuwa da cutar a ƙasashe da yankuna 210, fiye da mutane 153,000 sun mutu daga wannan cuta.
Fiye da mutane dubu 568 ne suka warke, kuma cutar tana yaduwa ne ta hanyar tuntuɓar mutane da juna, sau da yawa ta hanyar saukad da iska a cikin iska, kamar su tari ko magana.
Ko da yake waɗannan saukad da suna faruwa ne a lokacin numfashi, suna iya zama barazana ta hanyar sauka a ƙasa ko a saman ƙasa, amma ba a watsa su ta iska a nesa ba.
Mutane kuma suna kamuwa da cutar ta hanyar taɓa gurɓataccen wuri, sannan idanunsu, hancinsu ko bakinsu.
A saman duniya, kwayar cutar tana iya rayuwa har tsawon sa'o'i 72.
Yana da matukar cutarwa a cikin kwanaki uku na farko bayan bayyanar cututtuka, kodayake yana iya yaduwa kafin bayyanar cututtuka da kuma a cikin matakan da suka gabata.
Ana ba da shawarar yin amfani da abin rufe fuska ga marasa lafiya da ake zargin suna da cutar, da kuma masu kula da su.
Shawarwarin yin amfani da abin rufe fuska na likita sun bambanta: wasu hukumomi suna ba da shawarar kada a yi amfani da su, wasu suna ba da shawarar yin amfani da su, wasu kuma suna buƙatar hakan.
A halin yanzu babu allurar rigakafi ko magani na musamman don cutar COVID-19.
An samu kamuwa da cutar a yawancin ƙasashe a yankuna shida na WHO.
Mutane da suka kamu da cutar za su iya samun alamun cutar ko kuma su nuna alamun cutar mura kamar zazzabi, tari, gajiya da numfashi.
Alamun gaggawa sun haɗa da wahalar numfashi, ciwo ko kuma damuwa a kirji, rikicewar hankali, wahalar farkawa, launin toka a fuska ko a lebe; idan akwai alamun da aka ambata a sama, ya kamata ka nemi taimakon likita nan da nan.
A wasu lokatai, ba za a iya samun cututtukan da ke saurin numfashi ba, kamar su kumburi, kumburi, ko kuma ciwon hanci.
Ƙari ga haka, ana samun cututtuka na ciki da na hanji a cikin kashi dabam dabam, kamar su naƙuda, zubar da ciki, da kuma fitsari.
Wasu cututtuka da aka samu a ƙasar Sin sun nuna cewa suna da baƙin ciki a ƙirjinsu da kuma bugun zuciya.
A wasu lokatai, cutar tana iya ci gaba da zama ciwon huhu, rashin ƙarfi da kuma mutuwa.
Wannan shi ne lokacin da ake kira lokacin yin amfani da kwayoyin halitta.
Lokacin incuba na COVID-19 yawanci kwanaki biyar zuwa shida ne, amma zai iya kasancewa daga kwana biyu zuwa 14.
Kashi 97.5 cikin 100 na mutane suna fara bayyanar cututtuka a cikin kwanaki 11.5 bayan kamuwa da cutar.
Ba a san yadda waɗannan masu ɗaukar hoto ba za su iya ba da cutar ba, amma bayanan farko sun nuna cewa suna iya taimakawa wajen yaduwar kamuwa da cuta.
Ba a san yawan mutanen da suka kamu da cutar ba, amma ana nazarin su ne; kuma Cibiyoyin Kula da Cututtuka da Cututtuka na Koriya (KCDC) sun ba da rahoton cewa kashi 20% na duk waɗanda aka tabbatar da cutar da kuma asibitoci sun kamu da cutar ba su da alamun cutar.
Hukumar kula da lafiyar kasar Sin ta fara hada marasa alamar cututtuka a cikin takardar ta na yau da kullum daga ranar 1 ga Afrilu; daga cikin mutane 166 da aka samu a wannan rana, 130 (78%) sun ƙi nuna alamun cututtuka a lokacin gwajin.
Ruwan da kuma saliva suna iya samun ƙwayoyin cuta da yawa.
Sa'ad da kake magana da ƙarfi, za ka iya samun ƙarin saɓo a cikin iska fiye da yadda kake yi a lokacin da kake magana da ƙarfi.
Wani bincike da aka yi a Singapore ya nuna cewa idan mutum ya yi tari a waje, zai iya yin ta da nisa har zuwa mita 4.5 (ƙaffi 15) daga wurin.
A matsayinka na mai mulki, ba a watsa kwayar ta hanyar iska, amma National Academy of Sciences ta yi hasashen cewa za a iya watsa ƙwayoyin cutar ta hanyar bioaerosol, kuma gwajin iska da aka sarrafa ta hanyar tarin iska da ke cikin hanyoyin da ke waje da ɗakunan mutane ya nuna cewa akwai RNA na kwayar cutar.
Wasu hanyoyin magani kamar intubation da kuma aikin numfashi na zuciya (CPR) na iya haifar da yayyafa kayan numfashi kuma, saboda haka, yaɗa cutar a cikin iska.
Akwai kuma wasu masu tsoron cewa cutar za ta iya yaduwa ta hanyar ƙura, duk da haka, ana ganin wannan haɗarin yana da ƙananan. Kwayar cutar tana da haɗari sosai lokacin da mutane ke nuna alamun; ana iya yaduwar cutar kafin bayyanar bayyanar cututtuka, amma wannan haɗarin ba shi da yawa.
Ma'aikatan Cibiyar Tsare-tsare ta Turai (ECDC) sun ce ba a san yadda cutar take da sauƙi ba, amma an san cewa mutum ɗaya yana kamuwa da mutane 23 kuma yana iya rayuwa a cikin sa'o'i da yawa zuwa kwanaki.
A cikin takamaiman, an gano cewa a kan katako na katako, kwayar cutar tana iya rayuwa har zuwa kwana ɗaya, a kan filastik (polypropylene) da bakin karfe (AISI 304) har zuwa kwanaki uku, kuma a 99% na tagulla har zuwa awanni 4.
Amma, waɗannan ƙididdigar sun bambanta bisa yanayin zafi da zafi.
Sabulu da kayan wanka idan aka yi amfani da su yadda ya kamata suna da tasiri mai kyau wajen hana kamuwa da cuta: Sabulu yana lalata kitse mai kariya na kwayar cutar, yana hana ta aiki, kuma yana iya kawar da ita daga fata da sauran farfajiya.
Wasu abubuwa kamar benzodiazepines da chlorhexidine gluconate (abin da ke kashe cutar a tiyata) ba su da tasiri sosai a kan cutar. A cikin binciken da aka gudanar a Hong Kong, an ɗauki samfurin saliva a matsakaici kwanaki biyu bayan asibiti.
A cikin mutane biyar cikin shida, gwajin farko ya nuna cewa sun fi yawan cutar a cikin jini, kuma a cikin mutum na shida, an gano cewa sun fi yawan cutar a rana ta biyu.
Cutar ƙwayar cuta mai tsanani ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi ta hanyar numfashi.
Duk alamun sabon kwayar cutar SARS-CoV-2 suna faruwa a cikin 'yan uwan coronavirus.
Lokacin da yake waje da jikin mutum, ana kashe kwayar cutar da sabulu na gida wanda ke buɗe ƙwallon jikinsa. SARS-CoV-2 yana da alaƙa da SARS-CoV na asali.
Fushi  shi ne mafi yawan kwayoyin da COVID-19 ke shafawa, saboda kwayar ta shiga cikin ƙwayoyin mai karɓar baƙi ta hanyar enzyme na angiotensin-transforming 2 (ACE2), wanda ya fi yawa a cikin ƙwayoyin alveolar huhu na nau'i na II.
Kwayar cutar tana haɗuwa da ACE2 kuma tana shiga cikin kwayar mai masaukin baki ta hanyar amfani da glicoprotein na ƙasa  shipa (peplomer).
Kashi 12 cikin 100 na mutanen da aka yi wa kamuwa da cutar a asibiti a Wuhan sun sami mummunan rauni a cikin zuciya, wanda ya fi faruwa a cikin mummunan yanayin.
Ana samun cututtukan zuciya da jijiyoyi da yawa saboda rashin lafiyar jiki da kuma tsarin rigakafi da ke faruwa a ci gaba da cutar, amma lalacewar zuciya na iya kasancewa saboda ACE2 a zuciya.
Ƙaƙƙarfan ƙwayoyin ACE2 suna cikin zuciya domin suna aiki a cikin wannan gabashin.
Ana samun yawan cututtukan jini (31%) da kuma cututtukan jini (25%) a cikin marasa lafiya da ke cikin OIT tare da COVID-19, kuma yana iya nuna mummunan hangen nesa. Autopsia na marasa lafiya da suka mutu daga COVID-19 ya nuna samun cutar alveolar diffuse (DAD) da kuma lymphocyte-containing inflammatory infiltrates a cikin huhu.
Ko da yake SARS-COV-2 yana da alaƙa da ƙwayoyin epithelial na numfashi na ACE2, marasa lafiya da ke fama da cutar COVID-19 suna da alamun ciwon hanta.
A cikin wannan binciken, an gano cewa kwayoyin halitta na GM-CSF T-cell suna da alaƙa da sake dawo da kwayoyin cuta masu kumburi waɗanda ke ba da IL-6, da kuma mummunan cututtukan huhu a cikin marasa lafiya da COVID-19.
A lokacin da aka yi bincike, an gano lymphocyte infiltrates.
Hukumar ta WHO ta kuma wallafa wasu takardun gwaji game da cutar.
Hanyar gwajin polymerase chain reaction a ainihin lokacin (RT-PCR)  ita ce hanyar gwaji ta yau da kullum.
Ana gwada shi ne a kan samfurin numfashi da aka samu daga hanci, amma ana iya amfani da samfurin hanci ko naman gwari.
Ana shirya sakamakon a cikin sa'o'i da yawa zuwa kwanaki biyu.
Za ka iya yin gwajin jini, amma kana bukatar ka yi gwajin jini biyu a mako biyu, kuma sakamakon ba shi da muhimmanci.
Masana kimiyya na kasar Sin sun gano wani nau'in cutar coronavirus kuma sun wallafa tsarin kwayoyinta don haka masana kimiyya a cikin dakunan gwaje-gwaje a duk faɗin duniya za su iya yin gwaje-gwaje da kansu ta hanyar polymerase chain reaction (PCR) don gano cutar.
A ranar 4 ga Afrilu, 2020, ana gudanar da gwaje-gwaje na rigakafin da zai iya gano cewa akwai kamuwa da cuta a yanzu, da kuma yiwuwar kamuwa da cutar a baya, amma har yanzu ba a yadu ba.
A cikin binciken da aka yi a kasar Sin, an gano cewa gwajin ya yi daidai da kashi 60 zuwa 70 cikin ɗari.
A ranar 21 ga Maris, 2020, Hukumar Kula da Ingancin Abinci da Magunguna ta Amurka (FDA) ta amince da gwajin farko don ganewar asali a wurin, ta ba da izinin amfani da shi a ƙarshen wannan watan. Jagorancin ganewar asali da asibitin Jhunjnan na Jami'ar Wuhan ya fitar sun nuna hanyoyin gano kamuwa da cuta bisa ga yanayin asibiti da haɗarin cututtuka.
Hanyoyin biyu na biyu na subpleural na nau'in gilashin gilashin gilashi tare da rarraba ta gefe, asymmetrical da aposteorious sune alamun bayyanar cututtuka da aka gano a farkon lokacin cutar.
Ƙarƙashin subpleural, alamar sandar sandar sandar (ƙananan ƙarancin ƙofar tare da cika alveolar mai canji) da kuma haɗuwa suna haɓaka yayin da cutar ta ci gaba.
Babu bayanai da yawa game da cutar ta microcosmic da kuma cutar ta COVID-19.
Babban sakamakon binciken cututtuka da aka yi a lokacin buɗewa:
Maganin gani: pleurisy, pericarditis, ƙuntatawa da kumburi na huhu
Akwai nau'i hudu na cutar huhu:
irin ƙwayar huhu: kumburi na huhu, hyperplasia na huhu, manyan ƙwayoyin huhu, kumburi na interstitial tare da lymphocyte infiltration da kuma samar da kwayoyin giant masu yawa
irin cutar ta iska mai tsanani: cutar alveolar da ta lalace (DAD) da ta lalace.
DAD yana haifar da ciwon hanta na numfashi (ORDS) da kuma rashin ƙarfi.
cututtukan huhu: tsarin exudate a cikin alveolar rami da kuma interstitial fibrosis na huhu.
Jini: Rashin ruwa mai narkewa a cikin jijiyoyin jini (DVS-syndrome); halayen leuko-erytroblastic
Ka'idodin rigakafi don rage yiwuwar kamuwa da cuta sun haɗa da kasancewa a gida, guje wa wuraren da mutane suke, wanke hannuwanka da sabulu da ruwa a cikin minti 20, kiyaye dokokin tsabtace numfashi, da kuma guje wa taɓa idanu, hanci ko baki da hannayen da ba a wanke ba.
Hukumar ta ce idan kana tari ko kana jin tsaguwa, ka rufe bakinka da hanunka da suturar hannu, ko kuma idan ba ka da suturar hannu, ka rufe bakinka da hanunka da ɓangaren hannu na hannu.
Bayan ka ji tari ko kuma ka yi tari, ana bukatar ka yi tsabtace hannunka sosai.
Cibiyar Kula da Cututtuka da Rigakafin Cututtuka (CDC) ta ba da shawarar yin amfani da abin rufe fuska a wuraren jama'a, musamman don hana mutane kamuwa da cutar ba tare da alamun cutar ba. Dabarun nesa da zamantakewa suna nufin rage haɗuwa da marasa lafiya masu kamuwa da cutar tare da manyan rukuni na mutane; a cikin waɗannan matakan an rufe makarantu da kamfanoni, an iyakance motsi na 'yan ƙasa, kuma an soke manyan ayyukan jama'a.
Ƙa'idodin nesa kuma sun ce mutane su kasance a nesa da juna aƙalla mita 6.
Babu wani magani da aka tabbatar da ingancinsa a kan COVID-19. Tun da ana sa ran kammala aikin allurar riga-kafi ba kafin shekara ta 2021, yawancin matakan da ake ɗauka don hana yaduwar COVID-19 sun rage ƙaruwar annobar da aka sani da fitowa zuwa tudu.
CDC ta kuma ba da shawarar yin wanka a hannuwanku da sabulu da ruwa aƙalla na tsawon dakika 20, musamman bayan ka je bayan gida ko ka gurɓata hannu sosai, kafin ka ci abinci ko kuma bayan ka yi ta kuka ko ka yi tari.
CDC kuma ta ba da shawarar yin amfani da maganin kashe giya (ƙananan giya  60%) don sarrafa hannu, amma kawai idan sabulu da ruwa ba su samuwa. Ga yankuna inda ba a sayar da irin waɗannan maganin kashe lafiya, WHO tana ba da takardun magani guda biyu don samarwa a gida.
Ana amfani da ethanol ko isopropanol a cikin waɗannan sinadarai, waɗanda ke da ƙwayoyin cuta.
Ana amfani da hydrogen peroxide don kawar da rikice-rikice na kwayoyin a cikin giya kuma ba magani ne mai kyau don maganin hana hannu ba.
Ana ƙara glycerol a matsayin mai sanyaya ruwa.
An nuna wa marasa lafiya magani mai taimako, wanda zai iya haɗa da maganin zubar da jini, taimakon oxygen, da kuma taimakon sauran gabobin da suka shafi rayuwa.
Hukumar ta CDC ta ba da shawarar duk wanda ya yi zaton yana da cutar ya sa abin rufe fuska na likita.
An yi amfani da Oxygenated Membrane Oxygenation (ECMO) don magance matsalar rashin numfashi, amma ana ci gaba da nazarin amfanin.
Don ƙarfafa rigakafi, ana ba da shawarar kiyaye ka'idodin tsabtace jiki, salon rayuwa mai kyau da kuma abinci mai gina jiki.
Ana iya nuna hanyoyin da za a iya bi don magance cututtukan marasa lafiya a farkon lokacin cutar. Hukumar lafiya ta duniya da Hukumar Lafiya ta kasar Sin sun wallafa shawarwari game da kula da marasa lafiya da aka kwantar da su daga asibiti don COVID-19.
A Amirka, likitocin da ke ba da magani mai tsanani da kuma likitocin da ke ba da maganin huhu sun yi amfani da dandalin IBCC don yin amfani da shi.
A watan Afrilu na shekarar 2020, babu wani magani na musamman na COVID-19.
Wasu ma'aikatan kiwon lafiya suna ba da shawarar yin amfani da paracetamol (acetaminophen) a matsayin magani na farko don magance alamun cutar.
Idan ana yin wani aiki da zai iya haifar da iska mai iska kamar intubation ko bushewar hannu, dole ne a yi hankali don rage haɗarin watsa kwayar cutar, musamman a wuraren kiwon lafiya.
Ma'aikatan kiwon lafiya da ke kula da mutane da COVID-19, CDC ta ba da shawarar sanya ƙarin matakan tsaro a cikin iska mai guba (AIIR)  ban da daidaitaccen matakan tuntuɓar da iska. CDC ta buga shawarwari kan amfani da kayan kariya ta mutum (SII) yayin annobar.
Abubuwan da ake ba da shawarar don kare kanka: rigar kariya, numfashi ko abin rufe fuska, kayan kariya ga idanu da safofin hannu na likita. Daga cikin hanyoyin da aka lissafa a sama, ya fi kyau a yi amfani da numfashi maimakon abin rufe fuska na likita.
An amince da N95 don amfani a cikin masana'antu, amma FDA ta ba da izinin amfani da waɗannan masu numfashi bisa ga izinin gaggawa (EUA).
An tsara su don kare su daga ƙwayoyin iska kamar ƙura, amma ba a tabbatar da ingancin su daga wani takamaiman wakili na halitta ba idan aka yi amfani da su ba bisa ga umarni.
Idan ba a iya samun abin rufe fuska na likita ba, CDC ta ba da shawarar yin amfani da fuska mai kariya ko, a mafi ƙarancin hali, yin abin rufe fuska a gida.
A yawancin lokuta, yanayin COVID-19 ba shi da tsanani sosai don ya bukaci iska ta iska ko kuma wani zaɓi, amma akwai wasu lokuta da suka zama dole.
Ana nazarin nau'in tallafin numfashi ga marasa lafiya da ke asibiti da rashin numfashi da ke da alaƙa da COVID-19 a halin yanzu, tare da wasu shaidu don hana intubation ta hanyar hanci oxygen canyl tare da iska mai ƙarfi ko matsin lamba mai kyau na biyu a cikin hanyoyin numfashi.
Ba a san ko waɗannan hanyoyin guda biyu sun yi tasiri sosai a cikin marasa lafiya masu tsanani kamar yadda cutar ta HIV take yi ba.
Wasu likitoci suna zaɓar iska mai iska mai iska mai iska idan akwai, saboda wannan hanyar ta iyakance yaduwar ƙwayoyin cuta a cikin iska fiye da na hanci mai iska mai ƙarfi. Hadarin kamuwa da cutar mai tsanani ga tsofaffi (waɗanda suka wuce shekaru 60, musamman waɗanda suka wuce shekaru 80) ya fi girma.
Kasashe da yawa masu tasowa ba su da isashen asibitoci da za su kai mutane zuwa wani wuri, kuma tsarin kiwon lafiya ya zama da iyaka wajen magance karuwar yawan mutane da ke kamuwa da cutar COVID-19 da ke bukatar shiga asibiti.
Wani bincike da aka yi a ƙasar Sin ya nuna cewa kashi 5 cikin 100 na marasa lafiya sun shiga asibiti a wuraren da ake sa musu gaggawa, kashi 2.3 cikin 100 sun bukaci taimakon iska a cikin huhu, kuma kashi 1.4 cikin 100 sun mutu.
A kasar Sin, kusan kashi 30 cikin dari na mutanen da aka kwantar da su asibiti saboda COVID-19 sun shiga asibiti.
Yin amfani da iska ta iska a cikin huhu yana daɗa ƙalubale saboda cutar ta shan numfashi mai tsanani (ARDS) da ke tasowa a lokacin COVID-19, da kuma oxygenation suna haifar da ƙarin matsaloli.
Ana buƙatar iska mai ƙarfi da iska mai ƙarfi da PDCV don isar da iskar oxygen zuwa huhu da kuma samar da ƙaramin lalacewar iska wanda zai iya haifar da pneumothorax.
A cikin sababbin fan, ba za a iya samun ƙarfin ƙarfin ƙarfin iska mai ƙarfi ba.
An fara nazarin hanyoyin magance cutar a watan Janairun 2020, kuma a halin yanzu ana gwada wasu magungunan rigakafin cutar a asibiti.
Mafi kyawun sakamako shine remdesivir.
Ana iya ci gaba da samar da sababbin magunguna har zuwa 2021, amma wasu magungunan da ake gwadawa sun riga an amince da su don wasu dalilai ko kuma suna cikin gwajin gwaji.
Ana iya gwada magungunan rigakafin cutar a kan marasa lafiya da ke fama da irin wannan cuta.
Masu aikin sa kai da aka ba da shawarar a WHO suna shiga cikin gwajin inganci da aminci na hanyoyin magani. FDA ta ba da izini na wucin gadi don amfani da plasma na reconvalescence a matsayin magani na gwaji a lokacin da rayuwar mutum ke cikin haɗari mai tsanani ko kuma haɗari.
Ba a yi amfani da shi a asibiti ba, wanda ya kamata a yi don tabbatar da lafiyar da kuma ingancin magani.
A watan Fabrairun shekarar 2020, kasar Sin ta kaddamar da wani aikace-aikacen wayar hannu da aka yi amfani da shi wajen yaki da barkewar cutar.
Don shiga, dole ne mai amfani ya shigar da sunansa da lambar shaidar.
Aikace-aikacen zai iya gano 'ƙusurin' ta hanyar bayanan da aka yi amfani da su, don haka ya ƙayyade yiwuwar kamuwa da cutar.
Kowane mai amfani zai iya bincika matsayin wasu masu amfani uku.
Idan aka gano wani hadarin, ba wai kawai ana ba da shawarar yin zaman lafiya ba, amma ana kuma sanar da hukumomin kiwon lafiya na gida. Ana nazarin manyan bayanai da aka tattara daga wayoyin hannu, fasahar gano fuska, bin diddigin wayoyin hannu, da kuma fasaha ta wucin gadi  ana amfani da waɗannan kayan don bin diddigin mutanen da suka kamu da cutar da kuma mutanen da suka yi hulɗa da su a Koriya ta Kudu, Taiwan, da Singapore.
A watan Maris na shekarar 2020, gwamnatin Isra'ila ta ba da izinin jami'an tsaro su saka idanu kan bayanan wayar hannu na mutanen da ake zargin sun kamu da cutar coronavirus.
An dauki matakan tabbatar da killacewa da kariya ga mutanen da za su iya yin hulɗa da 'yan ƙasa da suka kamu da cutar.
A watan Maris na shekarar 2020, Deutsche Telekom ta ba da bayanan da aka tattara game da inda masu biyan kuɗi suke a watan Maris na 2020 don bincike da hana yaduwar cutar.
A Rasha, an gabatar da fasahar gane fuska don gano masu karya dokar.
Kwamishinan lafiya na Italiya, Giulio Galler, ya ce, masu amfani da wayoyin salula na duniya sun ce kashi 40 cikin dari na mutane suna ci gaba da tafiya a fadin ƙasar.
Gwamnatin Jamus ta gudanar da wani shiri na tsawon sa'o'i 48 na shirye-shirye a karshen mako, wanda ya kai fiye da mutane dubu 42.
Shugaban Estonia, Kersti Kallyolid, ta yi kira ga mutane su nemi hanyoyin magance yaduwar cutar coronavirus.
Mutane za su iya fuskantar damuwa saboda yin zaman rigakafi, ƙuntatawa a kan tafiya, sakamako na magani ko kuma tsoron kamuwa da cuta.
BBC ta nakalto Rory O'Connor: "Halin da ake ciki na zaman zaman lafiya, kadaici, damuwa game da lafiyar mutum, damuwa da kuma koma bayan tattalin arziki, yanayi ne mai kyau don cutar da lafiyar mutum da kuma lafiyar mutum".
Cutar tana iya faruwa a cikin sauƙi, tare da ƙananan alamun bayyanar cututtuka ko kuma babu alamun bayyanar cututtuka kamar sauran cututtukan iska na sama, kamar sanyi na yau da kullum.
A yawancin lokatai, marasa lafiya da ke da sauƙi suna warkewa cikin makonni biyu, yayin da a cikin marasa lafiya masu tsanani ko masu tsanani, yana iya ɗaukar makonni uku zuwa shida don magani.
Mata masu ciki na iya samun haɗarin kamuwa da COVID-19 mai tsanani bisa ga bayanai game da wasu irin ƙwayoyin cuta kamar SARS da MERS, ko da yake babu irin wannan bayanan game da COVID-19. A wasu mutane COVID-19 na iya cutar da huhu kuma ya haifar da ciwon huhu a matsayin rikitarwa.
A cikin mutanen da suka fi fama da cutar COVID-19, za a iya samun ci gaba da sauri zuwa cututtukan numfashi mai tsanani (ARDS), wanda ke haifar da rashin numfashi, tsokanar ƙwaƙwalwa ko rashin ƙarfi.
Abubuwan da ke tattare da COVID-19 sun haɗa da cutar sepsis, ɓarnar jini, da kuma matsalolin zuciya, koda da hanta.
An bayyana rashin daidaitaccen jini, musamman ƙara lokaci na prothrombin, a cikin kashi 6% na marasa lafiya da aka kwantar da su daga COVID-19, yayin da rashin aikin koda ya bayyana a cikin kashi 4% na wannan rukuni.
Kimanin kashi 20 30% na marasa lafiya da ke fama da cutar COVID-19 sun sami ingantaccen ƙwayar cutar hanta (transaminases).
A cewar wannan rahoton, matsakaicin lokacin da aka yi a tsakanin bayyanar cututtuka da mutuwa ya kai kwanaki goma, biyar daga cikinsu a asibiti.
Amma, matsakaicin lokacin da aka yi wa marasa lafiya da aka kai asibiti zuwa cibiyar kula da marasa lafiya da ke ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci gaba da ci.
A cewar bincike na farko, matsakaicin lokaci daga bayyanar cututtuka na farko zuwa ranar mutuwa ya kai kwanaki 14 tare da cikakken lokaci daga kwanaki shida zuwa 41.
Wani bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta yi ya nuna cewa mata sun mutu da kashi 2.8 cikin dari a tsakanin maza, amma mata sun mutu da kashi 1.7 cikin dari.
Binciken da aka yi game da cutar a cikin huhu bayan mutuwa ya nuna cewa an sami cutar alveolar da ke da ƙwayoyin cuta a cikin huhu biyu.
An lura da canje-canje na cututtukan huhu.
Fushinsa ya yi kama da na wani mai shan numfashi mai tsanani .
A cikin kashi 11.8 cikin 100 na mutuwar da Hukumar Lafiya ta Kasa ta kasar Sin ta yi, an samu ciwon zuciya da ya kai kashi 11 cikin 100 na yawan mutanen da suka mutu.
A cewar wani bincike da Amurka ta yi a watan Maris, kashi 89 cikin 100 na marasa lafiya da aka kwantar a asibiti sun riga sun sha wahala daga rashin lafiya.
Yawan mutuwar da ake samu a cikin yanayin ya bambanta saboda irin wannan bambancin yanki, da kuma saboda wahalar da ake samu ta hanyar yin hakan.
Idan ba a ƙidaya yawan mutane yadda ya kamata ba, hakan zai iya jawo ƙarin mutuwa.
Amma, mutuwar da aka samu daga cututtuka na dā na iya nufin cewa an yi kasa da yawan mutuwar da ake yi a yanzu.
Masu shan sigari suna da alamun COVID-19 masu tsanani sau 1.4 a gaba ɗaya, kuma waɗannan marasa lafiya sun bukaci magani mai tsanani sau 2.4 sau da yawa fiye da waɗanda ba sa shan sigari.
Wata asibitin Hong Kong ta gano cewa wasu marasa lafiya da suka warke daga cutar sun rage yawan huhu da kashi 20 zuwa 30 cikin ɗari, kuma an gano cewa sun lalace.
Idan ka warke, za ka iya samun ciwon daji.
A watan Maris na shekarar 2020, ba a san ko marasa lafiya da suka warke daga cutar suna da rigakafin rigakafi ba.
Idan aka yi la'akari da yadda sauran cututtukan coronavirus ke gudana, ana ganin hakan zai yiwu, amma an kuma yi rahoton cewa, bayan an warke daga COVID-19, gwajin gwajin cutar ya kasance mai kyau.
An yi imanin cewa a waɗannan lokutan, cutar ta yi tsanani fiye da yadda ta sake kamuwa da ita.
Ana ganin cewa kwayar halitta ce, dabba ce kuma cuta ce mai kamuwa da ita.
Ba a san ainihin asalin cutar ba, amma a watan Disamba na 2019, yaduwar kamuwa da cuta kusan gaba ɗaya ta hanyar watsa ta daga mutum zuwa mutum.
Binciken farko na mutane 41 da aka tabbatar da COVID-19, wanda aka buga a cikin The Lancet a watan Janairun 2020, ya kira ranar 1 ga Disamba, 2019 farkon ranar da aka fara samun cutar.
A cewar wani rahoto na WHO, ranar 8 ga watan Disamba ne.
Ana amfani da hanyoyi da yawa don tantance yawan mutuwa.
Dukkanin lambobi sun bambanta dangane da yankin da lokacin da cutar ta yadu, kuma suna shafar yawan gwajin, ingancin tsarin kiwon lafiya, tsarin kula da da aka yi amfani da su, lokacin da cutar ta fara, da kuma al'amuran yawan jama'a kamar shekaru, jinsi da kuma lafiyar jama'a.
A ƙarshen 2019, WHO ta ba da lambar gaggawa ta ICB-10 ga cutar: U07.1  don mutuwar daga kwayar cutar SARS-CoV-2 da aka tabbatar da gwaji da kuma U07.2  don mutuwar COVID-19 da aka gano ta hanyar asibiti ko cututtuka ba tare da tabbacin kwayar cutar SARS-CoV-2 ba.
A cewar kididdigar Jami'ar Johns Hopkins, a ranar 17 ga Afrilu, 2020, adadin mutuwar duniya da cututtukan kamuwa da cuta ya kai kashi 6.9% (153 822/2 240 191).
Wasu hanyoyin sun haɗa da ƙayyade yawan mutuwar sakamakon cutar (CFR), wanda ke nuna yawan marasa lafiya da aka gano sun mutu saboda cutar, da kuma ƙayyade yawan mutuwar sakamakon kamuwa da cuta (IFR), wanda ke nuna yawan marasa lafiya da suka kamu (duka waɗanda aka gano da waɗanda ba a gano ba) da suka mutu saboda cutar.
Wannan ƙididdigar ba ta da wani lokaci na musamman kuma tana nuna yawan mutanen da suka kamu da cutar daga lokacin da suka kamu da cutar har zuwa lokacin da suka kamu da cutar.
Ko da yake ba dukan marasa lafiya da suka kamu da cutar suke yin maganin rigakafi ba, idan akwai maganin rigakafi, za ka iya sanin yawan mutanen da suka kamu da cutar.
A tsakiyar annobar a Italiya, Castillone d'Adda, karamar ƙauye ce da ke da mazauna 4,600, mutane 80 (1.7%) ba su da rai.
A garin Gangelt, cutar ta bazu yayin bikin karnaval tsakanin matasa, yana haifar da ƙananan mutuwar, kuma ba duk mutuwar COVID-19 za a iya rarraba su a matsayin haka ba.
Ƙari ga haka, ba a cika kula da lafiyar Jamus ba.
A cikin Netherlands, kusan kashi 3 cikin 100 na yawan jama'a na iya samun rigakafi, bisa ga ƙididdigar jini na mai bayarwa.
COVID-19  sanannen sanadin mutuwar mutum 69 (0,004% na yawan jama'a).
Matsayin da cutar ke shafan mutane da kuma mutuwar mutane sun bambanta ga maza da mata.
Wani bincike da aka yi a ƙasar Sin da Italiya ya nuna cewa maza ne suka fi mutuwa.
Ƙungiyoyin da suka fi fuskantar haɗari  su ne maza da suka fi shekara 50; bambanci tsakanin maza da mata yana raguwa ne kawai daga shekara 90.
A kasar Sin, yawan mutuwar mata ya kai kashi 2.8 cikin dari na maza da kuma kashi 1.7 cikin dari na mata.
Ba a san ainihin dalilin wannan bambancin ba, amma zai iya kasancewa a cikin abubuwan da suka shafi al'ada da kuma hali.
Bambancin rigakafin jima'i, ƙarancin yawan shan sigari a cikin mata, cututtukan da ke tattare da maza (misali, hawan jini da ke faruwa a cikin maza a ƙarami fiye da mata) na iya haifar da ƙarin mutuwar maza.
A Turai, maza ne suka kai kashi 57 cikin 100 na wadanda suka kamu da cutar, kuma maza ne suka kai kashi 72 cikin 100 na wadanda suka mutu sakamakon COVID-19.
A watan Afrilu na shekarar 2020, gwamnatin Amurka ba ta gudanar da kididdigar jinsi game da COVID-19 ba.
Bincike na kimiyya ya nuna cewa cututtuka na kwayar cuta kamar Ebola, HIV, mura, da HIV suna da ƙididdiga daban-daban na jinsi.
Yawancin ma'aikatan kiwon lafiya, musamman ma ma'aikatan jinya, mata ne, kuma hakan ya sa suna da mafi yawan haɗarin kamuwa da cutar.
A ranar 11 ga Fabrairu, 2020, Hukumar Lafiya ta Duniya ta sanar da sunan cutar  COVID-19.
Shugaban WHO, Mista Tedros Adhanom Gebreissus, ya bayyana cewa: CO yana nufin korona, VI  virus, D  cuta (disease), kuma shekara 19  lokacin da aka fara gano cutar: 31 ga Disamba, 2019.
An zaɓi wannan sunan don kauce wa yin magana game da wani wuri na musamman (misali China), nau'in dabbobi, ko rukuni na mutane, kamar yadda shawarwarin duniya game da suna ke buƙata don hana lalata.
A cikin sakonnin jama'a, WHO ta yi amfani da kalmomin virus COVID-19 da virus wanda ke da alhakin COVID-19.
Ana kiran cutar da cutar kanta "Coronavirus".
A lokacin da cutar ta fara barkewa a Wuhan, China, ana kiran cutar da cutar coronavirus da uhank coronavirus.
A watan Janairun 2020, bisa ga shawarwarin 2015 game da amfani da wurare na ƙasa a cikin sunayen cututtuka da ƙwayoyin cuta, WHO ta ba da shawarar yin amfani da kalmomin accented respiratory disease 2019-nCov da 2019-nCoV a matsayin sunayen lokaci na cutar da cutar.
A ranar 11 ga Fabrairu, 2020, an buga sunayen hukuma na  COVID-19 da SARS-CoV-2.
Saboda ƙuntatawa a kan yawan hanyoyin samar da kayayyaki, wasu masu samar da sabis na dijital suna buga kayan likita kamar tampons don ɗaukar hanci, da kuma kayan aikin IOL.
A wani irin wannan yanayin, asibitin Italiya yana bukatar kwandishan da gaggawa, kuma mai ba da sabis bai iya kawo shi cikin lokaci ba, saboda haka an sake yin amfani da wani masana'antu na gida don buga kwandishan 100 a dare.
Bayan barkewar cutar COVID-19, an fara samun zurfin yada ka'idojin da ba daidai ba game da asalin cutar, yadda ta ke yaduwa, yadda za a hana ta, yadda za a bi da ita da sauran fannoni.
Wataƙila mutane za su iya kamuwa da cutar ga wasu dabbobi.
Binciken bai tabbatar da cewa cutar ta yadu a cikin aladu, ducks da kaji ba.
A yanzu haka babu allurar rigakafi da aka amince da ita ko kuma magani don magance cutar.
A halin yanzu kungiyoyin gwamnati, kungiyoyin ilimi da masu bincike a fannin suna gudanar da bincike na kasa da kasa kan alluran rigakafi da magunguna na COVID-19.
A watan Maris, WHO ta kaddamar da shirin SOLIDARITY Trial (TSARO NA SAURARA) wanda ke nufin tantance tasirin maganin abubuwa huɗu da aka fi ɗauka a yau.
Babu riga-kafin da aka shirya, amma ƙungiyoyi daban-daban suna aiki sosai don samar da magungunan da za su iya yin allurar.
SARS-CoV da SARS-CoV-2 suna shiga cikin ƙwayoyin mutum ta hanyar mai karɓar ACE2, saboda haka ana amfani da binciken da aka yi a baya game da SARS-CoV a cikin binciken kimiyya.
Akwai dabarun yin allurar rigakafi guda uku.
Na farko, masu bincike suna neman yin allurar rigakafi.
Yin amfani da irin wannan kwayar cutar, ko ta zama mara aiki ko ta mutu, yana nufin saurin amsawar rigakafin jikin mutum ga sabon kamuwa da COVID-19.
Hanyar ta biyu, wato, yin allurar rigakafi, tana nufin yin allurar da za ta sa tsarin garkuwar mutum ya kasance da ƙoshin lafiya ga wasu ƙananan kwayoyin cutar.
A cikin SARS-CoV-2, irin wannan binciken ya yi niyya ne don lalata furotin mai kama da S, wanda ke taimaka wa kwayar cutar ta shiga cikin mai karɓar kwayar halitta ta ACE2.
Hanyar ta uku ita ce samar da alluran rigakafi bisa tushen nucleic acid (DNA ko RNA- alluran rigakafi, sabuwar hanyar yin allurar rigakafi).
Ana buƙatar gwada alluran gwaji da aka tsara ta kowane ɗayan waɗannan dabarun don aminci da inganci. A ranar 16 ga Maris, 2020, an fara gwajin asibiti na farko na allurar a kan masu sa kai huɗu a Seattle.
An bayyana cewa an yi amfani da maganin rigakafi don yin maganin SARS-COV-2 amma an yi jayayya game da wannan.
A watan Afrilu na shekarar 2020, an gudanar da gwajin asibiti sama da 300.
An gwada magunguna bakwai da aka amince da su don magance zazzabin cizon sauro, kuma hudu daga cikinsu sun yi amfani da su don maganin hydroxychloroquine ko chlorophyll.
Ana yin nazarin maganin rigakafin cutar a yawancin binciken da aka yi a kasar Sin; a ƙarshen Afrilu, an gudanar da bincike tara na III a cikin ƙasashe da yawa.
A watan Afrilu na shekarar 2020, an yi nazarin nazarin ci gaban asibiti na alluran rigakafi da magungunan neman magani don magance COVID-19. Don wannan dalili, ana kuma bincika wasu magungunan riga-kafi na yanzu don magance COVID-19, gami da remdesivir, chlorine da hydroxychloroquine, lopinavir / ritonavir, da lopinavir / ritonavir a hade tare da interferon beta.
A watan Maris na shekarar 2020, akwai bayanan farko game da yadda ake amfani da remdesivir.
An samu ci gaba a asibiti a cikin marasa lafiya da aka yi amfani da remdesivir a matsayin banda.
A cikin gwaji na III, an riga an gudanar da gwaji a Amurka, China, da Italiya. An yi nazari a China a watan Fabrairun 2020, kuma an samu sakamako na farko.
Duk da haka, ana bukatar a yi bincike sosai.
Hukumomin kiwon lafiya na Koriya da na kasar Sin sun ba da shawarar yin amfani da chlorine.
Cibiyar Kwayar cutar Wuhan ta ba da shawarar yin amfani da gram guda a kowace rana, amma ta ce sau biyu yana da haɗari sosai kuma yana iya haifar da mutuwa.
A ranar 28 ga Maris, 2020, FDA ta ba da izinin gaggawa don amfani da hydroxychloroquine da chlorine a kan shawarar likitoci da ke kula da marasa lafiya da COVID-19.
Bayanai na farko sun nuna cewa ana bukatar karin rigakafin ribavirin don hana SARS-CoV-2 a cikin in vitro.
An ba da shawarar yin nazarin nitasoxanide a cikin in vivo, yana nuna hana SARS-CoV-2 a ƙananan taro. Bincike ya nuna cewa don shiga SARS-CoV-2 ta hanyar hulɗa da mai karɓar ACE2 yana buƙatar daidaita ƙwayoyin cuta na transmembrane protease serine 2 (TMPRSS2).
Binciken amfani da chlorine da hydroxychloroquine tare da azithromycin ko ba tare da shi ba yana da ƙuntatawa mai tsanani wanda ke hana ƙungiyar likitanci yin amfani da waɗannan hanyoyin magani ba tare da ƙarin bincike ba. Ozeltavir ba ya hana SARS-CoV-2 in vitro, kuma rawar da yake takawa a cikin maganin COVID-19.
Za a iya samun hypercytoquinemia a matsayin rikitarwa a ƙarshen COVID-19.
Akwai tabbaci cewa hydroxychloroquine na iya kasancewa mai ƙarancin ƙwayar cuta. A sakamakon wani karamin bincike da Hukumar Lafiya ta Kasa ta kasar Sin ta yi, an haɗa tocilizumab a cikin shawarwarin maganin coronavirus.
Wannan magani ya fito ne daga gwajin gwaji na biyu na ƙasa a Italiya bayan an sami sakamako mai kyau ga marasa lafiya da ke fama da mummunan cutar.
Idan aka haɗa shi da nazarin jini na ferritin don gano hadari na cytokine, ana amfani da shi don magance abubuwan da ake ganin suna kashe wasu marasa lafiya.
A cikin 2017, FDA ta amince da antagonist na interleukin-6 mai karɓar karɓa bisa ga binciken da aka yi a baya don magance cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan cututtukan
Har zuwa yau, babu wata hujja ta bazuwar da za a iya sarrafawa da ta nuna cewa tocilizumab yana da tasiri wajen magance cututtukan fitowar cytokine.
A halin yanzu ana ganin ba da maganin rigakafi mai tsaftacewa da kuma na musamman da tsarin rigakafin mutum ke samarwa ga marasa lafiya da suka warke daga COVID-19 ga mutanen da suke bukatar su a matsayin hanyar da ba a yi wa allurar rigakafi ba.
An gwada wannan dabarar wajen kula da marasa lafiya da ke fama da cutar SARS, amma sakamakon bai tabbata ba.
Kashewar cutar  sakamako ne da ake tsammani wanda maganin hana jiki zai iya kare mutum daga SARS-CoV-2.
Duk da haka, ana iya amfani da wasu hanyoyin, kamar su cytotoxicity na ƙwayoyin halitta da / ko phagocytosis.
Ana ci gaba da yin wasu nau'o'in maganin hana jiki, kamar yin amfani da kwayoyin cutar monoclonal.
Ana iya ƙara yawan amfani da jini mai ɗauke da jini, wanda ya ƙunshi jini mai ɗauke da jini daga marasa lafiya da suka warke kuma yana ɗauke da maganin rigakafin cutar.
Cutar coronavirus, wata ƙungiya ta rashin daidaito
Li Wenlian, likitan asibitin Wuhan, wanda daga baya ya kamu da cutar kuma ya mutu daga COVID-19 bayan ya ba da rahoton yaduwar cutar.
